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Abstract
Motivation: A rapid technological development in the biosciences and in computer science has made
it possible to analyse high-dimensional biological datasets, containing measurements for entire genomes,
transcriptomes and proteomes, on standard desktop computers. New experimental and computational tech-
nologies provide ample opportunities to improve our basic understanding of biological systems and develop
better methods for the monitoring, diagnosis and treatment of genetic diseases. However, common prop-
erties of the new high-throughput experimental data, like small sample sizes in relation to the number of
features, high noise levels and outliers, also pose novel challenges.
Goal: Ensemble and consensus machine learning techniques and data integration methods can address
some of these issues, but they often provide very complex models of the system of interest, which lack
interpretability and overfit the data. The goal behind this thesis was therefore to develop new approaches
to combine algorithms and large-scale biological datasets, including novel approaches to integrate analy-
sis types from different domains (e.g. statistics, topological network analysis, machine learning and text
mining), which are designed not only to exploit the diverse information content in the data sources and
the strength of different algorithms, but to provide compact and interpretable models, which enable the
extraction of new biological knowledge.
Approach: As the main contribution of this thesis, a novel framework and software collection for inte-
grative analysis of gene expression data, gene/protein sets, cellular pathway and protein interaction data
was developed and applied to real-world biological datasets from collaborating institutions, focussing on
problems in cancer biology.
The framework takes advantage of cross-study normalisation and cross-domain data fusion methods, and
enables both the comparison and modular combination of algorithms for different statistical learning tasks
(feature selection, classification and clustering). Ensemble and consensus analysis techniques employed
for this purpose are re-designed such that the model generation does not only seek to maximise predictive
accuracy and model robustness, but also to create compact and interpretable models. More importantly,
novel integrative analysis techniques have been developed, which combine algorithmic techniques from
different domains (machine learning, network topological analysis, literature mining and optimisation) and
use information from multiple data sources (gene expression data, protein interactions, cellular pathway
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definitions and gene/protein sets).
Main results: The key deliverables of the doctoral project are new ensemble, consensus and cross-domain
bioinformatics algorithms, and new analysis pipelines combining these and classical data mining techniques
within a general framework. This framework contains methods for the integrative analysis of both large-
scale gene and protein expression data (including the tools ArrayMining, Top-scoring pathway pairs and
RNAnalyze) and general gene and protein sets (including the tools TopoGSA, EnrichNet and PathExpand).
Among the biological findings obtained with these new software tools, a central result was the identification
of a novel tumour marker gene in collaboration with the Nottingham Queens Medical Centre, facilitating
the distinction between two clinically important breast cancer subtypes (framework tool: ArrayMining).
Other biomedically relevant findings resulted from a co-operation with the Spanish National Cancer Centre,
predicting novel candidate disease genes for Alzheimer’s disease and pancreatic cancer using an integrative
analysis combining cellular pathway definitions and protein interaction data (framework tool: PathExpand).
Moreover, associations between disease-related processes, including the verification of functional associ-
ations between prostate cancer development and different cellular processes, were identified using a new
rule-based classification method integrating gene expression and cellular pathway data (framework tool:
Top-scoring pathway pairs).
Apart from these results obtained from data fusion techniques, new insights were also gained from the com-
bination of diverse analysis techniques, as illustrated by a combined microarray gene selection and network
topological analysis, which identified genes that are differentially expressed in different cancers and have
outstanding topological properties when being mapped to a molecular interaction network (framework tool:
TopoGSA). Finally, new techniques for interactive visualisation and exploration of functional associations
in biological data facilitated the interpretation of different real-world datasets, with successful applications
in agriculture (analysis of gene regulation in a plant model organism) and biomedicine (analysis of cancer
gene expression data; framework tool: VRMLGen).
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Chapter 1
Introduction
Chapter abstract
This introductory chapter will provide a bird’s eye view of the goals behind the thesis and
the data sources and methods used to achieve them. It will delineate the scope of the project
and discuss in general terms how the work compares to and departs from previous biological
data analysis and integration approaches. Finally, it will guide the reader through the different
sections of the thesis and present a summary of the main results.
1.1 Background and Motivation
The spread of high-throughput technologies in the biosciences in recent years, including high-throughput
sequencing methods, DNA and protein microarrays, has led to an exponential increase of public biolog-
ical databases. The large amount of freely available data has raised hopes that researchers will in the
long run be able to obtain a more holistic understanding of the molecular mechanisms in living cells by
analysing complete gene-, protein- and metabolite networks, instead of considering their individual com-
ponents separately. However, although the data from high-throughput experiments offers new opportunities
for the biosciences, at the same time a multitude of new challenges arise from its typical characteristics:
Large numbers of features in relation to small numbers of samples pose several problems in the statistical
analysis, which have been extensively discussed in the literature under the headings “curse of dimension-
ality” [1], “multiple testing” [2, 3] and “feature redundancy and dependence” [4, 5]. Moreover, with regard
to a specific biological question of interest, the majority of features in a dataset might be irrelevant, hence,
extracting only the informative sub-structures can be akin to finding the proverbial needle in a haystack.
Additionally, single measurements within high-throughput experimental methods are often affected by dif-
ferent types of noise, providing the experimenter only with scaled and shifted versions of the original signals
and with outliers both among the samples and features. Apart from these problems affecting the statistical
analysis and evaluation, various computational difficulties arise commonly, spanning from general issues
concerning runtime complexity and memory management to data access efficiency problems in database
and web-server applications.
In summary, the most prevalent problems and research questions that have emerged in the field of high-
dimensional biological data analysis and which are addressed in this PhD are the following:
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• “Curse of dimensionality” problem: How can robust clustering or supervised prediction results be
attained for small sample-size datasets in which the number of features is by two orders of magni-
tude larger than the number of samples (in particular, in the case of an approximately uniform data
distribution [6])?
• Noise problem: How can genes, proteins or metabolites that are significantly differentially regulated
across different biological conditions be reliably identified, if the expression values of a large pro-
portion of genes/proteins/metabolites are masked or dominated by noise (with both technical and
biological sources of noise)?
• Multiple testing problem: How can spurious rejections of a null-hypothesis be avoided effectively by
reducing the dimensionality of the input data are or adjusting hypothesis tests to account for repeated
hypothesis testing?
• Evaluation problem: Given that evaluation methods to estimate the generalization error of machine
learning models tend to have limitations either in accurately estimating the variance or the bias on
microarray datasets with small sample size [7], how should a reliable validation pipeline be built?
• Methodological problem and “no-free-lunch” problem: Do any “methods of choice” exist for mi-
croarray data analysis, or which algorithms should be compared or combined to solve a specific
analysis problem efficiently and effectively? If several methods have been shown to have different
strengths and weaknesses on different datasets (e.g. datasets for different cancer types), how can a
robust analysis system be built, attaining a high performance across many diverse datasets?
In order to address these statistical and computational challenges in the analysis of high-dimensional data,
several new algorithms and data structures, tailored to specific analysis problems and experimental plat-
forms, have been developed in recent years. However, using methods optimised for a single data source
type does often not suffice to exploit the information content of multiple available datasets from diverse
platforms and biological domains, or to reach the model accuracy and significance that might be obtained
from combining the benefits of multiple search methodologies, scoring functions or data structures.
In many areas of computer science and biology, integrative analysis methods, which combine different data
sets and/or algorithms, have not only been shown to effectively increase robustness and accuracy of an anal-
ysis but are often essential requirements to verify a given biological hypothesis, to obtain sufficiently robust
prediction models or to solve a computational problem in a given time-frame. For example, in several appli-
cations of statistics and machine learning, ensemble and consensus approaches, which exploit the synergies
of diverse algorithms for the same problem type, provide significant improvements in terms of robustness
and accuracy on large-scale datasets with high noise levels [8–13]. Similarly, at the data collection and pre-
processing level, cross-study normalisation and data fusion techniques have been employed successfully to
obtain more stable prediction models or clustering results [14–16]. However, especially the application of
ensemble techniques, and in some cases also data integration methods, often tends to generate very com-
plex biological models, lacking interpretability and sometimes even overfitting the data. Cross-platform
normalisation methods often result in a significant loss of information due to the normalisation process,
and the quality of the outcome highly depends on the size of the intersection set between the features of
the considered input datasets [17]. Thus, the above list of problems to be addressed in high-dimensional
biological data analysis has to be extended by the following challenges in integrative data analysis:
• Cross-platform data integration problem: How can data sets obtained with different experimental
platforms (for the same cell types and phenotypes) be combined, if the overlap in the measured
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Figure 1.1: Overview of data and analysis types combined as part of integrative methods developed in this thesis to
obtain a better understanding of biological processes of interest
features (e.g. genetic probes on DNA chips) is small and the experiments are affected by different
systematic biases?
• General data integration problem: How can gene/protein expression data and other biological data
sources, e.g. molecular interaction, genomic, epigenetic and metabolic data, be combined to obtain
new insights or improve accuracy and robustness, while retaining a high level of interpretability?
These challenges and the previously mentioned problems in large-scale biological data analysis provide the
primary motivation for this thesis to investigate the potential of new integrative analysis techniques to obtain
improvements in terms of classical performance criteria (e.g. prediction accuracy, adjusted rand index in
clustering, model robustness), but at the same time also in terms of model interpretability and biological
insights gained. Moreover, as the main contribution of this thesis, new cross-domain analysis methods will
be presented, which combine both diverse data sources (gene/protein expression data, gene/protein set data,
protein interaction data and cellular pathway data) and analysis types (statistics, network analysis, machine
learning, literature mining). These novel integrative analysis techniques have been presented in dedicated
publications and are discussed in separate chapters of this thesis. Figure 1.1 provides a general overview of
the data and algorithm types considered as part of integrative biological analysis methods in this thesis.
Molecular networks are shown as the central data type in this figure, because their common representation
as graphs with nodes (corresponding to molecules) and edges (corresponding to molecular interactions)
provides a suitable data structure to map other data sources onto a single graph-based model (with nodes
corresponding to molecules and edges to associations). The other input data sources considered here, con-
sisting of large-scale functional genomics data (e.g. gene/protein expression datasets), and clinical records
and literature data, are typically only analysed by highly specialised algorithms. However, synergistic ef-
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fects cannot only be attained by investigating multiple input data sources independently, with different
dedicated analysis methods, and only interpreting their outputs together, but also by combining the analysis
techniques directly, either in a modular fashion or by integrating them into new algorithms operating on a
unified data structure for all biological inputs. Achieving these synergistic effects, while at the same time
retaining a high level of model interpretability and facilitating the extraction of new biological knowledge,
is the primary goal for this thesis. Details on the more specific objectives and the novel approaches to
achieve them will be provided in the following sections.
1.2 Aims and Scope
The current limitations in the statistical power and interpretability of computational models built from
high-dimensional biological data (see Background and Motivation section), motivate the main objective
behind the research conducted for this thesis: Improving the statistical analysis of these datasets in terms of
accuracy, robustness and interpretability by developing new integrative techniques to exploit the synergies
of diverse data sources, algorithms and data structures.
The methods developed for this purpose will mainly be applied to the study of microarray gene expres-
sion data, representing a prime example for the opportunities and challenges arising when analysing high-
dimensional and noisy real-world data. Moreover, for the study of microarray data a multitude of datasets
and algorithms are already publicly available, providing enough material for the comparison and combina-
tion of datasets and algorithms within the analysis framework proposed in this thesis. In spite of this focus
on a particular data type, most of the approaches presented here are equally applicable to protein expression
data and other functional genomics data sources, and one chapter of this thesis will therefore be dedicated
to the more general analysis of gene and protein lists obtained from any type of biological experiment (see
chapter 6).
Similarly, the biological applications of the framework will focus on a specific range of problems, mostly
associated with cancer biology, but examples for other biological problem types will be given to highlight
the wide range of further potential applications. The choice of this biological focus is motivated by the
expectation that due to the characteristics of complex genetic disorders and cancer diseases, which often
depend on multiple genetic and epigenetic influences, the analysis of this data is particularly likely to
benefit from integrative methods (see chapter 2 for details about the biological background and motivation
behind this dissertation). Thus, the biological scope of the thesis is limited to biomedically relevant and
representative example applications of the proposed integrative analysis methods, but at the same time
seeks to provide researchers in related scientific fields with sufficient information to transfer methodological
guidelines to their specific area of research.
Moreover, since the current restraints in the analysis of microarray gene expression data and similar large-
scale data sources, which are addressed in this thesis, have already been tackled by previous methods, these
will be discussed in detail in a literature survey as part of this thesis (see chapter 3). Due to the large
number of published analysis techniques, especially for the study of microarray gene expression data, this
survey will focus on state-of-the-art methods tailored to classical machine learning tasks (feature selection,
prediction and clustering) and on previous integrative analysis approaches combining data from multiple
biological sources (e.g. cellular pathway, molecular interaction and gene/protein expression data). These
existing approaches from the literature already address several common problems in the analysis of high-
dimensional biological data, but still have several limitations in terms of interpretability, robustness and
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applicability to a wide range of platforms. Therefore, the main goals and characteristics of the integra-
tive approach presented here, which differ from previous analysis and data integration systems, have been
chosen as follows:
• Methods are presented to combine algorithms and data types from diverse domains, in addition to
employing cross-study normalisation methods to combine datasets of the same type, and ensem-
ble/consensus methods to combine algorithms for the same problem
• Novelmodular combinations of previously published approaches interconnect both single algorithms
for specific analysis types and corresponding ensemble/consensus methods
• Different algorithms and different datasets are integrated in a unified approach, rather than consid-
ering data fusion methods and ensemble/consensus approaches separately. In this context, unified
means that instead of combining already existing analysis techniques based on diverse datasets in
a modular or sequential fashion, new methods are developed that operate directly on all input data
sources by exploiting different data representations, search methodologies and scoring functions com-
bined in a single algorithm.
• Instead of focussing only on maximising accuracy and robustness, the methods are designed to create
compact and human-interpretable models (maximising interpretability and accuracy/robustness at
the same time)
• Wherever possible, data analysis and parameter selection tasks are automated in order to provide
non-expert users with a simple way to access and configure the methods within the framework and
combine them to a valid statistical analysis pipeline (in most cases using an installation-free, operating
system independent and web-based interface)
• Interactive means to explore the data and statistical results from analysis, including navigable low-
dimensional data visualisations and sortable tables with dynamic and expandable content, are embed-
ded into the implementation of the framework
The last three aspects, which are all related to model interpretability, knowledge management and ease-of-
use, are realized by integrating automatic parameter selection methods, visualisation methods and various
approaches for enhancing model interpretability into the framework. These include automatic dimension-
ality reduction and feature selection methods, automatic model parameter selection using penalty terms for
model complexity, and novel self-devised rule-based classification methods generating small sets of deci-
sion rules. Moreover, automatic methods to handle class imbalances among the samples and redundancy
among the input features, and an automatic analysis of the statistical properties of features in ensemble
methods are part of the framework.
In addition to these functions and features provided for single analysis modules addressing a specific anal-
ysis type (gene selection, clustering, prediction, gene set analysis, etc.), different analysis types are also
linked together within the framework, providing multiple possibilities to forward the output from one anal-
ysis module to another. Correspondingly, to increase the impact and extend the framework’s range of
applications, its modules can also exchange data with external web-services, including the “Gene Cards”
web-server by the Weizmann Institute of Science and the “Gene Expression Omnibus” (GEO) data repos-
itory by the National Center for Biotechnology Information (NCBI). A further benefit of adopting a very
modular approach is that, although it requires more time for the initial implementation, it will facilitate
extensions of the framework in the future.
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In summary, the two main motivations behind this thesis are to exploit the synergies of different infor-
mation sources, both from the biological input data and from information extracted by different analysis
methods combined to an ensemble or consensus, and to enhance the interpretability of the resulting models.
Throughout the thesis, the methods employed to achieve these general objectives will not only be applied
on classical benchmark datasets for performance evaluation but also on novel real-world datasets to solve
specific biological problems, analysed in collaboration with external research groups.
1.3 Thesis Organisation
This thesis will first provide the reader with a background on data mining methods for high-dimensional bi-
ological datasets and some of their most important biological applications, and then present new integrative
analysis methods and techniques to increase model interpretability. Therefore, the dissertation is grouped
into the following chapters (excluding this introductory chapter):
Chapter 2 describes the biological background for this dissertation and the main applications for the bioin-
formatics methods developed as part of the PhD. It will present some of the main analysis tasks in
the study of genetic disorders and cancer diseases, and then explain why there is a need for novel
integrative “Systems Biology” approaches. The specific challenges that have to be addressed will be
discussed, as well as the opportunities that integrative approaches provide for improvements.
Chapter 3 contains a literature review about current methods for (low-level) pre-processing and normali-
sation and (high-level) computational analysis of high-dimensional biological data, with a focus on
integrative analysis techniques, including ensemble, consensus and cross-domain analysis methods.
In this context, microarray gene expression data will be discussed in particular detail as a prime
example for noisy, high-throughput experimental data. The review will start with an overview of
classical machine learning analysis approaches (feature selection, classification and clustering) and
then present extensions obtained by employing ensemble, consensus and data integration methods.
Chapter 4 contains a comparative evaluation of algorithms for the classical machine learning tasks feature
selection, prediction and clustering on high-dimensional microarray gene expression data. Three
different types of algorithms are considered in this comparison: a) single algorithm based classical
machine learning methods (e.g. support vector machines for classification), b) ensemble classification
and consensus clustering methods, and c) integrative methods using cellular pathway data in addition
to the microarray data.
Chapter 5 discusses the main component of the integrative data analysis framework developed in the PhD
project: The ArrayMining.net [18] tool set and web-application for microarray data analysis, con-
sisting of six analysis modules for Gene Selection (feature selection), Class Discovery (clustering),
Class Assignment (prediction), Gene Set Analysis, Co-Expression Network Analysis and Cross-Study
normalisation. Each module contains multiple algorithms, which can be compared and/or combined,
and additionally, different modules are interlinked to enable cross-domain integrative analyses (e.g.
Gene Set Analysis combined with Class Discovery Analysis). Although this tool set is applicable to
many high-dimensional biological datasets, example applications shown in this chapter will focus on
the analysis of gene expression cancer datasets, which led to the discovery of a novel, experimentally
validated breast cancer marker gene [19].
Chapter 6 introduces new integrative analysis methods for the general analysis of gene and protein lists
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obtained from an experiment. As further data sources, public molecular interaction data and cellular
pathway definitions are used within these tools. Specifically, TopoGSA [20], a web-application for
network topological analysis of gene and protein lists, EnrichNet [21], a web-server and algorithm
for network-based functional enrichment analysis, and PathExpand [22] an algorithm for extending
cellular pathway definitions using molecular interaction data will be presented, as well as modular
combinations with other tools from the framework.
Chapter 7 is dedicated to a new integrative rule learning method for increasing the interpretability of
machine learning models for biological systems. This approach, termed Top-scoring pathway pair
(TSPP) algorithm [23], relies on cross-domain data fusion, evolutionary learning and the extraction
of robust classification rules representing relations between the gene expression values in pairs of
cellular pathways. It generates compact sample classification models consisting of a combination of
easily interpretable decision rules.
Chapter 8 presents a software package for low-dimensional visualisation and interactive exploration of
biological data, VRMLGen [24], which is used in different modules of the integrative analysis frame-
work. VRMLGen generates interactive, web-based 3D data visualisations that are specifically tai-
lored towards the analysis of biological data, integrating functional annotation data into the plots,
highlighting regions of high data density, and interlinking data points with information from external
biological databases.
Chapter 9 will summarise the main biological results of the PhD project, including the identification of an
experimentally validated breast cancer marker gene, the proposal of candidate disease genes based on
computationally extended disease pathway definitions, and the prioritization of putative associations
between cancer mutated genes, cellular pathways and different disease processes.
Chapter 10 will provide a concluding summary and general discussion of the novel methods and results
presented in the thesis, as well as an outlook on possible future work.
1.4 Methodology
In order to obtain significant, biologically relevant and reproducible results, a methodology consisting of
multiple preparatory steps, and following widely accepted standards and guidelines during the development
of the data analysis and evaluation pipeline was employed for this project.
First, a survey of the relevant literature was conducted to identify knowledge gaps and promising target
applications and methods within the field of large-scale biological data analysis for the development of
novel analysis approaches that significantly complement or extend existing algorithms and procedures. An
updated version of this survey is also part of this thesis (see chapter 3).
While studying the literature, several high-dimensional microarray datasets were collected, including bench-
mark datasets, recently published real-world datasets and data from collaborating institutes. These datasets
were used to compare current feature selection, clustering and classification methods by setting up an eval-
uation pipeline, consisting of multiple widely recognized performance measures and cross-validation meth-
ods (e.g. using external cross-validation with nested cross-validation parameter optimisation [25] for classi-
fication and multiple cluster validity indices for clustering). A comparative evaluation of machine learning
methods using this pipeline is part of this dissertation (see chapter 4).
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This preparation and new ideas gathered while studying previous methods helped to design a framework and
implement corresponding software modules to combine previous machine learning and other data analysis
methods using new ensemble learning and consensus clustering techniques, and to explore new modular
combinations between analysis types. The analysis pipeline and software was designed in a manner that
would allow biological scientists and clinical practitioners without previous background in computer sci-
ence to apply the methods easily to their data, using a platform-independent web-application, automatic
parameter selection mechanisms, and simple, interactive interfaces and visualisations to explore the results.
More importantly, users have the possibility to both apply classical machine learning methods they might
already be familiar with, but also to compare and combine them with new methods. As the central compo-
nents of the framework, several new integrative analysis approaches were developed, which combine both
diverse algorithms and datasets, using unified graph-based representations of data from multiple biological
sources. Finally, in addition to the data pre-processing and analysis modules implemented for this frame-
work, several statistical methods for evaluation purposes and to improve the interpretability of the obtained
models were integrated into the analysis system.
To promote data exchange and prevent the framework from becoming an isolated system, the software was
interlinked with a multitude of external public data repositories and complementary analysis systems (Gene
Cards [26], GEO [27], ENSEMBL [28], DAVID [29], Gene Ontology [30], KEGG [31], and BioCarta [32],
among others).
Since one of the main goals of the doctoral project was to develop software of direct practical utility for
the biosciences, the data analysis system was also employed for the analysis of several current real-world
datasets in co-operation with different partner institutes, focussing mainly on applications in cancer biology.
Specifically, collaborations were set up with the Spanish National Cancer Institute (CNIO, Madrid, Spain),
the Weizmann institute of Science (Rehovot, Israel), the Queens Medical Centre, the School of Veterinary
Medicine and the Institute of Neuroscience at Nottingham University. These institutes provided access to
new data to address current research questions of biomedical relevance.
Thus, this plan to build an integrative analysis framework, evaluate different methods and obtain relevant
data to approach specific analysis problems provided the foundation for the milestones of the doctoral
project, which are reflected by the structure of this thesis and which were pre-defined in advance and
monitored throughout the entire duration of the project in regular meetings and progress reports.
1.5 Main Results
This final introductory chapter will provide an overview of the most important results obtained from the
doctoral project, including the implemented software packages and web-applications, the publications and
the main biological results. Detailed discussions of all the software tools and biological contributions will
be provided in dedicated chapters (see chapters 4 to 8).
1.5.1 The integrative analysis framework
The central result of the project is a software and algorithm framework for integrative analysis of large-scale
gene and protein expression data and general gene/protein lists, consisting of multiple interlinked analysis
modules, illustrated in figure 1.2.
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Figure 1.2: Modules and workflow of the integrative data analysis framework presented in this thesis: The ArrayMin-
ing system for integrative microarray gene expression analysis (top right, consisting of a Gene Selection, Class Dis-
covery, Class Prediction, Gene Set Analysis, Network Analysis and Cross-Study normalisation module), the PathEx-
pand method for integrative cellular pathway and molecular interaction data analysis (centre), the Top-scoring Pathway
Pairs (TSPP) method combining pathway definitions and gene/protein expression data (centre), the network-based
enrichment analysis method EnrichNet (centre right), the VRMLGen software package for creating interactive low-
dimensional visualisations of biological (centre right) and the network topological analysis method, TopoGSA (bottom
right). Modules containing new methods are highlighted by a star symbol, and new pipelines are indicated by dotted
lines.
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Each module provides access to multiple algorithms for an analysis task, enabling users to compare and/or
combine them using novel ensemble or consensus techniques. The modules enable the integration of ex-
ternal biological data, including functional annotation data, cellular pathway definitions and molecular in-
teractions, into the analysis, and can be combined sequentially into different user-configured cross-domain
analysis pipelines. Automatic parameter selection and optimisation mechanisms, the generation of compact
rule-based models, and interactive means to visualise, explore and statistically analyse the results obtained
from an algorithm, facilitate the usage of the software and the interpretation of the data.
Different components of this framework have been developed as independent software projects and pre-
sented in dedicated publications. The main component is the ArrayMining.net [18] tool set and web-
application for DNA- and protein-microarray data analysis, which is freely available on the internet since
February 2009, and has been accessed more than 31,000 times by more than 10,000 users. It consists of six
analysis modules (see the large blue boxes “Microarray input data” and “ArrayMining Analysis Modules” in
figure 1.2) for combining datasets from different microarray studies (Cross-Study normalisation), classical
machine learning tasks (Feature Selection, Clustering and Classification) including ensemble and consen-
sus methods, and new integrative and specialized analysis methods (Gene Set Analysis and Co-Expression
Analysis). Additionally, these modules are interlinked with the other algorithms in the framework and
external data repositories and web-services. ArrayMining.net will be discussed in detail in chapter 5.
A further component for microarray data analysis in the framework is the self-devised Top-scoring path-
way pairs (TSSP, [23]) algorithm, which integrates cellular pathway information into the machine learning
analysis of gene expression data to identify compact and easy-to-interpret decision rules for sample classi-
fication (see details in chapter 7).
Two other integrative framework tools, which also exploit information from pathway definitions and addi-
tionally make use of molecular interaction networks, are the new algorithm PathExpand [22], which extends
pathway definitions using a graph analysis on protein-protein interaction data, and EnrichNet [21], an ap-
proach to enhance classical functional enrichment analysis, estimating the significance of the functional
association between pairs of gene/protein sets using distance information from molecular networks (see
chapter 6).
The combined information content from interaction network and pathway data is also exploited by the web-
application TopoGSA [20], which maps a gene or protein set provided by the user to a molecular network
for the corresponding species and analyses its topological properties in comparison to gene/protein sets
representing known cellular processes, complexes and functional annotations (see chapter 6). Although En-
richNet and TopoGSA are not designed to make use of expression level measurements from gene or protein
expression data, these methods have a significantly wider applicability than the microarray-related analysis
modules, and can be employed to investigate gene/protein sets obtained from any biological experiment or
bioinformatics analysis in more detail.
In order to keep pace with recent developments, the framework additionally provides a method to analyse
the most recent and accurate type of large-scale gene expression data, RNA sequencing data. This software,
RNAnalyze [33], which has also been made available as a web-application, combines the information from
multiple gene selection methods within a gene set enrichment analysis approach.
Finally, methods for web-based interactive data exploration and low-dimensional visualisation are used
within multiple components of the framework, and have also been published in a dedicated software pack-
age, VRMLGen [24].
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1.5.2 Collaborative project results
Using combinations of the software tools within the framework, a wide range of biological analyses have
been conducted in collaboration with external institutes. One of the key results was obtained in co-operation
with the department of Histopathology at the Queens Medical Centre in Nottingham, using the gene set
analysis, ensemble feature selection and classification methods in ArrayMining to analyse data from a
large-scale microarray cohort study with samples from 128 breast cancer patients. In this pre-clinical study
a new candidate marker gene for a special breast cancer tumour subtype (the oestrogen-receptor positive
luminal-like subtype) was identified and experimentally validated by immunohistochemistry using tissue
microarrays. A dedicated manuscript, proposing the corresponding human gene RERG (“Ras-related and
oestrogen-regulated growth inhibitor”) as a new tumour marker, has recently been published [19].
A second cancer-related project, implemented in co-operation with the Spanish National Cancer Institute
(CNIO, Madrid) during a three-months secondment in Madrid, analysed sets of human genes known to
be mutated in more than 30 different cancer types using the tools PathExpand, TopoGSA and EnrichNet
from the framework. By combining molecular network and cellular pathway data, as well as the lists of
cancer-mutated genes, several disease-related pathways enriched in these genes were extended using the
PathExpand tool, and enrichment in cancer-mutated genes was also detected among the genes added by
the extension procedure [22]. Applying these analyses to cellular disease pathways enabled the proposal of
new putative disease genes, e.g. for Alzheimer’s disease the prediction of two candidates was corroborated
by previously published experiments.
In a related study, the complete set of known human cancer genes [34] was analysed with respect to its
topological properties when mapped to a molecular network using the TopoGSA tool. After assembling a
large-scale human protein interaction network in collaboration with the CNIO and mapping the genes onto
the network, TopoGSA determined their topological properties (e.g. their centrality and their tendency to
form clusters) and compared them to known gene sets representing cellular processes, complexes and func-
tional annotations. The final results revealed that cancer genes have markedly distinct topological properties
in comparison to gene sets representing metabolic and regulatory processes, even after accounting for bi-
ases resulting from the inclusion of small-scale studies in the construction of the interaction network [20].
To extract further information on cancer gene set associations from molecular network data in a follow-up
project, the EnrichNet approach and web-application [21] was developed, as an extension of classical func-
tional enrichment analysis. In contrast to existing methods, which assess the significance of the overlap
between the datasets (e.g. using the Fisher exact test) or compute the enrichment of “true positive” disease
genes among an experimentally derived ranking list of candidate disease genes (e.g. using the Kolmogorov-
Smirnov test), the EnrichNet approach makes use of network distance information to obtain more sensitive
estimates of the functional associations (see a detailed discussion in chapter 6). Both EnrichNet and To-
poGSA have been interlinked with the GeneCards web-service from the co-operating Weizmann institute
of Science (Rehovot, Israel) and used several hundred times by external visitors on the web.
Apart from these ongoing co-operations, various short-term biomedical research projects have been con-
ducted based on software from the framework. In a three-month collaborative project with the School of
Veterinary Medicine at Nottingham University, funded by the “Bridging the Gaps” initiative, microarray
analysis methods from the framework and various literature mining tools were combined to compare gene
expression samples from horse cartilage tissue under different drug treatments against arthritis. The goal
was to study the drug effect on a molecular basis, in order to develop more targeted therapies in the future.
To maximise the robustness and accuracy in the ranking of genes in terms of their differential regulation
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across diverse treatment types, special analysis methods exploiting per-gene replicate measurements on
the microarray chips were used and information from the literature was integrated into the analysis. This
methodology provided a set of 17 high-confidence target genes for further study of the cellular response to
drug treatment (the majority of which had previously been implicated in arthritis).
Similarly, in a still ongoing co-operative study with the Institute of Neuroscience at Nottingham University,
the effects of nicotine on the brain were analysed using gene expression data and rat brain cells as an animal
model, ensemble feature selection methods from the framework were employed to identify the genes with
the most significantly differential expression profiles in the nicotine and control samples.
A central part of the integrative analysis framework is dedicated to network analysis methods, including the
Gene Co-Expression Network Analysis module in ArrayMining, which builds a network of genes (repre-
sented as nodes), which are connected by edges if the corresponding gene expression values are significantly
correlated. This module was used in collaboration with the Division of Plant and Crop Sciences at Not-
tingham University, to generate a genome-wide network model describing transcriptional interactions in
dormant and germinating seeds, in the model plant organism Arabidopsis thaliana. The model enabled the
prediction of genes regulating the plant germination process with higher accuracy than previous alternative
methods. To allow external researchers to explore this data using their own query gene set, an interactive
network visualisation was developed and made publicly available on the web [35].
As part of the above projects, a new web-based 3D-visualisation software to inspect low-dimensional rep-
resentations of high-dimensional biological datasets was implemented additionally, to enable direct visual
inspection of the results for different analyses online. This software package, “VRMLgen”, enables users to
create interactive scatter plots, bar charts and 3D mesh visualisations in web-ready formats, and interlinks
biological features (e.g. gene and protein names) in the data via hyperlinks with public biological databases.
VRMLGen has been presented in a dedicated publication [24] and as an open-source software package in
the “Comprehensive R Archive Network” (CRAN, http://cran.r-project.org).
Finally, in addition to the biological applications of the algorithms and software tools developed in this PhD
project, some of the machine learning methods were also used to enter different data mining competitions.
By participating in these competitions, the performance of the ensemble machine learning methods on the
ArrayMining.net prediction server could be evaluated against a large number of other recent methods in
a fair and unbiased setting. In the KDD Cup 2009 machine learning competition (http://www.kddcup-
orange.com), among the 4921 complete valid entries from 465 entrants the best-performing ensemble
method developed during the PhD was ranked 53rd in the ”Slow Track” category. In a smaller data-mining
competition dedicated specifically to microarray analysis, the RSCTC Discovery Challenge 2010, the auto-
matic ensemble learning approach was ranked 26th out of 100 participants, with an average classification
accuracy across six data sets within 3% of the three top-ranked methods in the competition. These rankings
suggest that automated ensemble prediction methods can achieve competitive accuracies in relation to other
state-of-the-art approaches.
In summary, the results of this thesis highlight the benefits of ensemble, consensus and cross-domain inte-
grative analysis methods both for classical machine problems and new biology-inspired analysis and mod-
elling tasks, and cast light on the obstacles that have to be overcome to exploit these opportunities. Detailed
background information, methodological and biological results and critical method comparisons will be
provided in the next chapters.
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1.5.3 Software tools and web-applications
ArrayMining: A web-server for ensemble and consensus analysis of mi-
croarray data, www.arraymining.net (BMC Bioinformatics, 2009, accessed
more than 31,000 times, as of January 2011), interlinked with Gene Cards
[26], DAVID [29], GEO [27], KEGG [36] and Gene Ontology [30]
TopoGSA: A web-tool for comparative network topological analysis of gene
sets, www.infobiotics.net/topogsa (Bioinformatics, 2010, accessed more
than 2,900 times, as of January 2011), interlinked with Gene Cards [26],
KEGG [36], BioCarta [32], Reactome [37] and Gene Ontology [30]
TSPP: A software using pairwise relations between pathway expression fin-
gerprints for supervised classification of microarray sample classification
(German Conference on Bioinformatics, 2010)
VRMLGen: A software package in R for 3D-visualisation of high-dimen-
sional biological datasets on the web, http://cran.r-project.org/web/
packages/vrmlgen (Journal of Statistical Software 2010)
PathExpand: A visualisation of network representations of extended cellu-
lar pathways and processes, www.infobiotics.net/pathexpand (BMC Bioin-
formatics and RECOMB Computational Cancer Biology Workshop 2010)
SeedNet Online: An interactive gene co-expression network visualisation to
investigate transcriptional interactions between dormant and germinal Ara-
bidopsis thaliana seeds (Proc. Natl. Acad. Sci. USA 2011)
EnrichNet: A web-application for network-based gene set enrichment anal-
ysis, www.infobiotics.net/enrichnet (manuscript in preparation), interlinked
with Gene Cards [26], KEGG [36], BioCarta [32] and Gene Ontology [30]
RNAnalyze: A web-server for gene set enrichment analysis of RNA sequenc-
ing data (manuscript in preparation), interlinked with KEGG [36] and Gene
Ontology [30]
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Chapter 2
Biological Background and Fields of
Application
Chapter abstract
The development of new high-throughput technologies in the biosciences in recent decades,
including High-Throughput-Sequencing (HTS), DNA and protein microarrays, has provided
the scientific community with almost complete genome sequences for several species and a
multitude of transcriptome, proteome and metabolome datasets for diverse cell types under nu-
merous biological conditions of interest. This enormous amount of publicly available data has
raised hopes that researchers will in the long run be able to obtain a more holistic understanding
of the molecular mechanisms in living cells, especially under disease conditions, by analysing
complete gene-, protein- and metabolite networks and not only their individual components.
These new possibilities have led to the establishment of systems biology as a novel scientific
discipline, aiming at a holistic interpretation of interactions within biological systems. This
discipline is also accompanied by a novel scientific methodology, discovery science, in which
the discovery process, including hypothesis formation, is automated to a great extent and op-
erates on large volumes of data. This development can be seen as a complement to classical
reductionism, “the practice of describing or explaining a complex phenomenon in terms of
relatively simple or fundamental concepts, especially when this is said to provide a sufficient
description or explanation” (Oxford English Dictionary, 3rd edition, 2009). Importantly, re-
ductionism does not neglect the interactions between the different components of a systems,
but enables the filtering of variables, while still providing explanations for some system-wide
properties.
This chapter will provide an overview on some of the most important biomedical applications
and challenges for systems biology based bioinformatics approaches. It will briefly describe
genetic disorders and cancer diseases which are difficult to treat partly due to their complex
systemic properties and influences, and explain how new large-scale data sources enable a more
comprehensive and rapid biomarker discovery and drug target screening. More importantly,
the final section of this chapter will discuss how these data analysis tasks can profit from novel
network-based systems biology approaches and integrative analysis techniques. In combination
with the literature survey on classical machine learning methods and novel integrative data
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mining approaches (see chapter 3), this overview will provide the background and motivation
for the new integrative bioinformatics approaches presented in this dissertation.
2.1 Genetic Disorders and Cancer Diseases
Diseases with genetic components cover a multitude of malignancies and genetic disorders. Hereditary
single gene disorders alone account for more than 4000 different human diseases, and although cancer is
often referred to as a single condition, more than 200 different cancer diseases exist, differing in terms
of the affected organs and tissue types [38]. While most genetic disorders are mainly hereditary diseases
and occur relatively rarely (affecting one individual in several thousands or millions), cancer diseases are
frequently caused by environmental factors and often occur spontaneously. They also belong to the main
causes of deaths, with 13% of all world-wide human deaths in 2007 resulting from cancer [39]. Importantly,
although people at all ages can be affected by cancer, the risk tends to increase with age [40]. Given an
aging population in industrialised countries and a lack of causative treatments against cancers, the search
for effective therapies is therefore growing in significance.
In this section a brief overview of diseases with genetic components will be given, focussing on current ther-
apeutic approaches and their limitations. The next sections will discuss how new bioinformatics methods
for rapid identification of drug targets, virtual drug screening and rational drug design, as well as integrative
systems biology analysis approaches can help to overcome some of these limitations.
In general, genetic disorders can be grouped into single gene disorders, resulting from a single mutated
gene, andmultifactorial or polygenic disorders, which are associated with multiple genes, as well as external
environmental factors.
Single gene disorders are mostly inherited diseases with a multitude of possible inheritance patterns, some-
times affected by epigenetic influences like genomic imprinting [41] (e.g. silencing of an allele by CpG-
methylation of the corresponding promotor region). Generally, the inheritance patterns can be grouped into
recessive and dominant patterns, depending on whether the corresponding trait needs to be expressed on
two alleles (recessive) or only one allele (dominant) to determine the final phenotype (special cases of co-
dominant and semi-dominant diseases, where both alleles have the same influence on the phenotype, exist
additionally). Moreover, inheritance patterns can be distinguished according to whether the corresponding
gene is located on an autosomal or gonosomal (i.e. sex-linked) chromosome. Prominent examples for dif-
ferent single gene disorders and their inheritance patterns are shown in table 2.1. An example inheritance
pedigree for an autosomal dominant disease is shown in figure 2.1.
For most of these diseases, the precise genetic cause is well-known, e.g. an extension of a nucleotide
sequence region rich in CAG-repeats in the Huntingtin gene is known to cause Huntington’s disease, but a
causative treatment would require the development of a new gene therapy. However, bioinformatics data
analysis approaches can support the development of cheaper and more sensitive and specific methods for
diagnosis, prognosis and disease progression monitoring, and the identification and design of new drugs.
Interestingly, although most of these disorders have a relatively low prevalence of one in a few thousand
of cases and affected carriers would be expected to have a selective disadvantage, these genetic diseases
have not disappeared over thousands of years [42]. A likely reason for this long survival of low-prevalence
genetic diseases is that some disorders can also endow carriers with a selective advantage, e.g. heterozygous
carriers of sickle-cell anaemia have an increased resistance against malaria [43].
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Figure 2.1: Example inheritance pedigree for an autosomal dominant disease with only one heterozygous carrier of
the disease in the parental generation, resulting in a 50% chance for members of the first filial generation to carry the
disease (source: U. S. National Institutes of Health).
Table 2.1: Overview on genetic inheritance types and representative single-gene genetic disorders
Inheritance types Representative diseases
Autosomal dominant Huntington’s disease, familial hypercholesterolemia, Marfan
syndrome
Autosomal recessive sickle-cell anaemia, cystic fibrosis, phenylketonuria, spinal
muscular atrophy
Gonosomal, X-linked, dominant Aicardi syndrome, Rett syndrome
Gonosomal, X-linked, recessive red-green colour blindness, Hemophila A, Duchenne muscular
dystrophy
Gonosomal, Y-linked hyperthrichosis pinnae (human hairy ears trait), male infertility
Mitochondrial (maternal) Leber’s optic atrophy
2.2. Biomarker Discovery and Outcome Prognosis 18
However, complex, multifactorial disorders like the majority of cancers are much more widespread than the
above single-gene disorders. Importantly, multifactorial or polygenic disorders also include many diseases
which are not commonly associated with genetic disorders, e.g. heart disease, obesity, asthma, hyperten-
sion, inflammatory bowel disease and multiple sclerosis, which are often only partly influenced by genetic
pre-dispositions and partly by environmental and lifestyle factors. The complexity of these diseases results
both from the involvement of multiple genes in the disease and from the fact that defects in different genes
and proteins can result in similar deregulations of a cellular pathway or process.
In spite of the detailed knowledge available for many genetic disorders, for most of these diseases with
genetic components currently no cure exists and most therapies only attempt to reduce the severity of the
symptoms. For the future, scientists hope to develop somatic gene therapies [44], which compensate the
effect of mutated genes by inserting copies of the non-mutated gene into the genome of affected cells
(without affecting any germ cells for ethical reasons). However, several obstacles have to be overcome until
such gene therapies will become feasible. An effective therapy would not only require a targeted delivery
of the corresponding gene’s DNA to many affected cells, but also the integration of the DNA carrier into
these cells and into the cell nucleus, the controlled release of the DNA and the integration into the genome.
Although many DNA viruses operate similarly and integrate their DNA into the genome of the host cell, the
uncontrolled replication of viruses might rather represent a risk to the host organism than an opportunity for
a new gene therapy. Thus, there is a need for new, controlled drug delivery systems, a better understanding
of complex polygenic diseases and a new rapid drug target identification and rational drug design process.
Bioinformatics methods can assist biological and clinical researchers both in improving the basic under-
standing of genetic disorders, and developing diagnosis systems and therapies for these diseases using in
silico identification of new drug targets and techniques for rapid virtual drug screening, computational drug
design and optimisation of given drug lead structures. The next section will discuss techniques for discov-
ering biomarkers, which are useful for disease diagnosis and monitoring, as well as methods for predicting
the disease subtype and the long-term prognosis.
2.2 Biomarker Discovery and Outcome Prognosis
Classically, biomarkers are blood tests which measure the abundance of a protein that reflects the presence
and progression of a certain disease state, e.g. the presence of an antibody can point to an infection [45,46].
However, biomarkers can also be genes, RNA, cells, enzymes, hormones or other molecules (also known
as “molecular biomarkers”), imaging biomarkers (MRI, CT, PET), and even a classic laboratory parameter
like the body temperature can be regarded as a simple biomarker, e.g. for fever. Biomarkers are used for
monitoring the progression of a disease, but more importantly, they can also be used for the early detection
of a disease or disease risk. Early diagnosis is vital for the effective treatment of many diseases, espe-
cially cancers, because prior to metastasis tumours which are confined to one location can often be removed
completely. Without biomarkers, early and reliable disease detection is often impossible, because several
diseases like rheumatoid arthritis and Alzheimer’s start with a symptom-free phase [47, 48]. Similarly, if
biomarkers are used as a risk indicator for a disease, they can assist even in preventing the onset of a dis-
ease completely (“preventive medicine”), e.g. monitoring cholesterol levels can help to prevent coronary
diseases [49]. Moreover, biomarkers are particularly important tools for a more personalised medicine,
enabling doctors to adjust biomedical decision making to an individual’s specific disease state by obtain-
ing a molecular portrait of the individual (“molecular profiling”), improving the diagnosis and tailoring the
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treatment plan and therapy to the individual. In drug development, biomarkers can promote the identifica-
tion of new disease targets, and both directly and indirectly the improvement of drugs and design of novel
active compounds. For example, to evaluate a potential drug therapy, and in particular when testing the
safety of a drug in addition to its clinical effect, biomarkers can also be used as “surrogate endpoints” for
survival [50]. At a later stage of the drug development process, biomarkers can be employed in pharma-
cokinetics and pharmacodynamics studies (as part of clinical phase I studies), to identify a suitable dosis,
dosis interval and application type for a drug [51]. For this reason, clinical researchers distinguish between
disease-related and drug-related biomarkers, depending on whether a biomarker is used for predictive and
diagnostic purposes, or for studying drug effects.
High-throughput genomics, transcriptomics and proteomics experiments and bioinformatics methods ana-
lysing these data can help to speed up the discovery of new molecular markers. As illustrated in table 2.2,
providing an overview of bioinformatics applications in biomedicine, in silico biomarker discovery repre-
sents just one group of analysis approaches among a multitude of bioinformatics sub-disciplines linked to
biomedical research. Moreover, figure 2.2 shows an overview of typical stages in a biopharmaceutical drug
development pipeline, highlighting the stages in which bioinformatics methods can be used to speed up and
rationalize the development process (blue colour).
Table 2.2: Application of bioinformatics tools in biomedicine
Biomedical applications / clinical phases Supporting bioinformatics disciplines
Disease model generation high-throughput data mining, pathway & network analysis
Drug target identification in silico target screening (docking [52], feature trees [53])
Drug screening in silico drug screening (docking [52], feature trees [53], ligand
superposition [54])
Lead optimisation QSAR [55], CoMFA/CoMSIA [56], QM/MM [57]
Disease diagnosis and prognosis in silico biomarker discovery [58]
Drug pharmacokinetics & safety in silico ADME/Tox models [59]
Figure 2.2: Overview of common stages in a drug development pipeline. All stages in which bioinformatics methods
are applied to speed up the research and development process are highlighted in blue colour.
The classical biomarker discovery approach is applied to transcriptomics data like DNAmicroarrays or data
collected with other gene expression measurement techniques (qPCR = real-time quantitative polymerase
chain reaction, RNA sequencing, SAGE = serial analysis of gene expression, Northern blotting), to identify
molecular markers that enable a discrimination between a healthy control state and different disease states,
drug effects etc. Proteomics techniques are mostly using mass spectrometry and protein microarray tech-
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niques, e.g. LC/MS (liquid chromatography mass spectrometry), MALDI-TOF MS (matrix-assisted laser
desorption ionisation - time-of-flight mass spectrometry), 2D-PAGE (2D polyacrylamide gel electrophore-
sis), tissue microarrays and antibody (Ab) microarrays. More recently, new “-omics”-techniques analysing
all metabolites (Metabolomics), lipids (Lipidomics) and the entire complement of sugars (Glycomics), have
been developed to find new biomarkers.
All of these experimental platforms and measurement techniques for the discovery of biomarkers have in
common, that their measurements are affected by various sources of noise, and that multiple measurements
are made in parallel, requiring adjustments for multiple hypothesis testing in the statistical analysis as well
as special techniques to deal with the analysis of high-dimensional noisy data with small sample sizes (many
attributes in relation to few observations for each attribute). Therefore, bioinformatics analyses methods,
and in particular integrative techniques which exploit the synergies of complementary data sources and
different types of statistical, graph-based and information-theoretic analysis, are needed the robust identi-
fication and prioritisation of candidate biomarkers. Importantly, bioinformatics analysis and experimental
validation should go hand in hand, because noisy high-throughput data alone cannot provide absolutely reli-
able evidence for the verification of biological models, and the models are always simplified representations
of reality. Thus, a typical biomarker discovery pipeline will involve high-throughput data collection from
multiple sources (e.g. gene expression microarray, protein expression and molecular interaction data), data
integration and computational analysis (which is the main focus of this thesis), and experimental validation
using small-scale high-sensitivity experiments (e.g. repeated qPCR experiments). Chapter 3 will provide
an overview on previous computational analysis techniques for this type of data, as well as a motivation
for new integrative analysis methods. However, before covering the in silico analysis of the data, the next
section will first discuss the role systems biology approaches in the analysis of new large-scale datasets.
2.3 Role of Systems Biology in Elucidating the Basis of Complex Dis-
eases
The analysis of data from high-throughput experiments requires different approaches than those used in the
classical reductionist methodology. The measurements for single molecules (genes, proteins and metabo-
lites) in these experiments are frequently affected by high levels of noise, and often only when considering
properties of whole cellular pathways, processes and complexes, robust patterns and structures emerge in
the data, which can be verified by other experimental procedures and platforms. This observation also
matches with the basic rationale behind systems biology and synthetic biology, according to which many
functions within a biological system can only be explained by looking at the multitude of interactions be-
tween the components of the system, rather than only at single components in isolation. Studying single
structures and isolated processes in detail according to a reductionist method continues to be an indispens-
able scientific methodology, required to verify specific hypotheses at the single-molecule level. However,
the complementary systems biology approach, looking at the interplay between a multitude of components
in a biological system and studying patterns emerging on a system-wide level, is becoming as practically
useful as the traditional methodology.
Importantly, systems biology approaches are still consistent with the scientific method [60], i.e. experience
is used to form a conjecture (a testable hypothesis or model), and this theory/model is used to make pre-
dictions, which are falsified by an experiment. The knowledge gained from this procedure can again be
used to refine the model and repeat the whole process in an iterative, cyclic process. The main difference to
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the reductionist approach is that a multitude of hypotheses are formed, and advanced analysis methods are
required to filter these hypotheses to identify those providing the most relevant and significant information,
adjusting the results for the multiple testing problem [2, 3]). Moreover, systems biology accounts for new
interdisciplinary aspects of biology, combining knowledge and analysis techniques from molecular biol-
ogy, biophysics, biochemistry, biopharmacy, microbiology, mathematics, computer science, graph/network
analysis and other disciplines. This collaboration between experimental and quantitative scientists is often
an essential requirement, because many large-scale experimentation and data acquisition techniques pro-
vide noisy and high-dimensional data, which requires special computational analysis techniques to filter
out irrelevant information and reduce the dimensionality of the data. Furthermore, effective search method-
ologies often have to be employed to find the best model parameter combinations, providing a good fit to the
data and compact and interpretable explanations for the relations between variables. For this reason, sys-
tems biology has not only been driven by new system-wide experimental high-throughput techniques, but
also by new computational technologies, and bioinformatics algorithms and data structures, which enable
the analysis of high-dimensional data on standard desktop computers.
Systems biology methods do not only analyse large-scale “omics” datasets measuring abundances and ac-
tivities of many molecules in parallel, but a special focus lies on interactions, and dynamic relations between
different molecules and processes. The classical “omics” have therefore been extended by Interactomics
(the analysis of molecular interactions, like protein-protein interactions) and Fluxomics (the quantitative
study of the biomolecular fluxes, i.e. the rates of passage of biomolecular substances through a given
metabolic pathway, and the dynamic synthesis and conversion of these substances in metabolic networks).
Importantly, in agreement with findings showing that many genetic disorders are complex, multifacto-
rial and polygenic (see previous section), systems biology focuses on the network-based analysis of high-
throughput data and the multivariate analysis of activity and expression data, to account for the combined
influence of multiple genes, proteins and metabolites on a biological process of interest. Indeed, assays for
the diagnosis and monitoring of complex diseases might often require combinations of multiple biomarkers,
and a personalised medicine tailored to a specific patient can even necessitate conducting high-throughput
analysis for individuals (e.g. by devising a cheap diagnostic microarray, representing only replicates of the
most relevant biomarker genes; an example is the “MammaPrint” breast cancer molecular diagnostic test
based on a 70-gene signature [61]). Classical reductionist approaches would often not be adequate to anal-
yse data for developing diagnostic assays for complex diseases, unless a sufficiently reliable single-gene or
-protein marker exists for the disease under consideration.
In summary, systems biology approaches complement rather than replace the traditional reductionist meth-
odology, and provide new opportunities for the rapid identification of potential drug targets, and screening
for biomarkers and novel drug candidates. Apart from the new high-throughput experimental technologies
which promote the spread of systems biology studies, integrative bioinformatics analyses methods represent
one of driving forces behind systems biology, helping to uncover complex relations between attributes in the
data and speeding up screening processes by improved candidate biomarker, drug target and drug substance
rankings.
In order to introduce new integrative analysis methods and compare them to traditional algorithmic strate-
gies, the next chapter will provide a literature survey and overview of both classical machine learning meth-
ods and new biology-tailored and integrative approaches for the computational analysis of high-throughput
data.
Chapter 3
Literature Review
Chapter abstract
The analysis of complex, high-dimensional and noisy biological datasets has become a com-
mon challenge in both clinical and basic biological research. To address the statistical and
computational difficulties associated with new large-scale data sources, a multitude of highly
specific and tailored computational biology approaches for the investigation of large gene and
protein expression datasets and other high-throughput data sources have been developed in
recent years.
This chapter contains a literature survey discussing current methods for high-dimensional bi-
ological data analysis, with a special focus on ensemble/consensus and cross-domain inte-
grative analysis techniques, in order to provide the reader with a representative overview on
current state-of-the-art methods in this field and the limitations and opportunities for the devel-
opment of novel analysis tools. Since data normalisation and quality checking are important
pre-requisites for a successful higher level statistical analysis, corresponding lower level pre-
processing methods will be discussed first. However, the main goal of the chapter is to guide
the reader through a representative selection of current higher-level machine learning analy-
sis techniques and their integrative extensions combining information from multiple datasets
and/or algorithms. Most of these methods will be discussed and illustrated using input frommi-
croarray gene expression data as a prime example for high-dimensional biological data. How-
ever, these approaches are often directly applicable to dataset types obtained from other high-
throughput experimental technologies. For the lower level pre-processing methods, which are
typically data type and platform-specific, separate sections will deal with different input data
types, including microarray, protein-protein interaction and cellular pathway data.
3.1 Low Level Analysis: Pre-Processing, Normalisation and Quality
Checking
In high-throughput biological studies different samples are often affected by a different experimental bias
and quality of the corresponding biological material. To account for these technical and biological sources
of noise, data pre-processing and quality analysis methods are essential first steps in a data processing
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pipeline designed to extract new biologically meaningful insights from the input. This section will discuss
these challenges and current methods to tackle them, using the example of microarray gene expression
data as a representative input data type, and highlighting typical problems in high-dimensional biological
data analysis. Though an exhaustive discussion of microarray pre-processing methods is beyond the scope
of this thesis, a diverse selection of widely used approaches will be presented, illustrating that a straight-
forward “method of choice” for data pre-processing and normalisation does not always exist in biological
data analysis. The discussion will also reveal that there is a wide room for improvement even for low level
pre-processing methods, due to a multitude of error sources which are difficult to model realistically. A
summary of the general types of higher level machine learning analyses, which are the main focus of this
chapter, are shown in figure 3.1, whereas figure 3.2 provides an overview of the workflow for the low level
analysis of microarray data.
Figure 3.1: Overview of supervised and unsupervised higher level statistical learning methods considered in this survey,
including integrative methods to combine algorithms and datasets within and across different domains in biology and
computer science.
3.1.1 Microarray technology - Introduction
Microarrays have been one of the first miniaturised high-throughput experimental technologies in the bio-
sciences, and in spite of recent advances in RNA sequencing technology, they still belong to the most
widely used large-scale measurement devices in clinical and biological research. The wealth of information
gathered in microarray studies and the variety of problems that have to be addressed in the analysis of the
data, make microarrays a prime example for the opportunities and challenges of biological high-throughput
technologies.
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Figure 3.2: Overview of a typical microarray analysis workflow. This survey will focus on the steps following after the
microarray image analysis, in particular higher level analysis methods.
With DNA gene expression microarrays (also known as DNA chips, gene arrays or gene chips) the activity
levels of thousands of genes from a cell sample can be measured using an approximate quantification of
the messenger RNA abundance for each gene. Thus, especially for organisms with a small genome, a
microarray enables the measurement of the entire transcriptome of a cell, i.e. measuring the expression
levels of all genes in a certain cell type under well-defined conditions. This technology has countless
applications with high practical relevance in basic biology and biomedicine, including the comparison of
different disease states (e.g. tumour types and progression states) in biological samples, the analysis of the
effects of drugs, toxins or viral infections, the identification of new marker genes for disease monitoring
and outcome prediction, and the discovery of new drug targets for developing novel therapies.
However, microarray studies also have several practical limitations. In contrast to more accurate methods
for gene expression level determination like real-time PCR [62], they can often only provide relative ex-
pression levels, i.e. enable a relative comparison of expression levels in cells from different tissue types,
alternative disease states or different environmental conditions. More importantly, current microarray stud-
ies are mostly characterised by small sample sizes and high noise levels, several outliers and systematic
bias. Results obtained using different chip technologies and experimental procedures from different labo-
ratories are often hardly comparable (Cross-Study normalisation will therefore be considered as a special
data integration problem in this thesis, see section “Cross-Study normalisation” below). Even if different
laboratories use the same microarray platform, high experimental reproducibility is mostly only achieved
within a single laboratory after several months of practical training. Moreover, due to the high costs associ-
ated with microarray experiments and the problem of multiple testing [2, 3], the sample sizes are often too
small in relation to the number of genes to robustly identify genes with significant differential expression
across the sample groups. Therefore, before discussing higher level analysis methods in detail, the next sec-
tions of the survey first review the various typical sources of additive and multiplicative noise in microarray
experiments, as well as several methods to adjust for bias and filter out noise.
Another major challenge in microarray data analysis, occurring especially when employing the technology
to study cancer diseases and genetic disorders, is that these biological conditions often have multiple, com-
bined causes and/or several alternative causes. In addition to information on non-linear relations between
the features in transcriptomic data, genetic, epigenetic, proteomic and metabolomic information is often es-
sential to understand the origins of a genetic disease (e.g. for epigenetic diseases like the Prader-Willi [63]
and Angelman syndromes [64]). The risk for an individual to develop a certain cancer disease is typically
influenced by a complex combination of hereditary risk factors, environmental influences and/or sponta-
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neous mutations [65, 66]. This motivates the combination of microarray analysis with other biological data
sources, clinical measurements and algorithmic and biological analysis techniques. [3mm]
Especially for basic biological research, integrative analysis techniques are required to obtain a more com-
plete picture of the molecular processes in cells under biological conditions of interest. Therefore, the
second part of this survey will not only focus on tailored higher level analysis techniques for microarray
data, but specifically on methods that integrate additional data sources and multiple algorithms into the
analysis.
3.1.2 Microarray data pre-processing
The vast quantities of raw image data obtained from the scanning process during a microarray experiment
contain a large amount of uninformative data and do not provide an adequate input for statistical analysis.
Several image analysis, filtering and normalisation steps, summarised under the notion low-level analysis,
should be carried out prior to the final statistical analysis for data interpretation. Since the image analysis
procedures, involving image addressing [67], segmentation [68] and background correction [69], require
specialised algorithms and sometimes manual adjustments which are not within the scope of this thesis,
only the computational methods for the subsequent quality assessment, normalisation and summarisation
steps will be discussed in this section.
Though low-level analysis is a common requirement for all microarray experiments, there is no agreement in
the scientific community on a single “method of choice” to accomplish this task. Instead, many competing
approaches for each step of a microarray analysis have been published in the literature and new approaches
are still emerging. Due to the different pros and cons of these methods a frequent recommendation is to test
different popular approaches and compare the final results. In the following sections, the general procedure
of a low-level analysis will be outlined and some examples given for different approaches to realise each
single step in the pre-processing pipeline.
Quality Assessment
In order to prevent erroneous biological conclusions from a microarray analysis, low-quality spots and
outliers should be filtered out from the data in a preliminary quality assessment step. Often already simple
visualisations of the raw data using pseudo-colour image representations (also known as “false array plots”),
histograms and box-plots allow the experimenter to recognize errors quickly. MA-plots (or M vs. A plots),
in which the log ratio of the red and green intensities (M = log2(R/G)) for two-colour microarrays is plotted
against the average log intensity (A = log2(R×G)/2), can reveal an unwanted dependency of the log ratio
on the average log intensity. An exampleMA-plot for simulated data and created using the software package
limma [70] is shown in Figure 3.3 (in this case, no unwanted dependency between the M- and A-values can
be observed). This plot can also be used as a basis for normalisation methods, making the data for different
chips in a study more comparable (see Normalisation section below).
Additionally, many microarray software tools judge the quality of single spots using a combination of visual
criteria, e.g. spot area, diameter and circularity, using adjustable cut-off values. Often spots are also flagged
as unreliable if their pixel values vary too much according to a simple hypothesis test (used for example in
the MAS 5.0 and QuantArray software).
McClure and Wit have summarised computationally inexpensive techniques to identify different types of
quality problems in order to rectify them or to exclude corresponding data entries [71]. They distinguish
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Figure 3.3: Example MA-plot for simulated data and created using the limma software package [70]. Microarray spots
which do not correspond to the genes to be analysed, but to reference probes for normalisation, are highlighted by
coloured points. The continuous line corresponds to a smoothed scatter plot line computed using locally-weighted
polynomial regression (LOWESS technique), using a smoother span of 30%, i.e. the smoothness at each value takes
into account 30% of all data points.
between four general problem types (simple clerical mistakes, array-wide hybridization problems, normali-
sation and mishandling problems) and suggest three main techniques to identify them (dimension reduction
techniques including visualisation methods, false array plots and correlograms). If the genetic probes have
not been arranged in a special order on the array, than a false array plot should normally not exhibit any spe-
cific patterns, otherwise such patterns can help to identify technical error sources. Similarly, correlograms,
which visualise the correlation between expression level intensities at increasing level of separation between
the probes on the array, can help to discover unwanted spatial correlation patterns between neighbouring
probes on a DNA chip.
Although most quality assessment tools employ a direct statistical analysis of the data for single microar-
rays, experimental reproducibility should ideally be tested additionally as one of the most reliable validation
measures, especially when establishing a new microarray laboratory. Per-gene replicates on the same chip
are not sufficient for this purpose, since they cannot help to detect biases affecting a whole experiment.
When repeating a microarray experiment, experienced laboratories reach over 95% reproducibility [72].
Additionally, cross-chip (and some times also cross-study) normalisation has to be applied, because not
only single experiments but also single biological samples and even the whole experimental procedure in
a laboratory might be affected by systematic biases. These biases mainly result from both technical and
biological noise, e.g. due to varying laboratory conditions and the accuracy in carrying out the reverse
transcription and amplification, the array hybridisation and the washing steps.
In summary, automatic computer-based quality assessment methods assist the experimenter in identifying a
multitude of possible error sources, but the results for each single array should also be inspected manually
using visualisations and statistics, because often only the experimenter can determine whether a sample
with an outstanding signal intensity distribution represents an outlier or a special biological phenotype.
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Normalisation
A great variety of possible noise sources, which scale and shift the original signal intensities, can influence
the microarray-based measurement of gene expression. The main purpose of normalisation is to filter out
these effects in order to make different experiments comparable and obtain a reliable estimate of the relative
abundance of mRNA for specific genes in the biological samples. Since the normalisation process could
also remove important biological information, the goal is to maintain the biological variability in the data,
while removing or reducing the variability resulting from the experimental procedure and the limitations of
the measurement technology. However, single normalisation methods typically do not account for all known
sources of noise, and even for specific, partial normalisation tasks no single approach has been accepted as
a standard by the scientific community. Therefore, a suitable combination of normalisation methods should
be chosen from the wide spectrum of available approaches in the literature.
The classical microarray normalisation methods use a selection of genes with nearly invariant expression
levels across all tissues and experimental conditions (so-called House-keeping genes (HKGs)) as a control
to adjust the intensity values on all arrays. However, this method proved to be ineffective, as over the years
more and more special cases were identified, in which HKG expression levels varied significantly across
different conditions. Nevertheless, attempts have been made to use other selections of control genes or to
improve other normalisation methods by restricting the analysis to a specific selection of genes [73].
The more widespread global normalisationmethods use information from the entire dataset in order to make
different microarray experiments in the same laboratory comparable. These methods are mostly requiring
the assumptions that the majority of genes on an array platform is not differentially expressed across the
studied conditions, the number of data points is large and that there is an approximate relative symmetry
between up- and down-regulation of genes. Global normalisation methods are only suitable, if no local
print-tip block effects or intensity effects occurred during the microarray experiment [74]. The simplest
global method for normalisation is linear scaling, where a baseline array is chosen and the intensities of the
other arrays are scaled until all arrays have the same mean intensity as the baseline array. However, in most
cases non-linear methods, e.g. using scatter plot smoothers, are more appropriate due to the non-linear
nature of various types of noise in microarray experiments.
Many global normalisation methods can also be applied locally, i.e. on a physical subset of the data. Local
normalisation is often used for groups of genetic probes which were deposited by the same spotting pin,
when the array was printed, in order to correct for systematic spatial variation on the array.
Signal-dependent normalisation (or intensity-dependent normalisation) is the generic term for methods
accounting for the intensity-dependence of gene expression ratios, which are typically larger in the low-
intensity range. Using a MA-plot (see previous section on Quality Assessment) the distribution of differ-
entially expressed genes across the entire intensity range can be made uniform by subtracting a local linear
or polynomial regression fit from the data using the non-parametric methods LOWESS (= locally weighted
scatter plot smoothing [75], see an example in the previous MA-plot in figure 3.3) and LOESS (= locally
estimated scatter plot smoothing [76]). This approach can be applied both on the colour channels in a single
two-colour array [77] and on the probe intensities from two distinct arrays. Again, applying these methods
only locally often provides improved results, i.e. the corresponding “Subarray LOWESS” method typically
outperforms global LOWESS.
In recent years, several algorithms have been developed to attain more stringent normalisation properties.
For example, Quantile normalisation [69] and Qspline normalisation [78] attempt to make the empirical
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distribution of intensity values similar for all chips using the assumption that the distribution of the real gene
abundances is approximately the same in all samples. In quantile normalisation, for each expression level
on each chip the corresponding quantile in the pooled distribution of probes on all chips is computed and the
original value is transformed into that quantile’s value on a given reference array. The more recent Qspline
method also computes signal intensity quantiles, but both on the arrays’ signal intensities and on so-called
“target intensities”, which can be derived either from another reference array or calculated as averages
from multiple arrays. The quantiles are then used to fit B-splines, i.e. piecewise polynomial functions with
minimal support with regard to chosen properties like degree, domain partition and smoothness, which have
been shown to adequately estimate smooth relationships [79]. By using quantiles instead of the original
values, the fitting problem is greatly simplified. This does not only increase the processing speed but also
reduces the risk of over-fitting.
More recent microarray normalisation methods use mathematical error models consisting of a combination
of additive error-terms, where each term attempts to model the contribution of one specific error type.
Commonly, microarray error models assume that the measured intensity (y) corresponds to the sum of a
scaled version of the real intensity x (multiplicative noise) and an offset value (additive noise):
yik = aik+bikxik (3.1)
where index i refers to the sample, i.e. the array, index k refers to the genetic probe, a is the offset and b a
scaling normalisation factor (also known as “gain”) [80].
This error model can be refined by splitting up the offset and gain into subcomponents corresponding to
different types of error sources. More precisely, the offset can be written as the sum of a per-sample offset
ai, depending only on the array and not on the probes, and an additive noise component εik assumed to have
a normal distribution (εik ∼ N(0,b2i s21)). The gain contains multiplicative sources of noise, ηik ∼ N(0,s21),
as well as factors depending only on the sample (per-sample normalisation factor bi) or only the genetic
probes (sequence-wise probe efficiency bk). On the whole, the following refined error model is obtained:
yik = ai+ εik+bibkexp(ηik)xik (3.2)
With this error model it has been shown that there is a dependence of the variance of the measured intensities
on the expected intensity values [80, 81] (using the linearity of the expectation and E(εik) = 0):
E(yik) = E(ai)+E(εik)+E(bibkexp(ηik)xik) (3.3)
xik = (E(yik)−aik)/(bibkE(exp(ηik))) (3.4)
x2ik =
(E(yik)−aik)2
b2i b
2
kE(exp(ηik))
2
(3.5)
Var(yik) = E(y
2
ik)− (E(yik))2 (3.6)
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Insert 3.3 into 3.6:
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Insert 3.5 into 3.7:
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Var(exp(ηik))
E(exp(ηik))2
(E(yik)−aik)2 (3.9)
Equation 3.9 reveals that the variance of the measured intensities is a quadratic function of the expected in-
tensity value. This undesired effect can be compensated by a dedicated normalisation method, the Variance-
stabilizing transformation (VSN), introduced independently by Huber et al. and Durbin et al. [80,81]. The
VSN is an integrative normalisation method that combines several low-level analysis steps within one pro-
cedure. It performs both background adaptation and normalisation, using the information of all chips to
estimate background adaptation parameters, instead of considering each array separately. However, the
main benefit of the VSN method is the capacity to filter out intensity-dependent variance. Depending on
whether the error model includes a bias offset, additive or multiplicative noise or a combination of these
terms, different variants of the VSN method can be derived. In the most general case of additive and mul-
tiplicative noise, as in the error model shown above, variance stabilization is achieved by the generalized
logarithm (or glog-) transformation, a generalized form of the logarithm and the inverse hyperbolic sine
function (arcsinh). This function makes the variance across replicates independent from the mean signal
intensity:
glogc(x) = ln
(
x+
√
x2+ c2
2
)
(3.10)
vsn(xik) = glog(
xik−ai
bi
) (3.11)
where ai is a background offset and bi the scaling parameter for array i. In the special case of c = 4, the
glog-function corresponds to the arcsinh-function, and for c = 0 the natural logarithm function is obtained.
Glog-transformed data are linear at the low intensity values (to compensate for the higher variance) and
logarithm-like at high intensity values. The parameters can be fitted by means of a maximum-likelihood
procedure.
More recently developed normalisation methods additionally use sequence-specific probe affinities (e.g.
GC-RMA [82]) and account for non-specific hybridization of the target DNA to be analysed with the probe
DNA that is immobilised on the microarray chip (e.g. BGX [83] and PUMA [84]). Some methods even
attempt to model the hybridization process directly, e.g. by physicochemical models for a specific array
type [85], but most of these models are not yet fully recognized by the scientific community.
Since an exhaustive discussion of normalisation methods is beyond the scope of this thesis, the approaches
discussed above are only a small representative selection of the available approaches, highlighting the types
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of problems that are addressed by most of the commonly used methods. A more comprehensive overview
on widely accepted, classical normalisation methods can be found in a review article by John Quackenbush
[86].
Summarisation
If replicate genetic probes are present on the chip platform used in a microarray study, these replicates
can be used to filter out noise and obtain more robust point estimates. For this purpose, the normalised
signal intensities of the replicates representing one genetic probe have to be summarised to a single value.
Even for this seemingly simple task of combining multiple probe intensities to a single expression value, a
variety of alternative methods exist. However, these methods are often already part of common integrative
approaches, which provide summarisations that match well with the included background adaptation and
normalisation methods.
For single-array replicates, the most common summarisation approaches simply compute the average or
median of the logarithm (or vice-versa) for all probe intensities. Additionally, the maximum and minimum
values are often excluded to avoid influences of outliers on the final expression value. Alternatively, instead
of simple averaging Tukey’s Biweight Algorithm [87] can be used to obtain more robust averages, by first
determining the median and then its absolute distance to each data point, in order to assign weights for
the contribution of each intensity value to the average (far-off outliers obtain low weights). The process
can be applied iteratively, but typically a 1-step Tukey Biweight is considered as sufficient. Indeed, most
of the current popular summarisation methods use weighted sums of the probe set values like in Tukey’s
Biweight algorithm and only the methods to estimate the weights differ, e.g. Li and Wong [88] suggest
weighted sum conditional least squares estimates and Lazardis et al. [89] propose a non-parametric method
functionally related to leave-one-out cross-validation, which estimates and weights the performance of each
single probe intensity value estimate by comparing it against an estimate derived from the other replicate
probes. For multi-array replicates, typically a linear model fit (optionally using M-estimation [90]) is used
for summarisation. A commonly used alternative is themedian polishmethod proposed by John Tukey [91],
which fits an additive model using an iterative algorithm to increase model robustness.
In brief, summarisation methods typically employ robust averaging techniques, using different approaches
to achieve high robustness with regard to outliers.
3.1.3 Protein interaction data pre-processing
Molecular interaction data and specifically protein-protein interactions, corresponding to physical binding
reactions in which both interaction partners are proteins, belong to the most frequently used data sources
in computational systems biology analyses and integrative bioinformatics methods. In this section, data
pre-processing methods required to build a protein-protein interaction network using publicly available
data are reviewed, focussing on their opportunities and limitations in integrative analysis approaches for
high-dimensional biological datasets.
The pre-processing and filtering of protein interaction data is typically less complex and time-consuming
than for other high-throughput data sources like microarray data. In contrast to the multitude of low-level
image analysis and normalisation steps required in a typical microarray study, pairwise interactions only
need to be filtered and categorized using simple criteria like the experimental method(s) employed to verify
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the interaction and different types of confidence scores. However, regarding the reliability of the data,
the assembly of protein interaction networks is affected by similar limitations as other biological datasets
obtained from high-throughput technologies. Public interaction databases, including BioGRID [92], MIPS
[93], DIP [94], MINT [95], HPRD [96] and IntAct [97], are known to contain a significant amount of false
positives and false negatives. These erroneous data entries and other limitations result from a variety of
problems in the experimental validation of protein-protein interactions, in particular:
• Some interactions only take place in the proteins’ native compartments, which might not be the
compartments assessed in the detection experiment.
• Several experimental methods are biased to detect only specific types of interactions, a coverage bias
that reflects different strengths and weaknesses of different methods [98]. For example, transcrip-
tion factors cannot be studied with the Yeast-2-Hybrid (Y2H) technique, because the corresponding
fusion hybrids could activate the transcription of a reporter gene even without an interaction. Simi-
larly, methods using purified protein complexes tend to underestimate the number of interactions for
proteins involved in transport and sensing [98].
• Common experimental techniques like Tandem Affinity Purification (TAP) or Co-Immunoprecipita-
tion (CoIP) cannot detect direct binary interactions between proteins, but only co-occurrences within
the same complex
• The application of some methods (e.g. Y2H) might inadvertently lead to conformational changes in
the proteins of interest, and thus prevent a correct detection (increasing the number of false negatives).
• Only few techniques, like the Yeast-2-Hybrid (Y2H) method, also detect unstable and transient in-
teractions, but do not always enable the experimenter to distinguish these from other more stable
interactions.
• Interactions which are predicted as being possible, do not necessarily occur in the real physiological
setting.
In summary, the current data sources provide only a simplified representation of the real networks of pro-
tein interactions in living cells, mostly ignoring the differences between different tissues, diverse cellular
compartments and transient vs. stable interactions, and containing several type 1 and type 2 errors.
To reduce the number of false positive interactions when assembling the data for a large-scale protein-
protein interaction network, the first pre-processing step after collecting the unfiltered data for the species
of interest, is typically a simple filtering, taking into account the experimental methods used to verify the
interactions. Generally, interactions that were verified by multiple independent experiments and different
technologies can be considered as more reliable than those confirmed by only a single experiment. However,
the overlap between the datasets from different experiments has been shown to be very small in many cases
[98]. A further important filtering criterion is the type of experiment: Interactions that were only verified
by methods detecting co-occurrences within the same protein complex, e.g. TAP and CoIP, should in most
cases be excluded from the analysis, unless the investigator wishes to build a network representing general
“functional associations” between the proteins rather than direct physical interactions. To facilitate these
filtering tasks, several public databases provide their molecular interaction data in the HUPO PSI-MI data
exchange format [99], including standardized names for the experiments (e.g. two-hybrid experiments have
the PSI-MI code “MI:0018”). As part of the data preparation for this thesis, a PSI-MI parser was written
in the scripting language Python; however, for various databases not supporting this standard, separate
dedicated parsers had to be implemented additionally.
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Improved filtering methods rely on confidence scores in addition to the information on the experimental
methods. These scores can also be used to assign weights to the interactions instead of filtering low-
confidence edges out. In graph-based representations of the data, where nodes correspond to proteins
and edges to interactions, these interaction weights become edge weights, which can be used for distance
computations in the network, e.g. to be used in algorithms to identify dense communities of nodes in the
network. A multitude of validation methods and confidence assignment schemes have been presented in the
literature. They are using several independent confidence measures, including
• the functional similarity between interacting proteins, measured by the semantic similarity between
corresponding functional terms in the Gene Ontology [100] biological process graph [101–103]
• the gene neighbourhood method [104,105], predicting proteins as functionally related and more likely
to interact in the species of interest, if their genes are found to assemble in putative operons and in a
conserved gene order in different orthologs (homologous genes in another species)
• the analysis of gene fusion data, considering the proteins for genes whose orthologs are fused in
another organism as more likely to interact [106–108]
• the identification of orthologs which are known to interact in other species can point to an interaction
of their homologous proteins in the species of interest, if the interaction is conserved across many
species (these conserved interactions are also known as “interologs”) [109]
• the comparison of phylogenetic profiles, i.e. fingerprints for the co-occurrence of genes/proteins
across different species stored in binary vectors, which can predict genes with similar function and
proteins more likely to interact from the similarity or complementarity of these binary profile vectors
[110, 111]
• co-expression of genes found in microarray, RNA sequencing or qPCR data, increasing the likelihood
of the corresponding proteins being interaction partners or functionally associated [112]
• correlation with localization, since proteins will only interact if they are co-localized in the same
cellular compartment [113]
• correlated gene mutations between interacting protein families, which can point to conserved binding
sites for interactions [114]
• topology-based scores, analysing the local topology in the network surrounding the interaction of
interest, e.g. using the number of non-shared interaction partners [115] or the Czekanowski-Dice
similarity and its iterative extensions [116,117]
• text-mining based scores, e.g. taking into account the publications in which an interaction is reported
(care must be taken when using automatic methods, e.g. searching for phrases like “A binds to B” or
“A interacts with B”, because the context might not always be a supportive statement, e.g. “...these
results do not support the conclusion that A binds to B”) [118]
Typical approaches combine several of these scoring approaches into ensemble probabilistic scores (see
[119] for an example). However, the information required to compute these scores is not always available
for all interactions, especially when analysing non-human species; hence, in many cases only unweighted
networks are built or only topology-based weights are computed. Depending on the distance measure used
in the analysis of the protein-protein interaction (PPI) network, e.g. the discrete shortest path distance or
continuous kernel-based or random walk distances, a weighted network might not always be required as
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input, though weights that accurately reflect the significance of edges are likely to provide more sensitive
results in statistical analyses.
Importantly, when building a network from individual interactions, the final protein-protein interaction net-
work obtained after a filtering procedure does not necessarily consist of a single connected component,
which is required as input by some integrative analysis methods. However, in most cases, the output con-
tains one large connected component (containing several thousand nodes) and only few and small additional
components (containing less than a few dozen nodes), so that the small components can be removed without
losing a significant amount of information.
In order to increase the number of interactions which are correctly covered by an assembled PPI network,
the true positives, some studies have also included in silico predicted protein interactions obtained from
bioinformatics methods taking into account both structural information [118, 120] and the data sources
for inference of functional associations mentioned above. The prediction methods have been evaluated
using large reference sets of known interactions, and several published methods reach high test set accu-
racies [121]. However, the reference sets used for model training are incomplete and sometimes biased
(low-abundance proteins are typically neglected), and even if only high-confidence predictions are added
to a PPI network, the coverage is usually increased at the expense of a higher number of false positives.
Therefore, the choice of the methodology for constructing PPI networks, and thus the choice of the cover-
age/accuracy trade-off, should depend on the purpose of the higher level analysis method: For predictive
tasks relying more on high coverage than local accuracy, the inclusion of predicted interactions might im-
prove the performance, but for methods which aim at the biological interpretation of local structures in the
network, only experimentally verified interactions should be used in the input.
Since PPI networks are scale-free, i.e. their node degree distribution follows a power-law [122], the scale-
free property enables the estimatation of the percentage of covered protein interactions using a known
estimate of the percentage of covered proteins from the whole proteome of a studied species. These esti-
mates can help to guide the decision on whether methods to increase the coverage (see above) should be
applied, or whether the current coverage is sufficiently high.
Example integrative bioinformatics methods using protein interaction networks as data sources will be
discussed in the higher level analysis part of this survey (see below) and in chapters 6 and 7.
3.1.4 Gene/protein name standardisation
One of the most common data pre-processing tasks in the integrative analysis of functional genomics data, is
the standardisation of gene and protein names, i.e. the mapping of different identifier formats onto a single,
standardised format. This task is complicated by a multitude of naming conventions, which differ across
diverse biological disciplines and partly even contain ambiguities. These naming ambiguities include cross-
and intra-species ambiguity (e.g. the name “CAT” stands for different genes in cow, chicken, fly, human,
and other species), and ambiguities with general English words (e.g. the mouse gene “hair loss” or the fly
gene “lie”) and medical terms (e.g. the mouse gene “diabetes”, see [123] for more details and examples).
Moreover, further difficulties arise from several spelling variations used in the literature, which do not
adhere to any standards (e.g. “ABC-1” or “ABC 1” instead of “ABC1”).
In high-throughput data analysis, the situation is even more difficult, because the molecular identifier for-
mats do not only differ across the diverse branches of biology, but even across single experimental platforms.
For example, genetic probes on a microarray chip are typically named using platform-specific identifiers.
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Often some of these probes correspond to unknown genes with missing annotations and cannot be mapped
onto any standard gene identifier. Furthermore, in many cases genes are represented by multiple probes on
a chip; hence, it might be necessary to summarise the expression values for these probes for one gene into
a single value per sample (see Summarisation section above). These issues are not limited to genetic data,
but similar problems occur in the analysis of protein expression data.
The scientific community has recognised the problem of different and complex naming conventions, and for
most of the recent experimental platforms, mappings of the platform-specific identifiers to unambiguous,
standardised identifiers like the ENTREZ [124] or ENSEMBL [28] gene name format are directly provided
with the analysis software. However, the situation becomes more complex if the experimenter aims at
integrating data from very diverse and partly unstructured data sources, e.g. combining experimental data
with cellular pathway and process data, molecular interaction networks and information from the literature.
In this case, public gene and protein annotation databases typically only contain the necessary mapping
information for a subset of the identifiers occurring in the input data.
To address this problem, several gene/protein name conversion tools and web-services, which integrate data
from multiple public databases and recognise simple spelling variants, have been published in recent years.
These include the DAVID functional annotation web-service and database [29], the CNIO IDconverter web-
application [125], the MatchMiner database and web-tool [126] and the R/bioconductor software package
“biomaRt” [127,128], among others. For some applications, e.g. when considering data for a special species
or using articles extracted from the bioscientific literature within an integrative analysis method, even these
dedicated gene/protein name conversion services cannot provide sufficiently large dictionaries to obtain
enough correct mappings using both exact and approximate string matching. For these situations, text-
mining based systems for an automatic creation of synonym dictionaries have been proposed [129–132].
These approaches require both algorithms to address the task of finding gene/proteins mentions within full-
text articles, known as named entity recognition (NER), and to normalise the resulting gene/protein lists.
In contrast to the gene/protein name conversion web-services, these methods do not only use approximate
string matchings but also apply several string transformations. In some cases, they are also capable of
taking contextual information into consideration [133]. As part of the BioCreative competition [132,134], a
comparative evaluation of a multitude of corresponding techniques has been conducted for different model
organisms, with the highest ranked systems reaching a balanced 80% precision / recall or better. The current
approaches include machine learning methods [135–137], extensions of string matching using automatically
extracted dictionaries [138], rule based approaches [139] and integrative approaches combining multiple
methods together [140].
In the future, increased efforts to ensure the use of standardised identifiers for new experimental platforms
and to improve the annotation of the bioscientific literature (e.g. annotating the PubMed database with
MeSH keywords [141]) are likely to reduce the impact of the gene/protein normalisation problem signifi-
cantly.
3.2 Higher Level Analysis - Introduction
When all required pre-processing procedures have been applied to the data from a high-throughput biolog-
ical experiment, the resulting input data for all subsequent analysis steps is typically a continuous-valued
matrix with columns corresponding to the samples and rows corresponding to genes or proteins (or ge-
netic probes, in the case of microarray gene expression data). Using this input, and optionally additional
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biological data for an integrative analysis, the higher level analysis methods discussed in the following
sections mainly aim at the identification of important features (feature selection), the discovery of infor-
mative patterns and structures in the data (clustering), or the creation of predictive models (classification
and regression) for the biological interpretation of the data. Moreover, integrative extensions and modifica-
tions of these analysis types using additional biological data and algorithms from graph/network analysis,
optimisation and literature mining, can help to better understand the molecular processes of interest.
Depending on the biological question behind the experiment, the selection of the general type of analysis
method is often straightforward. In most cases unsupervised learning techniques should be applied when
patterns and structures like natural groupings of features (genes, proteins, etc.) or samples are to be identi-
fied in the data, and supervised learning techniques should be used, when labelled training data is available
and individual samples or genes are to be classified into one of several given biological categories. Typical
examples for the output generated by unsupervised learning methods are clusterings of samples to identify
tumour subtypes or clustering of features (genes, proteins or gene/protein groups) to identify molecules with
similar changes in the measured abundance across different biological conditions. Examples for supervised
learning results are the predicted memberships of new samples to certain sample groups (e.g. “tumour”
or “healthy”) or the predicted membership of genes to groups of functionally related genes. Another su-
pervised analysis task is the identification and selection of differentially expressed genes/proteins to find
molecules whose abundance differs significantly across different sample groups and which might therefore
be functionally related with the biological conditions of interest. If these conditions are disease-related
and, ideally, a large-scale experimental validation confirms the utility of certain molecules in the dataset
as biomarkers, this type of analysis can support the development of new assays for disease monitoring and
diagnosis.
Apart from these classical analysis types, new integrative methods which take additional biological knowl-
edge into account, e.g. to analyse the data in the context of cellular pathways and interaction networks, will
be considered in the last part of this survey.
3.3 Dimensionality reduction and feature selection
Dimensionality reduction and feature selection approaches are particularly useful for the analysis of datasets
obtained from high-throughput experiments like microarray gene expression profiling. For these datasets
the number of features (the matrix rows corresponding to genes or proteins) typically exceeds the number
of samples (the matrix columns corresponding to different biological samples) by approx. two orders of
magnitude, and a majority of the features is uninformative with regard to the biological question of in-
terest. Thus, in addition to the pre-processing methods discussed in the previous section, dimensionality
reduction methods are often also applied to identify or extract informative features and decrease the number
of features. Moreover, dimensionality reduction can also profitably be combined with integrative analysis
techniques, e.g. by grouping functionally related genes or proteins together using additional biological in-
formation before applying the reduction (see section on “Integrating Cellular Pathway Data” below and the
TSSP approach in chapter 7).
Here, two of the main types of dimensionality reduction methods will be reviewed in separate sections:
Unsupervised approaches, including both feature-preserving methods and feature extraction methods, and
supervised approaches, again including methods retaining the original feature definitions (also known as
feature selection methods) and supervised feature extraction methods. Supervised feature selection in
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particular, is a fundamental task in biological data analysis, as it enables the identification of diagnos-
tic biomarkers (genes, proteins or metabolites) corresponding to predictor attributes in the data, whose
abundance values enable a discrimination between different biological conditions of the samples. For this
reason, supervised selection methods will occupy the main part of this section, whereas unsupervised di-
mensionality reduction will be discussed first, but in less detail. A general overview of the feature selection
methodologies that will be the main focus in the following sections is given in figure 3.4.
Figure 3.4: Overview of generic feature selection methodologies and example algorithms, consisting of univariate and
combinatorial filters (left) and wrapper approaches (right).
3.3.1 Unsupervised filtering
Unsupervised dimensionality reduction approaches are often considered as pre-processing methods rather
than higher level analysis techniques. However, in the case of high-dimensional datasets, these methods
can already enable a first interpretation of the data using low-dimensional visualisations, often revealing
biologically meaningful groupings and other structures and patterns in the data.
Nevertheless, the main motivation behind these methods is to alleviate computational and statistical prob-
lems in the analysis of the data, summarised under the notorious expression curse of dimensionality [1].
This term describes data analysis problems related to the fact that the mean Euclidean distance between
points uniformly distributed in an n-dimensional hypercube as well as the mean distance from the centre to
the closest data point increase exponentially with the dimension n. Thus, if one considers a local, supervised
learning method like the k-Nearest neighbour approach applied to a data set with a uniform distribution of
data points, then for a higher dimensionality of the data set, the expectation is that exponentially more
training data points are required in order to find the same number of observations within a certain distance
of the query point [142]. Moreover, in higher dimensions, extrapolation will be required more often than
interpolation to make predictions, since uniformly distributed data points are expected to be closer to the
boundaries than to the centre of the input space. Although in microarray experiments the distribution of
data points in the feature space is often significantly different from the uniform distribution, this does not
always alleviate the dimensionality problem. Often some data points are clustered together locally, which
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simplifies the identification of groupings, but this advantage is compensated by a substantial degree of noise
masking the real intensity values.
Moreover, due to the high number of genes/proteins in most expression datasets, some of themmight appear
to be significantly differentially expressed in a subsequent supervised feature selection by mere chance, if
the hypothesis test used to select the features is not adjusted for the number of tests (an issue known as the
“multiple testing problem” [2,3]). Dimensionality reduction can alleviate this problem by either computing
a small number of derived features (feature extraction), covering the majority of the variance in the data, or
by removing features considered as uninformative by a filtering criterion (unsupervised filtering).
Unsupervised filtering can, for example, remove microarray genes which display a low variance and/or
low expression values across the samples in a dataset and are therefore regarded as uninformative. Early
microarray filtering approaches eliminated genes with a small number of two-fold differences to the mean
expression value [143], a small difference between the maximum and minimum expression value, or a
small variance across the samples [144]. However, for some functionally important regulator genes, small
expression level changes might still have significant biological effects, hence, these genes should not be
filtered out. Accordingly, recent analysis methods try to circumvent this filtering step or replace it by more
advanced techniques. These include a recently published parameter-free filtering method by Tritchler et al.
(COVSUM [145]), which avoids the removal of regulator genes with small variance in expression values, by
filtering genes depending on their covariance with other genes, rather than only their variance. This method,
which uses the sum over the absolute values in rows of the covariance matrix as the filtering criterion, and
replaces the manual threshold selection by a two-group clustering method, has been shown to perform well
for higher level analysis tasks on both simulated and real-world data.
A further alternative to simple filtering methods, is to select the most informative features in terms of their
contribution to the overall variance in the data, using information from feature extraction methods like Prin-
cipal Component Analysis (PCA). For example the sparse PCAmethod [146], which uses sparse vectors as
weights for a linear combination of the original variables, can help to remove genes with small information
content, by filtering out the genes with corresponding zero-entries in the first sparse principal component
vector. Other dimensionality reduction methods relying fully on feature extraction will be discussed in
detail in the section on unsupervised learning algorithms (see below).
Since class labels are available for most microarray datasets, more advanced supervised filtering methods
are often applied during a feature selection analysis (see next section). Thus, in current analysis approaches,
unsupervised filtering is mainly used as a pre-processing method for high level unsupervised analysis meth-
ods like clustering and network analysis and often completely circumvented for supervised analysis tasks.
Therefore, in the microarray data analysis software ArrayMining, from the integrative framework developed
as part of this PhD project, the sparse PCA and the COVSUM method have been integrated into the unsu-
pervised analysis modules, whereas other dimensionality reduction techniques are used for the supervised
analysis modules.
3.3.2 Supervised feature selection
Using only unsupervised filtering methods, the number of features in high-dimensional biological data can
typically not be reduced sufficiently to avoid statistical problems associated with the “curse of dimension-
ality”, and to obtain a compact and interpretable set of features as input for predictive model building.
Therefore, if labelled training data is available, supervised feature selection methods are invaluable both
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for the interpretation of the data and to find the most informative features in classification and regression
models. In this section, a brief introduction on the importance of feature selection for improving the in-
terpretability and complexity of predictive models in terms of finding an optimal bias/variance-trade-off
will be given, and then the two main types of feature selection methods will be discussed in detail: Filters,
relying on direct statistical measures of the informativeness of features, and wrappers, employing a search
algorithm and a statistical learning method to score feature subsets by evaluating predictive models built on
them.
Although a multitude of genes/proteins can be significantly differentially expressed across different bio-
logical conditions, predictive models containing only a small set of highly significant features rather than
all statistically significant features are often considered as preferable, because these models are easier to
interpret and the risk for model overfitting is reduced. Overfitted prediction models typically have a very
low bias and training error, but tend to display a higher variance resulting in a high generalization error and
poor test set performance. The objective of creating parsimonious models, also matches with the concept
of “Occam’s razor” [147], according to which simpler explanations of a phenomenon are always prefer-
able to more complex models, if there is no additional information favouring a complex model. Applying
a gene selection algorithm to obtain a reduced subset of informative genes decreases the complexity of a
prediction model built upon these features and will also reduce the generalisation error, if the simplified
model provides a better trade-off between the bias and variance contribution to the error (also known as the
bias-variance trade-off (see Fig. 3.5 for an illustration) [6].
Figure 3.5: Illustration of the bias-variance trade-off in statistical learning. Supervised feature selection can help to
reduce model complexity to obtain an optimal balance between bias and variance that minimises the expected test
error [6].
Although for the sake of structural clarity, feature selection and classification methods will be discussed
in different sections, from an algorithmic perspective, several studies suggest that applying feature and
model selection jointly provides better prediction results [148]. Therefore, after first reviewing supervised
filter methods, which are independent from prediction methods, wrapper-based methods combining feature
selection and prediction will be presented in a dedicated section.
Filter methods
Earlier microarray studies often made use of filter techniques, which try to identify informative subsets of
features using simple empirical statistical measures and hypothesis tests, without directly evaluating their
predictive power.
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Univariate filters: The most traditional feature selection methods are parametric and non-parametric uni-
variate filters, including the parametric student’s t-test, the non-parametric Wilcoxon-Rank-sum statistic,
the F-statistic, the signal-to-noise-ratio, the fold change and the correlation to the response variable (using
different association measures like the Pearson correlation, Spearman’s rho, Kendall’s tau, mutual informa-
tion, the normalised compression distance [149] or combinations of different measures). A more recently
introduced test statistic tailored specifically for microarray gene expression analysis is the empirical Bayes
log odds’ test statistic [150], which uses a shrinkage technique to shift the gene-wise sample variances
towards common values, reducing the effects of outliers (a moderated variant of this statistic additionally
obviates the need for estimating certain meta-parameters of the method [151]).
Most of these hypothesis tests used in filter methods require simplified assumptions, e.g. a parametric
student’s t-test relies on the assumption that the data is generated by sampling from normal distributions for
the features with common variance and tests the null hypothesis that the means are equal.
Importantly, when filtering a large number of individual genes using these methods, the significance crite-
rion needs to be adjusted for multiple testing [2] in order to restrict the expected number of false positives.
Corresponding methods requiring the assumption that the statistical tests are independent from each other
include the classical Bonferroni method [152], where the size of the allowable error α is simply divided
by the number of comparisons, and further developments like the Bonferroni-Holmes [153] approach and
the more recently introduced Benjamini-Hochberg method [3], which enables a direct control of the ex-
pected false discovery rate (FDR). Moreover, if the tests are assumed to be interdependent, the Benjamini-
Hochberg-Yekutieli procedure [154] provides an alternative means to control the expected FDR.
Margin-based feature selection: Using simple univariate filters in combination with multiple testing ad-
justments can already provide an experimenter with a wealth of statistically significant and biologically
meaningful information. However, especially when analysing complex genetic diseases, functional rela-
tions and interactions between multiple genes/proteins often influence the observed phenotype of the sam-
ples, and univariate methods cannot account for these interdependencies between different features. More
recently, several margin-based and combinatorial filters have therefore been developed. The margin is a
confidence measure for a classifier with regard to its decision on a single sample by computing the distance
from the corresponding data point to a decision boundary [155]. Margin-based feature selection methods
try to weight each feature to receive a maximal margin, and corresponding weighting methods have been
shown to be more robust against dependencies between attributes than the ranking scores of classical uni-
variate filters [156]. Other filters, which directly score the combined information from multiple features
on the outcome variable, or explicitly remove redundant features from the data, will be discussed in the
following section. Importantly, however, the capacity to consider global information or model feature de-
pendencies typically comes at the expense of a reduced speed and scalability in comparison to classical
univariate methods.
Among the margin-based filters, an example for one of the most popular methods in microarray analysis is
the RELIEF method [157] which iteratively adjusts feature weights according to the features’ capacity to
distinguish between the distances of randomly selected samples to their nearest neighbour with a different
class label (“miss”-sample) and the nearest neighbour with the same class label (“hit”-sample). Since the
classical RELIEF method is limited to two-class data without missing values, and is strongly affected by
noise, several extensions have been proposed (alphabetically named RELIEF-A, RELIEF-B, etc. up to
RELIEF-F [158]) which attempt to overcome these restrictions. The most recent extension, I-RELIEF,
additionally addresses the problem that in the original RELIEF algorithm the nearest hits and misses for a
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sample are defined in the original feature space and and not in the new weighted feature space [159].
In summary, margin-based feature selection methods are particularly useful in cases, when strong depen-
dencies are observed between different attributes, but the direct consideration of these dependencies using
combinatorial filters or wrappers (see next sections) would lead to a combinatorial explosion.
Combinatorial filters - (2) penalization and removal of redundancy: An alternative approach for tak-
ing feature-dependencies into consideration is to penalize redundant features, while searching through the
space of feature subsets rather than considering individual features independently. Hall’s Correlation based
feature selection (CFS) [160, 161] was one of the first attempts to exploit this idea, by identifying subsets
of features with a high average correlation to the response variable but low correlations amongst each other.
This concept is formalised by the following feature subset score:
CFS(S) =
kcr f√
k+ k(k−1)c f f
(3.12)
where S is the selected subset with k features, cr f is the average feature-class correlation and c f f the average
correlation between feature pairs in S. While the denominator reduces the score for correlated features to
eliminate redundant variables (minimising redundancy), the numerator promotes features with high corre-
lation to the class variable in order to retain them as discriminative predictors (maximising relevance). For
discrete features the symmetrical uncertainty can be used as a correlation measure, whereas for continuous
features usually the Pearson correlation is chosen as association measure. The CFS scoring function can in
principle be used in combination with any search algorithm to explore the space of feature subsets; however,
the original CFS publication proposed a fast greedy best-first search strategy as the method of choice [161].
A similar approach, explicitly removing redundant features, was introduced by Ding and Peng [4] as their
minimum redundancy - maximum relevance (MRMR) selection framework. They defined different mea-
sures for the relevance and redundancy of features using the mutual information (for discrete attributes) or
the F-test (for continuous attributes). For example, in the discrete case, the minimum redundancy is de-
fined as the minimum average mutual information across all pairs of features in a subset, and the maximum
relevance as the maximum average mutual information between the features and the outcome variable (i.e.
the known biological conditions for the samples, encoded as an ordinal variable). Using a greedy search
procedure and MRMR selection in combination with an SVM and a Naive Bayes classifier, high average
LOOCV accuracies were obtained on two binary-class and three multi-class microarray cancer datasets.
Combinatorial filters - (3) information theoretic measures: After the introduction of the CFS method,
other research groups aimed at providing improved combinatorial filters by employing measures from infor-
mation theory in the feature subset scoring function. For example, the balanced information gain (Bg) [162]
was proposed as an alternative to the CFS score to estimate the contribution of a feature for class separation:
Bg( fm) =
I(C| fm)
log2κ
(3.13)
where fm ∈ F is a numerical feature, C the class variable, I(C| fm) the information gain (also known as
Kullback–Leibler divergence or relative entropy) of fm with respect to C. The parameter κ is a penalty on
the bias of the information gain in the case of nominal features with many possible values (or numerical
features with high “discretization cardinality”, i.e. a high number of value ranges obtained when applying
an adaptive discretization procedure). Similar to the CFS approach, the authors used a forward selection
3.3. Dimensionality reduction and feature selection 41
algorithm to explore the search space of feature subsets, naming their approach efficient feature selection
(EFS). When evaluating the feature subsets obtained with EFS using a random forest based learning algo-
rithm (see Class Prediction section) on two microarray benchmark datasets for sample classification, EFS
provided significantly better accuracies than CFS on both datasets, while the number of used features was
similar.
Another fast filter method using an information theoretic measure was proposed by Zhang and Deng [163],
who estimated the goodness of a set of features as discriminative predictors by means of the Bhattacharyya
distance. This distance measure provides an upper bound of the Bayes minimum error probability [164]
and can therefore be used to derive informative criteria for feature selection to build predictive models.
Specifically, for two multivariate Gaussian distributions, their distance can be quantified as follows:
1
8
(M2−M1)T [∑ 1+∑ 2
2
]−1(M2−M1)+ 1
2
ln
|∑1+∑2
2
|√|∑ 1||∑ 2| (3.14)
While the first term scores the class separability according to the difference between the class means M1
and M2, the second term provides the separability derived from the difference between the class covari-
ance matrices ∑ 1 and ∑ 1. In contrast to the widespread assumption that feature selection and classification
should be considered in combination as a single optimisation problem to obtain the best predictive per-
formance, according to which wrapper-based methods (see next section) would be expected to outperform
filter methods, Zhang and Deng argue that the Bayes error is theoretically the best criterion to evaluate the
effectiveness of a feature set for classification and depends only on the feature space, not on the classifier.
Their method, the Bayes Based error Filter (BBF), takes the Bayes error indirectly into account for feature
selection by controlling its upper bound using the Bhattacharyya distance.
A further distance measure derived from information theory and used in many feature selection methods is
the mutual information (MI). The MI is a more general association measure than the Pearson correlation,
accounting also for higher-order dependencies between the selected features and the outcome variable,
and similar to the Bhattacharyya distance, it is related to the Bayes error. More specifically, Hellman and
Raviv [165] showed that an upper bound on the Bayes error E( f ) for a feature f is obtained by:
E( f )≤ 1
2
(H(C| f ) = 1
2
(H(C)− I(C,y)) (3.15)
where I(C, f ) is the MI between the class variableC and the feature f . Since this bound is minimised when
the MI is maximised, I(C, f ) is a valid approximation of the Bayes error. Another Bayes error bound using
the MI had been proven earlier by Fano [166]. A practical drawback of the MI is that it requires discretized
input variables or alternatively, a procedure for estimation of the entropy when using continuous variables.
When applying a discretization method, even if the assumption of an underlying group of nominal variables
for the features is valid, the risk of losing important biological information is high. However, discretization
procedures have also been employed successfully to remove noise in microarray data [167].
The MI measure can also be used to compute a normalised, symmetric variant of the MI, the symmetric
uncertainty (SU) [168], which is frequently used in microarray analysis:
SU(X ,Y ) =
2.0×MI
H(Y )+H(X)
(3.16)
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where H(X) is the Shannon entropy of variable X and MI the mutual information of X and Y .
An even more general association measure than the MI and SU, is the normalised compression distance
(NCD) [149], which is derived from the theory of Kolmogorov complexity [169] and in practice computed
from the lengths of compressed data files for single inputs and pairwise input concatenations. The NCD of
two objects (e.g. discretized gene or sample vectors) x and y is defined as:
NCD(X ,Y ) =
C(XY )−min(C(X),C(Y ))
max(C(X),C(Y )
(3.17)
where C(X) is the length of a compressed version of variable X and XY is the concatenation of X and
Y . Since the NCD only provides very rough approximations of the theoretically optimal normalised in-
formation distance (obtained when the compressor reaches the Kolmogorov complexity of the data), the
estimated distances can often be very inaccurate, especially for small input vectors. However, if non-linear
inter-dependencies between variables are to be captured, combining the NCD with other distance measures
can help to find improved predictors [170].
Another information theoretic attempt towards feature selection, which does not only rely on a special dis-
tance measure but on a formal framework for defining optimal attribute subset selection, is the Markov
blanket filter introduced by Koller and Sahami [171]. In agreement with other combinatorial filters like
CFS, the goal is to find feature subsets with maximised relevance with respect to an outcome variable and
minimised redundancy among the features. However, by modelling dependencies between features as a
Bayesian network, a new graph-based interpretation of redundancy, the Markov blanket, is obtained, pro-
viding an alternative method to remove redundant information from the feature space. A Markov blanket
for a node v in a Bayesian network (where the nodes correspond to the features and the edges to conditional
dependencies) is the set of nodes composed of v’s parents, children and its children’s parents. Figure 3.6
shows an example graph, where the nodes corresponding to the Markov blanket of node v have been high-
lighted in blue colour.

Figure 3.6: Example illustration of a Markov blanket in a sub-graph of a Bayesian network. The node v’s Markov
blanket is highlighted by blue colour and surrounded by a grey circle.
The Markov blanket is the only knowledge needed to predict a node’s behaviour; hence, a node which has
a Markov blanket can be removed from the network without losing any information. Thus, the idea behind
Markov blanket filtering is to start with the full set of features and iteratively remove features for which
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a Markov blanket is found within a greedy backward-elimination algorithm. Since there might not be a
full Markov blanket for every feature containing redundant information, a heuristic is applied to estimate
how close a candidate set Mi is to a Markov blanket and features that are approximately subsumed by the
information content of such a set are also removed. Candidate setsMi for a feature fi are the k features with
the largest magnitude of correlation to fi and the “Markov blanket likeness” is scored using the expected
cross-entropy of fi andMi. The main benefit of the Markov blanket approach is that it can remove redundant
features while still being more computationally efficient than most wrapper methods (see below). However,
the approach also has significantly higher computational demands than univariate filters.
Signal processing based methods: Although most feature selection methods apply association measures
on the original, untransformed data, the normalised compression distance (see above) is not the only exam-
ple using transformed data to assess the similarity/distance between different variables. Subramani et al.
showed that mathematical transforms from the field of signal processing, which are frequently used in im-
age and video processing, can also provide benefits in the feature selection domain [172]. When analysing
genes with the Haar Wavelet power spectrum of the gene vectors, they observed significant differences
between the spectra for different diagnostic outcome classes. Building upon these results, they developed
a new class separation measure and computationally simple and fast methods for gene selection and clus-
tering. Wavelet transforms have several advantages over other transforms in this context, as they provide
a lossless signal transformation with results that have good properties of localization both in time and fre-
quency. Especially the capacity of these transforms to spatially adapt to varying frequency behaviour can
be exploited for class distinction tasks in data analysis. The authors use the Haar wavelet because it consists
of very simple low- and high-pass filters and can be computed efficiently. A technical drawback of the Haar
wavelet transform is that it only accepts a number of input points corresponding to an integer power of 2. To
address this limitation, zeros can be appended at the right end of the input data, extending the lengths of the
gene rows to the next largest number x = 2n (a technique known as “zero-padding”). Using this approach,
Subramani et al. modelled the values of each gene across multiple samples (i.e. the input matrix rows)
as one-dimensional signals and applied the 1D-Haar transform on them to compute a local wavelet power
spectrum at different levels of detail of the signal decomposition (see [172] for details). Genes with a high
difference in the average spectra across the subsets are selected as predictors for classification. When com-
paring the best-ranked genes on real-world data against those obtained using classical selection methods,
the results revealed a high similarity. Therefore, the main benefit of this wavelet-based feature selection lies
in the very efficient computation of the feature ranks.
A further wavelet-based selection approach [173] used only a subset of orthogonal wavelet approximation
coefficients, in order to reduce the dimensionality of the input microarray data. In combination with a
genetic algorithm to explore the space of these compressed features, promising results where obtained
using a linear discriminant classifier on four benchmark datasets.
Recently, Nanni and Lumini extended previous methods by considering orthogonal wavelet detail coeffi-
cients from multiple wavelet types (Haar-wavelets, Daubechies, Symmlets and Coiflets of different orders,
among others) [174]. For each set of coefficients, a support vector machine was trained, and feature se-
lection was applied on the classifiers using Sequential Forward Floating Selection [175]. Using different
cross-validation schemes, areas under the ROC curve above 0.9 were obtained for four microarray datasets
when combining the selected SVMs into an ensemble.
Ensemble feature selection: Many approaches for microarray feature selection combine multiple algo-
rithms to exploit their different strengths, i.e. employ ensemble learning techniques. Although feature
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selection typically attempts to reduce the number of features used in a model, increasing model inter-
pretability and reducing model complexity, some researchers argue that in large-scale datasets often many
of the unselected features contain discriminative information that should be taken into account. Therefore,
in addition to classical techniques using the intersection set or a majority vote combination of results from
filter methods, various specialised ensemble approaches have been developed.
For example, Skurichina and Duin proposed to use ensemble learning with classifiers constructed on se-
quentially selected sets of features [176]. The general idea is to first determine an optimal feature subset
with respect to a given scoring function, then a second-best subset on the remaining set of features, and
iteratively repeat this procedure until all features have been assigned to one of several ranked subsets. The
ranked list of feature subsets is then used as input for an ensemble prediction method. This generic ap-
proach enables the experimenter to identify the most discriminative features, while at the same time taking
into consideration other less informative attributes. The authors conducted experiments with three types of
subset selection mechanisms (simple forward selection algorithms, Principal Component Analysis (PCA)
and random feature selection) on several real-world data sets, and observed that the mean classification error
of an ensemble of Linear Discriminant Analysis (LDA) classifiers was significantly reduced by additionally
considering low-rank feature subsets.
A more complex evolutionary search approach towards ensemble feature selection was adopted by Deutsch
[177] in the GESSES (genetic evolution of sub-sets of expressed sequences) algorithm. This method con-
structs an initial gene pool using a filter and applies an evolutionary algorithm using a statistical replication
operator (or alternatively deterministic evolution) and simulated annealing to evolve an ensemble of differ-
ent gene subspaces to provide an optimal set of k-nearest neighbour predictors (k-NN with k = 1) in terms
of a score closely related to the LOOCV-accuracy. GESSES provided competitive classification results on
four microarray cancer benchmark datasets, including a multi-class prediction problem, but the ensemble
models tend to be complex.
In summary, filters include many state-of-the-art feature selection methods, and especially combinatorial
filters, ensemble filters and signal-processing based methods provide informative attribute selections at low
computational costs, whose predictive power can often compete with wrapper-based methods, discussed in
the next section.
Wrappers and embedded methods
Filter-based feature selection methods are computationally efficient and provide attribute rankings, which
are useful for data interpretation and dimensionality reduction prior to the application of other higher-
level analysis methods. However, for the specific task of building predictive models for classification and
regression analysis, the filter-based scoring functions often only provide crude estimates of the combined
utility of multiple features.
As an alternative, wrappers directly combine the feature evaluation process with the chosen prediction
method by ranking feature subsets using the prediction results of the model built upon them. Wrapper
methods can account for effects of inter-correlations and redundancies among the feature variables and thus
remove redundant features from the selection that would unnecessarily be selected by a univariate filter.
Even in comparison with combinatorial filters, wrappers tend to select feature subsets with superior predic-
tive performance, because the filter-based scoring of feature subsets can only provide a rough estimate of
the relative scores to be expected in a direct predictive evaluation using the learning method of choice and
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an external test set. However, the benefits of wrappers for feature selection typically come at the expense
of higher computational costs, due to the expansion of the search space when considering combinations
of features, and the necessity to train and evaluate a predictive model for every subset evaluation. When
considering both algorithmic effectiveness, in terms of maximising the predictive accuracy, and efficiency,
in terms of minimising runtime, comparative evaluations suggest that filter methods tend to provide a better
trade-off between both goals [178]. In practice, the runtime problems associated with wrappers can how-
ever be alleviated by employing fast search algorithms or using simple or very efficient statistical learning
methods.
Ideally, the search algorithm’s balance between exploitation and exploration of the search space should
provide a quick convergence, but at the same time avoid entrapment in local minima. For microarray
datasets, fast search heuristics are used in most cases, since exhaustive search is already infeasible on
standard computers when the number of features is in the range of a few hundreds (the number of possible
feature subsets for n features is 2n−1 and n is typically in the range of thousands to a few ten thousands).
Therefore, filter methods are still widely used for microarray analysis, and for wrappers both the search
algorithm and the classifier are typically chosen to be as simple and efficient as possible to reduce the
computational costs.
Wrappers using efficient learners: One of the first prominent examples for wrappers employed in gene
expression data analysis was the method by Inza for gene subset selection based on a LOOCV scheme
and four machine learning algorithms (IB1, Naive-Bayes, C4.5 and CN2), evaluated on three benchmark
microarray cancer data sets [179]. The author used a simple sequential forward search (SFS) algorithm to
explore the feature subset space. When applying the supervised learning algorithms for classification, pre-
diction accuracies above 85% were achieved in all cases using less than seven genes as features. However,
the reported CPU times for the analysis (e.g. 203,053 seconds in the worst case) are often considerably
higher than usual runtimes required when using simpler filter methods.
An earlier attempt to use wrappers in microarray feature selection employed a k-nearest neighbour algo-
rithm (k = 3) in combination with a standard generational genetic algorithm (GA) [180]. This method
classified 33 out of 34 test samples in a leukaemia data set [181] correctly, using a training set of 38 sam-
ples. However, no cross-validation was applied and 50 genes were included in the prediction, after ranking
features according to the frequency of their selection in the GA. The strategy to compensate for a compu-
tationally expensive evolutionary search algorithm by employing a simple classifier was also adopted in an
alternative approach combining the fast Naive-Bayes classification algorithm with an Estimation of Distri-
bution Algorithm (EDA) [182]. Although EDAs are stochastic in nature like other evolutionary algorithms,
a robust selection of genes across different initializations was obtained in this study.
Instead of using simple and fast machine learning approaches like k-NN and Naive Bayes, more complex
techniques including regularised classification methods [183] can also be employed, if the algorithm or im-
plementation is particularly efficient. For example, Roth used a very efficient version of the Least absolute
shrinkage and selection operator (LASSO) [184] by Osborne et al. [185] and additionally extended it to
work with general loss functions (“Generalized LASSO”) [186]. The main benefits of the models with
l1-regularization obtained from this technique, are that they are mostly very sparse, easy to interpret and
provide posterior probabilities instead of only binary class labels as output. The method was tested on a
well-known leukaemia benchmark dataset using a Monte Carlo cross-validation procedure (200 randomly
chosen 80%/20% training/test set splits) reaching a comparatively low average error rate (0.025) for a low
average number of selected genes (24.4).
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Wrappers using efficient search methodologies: An alternative strategy to alleviate the problem of high
runtimes in wrapper-based feature selection is to use more efficient search space exploration methods, like
evolutionary algorithms, instead of simplifying the scoring function. In most of the corresponding ap-
proaches, solutions are represented by a binary bit-string with length equal to the number of features/genes
in the dataset, encoding selected features by 1, and others by 0. For example, a parallel genetic algorithm
(PGA) [187] has been proposed, using a two-criteria fitness function including the test set accuracy of a
correlation-based classifier and a penalty term for complex models proportional to the size of the selected
feature subset. Although this classifier is only applicable to binary class problems, the possibility to paral-
lelize the computation on separate CPUs enables further improvements in terms of runtime efficiency.
A genetic algorithm (GA) has also been used by Peterson and Thaut [148]; however, they applied a simple
GA in combination with support vector machines (SVM) with a 2nd order polynomial kernel or the radial
basis function (RBF). In their wrapper approach, the classification accuracy was evaluated using a stratified
10-fold cross-validation scheme on a Lymphomamicroarray dataset, resulting in 30 test sets to evaluate each
combination of parameter settings they tested. Overall, their feature selection method performed favourably
in comparison to using a full feature set and random feature subsets, but was not compared against other
selection schemes.
GA-based feature selection has been further extended by Ooi and Tan [188], who presented an approach
optimising both the features and the feature subset size automatically, using a maximum likelihood classi-
fication (MLHD) method as the scoring function. In contrast to previous GA-based selection approaches,
solutions have a more compact string representation, in which the first element R denotes the size of the
selected subset and the remaining entries the indices of selected genes up to a given maximum size Rmax
(Rmax can be larger than R, in which case only the first R entries are considered for classification). Using
extensive evaluations on real-world data, recommendations were derived for the choice of the selection and
crossover operator and other GA-parameters. The authors presented cross-validation and test set predic-
tion results on multi-class microarray benchmark datasets according to which their method outperformed
previous competitive approaches.
Finally, apart from evolutionary algorithms, fast greedy search approaches can be employed to decrease the
runtime, including both top-down approaches (eliminating one feature at a time) and bottom-up approaches
(adding one feature at a time to the subset selection). One of the most prominent examples for this type of
approach is the combination of linear SVMs with a top-down recursive feature elimination (RFE) selection
procedure [189], outperforming classical filters on several microarray datasets.
Embedded methods: Even with efficient scoring functions and search methodologies, wrapper-based at-
tribute selection is still computationally more expensive than other approaches. However, some prediction
methods enable an implicit selection of features by using internal model parameters for the selection, a
strategy termed as “embedded selection”. These methods are specific to the prediction algorithm and cou-
ple the feature selection tightly with the model generation, similar to wrapper approaches, but the runtime
is reduced drastically by avoiding the separate scoring of entire feature subsets and the search space explo-
ration.
The most prominent example for embedded feature selection is the decision-tree based random forest (RF)
[190, 191] classification and regression method, assessing the importance of features during the model
construction phase. In the RF approach this can be achieved by computing the Gini index [192], a measure
for the inequality of the class distribution across child nodes in a decision tree. In the domain of microarray
analysis the RF method has often been applied successfully [193, 194], although predictor correlations can
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lead to spurious signals in some cases [195].
Other embedded methods select features by using the weights assigned to attributes in linear prediction
models as feature scores. For example, such techniques can be applied to ridge regression [196] and regu-
larized logistic regression [197].
Wrapper/filter hybrids: Due to the benefits of wrappers in terms of predictive power, and the advantages
of filter methods in terms of efficiency, various research groups have presented hybrids of these approaches.
A prominent example is the two-stage hybrid proposed by Xing, Jordan and Karp [198]. In the first stage,
unconditional univariate mixture modelling was applied to fit a two-component Gaussian mixture model
using an EM algorithm to estimate an underlying binary state for each gene, and to filter genes according
to their mixture overlap probability (a redundancy-based filtering approach). The remaining features were
ranked and filtered again based on a mutual information selection scheme, and finally Markov blanket
filtering (see section on filters above) was used in the final pre-filtering step. The selected features were then
embedded into three different prediction methods (a Gaussian quadratic classifier, logistic regression and
k-NN using the Pearson correlation as distance metric) and evaluated on gene expression cancer data [181]
using both cross-validation and a training/test set partition. Although best error rates between 0% and 2.9%
were obtained, considering gene sets sizes between 2 to 100, a low number of 34 test samples and the
consideration of only one dataset limit the informative value of this comparison with other approaches in
the literature.
To improve upon the simple correlation and separation measures used as filters in the first stage of hybrid
approaches, C. H. Yang et al. proposed to combine an information theoretic measure related to the mutual
information, the information gain (IG) with a wrapper selection method. After the IG is used to pre-
select features, a simple generational GA with a 2-point crossover operator in combination with a k-nearest
neighbour classifier and LOOCV is employed for the final selection task. On 8 of 11 microarray cancer
benchmark datasets, the IG-GA method achieved the highest test set accuracy in comparison to ten other
commonly used algorithms (no comparison using cross-validation was carried out).
Similarly, Akadi et al. proposed the use of a combinatorial filter, MRMR (Minimum Redundancy-Max-
imum Relevance, see section on filter methods), as an extension of univariate filters in combination with
a GA-based wrapper [199]. By combining this methodology with the Naive Bayes method and SVMs as
scoring functions in the GA, LOOCV accuracies and gene set sizes obtained on five microarray cancer
datasets were superior to those reached by the independent application of the filter and wrapper methods.
Recently, hybrid selection methodologies have also employed ensemble selection approaches in both the
filter and wrapper algorithms. Leung and Yong presented a multiple-filter-multiple-wrapper (MFMW)
method, combining 3 filters (signal-to-noise ratio, t-statistic and Pearson correlation) and three classifiers
(weighted voting, k-NN and SVM) [200]. The ensemble of filters was obtained by computing the union list
of selected genes, while the ensemble of wrappers resulted from selecting gene sets with minimal number
of wrong or undecided predictions according to a unanimous voting scheme for classification. The authors
showed that MFMW outperforms corresponding SFSW techniques in all cases on six benchmark datasets
in terms of the average LOOCV accuracy.
In summary, wrappers and embedded methods typically have the capacity to provide feature subset se-
lections with superior prediction performance (given the chosen classification method) than filter-based
approaches. However, in terms of cost-efficiency and with a limited runtime in most practical scenarios,
filters are often the method of choice [178], and especially if combinatorial filters or filter ensembles are
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used, high performance can still be achieved at relatively short runtimes. Moreover, to fine-tune the balance
between performance and runtime, filters and wrappers can be combined flexibly in hybrid approaches, pre-
processing the data with filters and then exploiting the efficiency of wrappers. In the future, as multi-core
CPUs become more affordable, parallelized wrappers are likely to make the direct application of wrap-
pers on unfiltered datasets more practically feasible, allowing experimenters to avoid potential performance
bottlenecks of simple pre-processing filters.
3.4 Class Discovery (Unsupervised Machine Learning)
Apart from identifying informative genes, proteins or metabolites in large biological datasets using fea-
ture selection methods, another frequently occurring task for machine learning methods is to address the
question whether biologically meaningful groupings of similar samples or features occur within the data.
Unsupervised learning methods aim at the identification of such interpretable but non-trivial groupings and
structures in the data. In contrast to supervised analysis techniques for predictive model generation, un-
supervised methods do not require any training data with class labels or numerical outcome variables, but
are also incapable of using this information, if it is available. However, clustering methods, which rep-
resent the most prominent class of unsupervised learning algorithms, often provide an intuitive means for
classification, e.g. by labelling new samples according to their distances to the cluster centroids.
In microarray analysis, both the genes and the samples can be clustered depending on the goal behind the
experiment. Clustering of sample vectors is used to identify natural groupings of similar samples (e.g.
groups of biological samples representing different tumour subtypes), whereas clustering of feature vec-
tors can help to discover genes/proteins with similar expression patterns, which might point to functional
associations.
In this section, apart from classical partition-based and hierarchical clustering techniques, more recent un-
supervised methods will be reviewed, which abandon the assumption that the data can be grouped into
distinct, non-overlapping classes. These approaches model internal structures in the data as probabilistic
mixtures or overlapping processes and assign probabilities for the membership in different classes to each
instance. Importantly, the multitude of existing clustering methods is also complemented by several ap-
proaches to analyse the validity of clusters. These techniques are reviewed in detail here, because often a
multitude of informative patterns can be identified in the data using different clustering methods and param-
eters, and validity measures enable an evaluation of the significance of the identified structures. However,
no gold standard for the validation of clustering result exists, hence, this survey will also provide guidance
on how to compare and combine multiple clustering methods and validity measures to obtain more robust
and reliable results. Figure 3.7 shows an overview of different categories of clustering approaches that will
be discussed in the next paragraphs, as well as some of the representative algorithms.
Clustering approaches and related methods
In the literature, three general categories of clustering algorithms are typically distinguished [6]:
• Combinatorial algorithms are methods operating directly on the observed data, i.e. without using
derived latent variables or probabilistic models. These algorithms belong to the most frequently
used techniques; however, they are not designed to model overlapping groupings and require the
specification of a pre-defined number of clusters.
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Figure 3.7: Overview of unsupervised learning methods (non-comprehensive)
• Mixture modelling approaches assume that the data points are samples drawn from a certain proba-
bility distribution. Their density is described by a parametric mixture model, which can for example
be fitted by a maximum likelihood approach.
• Mode seekers (or bump hunters) are methods which try to structure the data by identifying distinct
regions of high data density, separated by low density regions.
The last type of methods, density-based approaches, will not be considered in detail here, because although
some microarray clustering approaches rely mainly on the analysis of data density [201], the results are
often difficult to interpret in high-dimensional spaces and most of these methods are not yet widely used by
microarray experimenters.
Apart from the algorithmic categories above, another line of distinction can be drawn between partition-
based clustering methods, searching for data partitions which optimise a certain merit function, and hier-
archical clustering methods, iteratively dividing or merging clusters in a hierarchy of clustering levels, by
starting with a single large cluster for the entire data set (top-down approach) or many small clusters for
each data point (bottom-up approach) [202]. Importantly, many clustering techniques are at the same time
dimensionality reduction methods, since mapping the data into a lower-dimensional space can facilitate
both the group separation task and the interpretation for the user (see also the discussion of the “curse of di-
mensionality” in the section on feature selection). More recently, links between graph/network analysis and
clustering techniques have been discovered and exploited in graph-theoretical clustering methods, which
will also be discussed in the method overview in the following section.
Combinatorial algorithms: One of the earliest and simplest combinatorial, partition-based clustering
methods is the k-Means algorithm, which in spite of its simplicity has been shown to be highly effective in
many practical applications. Starting with a given assignment of the data points to a pre-defined number of
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k clusters (e.g. a random assignment), a two-step iterative procedure calculates the cluster centroids (i.e. the
averages of the cluster member coordinates) for the current assignment, re-assigns the data points to their
nearest cluster centroid, and then iteratively repeats this procedure until convergence or a maximum num-
ber of iterations is reached. The objective function minimised by k-Means is the sum of squared distances
between data points and their associated cluster centres.
Different variants of this general k-Means clustering scheme have been developed by Hartigan and Wong
[203] (often regarded as the “standard” k-Means algorithm), MacQueen [204], Forgy [205] and Lloyd [206].
In spite of the success of these methods, an important general limitation of all k-Means variants is the strong
dependency of the output on the initialisation. If random assignments are used, the procedure should be
repeated several times with different initialisations to avoid entrapment in local minima of the objective
function. If the number of clusters k is unknown, cluster validity measures (see section below) can be used
to identify a suitable value for this parameter. However, there are many different ways to define optimality
for cluster separations, and since there might be multiple biologically meaningful structures in the data, it
is recommendable to consider several different solutions.
K-medoids is a robust variant of k-Means usingmedoids instead of centroids as an alternative representation
of the cluster centre. The medoid for a cluster is the data point closest to all other (current) members of
the cluster with respect to a given similarity measure. After starting with an initial cluster assignment, the
algorithm iteratively calculates the medoids for the current assignment and then re-assigns observations
to the cluster of their closest medoid. Using medoids instead of centroids as cluster centres reduces the
influence of outliers on the final cluster assignments and therefore tends to provide more robust clustering
results. Moreover, any (dis-)similarity matrix will suffice as input for the algorithm, and the Euclidean
distance does not necessarily need to be used as a distance metric. However, a significant practical drawback
for high-dimensional data is that the runtime for computing the cluster medoids is quadratic in the number
of data points.
A further robust alternative to the k-Means algorithm is the Partitioning around medoids (PAM) clustering
method [207]. In contrast to k-Means and similar to k-Medoids, PAM minimises a sum of within-cluster
dissimilarities instead of a sum of squared Euclidean distances, using medoids as robust cluster centre
representations. Accordingly, a proximity matrix is required as input, which can be computed from the
original data using a distance measure of choice. The PAM algorithm clusters the data in two iteratively
repeated phases: In the “Build”-phase, k initial medoids are selected, typically by choosing k centrally
located data points. In the subsequent “Swap”-phase, the sum of within-cluster dissimilarities is reduced
iteratively, by considering all possible pairings of a medoid with a non-medoid data point and swapping
their roles if this reduces value of the objective function. This swapping process continues until no further
reduction is possible. Similar to the K-Medoids approach, a quadratic runtime complexity can render the
application of PAM infeasible for very large data sets, but extensions of PAM like CLARA [207] and
CLARANS [208] using sampling techniques with improved efficiency have been developed to address this
problem.
Apart from these k-Means and k-Medoids derived algorithms, the group of partition-based clustering meth-
ods also contains approaches involving dimensionality reduction of the data. A prominent example which
is frequently used for microarray analysis is the Self-Organizing Map (SOM) approach by Kohonen [209].
SOMs provide easily interpretable low-dimensional visualisations of the clustering results, however, the
selection of suitable parameters is often difficult. The SOM procedure maps the data points into a low-
dimensional topological map according to their closeness to overlaid prototype grid points in the map.
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More precisely, a SOM can be generated using the following online pseudocode algorithm:
1. choose a random data point xi
2. find the prototype m j on the grid that is closest to xi
3. for all neighbour prototypes mk of m j (neighbours = points within user-defined Euclidean distance
threshold r): Move mk into the direction of xi, so that the magnitude of the movement is proportional
to the distance between mk and xi and to a learning rate parameter α (mk += α(xi−mk))
4. reduce the learning rate α and the distance threshold by a small amount and repeat the procedure
iteratively
If a small enough value is chosen for threshold parameter r, such that every neighbourhood only con-
tains one data point, this algorithm corresponds to an online version of k-Means with an additional low-
dimensionality constraint. This inherent low-dimensionality constraint in SOM can however also limit the
applicability of the method, since significant errors might be introduced due to the dimension reduction.
When calculating this “reconstruction-error” for k-Means- and SOM-models after dimensionality reduc-
tion, the error is generally smaller for k-Means, but as long as the difference to k-Means is not large, SOMs
can still be used effectively.
Mixture modelling and fuzzy approaches: Apart from these classical clustering algorithms, mixture
modelling methods have been developed, which are often inspired by the closely related original k-Means
method. One of the most prominent examples is the Gaussian Mixtures approach derived from the concept
of Gaussian mixture models (GMM), which has already been employed for several other purposes includ-
ing density estimation. In the context of unsupervised learning, a Gaussian mixture can be understood as a
“smoothed” variant of k-Means clustering, where every class (i.e. every biological condition) is modelled
by a multivariate Gaussian function and the samples are assumed to be drawn from a mixture of these dis-
tributions. Importantly, each data point can be generated by choosing one of these functions with a given
probability, hence, observations are considered to belong to a specific class only with a certain probability.
Mixture modelling based clustering extends the k-Means algorithm by replacing the two iteratively repeated
centroid-computation and membership-assignment steps by the two steps of an EM-algorithm: The expec-
tation step (E-step) computes the expected values for the so-called “responsibilities” of all data points (i.e.
estimates of the conditionals p(zi|x j), for the mixture component zi and observation x j, given a model with
M components and N observations, with i ∈ M and j ∈ N) using the current parameter estimates for the
distributions. These responsibilities are then provided as input in the maximisation step (M-step) to update
the distribution parameters, which enter the next iteration until convergence is observed.
An alternative possibility to account for contradicting evidences for the assignment of observations to dif-
ferent clusters is Fuzzy clustering. Instead of assigning the samples to crisp sets, a partial membership to
several categories is estimated and expressed by membership functions taking values between 1 (full mem-
bership) and 0 (no membership). The Fuzzy C-Means (FCM) algorithm [210] is a typical representative of
these fuzzy clustering approaches, minimising the following objective function:
J(U,V ) =
C
∑
i=1
N
∑
j=1
umikd
2
ik (3.18)
where d2ik = (xk− vi)T (xk− vi) corresponds to the squared Euclidean distances between the data points xk
and the cluster centres vi (stored in matrix V ), uik are the membership degrees (stored in matrix U), C is
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the number of clusters and N the size of the data set. The so-called “fuzzifier” m is a user-defined trade-
off parameter with a value greater than 1, determining the balance between crispness and fuzziness (also
known as “sharpness”). The smaller the value of m (i.e. the closer m is to 1), the closer the membership
values uik will be to 0 or 1, and the greater the value of m, the more similar the membership values become
(in practice m ∈ [1,2.5] is often used [211]). Similar to k-Means, the optimisation algorithm is using an
iterative two-step procedure, minimising the objective function.
Hierarchical algorithms: If the experimenter assumes that the data might have an underlying hierarchical
structure, which is often the case for transcriptome and proteome datasets due to the regulatory effects of
transcription factors and signalling proteins, hierarchical clustering approaches can be used as an alternative
to partition-based methods. The main benefits of hierarchical clustering schemes are that they do not require
a pre-specified number of clusters as input parameter and provide easily interpretable tree visualisations
(dendrograms) of the clustering results. A dendrogram is a rooted tree, where the root represents the entire
data set, the inner nodes correspond to the cluster of all their children and the leaves stand for single data
objects.
In microarray analysis, a hierarchical clustering is often applied to both the samples and features, and the
resulting groupings of sample and feature vectors in the expression matrix are visualised in a heat map,
coloured according to expression value ranges (see an example in figure 3.8, containing a dendrogram for
the genes (left vertical axis) and samples (top horizontal axis)).
However, the applicability of these methods is limited by the assumption that the data has a hierarchical,
tree-like structure. Since only n-1 parameters are required to describe the cluster dendrogram for a data set
with n observations, a problem arises from the potential loss of information that can occur when transform-
ing the original dissimilarity matrix (requiring n(n-1)/2 parameters for its description) into a dendrogram.
In order to verify the validity of the assumption that the data has a tree-like structure and only a negligible
information loss occurs due to the transformation into a dendrogram, the “tree-likeness” of the pairwise
distances in the dataset can be estimated with the cophenetic correlation coefficient (CCC). The CCC is the
correlation between the original dissimilarities of observations in the distance matrix and the “cophenetic
dissimilarities” in the final tree, i.e. the inter-group dissimilarities determined by searching the smallest
common ancestor of two data objects in the dendrogram. If a CCC close to 1 is obtained, the calculated
dendrograms can safely be assumed to provide a good representation of the original input data.
In order to build a clustering dendrogram, two alternative strategies can be adopted. The top-down (or divi-
sive) approach starts with a single cluster containing the entire dataset and iteratively divides clusters into
the subclusters with the largest between-cluster dissimilarity. By contrast, the more common bottom-up (or
agglomerative) approach is initialised with a cluster for every single object and iteratively combines clusters
with the smallest between-cluster dissimilarity. Several measures for the between-cluster dissimilarity have
been proposed in the literature, e.g. the minimum distance between two members from different classes
(Single Linkage (SL)), the corresponding maximum distance (Complete Linkage (CL)) and the average
distance (Average Linkage (AL)).
AL-based clusterings tend to be superior to SL- and CL-based results, providing more compact clusters and
avoiding concatenations, but at the expense of higher runtimes. Further alternative agglomerative clustering
methods includeWard’s minimum variance method [212], which tries to find spherical and compact clusters
(often similar to the CL-clusters) and McQuitty’s Similarity Analysis by Reciprocal Pairs [213], which
merges clusters with highest average similarity until the similarity measure between every pair of clusters
is less than a predefined cut-off. In order to choose the best clustering method for a specific dataset, the
3.4. Class Discovery (Unsupervised Machine Learning) 53
samples
GATA3
 BTF3
C1orf64
AGR3
CA12
ESR1
CIRBP
TBC1D9
EVL
KDM4B
IGF1R
TTC8
MYB
VAV3
S100A8
C6orf115
SOD2
ACTR3
PSME4
CMYA5
SOX11
PSAT1
CHAC1
GFRA1
 KCNK15
RERG
DNALI1
KCTD6
SYTL4
WRD19
ge
ne
s
Heat map − AL hierarchical clustering
−2 2
Row Z−Score
Color Key
Figure 3.8: Example heat map created for 128 breast cancer microarray samples and 30 genes analysed in collaboration
with the Queens Medical Centre in Nottingham [19] (see chapter 8 for details). Both the samples and the genes
are clustered using average linkage hierarchical clustering with a Euclidean distance metric. The sample columns
highlighted in blue and red correspond to two different clinically relevant tumour subtypes (blue = luminal group,
red = non-luminal group; since the genes were selected in a supervised manner, the clustering was only applied for
visualisation purposes).
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experimenter can compute the cophenetic correlation coefficient to compare the different approaches.
For divisive clustering, which is less frequently applied than agglomerative techniques, a separation rule
to split parent clusters into child clusters can be obtained using an iterative k-Means or k-Medoids clus-
tering with k = 2. An interesting, parameter-free alternative is the Macnaughton-Smith algorithm [214].
This approach places the observation with the largest dissimilarity to all other items in the initial cluster
(G) into a new cluster (H), and iteratively moves the members from cluster G with the highest difference
between the average dissimilarity to G and to H (dissim(G)-dissim(H)) to cluster H, until this difference
becomes negative. This procedure is repeated by selecting the cluster with the largest diameter and dividing
it analogously into two sub-clusters until all elements are assigned to a different cluster, and a complete
dendrogram has been built.
A more recently developed, related method is the Cluster Affinity Search Technique (CAST) [215], which
improves upon previous greedy search based hierarchical clustering methods by allowing the algorithm to
alter cluster assignments even when there are no more unassigned observations left after an initial greedy
cluster construction. Specifically, in a special “REMOVE-step”, cluster members are moved back to the set
of unassigned objects, if their average similarity to the other cluster members falls below a given threshold.
This technique decreases the risk that the objective function, the sum of pairwise dissimilarities within the
clusters, converges to a local minimum.
However, in contrast to the fuzzy clustering extensions of partition-based clustering methods, classical
hierarchical methods cannot model uncertainty in the data. Therefore, more recently, hierarchical clustering
has been extended to provide a probabilistic model of the data using a Bayesian approach [216, 217]. This
Bayesian agglomerative clustering method does not only account for the uncertainty in the data, but also
frees the user from the choice of a distance metric and the selection of parameter values, by using Bayesian
hypothesis testing to decide on cluster merges. The algorithms runs in polynomial time, consisting only of
a one-pass bottom up merging procedure, and has provided new biological insights on microarray data for
the plant model organism Arabidopsis thaliana [217].
Ensemble/hybrid approaches and other techniques: Similar to the feature selection domain, where hy-
brid and ensemble approaches have outperformed many of the traditional algorithms, the ideas of combining
the outputs from multiple methods (ensemble/consensus approach) or sharing information between differ-
ent algorithms running in parallel or sequentially (hybrid approach) have also been applied to the clustering
problem.
The simplest ensemble clustering techniques, apply the same clustering algorithm multiple times with dif-
ferent parameters and aggregate the results. For example, the recently proposed MULTI-K algorithm [218]
applies the k-Means method several times, sampling the number of clusters from a uniform distribution be-
tween a chosen minimum and maximum number of clusters. The clustering results are modelled as graph,
where the nodes represent observations and the edges between them receive weights, increasing by 1, each
time the corresponding nodes are clustered together. After completing this weighting procedure, all positive
edge weights are iteratively reduced by a unit weight until they are zero (i.e. the nodes are disconnected),
so that the graph is progressively decomposed into smaller connected components. By plotting the number
of reverse weight reduction steps (y-axis) against the number of divided sub-graphs (x-axis), resulting in a
so-called “cut-plot”, robust cluster structures can be identified as long horizontal regions in this plot, and
the y-axis value for the longest region is the estimated number of clusters. When comparing these clusters
with those obtained by traditional clustering methods using the adjusted rand index with known outcome
classes (see section on validity measures below), MULTI-K tends to provide superior results [218].
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The most common ensemble clustering methods count and compare the cluster associations of sample
pairs across the base clusterings to calculate a similarity matrix or graph (some approaches also use the
synonyms agreement [12], consensus [11] or co-association matrix [219]). The final clustering is then
obtained by applying a function that integrates the information from the matrix into a single ensemble
clustering result (e.g. using fuzzy k-means or hierarchical clustering). In contrast to this pairwise sam-
ple similarity based approach, other research groups have tried to integrate multiple clustering results by
analysing sample-cluster relations. They introduced the binary cluster-association matrix, in which the
rows represent the samples and the columns the clusters in different clustering solutions (given a fixed
number of clusters), setting the matrix entries to 1, if a sample was assigned to the corresponding cluster,
and 0 otherwise [220, 221]. Although good consensus clustering results have been obtained both using
similarity matrices and cluster-association matrices, relations between the clusters are ignored in both ap-
proaches. Therefore, more recently, the link-based cluster ensembles (LCE) method has been developed as
an extension of the above ensemble clustering techniques. LCE summarises the information from multi-
ple clustering results and additionally identifies and preserves associations between the clusters [222, 223].
Using the binary cluster-association matrix (BM, see above), which contains crisp associations between
samples and clusters, a refined cluster-association matrix (RM) is computed by taking into account the sim-
ilarity between clusters. These similarities are used to refine the binary assignment of samples to single
clusters (1 = “known association”, 0 = “unknown association”) into probabilistic real-valued assignments
to multiple associated clusters. While all entries in the original BM equal to 1 are preserved, the zero entries
are replaced by the similarity between the corresponding clusters and the cluster with value 1. This cluster
similarity is estimated using a new link-based algorithm operating on a graph representation of the BM
(vertices = clusters, edge weights = number of shared samples / number of sample in both clusters) and the
Connected Triple method [224].
Apart from combining multiple clustering results using consensus techniques, increased robustness can also
be achieved by combining different search methodologies within the algorithm, e.g. using hybrids of mul-
tiple optimisation techniques. For example, Marinakis et al. have presented a clustering approach, merging
an evolutionary algorithm (Honey Bees Mating Optimization Algorithm, HBMO) with the Greedy Ran-
domized Adaptive Search Procedure (GRASP) [225]. This method is also an example for the combination
of unsupervised feature selection (using HBMO) with clustering (using GRASP).
In summary, depending on the nature of the data, partition-based, hierarchical and mixture modelling ap-
proaches towards clustering are all capable of providing new biological insights in microarray data analysis.
More recent extensions employing hybrid or consensus techniques, exploit the benefits of different types
of clustering algorithms, data representations and dimensionality reduction methods in order to find cluster
structures which are more robust with regard to noise. Although some clustering methods can also auto-
matically determine the optimal numbers of clusters or processes, the computation of validity indices is still
required for validation purposes (see next section).
Cluster validity / Selection of the number of clusters
For clustering methods relying on a fixed number of clusters or processes, regardless of whether cluster
assignments are crisp or whether the clusters can overlap, the selection of the number of these groupings
is a key parameter of the algorithm. Using many clusters could result in artificially separated data points
with similar properties, whereas creating few clusters might force the algorithm to group very dissimilar
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objects together. In both cases, more biologically meaningful, inherent structures in the data could remain
concealed due to an inadequate parameter selection. Thus, the outcome for different parameter choices
should be compared and validated objectively.
For this purpose, several cluster validity indices have been proposed. These measures and the main ideas
behind them can be grouped into three categories [226]:
• internal validity measures using cluster compactness/division: quantifying cluster homogeneity and
separation
• internal validity measures using cluster robustness: assessing cluster stability and reliability based
on p-values
• external validity measures: assessing the agreement with a reference partition, requiring external data
as a “ground truth”
Since these validity measures could theoretically be used both for parameter optimisation and for the vali-
dation and comparison of the final clustering with other methods, the experimenter has to make sure not to
use the same or related measures for both of these purposes.
Compactness/division-based measures: The homogeneity- and separation-based methods score the sim-
ilarity of objects within a cluster and/or the dissimilarity of objects across clusters. Depending on the sim-
ilarity matrix provided as input, the most common validity measures combine similarities of single pairs
of observations into an overall similarity score for cluster pairs by just averaging pairwise similarities. A
less computationally expensive alternative for high-dimensional data is to only consider the average simi-
larity of the cluster centroid/medoid to the remaining cluster members. Moreover, after having computed a
homogeneity score for single clusters and/or a separation score for a single cluster-pair, the corresponding
measures for a complete clustering result can analogously be obtained by averaging over all clusters (or
respectively, all cluster pairs).
One of the most frequently used validity measures combining both within- and between-cluster dissimilarity
is the average silhouette width [227]. For an object i assigned to a cluster A, the silhouette width s(i)
is computed using the average dissimilarity of i to all other objects of A (termed a(i)) and the average
dissimilarity of i to all objects of the nearest neighbour cluster (termed b(i)):
s(i) =
b(i)−a(i)
max(a(i),b(i))
∈ [−1,1] (3.19)
An observation i with a score s(i) close to 1 has a high between-cluster dissimilarity in relation to the
within-cluster dissimilarity and would be considered as well assigned, whereas a value for s(i) close to -1
is a strong indication for a wrong assignment. Accordingly, the higher the average silhouette width S¯ across
all objects, the higher the confidence for the overall clustering result. An estimate of the “optimal” number
of clusters k, in terms of homogeneity and separation) can therefore be obtained by choosing the k that
maximises S¯.
A similar measure, the Dunn index [228], computes the ratio between smallest inter- and largest intra-
cluster distance. Formally, for a given clustering, where ci represents cluster i, the Dunn index D is defined
as follows:
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D= min1≤i≤n
{
min1≤ j≤n,i 6= j
{
d(ci,c j)
max1≤k≤nd′(ck)
}}
(3.20)
where d(ci,c j) is the inter-cluster distance between clusters ci and c j, d
′(ck) is the intra-cluster distance of
cluster ck and n is the number of clusters.
Another popular compactness-based validity index is the C-index [229] which can be computed as follows:
C =
S−Smin
Smax−Smin (3.21)
where S is the sum of distances over all pairs of objects from the same cluster. If the number of these
pairs is l, then Smin is the sum of the l smallest distances, considering all pairs of objects (including objects
assigned to different clusters), and accordingly, Smax is the sum of the l largest distances across all pairs.
Since a good cluster should be as compact as possible, and the compactness of a cluster is represented by S,
with the worst-case being S= Smax, the smaller the average ofC across all clusters, the better the clustering
result.
Finally, one of the statistically most effective internal cluster validity indices is theCalinski-Harabasz index.
This index (G) performed best among 30 indices evaluated on synthetic datasets in a well-known study by
Milligan and Cooper [230] and is defined as follows:
G= B
c−1/
W
n−c (3.22)
where B is the sum of the squares of the distances between the cluster centroids and the mean of all objects
in all clusters (“between-cluster sum of squares”),W is the sum of the squares of the distance between all
objects and the class centroid to which the object belongs (“within-cluster sum of squares”), n is the total
number of features and c is the total number of clusters. Again, this validity measure relies on maximising
the between-cluster distances and minimising the within-cluster distances (i.e. the larger the score, the better
the clustering result), and also accounts for the number of clusters c, so that the score does not improve with
increasing c.
A fundamentally different approach towards cluster validity assessment is employed by the Gap statistic
[142], proposed by Tibshirani et al., which makes use of a reference distribution as a null model. The idea
is to compute the change in cluster dispersion, measured as the pooled within-cluster sum of squares around
the cluster means in terms of the Euclidean distance, for different numbers of clusters k, and compare it to
that expected under an appropriate null distribution. The parameter k is then chosen such that the difference
between the observed value and the null model, called the gap, is maximal. A high gap indicates a clustering
result with high significance (for a theoretical motivation, see [142]). Moreover, a simulation study for a
uniform reference distribution showed that the Gap statistic outperforms many other well-known validation
methods from the literature.
Robustness-based measures: Stability-based validity measures evaluate how robust a clustering result is
against noise or removal of data. These measures are computed by creating new artificial datasets, removing
single columns from the original data, or introducing artificial noise into the data, and comparing the new
clustering results with the original result using a cross-classification table. For example, the average pro-
portion of non-overlap (APN) is the average percentage of observations which are placed in diverse clusters
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in both results, the average distance (AD) measures the average distance between samples assigned to the
same cluster for both results, and similarly, the average distance between means (ADM) represents the av-
erage distance between cluster centroids. Another stability measure is the figure of merit (FOM), which is
given by the average intra-cluster variance of a randomly removed observation, according to a clustering
with the remaining samples. Thus, by choosing the clustering parameters such that the APN, AD, ADM
and FOM measures are minimised, a more stable and reliable clustering result can be obtained (see [231]
and [232] for more details and implementations of these validity indices).
Agreement with a reference partition: Another group of methods, which are often also referred to as
“co-clusteredness” indices, can only be used when a reliable, external reference partition of the samples is
available. In this case, a new clustering result can be evaluated by a measure for the similarity between the
clustering output (C) and the reference partition (P) as a “ground truth”. These methods are for example
used to evaluate new clustering methods on data sets for which a good clustering result is already available
(e.g. obtained from another algorithm), or to check whether a categorisation of the samples by human ex-
perts (e.g. clinical tumour grades for cancer patients) matches to natural groupings within the experimental
data, identified by a clustering method.
In order to compare clustering partitions, a n× n binary matrix C can be built (n = number of instances),
settingCi j = 1 if instance i and j belong to the same cluster andCi j = 0 otherwise (and analogously, matrix
Pi j can be obtained from the reference partition). By counting the number of true positive matches TP for
these matrices (where Ci j = Pi j = 1) and respectively, the true negatives (TN, Ci j = Pi j = 0), false positives
(FP, Ci j = 1,Pi j = 0) and false negatives (FN, Ci j = 0,Pi j = 1), a variety of similarity and dissimilarity
estimates can be extracted from this data:
Similarity indices:
Rand statistic: RI =
TP+TN
TP+FP+TN+FN
(3.23)
Jaccard coefficient: JC =
TP
TP+FP+FN
(3.24)
Folkes and Mallows index: FM =
√
TP
TP+FP
· TP
TP+FN
(3.25)
Dissimilarity indices:
Minkowski measure: MI =
√
FP+FN
TP+FN
(3.26)
Moreover, the corrected or adjusted Rand index (ARI) [233] normalises the original rand statistic (see
above) so that its maximum is one and its expected value is zero when random partitioning is used (this
statistic can be seen as a special form of Matthew’s correlation coefficient for pairwise assignments of
observations):
Adjusted Rand Index: ARI =
TP ·TN−FP ·FN√
(TP+FP) · (TN+FN) · (TP+FN) · (TN+FP) (3.27)
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Since the ARI accounts for both specificity and sensitivity, and normalises the results for better compara-
bility, it is often regarded as the method of choice.
If no reference clustering results are available, single outcomes can also be evaluated using estimates of the
probability that the clusters were formed by chance, derived from the analysis of additional external data.
For example, given the known membership of genes in the functional categories of the MIPS database [93],
Tavazoie et al. proposed a p-value significance score for clusters using the hypergeometric distribution
[234]. This p-value corresponds to the probability of observing k or more genes belonging to the same
functional category in the same cluster ( f is the total number of genes in a functional category and g the
total number of genes across all categories):
p= 1−
k−1
∑
i=0
(
f
i
)(
g− f
n−i
)
(
g
n
) (3.28)
A limitation of this method is that many genetic probes in microarray studies have not yet been functionally
annotated and predictions of the membership to a functional category, e.g. using sequence homology, might
often not be reliable enough.
In practice, the decision on a suitable number of clusters should be made by considering the combined
information from different validity measures to account for the diverse possibilities to measure the quality
of clustering results. Moreover, an experimenter might also want to inspect the results for different numbers
of clusters, since multiple biologically meaningful patterns might occur in the data and only be identified,
when interpreting the data using different stable partitions. A more detailed overview on different cluster
validity measures can be found in a review by Boutin and Hascoe¨t [235].
3.5 Class Prediction (Supervised Machine Learning)
Many large-scale transcriptomics, proteomics and metabolomics datasets do not just consist of measure-
ments of the abundance of certain molecules (mRNA, proteins and metabolites), but also contain additional
annotation data for both the samples and the attributes. In particular, class labels representing the biological
conditions of the samples (e.g. categories like “normal tissue” and “tumour tissue”) or numerical data (e.g.
survival times) are available in a majority of cases. In addition to the unsupervised dimensionality reduction
and clustering methods considered in the previous sections, the information from these additional depen-
dent variables enables the application of supervised analysismethods. These techniques include supervised
feature selection methods (see section on feature selection above), but more importantly, classification and
regression methods, which enable the experimenter to find a predictive function that relates the input fea-
tures to the given outcome variable(s). Such predictive models can be useful both for the interpretation of
the data, explaining how certain features (molecules) affect the outcome (the biological conditions), but also
to predict the outcome for new, unlabelled samples. These predictions can be of great practical use in many
bioscientific and biomedical applications, including clinical diagnosis and prognosis, especially when the
predicted attribute value cannot be measured directly or the measurement would be too difficult or expen-
sive to be repeated many times (see chapter 2 on biomarker discovery). Moreover, if the predictive model
is not too complex for human interpretation, model inspection might help to improve the understanding of
a biological process (e.g. a studied disease) and to find new ways of influencing it (e.g. by identifying new
drug targets).
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In general, supervised analysis methods can be grouped into regression techniques to predict numerical
outputs, e.g. the expected survival time for a tumour patient, and classification methods to estimate cate-
gorical outputs, e.g. the assignment of a patient’s sample to a specific disease class. When analysing gene
expression data, prediction approaches also differ depending on whether time-series data or relative expres-
sion levels of different tissue types are analysed. Moreover, similar to clustering approaches, prediction
methods can be applied both to the columns (representing samples) and rows (representing genes, proteins
or metabolites) of a data matrix. These two problems are structurally very dissimilar, due to the large differ-
ence between the number of samples and the number of features in a high-throughput experiment. Sample
classification requires feature selection and is affected by the multiple testing problem, while gene function
classification is complicated by small numbers of features (samples) and large numbers of observations
(genes), many of which are not differentially expressed under the studied conditions. This section will fo-
cus on microarray sample classification and regression and only provide a general introduction on different
types of approaches, discussing representative algorithms (see figure 3.9 for an overview).
Figure 3.9: Overview of supervised learning methods and meta learning techniques discussed in this survey (non-
comprehensive)
Sample classification and regression
When high-throughput technologies like microarrays were first introduced, applying supervised analyses
to this type of data had first been considered as infeasible due to the small sample sizes, the noise and the
multiple testing problem in gene selection. Instead, the results from unsupervised clustering of samples
were used in order to identify subclasses and estimate to which of these groups a new sample most likely
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belongs [236]. However, though unsupervised analysis provides a useful instrument for class discovery, the
assignment of a sample to a class according to its distances to the class centroids often led to unsatisfactory
prediction results. Thus, when larger data sets became available and more powerful methods for dimen-
sion reduction and combinatorial feature selection were applied, research groups started to use well-known
supervised learning techniques, which had already been applied successfully in other scientific fields. The
following paragraphs will discuss the benefits and limitations of these generic machine learning methods,
as well as extensions specifically tailored for microarray gene expression analysis.
Linear methods and extensions: Although simple prediction methods using linear functions as decision
boundaries like linear regression and Fisher’s Linear Discriminant Analysis [237] are not adequate for the
analysis of high-dimensional and noisy datasets, several variants of these approaches provide competitive
prediction results obtained from human-interpretable models.
One possibility to make simple linear classifiers applicable to microarray data is to use regularization tech-
niques. In particular, the regularized least-squares (RLS) approach has been very successful in microarray
sample classification. RLS minimises the Residual Sum of Squares (RSS) in combination with a penalty
term limiting model complexity:
minw =
1
l
∑
i=1
l(yi−w · xi)2+λ(||w||2−α) (3.29)
where l is the size of the training set, xi ∈ Rn are the inputs, yi ∈ {0,1} the outputs, α ∈ R and λ is a free
regularization parameter that can be chosen using nested cross-validation. The major benefit of RLS is
that solving a classification problem by minimising the expression in equation 3.29 only requires solving
a linear system of order equal to the number of features or the number of training samples [238]. Another
special advantage is the possibility to measure the leave-one-out (LOO) error by only training a single
machine learning model. Thus, the computational cost is low and the obtained linear models are relatively
simple to interpret, although they are typically not as sparse as those produced by other regularized learners.
Ancona et al. compared the accuracy and number of selected genes for RLS with support vector machines
(SVMs) as a state-of-the-art technique for microarray cancer classification [238] (see section on kernel
methods below). The signal-to-noise filter and a recursive feature elimination strategy (RFE, see section on
feature selection methods) where used to determine relevant attribute sets. Evaluating the LOOCV accuracy
for these methods on three microarray data sets (for leukaemia, colon cancer and a dataset with multiple
cancer types) the authors concluded that in spite of the simplicity of RLS models, a similar generalisation
capability to SVMs is obtained. This might however not be the case for other microarray data sets, in which
non-linear dependencies play a more important role.
Regularized extensions also exist for the most well-known classification approach using linear decision
boundaries, Fisher’s Linear Discriminant Analysis (LDA). One of these extensions explicitly dedicated to
gene array data is Prediction Analysis for Microarrays (PAM, not to be confused with the “Partitioning
around medoids” clustering method with the same abbreviation) by Tibshirani et al. [239]. PAM, also
known as the nearest shrunken centroid method, addresses the “curse of dimensionality” problem by di-
rectly combining feature selection and classification within the algorithm. This is achieved by shrinking
the class centroids towards the centroid of the entire dataset to reduce the effect of outliers, and applying a
soft thresholding to set many of the class centroids’ vector components to 0. Thus, some features (genes)
for which all centroids have a 0-entry are completely removed from the class separation problem without
applying a separate feature selection method. In order to choose the amount of shrinkage, which can be un-
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derstood as a bias/variance trade-off parameter (see supervised feature selection section), a cross-validation
procedure is applied and the misclassification error is minimised. A major benefit of the PAM approach is
that the influence of noisy genes is reduced by the shrinkage procedure and that the implicit gene selection
is completely automated and interlinked with the prediction algorithm. Drawbacks of the PAM approach
are the restrictive model assumptions, e.g. the covariance matrix is assumed to be diagonal, and the results
greatly depend on the correct estimation of the regularization parameters.
A similar method which was also derived from a regularized version of LDA is the shrunken centroids
regularized discriminant analysis (SCRDA), proposed more recently by Guo et al. [240]. Instead of assum-
ing the covariance matrix to be diagonal, the matrix entries are estimated in a more general manner using
a regularization that eliminates features from the classification problem. However, SCRDA cannot really
achieve variable selection, since even genes that do not contribute to classification are still involved in the
construction of the decision rule, as shown by another group [241]. Nevertheless, the authors demonstrated
that SCRDA performs slightly better than PAM on several benchmark data sets. However, in this extension
of LDA the decision boundaries can be non-linear and more difficult to interpret.
Neighbourhood methods: Neighbourhood-based prediction methods, which classify samples according
to their proximity to known training samples (usually using a distance metric like the Euclidean dis-
tance), are often very successful in microarray analysis, in particular when being used in combination
with other techniques. Simple and fast approaches like the k-nearest neighbours (k-NN) method, which
assigns new unlabelled samples to the majority class of the k closest training samples in Euclidean space,
have achieved good classification accuracies in combination with search metaheuristic like genetic algo-
rithms using wrapper-based feature selection [180] (see feature selection section), and in combination with
different noise-reduction filters [242].
The first extensions of the k-NN method provided runtime and memory allocation improvements by tak-
ing advantage of the redundancy in some datasets, clustering nearby data points together and storing these
clusters instead of the data points (agglomerative nearest neighbour method [243]). Moreover, several
extensions used other distance functions, e.g. the KStar (or K*) method employs an entropy-based dis-
tance measure [244]. However, these methods and the original k-NN suffer considerably from the “curse
of dimensionality”, providing biased predictions in high dimensions and assuming class conditional prob-
abilities to be locally constant. Therefore an adaptive form of the k-NN method was introduced [245],
which applies a linear discriminant analysis locally to estimate an alternative, adaptive metric for the neigh-
bourhood computation. This Discriminant adaptive nearest neighbour (DANN) classification method first
computes local decision boundaries around the class centroids (similar to Fisher’s LDA), and then adapts
the neighbourhoods, by shrinking them in directions orthogonal to the decision boundaries, and elongating
them parallel to the decision boundaries. In contrast to classical spherical neighbourhoods, the resulting
ellipsoidal neighbourhoods are less likely to overlap with the local decision boundaries. The authors pre-
sented various simulated and real-world example datasets on which DANN reaches superior performance
both in comparison with the k-NN method and LDA. Since a multitude of methods are available to compute
linear decision boundaries, a variant of the DANN method was later introduced by Domeniconi et al., who
computed locally adaptive distance functions using SVM decision boundaries [246].
A further idea to adjust the neighbourhood computation uses semi-supervised learning [247], i.e. exploiting
information from additionally available unlabelled data. Driessens et al. presented a corresponding classi-
fier, called YATSI (Yet Another Two Stage Idea), which takes unlabelled data into account and re-weights
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the k-NN algorithm using both labelled and unlabelled data [248]. Comparative evaluations on real-world
data suggested that this technique significantly outperforms the original k-NN method, if sufficient unla-
belled data is available.
More recently, a new method, ROC-kNN, was proposed to optimise the distance function for k-NN with re-
gard to the classifiers area under the Receiver Operating Characteristic (AUROC) [249]. Specifically, a new
distance function is derived by a procedure for re-weighting features, which first computes the ROC curve
for a series of point pairs, obtained from a threshold value for a single variable xi and the corresponding
outcome class yi, and then uses the AUROC as a feature weight. To select the threshold values for a feature
required to generate the corresponding ROC curve, only the feature values on the interval between the two
observations whose distance is calculated are used, widening this interval only if it covers less 50% of all
values for the feature in the dataset. When comparing ROC-kNN with other approaches on 12 datasets,
the method was always superior to the classical k-NN algorithm, and on some datasets also outperformed
state-of-the-art non k-NN classifiers. However, if the sample size is small like in typical microarray studies,
the computation of ROC-based weights is less reliable and support vector machines still tend to provide
better performance.
In summary, when using nearest neighbourhood techniques as stand-alone methods, they tend to perform
well on high-dimensional and noisy data only when adjusting the neighbourhood or distance function def-
inition to the input data. However, even simple variants of the k-NN method can be of great practical
use when being combined with other prediction and filtering methods, as well as search space exploration
metaheuristics in wrapper-based feature selection approaches.
Kernel methods: Generic kernel-based machine learning methods, and in particular standard implemen-
tations of support vector machines (SVMs) with a linear kernel, belong to the microarray classification
methods achieving the highest accuracies on many datasets. The main benefit of these methods lies in the
so-called “kernel trick”, which makes observations linearly separable by mapping them from the original
space O into another, higher-dimensional inner-product space S, using a kernel function to describe the
inner products in space S. A linear classification problem in the space S will then correspond to the original,
non-linear classification problem in O. As long as a linear kernel is used, the models can also be interpreted
easily by inspecting the feature weights, although an additional feature selection is often required to reduce
the number of features. Nevertheless, various research groups have tried to optimise SVM-based prediction
for the specific task of analysing high-dimensional, noisy data with small sample sizes.
A prominent example for these extensions was the introduction of the maximum entropy kernel (ME) [250].
Instead of employing a pre-defined kernel function, the ME kernel approach uses more adaptive functions
for distance computations, similar to some of the techniques discussed in the section on neighbourhood-
based prediction methods. More specifically, the kernel is generated in an entropy maximisation process
using the input sample distance matrices as constraints. Using any type of distance or similarity data as
input, the procedure expands the distances between most sample pairs in the feature space, except for the
most similar samples, which are held together by the constraints. In the resulting feature space, heteroge-
neous datasets tend to become less entangled, and the problem of finding a discriminant boundary is greatly
simplified. This new SVM approach was compared to SVMs with other kernels (linear, polynomial, RBF,
and two other distance-based kernels) on three gene array benchmark datasets using the matrix of Euclidean
distances as input for the kernel generation. The genes to be used for classification were selected by a two-
sample t-statistic, embedded into each cycle of a LOOCV procedure. Average accuracies above 87.5% were
reached on all datasets, even when introducing high levels of noise into a dataset. Comparing the results to
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other kernels for feature selections with 8 to 296 attributes, the ME kernel reached better results in the great
majority of cases. On the whole, the results suggest that the adaptive kernel can reduce the effects of noise
and thus provide a better separation between the sample classes,
In addition to improvements with regard to the used kernel functions, recent research efforts have also been
devoted to finding more suitable definitions of the penalty term [251] and the loss function [252] for SVMs.
Moreover, special advantages of SVM-based models in the analysis of small sample high-dimensional data
have been exploited by combining SVMs with the active learning paradigm [253]. In contrast to classical
machine learning techniques, which use all the training data at once and build a predictive model in a single
pass, active learning attempts to make an informed selection of the labelled instances to train the classifier
and can iteratively update an existing model, when new data becomes available. This approach can help
to circumvent problems arising from class imbalances in the training data, and a limited availability of
labelled data. The procedure proposed by Liu et al. [253] initially chooses a random training sample from
both classes in a binary classification problem and builds a preliminary classifier. While there are still
unlabelled samples, the current classifier is applied to each of them and the m samples which are most
informative for the classifier are selected, labelled and a new classifier is trained on the updated set of
labelled samples. While this procedure is repeated iteratively, new data obtained from a recent experiment
can be added dynamically to the sample pool. Applying this SVM-based active learning algorithm on
three microarray data sets (colon cancer, lung cancer and prostate cancer), areas under the ROC curves
above 0.81 were obtained for all data sets (m = 1 or 5), whereas the AUCs were below 0.5 when using
passive learning. Moreover, the results showed that active learning could reduce the cost for classification,
in terms of the required number of training samples. For example, in the case of the lung cancer data, only
31 labelled examples were needed to find 96% of the total positives. The observation that active learning
approaches work particularly well with margin-based classifiers like SVMs has also been confirmed in other
studies [254, 255].
In addition to the successful application of support vector classification and regression techniques in many
domains of high-dimensional data analysis, other kernel-based prediction approaches like Gaussian process
(GP) regression [256] and Kernel Fisher discriminant analysis (KFDA) [257] have recently been considered
as alternatives, but in comparison to SVM approaches currently only limited information on their utility for
microarray data analysis is available in the literature.
Overall, kernel-based approaches include several state-of-the-art methods in terms of predictive perfor-
mance and runtime efficiency, however, especially for the non-linear approaches, the direct interpretation
and extraction of biological knowledge from the models is often difficult and prevents a wider acceptance
in the scientific community.
Neural network based methods: Artificial neural networks (ANNs), inspired by the mechanisms of real
biological networks, have a long tradition in machine learning [258] and are widely used in many domains
of bioinformatics, due to their capacity to learn non-linear decision boundaries and their flexibility to deal
with noisy data. The classical multilayer perceptron (MLP) feed-forward approach for these graph-based
models consist of layers of nodes (representing neurons) connected by directed, weighted edges (represent-
ing possible paths to forward signals), transmitting the input data from an input layer of nodes through a
user-defined number of hidden layers to the output layer, providing the prediction results of the model.
To obtain these predictions, the data are processed at each node, typically by computing a nonlinear edge-
weighted sum of the incoming data and processing it by a pre-defined activation function (usually a sigmoid
function like the hyperbolic tangent). A model can be trained by adjusting initial edge weights using a back-
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propagation algorithm [6] to minimise a given cost function (e.g. the mean-squared error between the target
values and the network’s output). Since ANNs require at least one hidden layer to provide non-linear
models, this methodology has been criticized for providing models that are difficult to interpret and easily
overtrained, due to their large number of parameters and the lack of general rules to choose the number of
hidden nodes [259]. However, state-of-the-art performance has been reached with ANNs in many fields
of bioinformatics (e.g. to predict properties of proteins like residue contacts [260], disulfide connectiv-
ity [261], or the topology of transmembrane domains [262]), and several extension to the standard MLP
feed-forward approach have been proposed for high-dimensional, noisy biological data.
Although ANNs are capable of feature selection to a certain extend, e.g. by reducing the weight of edges
with small contribution to the predictive power of the system to zero, the large number of uninformative
features in typical high-throughput experimental data poses a major problem for these network-based mod-
els. Therefore, the first approaches using ANNs for supervised microarray analysis have applied different
pre-filtering approaches before training a network model. For example, Khan et al., who aimed at classify-
ing microarray samples for small, round blue-cell tumours (SRBCTs) into four diagnostic categories, first
filtered out genes with small intensity levels across the samples, and then extracted 10 features correspond-
ing to the 10 dominant principal components from a projection of the genes using PCA eigenvectors [263].
Linear ANNmodels were then calibrated using these 10 features within a 3-fold cross-validation procedure,
providing 100% accuracy in all cases.
More recent approaches for microarray sample classification employ hidden layers to obtain non-linear
classifiers, e.g. the method by Lancashire et al. [264, 265] contained a single hidden layer with between
2 to 5 nodes. Instead of applying a separate feature selection method, an ANN model was trained for
each single feature over 50 randomly selected sample subsets. Average mean squared error (MSE) values
were calculated over the predictions of the 50 models for separate test sets to rank the features. Then, the
best out of the total n features was selected to generate the final model, and sequentially, each of the n-1
other features were added to this model, creating n - 1 two-feature models and applying the above training
and performance evaluation procedure again. This process was repeated iteratively until no significant
improvement was obtained from adding further features to the model. Using this procedure to classify
breast cancer samples from a separate validation set into different clinical categories, a set of 9 genes,
capable of predicting distant metastases with 98% accuracy, was obtained. On a second independent dataset
of 295 samples, the model achieved 63% accuracy, indicating that the model also possesses a certain level
of predictive power in a cross-study classification setting, where external samples are affected by a study-
specific bias.
To automatically improve the architecture of neural networks, several evolutionary computation based meth-
ods have been proposed, e.g. genetic programming has been employed to optimise the ANN architecture
for modelling and detecting gene-gene interactions in human disease studies [266, 267]. The resulting
models had a better predictive performance and were superior in detecting gene-gene interactions when
non-functional polymorphisms are present in the data.
Recently, several efforts have been made to increase the interpretability of ANN models. Some research
groups have presented methods to extract simple “if-then-else” classification rules from neural networks,
which outperform classical decision trees on real-world data [268, 269]. Specifically, fuzzy-neuro networks
were proposed, which enable fuzzy rule-based classification using ANNs and can account for uncertainty
in the data. Most of these approaches use fuzzy sets to transform the continuous input data into linguistic
terms, apply an ANN and extract decision rules from it [270–272]. For example, a classical feed-forward
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network structure has been combined with a special hidden layer with the same number of nodes than the
input layer, in which the input is transformed into 3 linguistic groups (“small”, “medium”, “large”) using
a Gaussian membership function [273]. The linguistic features with the highest membership values are
assigned to a dedicated class (+1), whereas all other remaining features receive a different class label (-1).
Weighted links connect these features from the special hidden layer with the output layer, containing one
node per biological condition in the dataset and applying a sigmoid activation function on the incoming data.
Thus, by training the weights of these links using back-propagation, an attribute selection is performed that
selects the most informative linguistic features with regard to the class separation problem. From a model
trained with this procedure, two types of decision rules can be extracted from the top n features with largest
weights in the network: Disjunctive decision rules for each class (termed “simple OR rules”), or decision
rules considering the order of important linguistic features and the class order (termed “layered rules”). In
both cases, a small number n is chosen (e.g. n = 9) and each of the n top-ranked features is used in the
rules. Applying this fuzzy-neuro learning approach to a colon cancer dataset, cross-validated accuracies
above 90% were obtained in comparison to SVM models and conventional ANN approaches, all reaching
average accuracies below 82% with similar numbers of features.
These recent advances in neural network based classification of high-dimensional biological data suggest
that hybrids of the original feed-forward ANN approach with rule-based methods can generate interpretable
models comparable with the state-of-the-art in terms of accuracy.
Bayesian learning methods: Due to the high uncertainty in single gene or protein expression values in
large-scale array datasets, probabilistic machine learning methods are a natural choice for the analysis of
this data. Most of these methods apply Bayes’ theorem, i.e. they calculate the posterior probability of a
hypothesis H given an evidence E (p(H—E)) from the prior probabilities of E and H and the likelihood of
E given H:
P(H|E) = P(H)P(E|H)
P(E)
(3.30)
This approach enables the experimenter to include prior knowledge into the estimation of predictive func-
tions. The simplest Bayesian classifier, Naive Bayes, assumes that all features contribute independently to
the prediction of the outcome classes and estimates model parameters like the class priors from the relative
frequencies observed on the training set (corresponding to a maximum likelihood estimation). The trained
probability model can then be used to classify new samples, by assigning them to the class (hypothesis)
with the highest estimated conditional probability. Although Naive Bayes (NB) classifiers tend to be out-
performed by many other machine learning methods like SVMs and RFs on high-dimensional noisy data,
they are very efficient and work particularly well in wrapper-based feature selection approaches (see feature
selection section). Moreover, NB does not contain any tuneable parameters or involve any model selection.
In order to address the limitations of the feature-independence assumption behind NB, the Averaged One-
Dependence Estimators (AODE) approach was developed, using a weaker independence assumption than
NB. Although this method often significantly outperforms NB, the computational costs only increase lin-
early with the number of samples [274]. However, for high-dimensional datasets the application of AODE
can still be infeasible, since the runtime also has a quadratic dependence on the number of features.
An alternative approach to make the NB method applicable to high-dimensional data was therefore pro-
posed by Bressan and Vitria using the new feature extraction method class-conditional independent compo-
nent analysis (CC-ICA) [275]. CC-ICA enables the application of NB in a derived feature space obtained
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from an independent component analysis (ICA), in which the class-conditional independence assumption
is fulfilled. This pre-processing approach improved the accuracy of the original NB algorithm on many
real-world datasets, however on microarray datasets with a small sample size per class, the ICA transfor-
mation cannot be applied. To solve this problem, Fan et al. introduced a partition-conditional independent
component analysis (PC-ICA) [276], which represents a compromise between ICA and CC-ICA for fea-
ture extraction, splitting the samples into different partitions in a manner that enables the application of
ICA-based feature extraction within each partition (where partitions can consist of samples from multiple
classes). To obtain these partitions, a hierarchical clustering method can be applied, e.g. average linkage
hierarchical clustering. Only if enough samples per class are available to apply ICA directly on each class,
no partitioning will be applied, and PC-ICA becomes equivalent to CC-ICA. When evaluating the perfor-
mance of PC-ICA based NB classification on two microarray cancer datasets (leukaemia and lung cancer),
PC-ICA overall provided higher average accuracies than classical ICA.
Other Bayesian classification approaches avoid the independence assumption in NB completely, and instead
take the dependency between features directly into account. A recent example is the network-based sparse
Bayesian classifier (NBSBC), which models the dependency between features in a graph representation,
where nodes correspond to features and edges connect features that should be either both included or ex-
cluded in the final prediction model [277]. The NBSBC approach implements an approximate Bayesian
inference using the expectation propagation algorithm [183, 278] and was evaluated on four real-world
classification problems in comparison against two other classifiers, which also incorporate information on
feature dependencies from a network into the analysis - the network-based SVM (NBSVM) [279] and the
Graph Lasso (GL) [280]. On three of the four datasets, and in particular on microarray data, NBSBC
reached the highest predictive performance and always outperformed its predecessor, the sparse Bayesian
classifier (SBC), which results from NBSBC when ignoring the feature dependencies.
On the whole, Bayesian classification methods have particular strengths in the analysis of noisy biological
data, but since an exact Bayesian inference is currently not feasible on high-dimensional data, approximate
inference methods have to be used.
Rule- and tree-based methods: A major drawback of some of the most accurate prediction methods
for high-dimensional biological data, affecting both SVMs with non-linear kernels and classical Artificial
Neural Networks (ANNs), is the complexity of the generated models, which often impedes human interpre-
tation. In clinical applications of machine learning, simple decision trees (e.g. C4.5 [281] and CART [282])
are therefore often preferred in spite of their weaker performance on many datasets, because these models
can easily be visualised and interpreted as combinations of simple “if-then-else” decision rules (often they
are referred to as white-boxmodels, as opposed to black-boxmodels like SVMs, ANNs, etc.). The rationale
is that a model should be useful in terms of helping the experimenter to understand the data, and robust in
terms of providing simple rules that are applicable also to data from other experimental platforms.
However, classical decision trees tend to have a poor predictive performance in domains with high noise
levels, large numbers of uninformative features, inconsistencies and uncertainty [283]. Features can typ-
ically not be weighted but are either fully included into the model as tree nodes or completely excluded,
and the only complexity reduction consists in pruning the tree after completing the tree building procedure.
Moreover, the tree nodes, corresponding to splitting rules obtained by choosing an attribute and a split
point, are normally added using a simple greedy search procedure. In order to obtain a better predictive
performance while preserving high model interpretability, various new rule-based prediction methods have
been developed in recent years.
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A very simple, but robust and effective rule learning approach for microarray sample classification is the
top-scoring pair(s) (TSP) classifier by Geman et al. [284]. This method only compares the expression levels
within a single pair of genes, but applies an exhaustive search through all pairs of genes to identify the most
discriminative feature pairs. The corresponding scoring function s(i, j) simply computes frequency-based
probability estimate for observing lower expression levels in a gene i in relation to a gene j in a sample
class c = 1, and the opposite relation in sample class c = 2:
pi j = P(Xi < X j|c= 1,2) (3.31)
s(i, j) = |pi j(1)− pi j(2)| (3.32)
TSPs provide very simple decision rules of the form “if gene A has a significantly higher expression level
than gene B, assign the corresponding sample to class 1, otherwise to class 2”. Since these rules rely on
relative comparisons of expression values rather than on absolute mRNA abundances and fitted threshold
values, they are very robust with regard to study-specific bias. Moreover, the method is parameter-free
and in spite of the quadratic runtime during the exhaustive search for TSPs, the computation is feasible
on typical microarray data, due to the simple scoring function. To evaluate the statistical significance of
the TSP-scores, a simple non-parametric permutation analysis can be performed. However, when testing
the approach on real-world data, the assumption that a single gene pair, or a small number of TSPs can
already provide accurate sample classification results is not fulfilled on all datasets, although in many cases,
state-of-the-art accuracy has been achieved (e.g. on leukaemia, prostate and breast cancer microarray data,
average LOOCV accuracies above 79% were reached).
Some of the limitations of the original TSP approach can be overcome with simple extensions, e.g. enabling
TSP to handle multi-class problems, or to create hierarchical and ordered combinations of multiple TSP
decision rules [285], as well as weighted rules [286]. The method can also be used as a feature selection
approach in combination with other machine learning techniques like SVMs [287]. Moreover, a new variant
of the TSP approach, integrating information from cellular pathways into the analysis, was developed as
part of this doctoral project, and will be presented in chapter 7 of this thesis.
More recently, Li et al. introduced an alternative prediction model using gene pairs and simple linear models
to explain the relation between the gene expression values in a sample class [288]. More specifically, for
two genes g1 and g2, the authors fit a linear regression model, but only in the first group of samples
(class 1). In class 1, the expression values of g1 can then be predicted from g2 using the model, whereas
when applying this model in class 2, if the relation between g1 and g2 has changed, a large deviation (or
bias) between predicted and observed values will be obtained. Accordingly, the two sample types can be
distinguished by computing the difference of the predicted biases. By contrast, the TSP approach classifies
samples according to the difference of frequency counts for the relations of expression values in the sample
classes (see above). As further extensions, Lie et al. combine rules to majority-vote ensembles and use a
GA to speed up the search process for the top-scoring gene pairs. Experimental results using LOOCV on
leukaemia, lung, breast and colon cancer data showed that the method reaches similar average accuracies
(between 90 and 100%) like other state-of-the-art approaches, using only a small number of genes.
Since rule-based learning models have particular benefits in terms of interpretability, the study of new
approaches in this category, including the evolutionary machine learning system BioHEL (see chapter 4 for
details) and the self-devised Top-scoring pathway pairs method (see chapter 7), has been one of the major
goals of this doctoral project.
3.5. Class Prediction (Supervised Machine Learning) 69
Ensemble learning methods:
The great variety of successful prediction methods for microarray sample classification discussed in the
previous sections suggests that a multitude of diverse methods can deal effectively with high-dimensional,
noisy data with small sample sizes. Thus, by combining the models obtained from these learning algorithms
into a unified model, their different strengths might be better exploited.
The theoretical benefits of ensemble learning, in particular its variance-reducing effects, have already been
described in detail elsewhere [8]. Briefly, ensemble learning methods can be applied successfully if the
base classifiers that are to be combined into a single model, provide a higher accuracy than a random class
assignment and are diverse, so that they can complement each other to provide better predictions than the
individual base classifiers [289]. However, a common drawback of ensemble learning is the high complexity
of the resulting model, especially if the number of base classifiers and their individual complexity is high.
This problem can be alleviated by post-processing the base classifier models using simple statistics, e.g. by
computing averaged ranks of the features included in the base classifiers to obtain a robust and informative
ranking of features. Moreover, the number of base classifiers can be adjusted as a trade-off parameter to
obtain an optimal balance between the ensemble model’s bias and variance (see the “bias-and-variance
trade-off” described in the “supervised feature selection” section). Thus, in spite of potential drawbacks in
terms of model complexity, considering different ensemble prediction approaches on the basis of adequate
single-algorithm classifiers is a useful technique to better exploit the information content in biological
datasets and reduce problems associated with high variance and the curse of dimensionality.
Most ensemble learning approaches are using model averaging, i.e. the base models are applied indepen-
dently on the target samples and the ensemble prediction is obtained by computing an (optionally weighted)
average across the base model predictions. For regression problems, this is achieved by computing the mean
prediction for each sample, whereas for classification problems, a majority voting scheme can be adopted.
More advanced ensemble learning techniques attempt to explicitly promote model diversity and/or improve
the assignment of weights to the base classifiers, e.g. by considering their predictive accuracy and diversity
in comparison to other base classifiers.
Three of the most wide-spread, generic ensemble learning techniques are bagging, boosting and stacking.
Bagging stands short for bootstrap aggregating, a procedure introducing diversity into the base classifiers
by using a resampling technique known as bootstrapping [290, 291]. Bootstrapping applies random sam-
pling with replacement on an original dataset, to obtain equally sized resampled versions of this dataset.
These bootstrap resamples of the original data can be used to create a more robust classifier by training
independent prediction models on them and applying model averaging (see above) to obtain an ensemble
classifier. This technique has been applied successfully in many scientific and industrial problem domains,
including the analysis of high-dimensional biological data. For example, bagged ensembles of SVMs have
been shown to provide more stable and equal or better sample classification accuracies than single SVMs
on leukaemia and colon cancer microarray data [292].
Importantly, randomisation and resampling techniques can be applied both to the samples and to the fea-
tures of a dataset. Due to the large number of features for typical microarray datasets, a commonly used
technique is to only apply resampling on the samples and random selection on the features to obtain diverse
input data for ensemble learning. One of the most well-known algorithms employing this approach is the
random forest (RF) method introduced by Leo Breimann [190, 191]. The RF approach trains unpruned
classification and regression trees (see section “Rule- and tree-based methods” above) using bagging to
determine the input samples and a random candidate feature selection for each node in the tree. The di-
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verse base classifiers obtained from this procedure are then combined to a model averaging ensemble. The
RF algorithm belongs to the few machine learning techniques with known convergence proofs for the gen-
eralisation error [191], and is one of the most popular machine learning approaches next to SVMs. On
large-scale bioscientific datasets, special RF variants often outperform other state-of-the-art approaches,
e.g. for microarray sample classification, Amaratunga et al. replaced the random sampling of genes by a
sampling procedure accounting for the significance of differential expression [293], Zhang et al. introduced
a deterministic variant of random forests [294, 295], and to reduce the complexity of the models, Zhang
and Wang proposed a method to find the smallest sub-forest that achieves the same prediction accuracy as
a given large random forest model [296].
However, resampling and random selection techniques are not always the most effective methods to intro-
duce diversity into the base classifiers of an ensemble learning approach. Boosting algorithms represent a
further class of ensemble approaches, in which weighted base classifiers are iteratively added to a combined
model and at the same time weights are assigned to the samples, such that misclassified samples receive
higher weights than correctly classified samples. These sample weights are then used in subsequent itera-
tions to add base classifiers that focus on improving the predictions for the misclassified samples, hence,
diversity is introduced into the base classifiers by forcing them to have different prediction strengths on
different groups of samples. Depending on the procedure to calculate the sample and classifier weights,
a multitude of different boosting techniques have been developed, including the classical AdaBoost ap-
proach [297], a variant using a logistic regression cost functional (LogitBoost) [298], and a linear pro-
gramming approach to combine optimally weighted base classifiers (LPBoost) [299]. However, Dettling
and Bu¨hlmann showed that these classical boosting methods are often not robust enough for noisy, high-
dimensional microarray data, and developed a boosting variant in conjunction with decision trees, which
provided increased performance on publicly available gene array data sets [300].
An alternative and very effective generic approach to learn weights for base classifiers is to use a meta-
learning technique, i.e. to apply a higher-level machine learning algorithm in order to estimate the optimal
weights. This approach, known as stacking, stacked generalisation or blending [301], uses the same cross-
validation schemes that are also employed for model selection or for single-model parameter fitting, but
applies them to fit the base classifier weights for optimally combining models into an additive ensemble.
Stacking techniques have recently become very popular methods in the machine learning community, due
to their success in one of the largest data mining competitions, the Netflix prize [302], where the two best-
performing methods both used stacking. However, in bioscientific research, stacking methods have not yet
been widely employed, since they tend to have a poor runtime performance on large-scale datasets and the
ensemble models they generate are often difficult to interpret.
On the whole, ensemble learning methods provide an effective means to improve the results of single-
algorithm classifiers. In many cases, potential drawbacks in terms of low model interpretability can be
alleviated by using techniques like the search for smallest sub-forests in random forest models, or by com-
puting statistics on the occurrence of features in different base classifier models. Due to the increasing
number of available algorithms and data sources for the same biological problems, ensemble techniques
capable of aggregating diverse information are likely to become even more relevant and valuable in the
future.
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3.6 Data Integration 1: Cross-Study Analysis
In the assessment of new microarray prediction methods, such as those discussed in the previous sections,
a typical strategy to circumvent problems with small sample sizes and experimental bias in a single study
is to train and test the method on a variety of different data sets. However, if the purpose of the study is
to analyse the data rather than to compare algorithms, this approach does not really solve the small sample
size problem, because microarray studies using different platforms or carried out in different laboratories
are typically not directly comparable, even if the same cell type is analysed under the same conditions.
Thus, without cross-platform normalisation, the predictor can often only be trained and tested successfully
on data from a single platform with a precisely defined experimental procedure.
To alleviate the problems associated with small sample sizes, three basic approaches exist:
• using improvements in microarray technology, noise filtering and analysis techniques to obtain more
robust models
• combining gene array data with external biological data (e.g. biological databases or clinical indices)
• integrating microarray data from different laboratories and platforms by cross-study normalisation
While the first two points are discussed in other dedicated sections of this chapter and make important
contributions to the solution of the problem, the integration of similar microarray data from different studies
is certainly the most promising approach to cope with the small sample size problem.
The first cross-platform integration techniques used simple transformations of the raw expression data, e.g.
by median rank scores or quantile discretization [303]. The median rank scores approach replaces the
gene expression values of a target dataset by the median expression values of genes from a reference study
whose positions in a sorted vector correspond to the expression value rank in the target dataset. Although
this transformation will to a certain degree result in a loss of information, the data distributions become
comparable and the datasets can be combined.
In the second transformation approach, quantile discretization, each data set is discretized into the same
number of bins using the quantiles of the array expression values as cut-points. The central bins are merged
and all expression values are replaced by integers corresponding to the bin they have been assigned to.
Again valuable information might be lost, but the transformed data sets have the same value ranges and
the discretized data enables the application of machine learning methods which are not compatible with
continuous data.
Both methods were applied to integrate example data sets and the transformed data for three pairs of studies
(breast cancer, prostate cancer and acute myeloid leukaemia) were used to train SVM classifiers. The
approaches both achieved cross-validation accuracies above 85% and outperformed models trained on the
respective single data sets. The authors also observed positive effects of the integrative analysis on the gene
selection results. Important differentially expressed genes, which are missed in either of the single-platform
analyses are identified by the combined analysis.
A more recent method for integrative array analysis is the XPN cross-platform normalisation method by
Shabalin et al. [14]. The approach applies linked gene and sample clustering on the studied data sets and
is based on a block-linear error model. Specifically, every expression value xgsp for a gene g in sample s of
study p is assumed to be a scaled and shifted block mean with additional noise:
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xgsp = Aα∗(g),β∗p(s),p ·bgp+ cgp+σgpεgp
where Ai jp are the block means and the functions α
∗(g) and β∗p(s) define groups of linked genes or samples,
respectively. The model also contains platform- and gene-specific sensitivity (bgp) and offset (cgp) param-
eters and independent Gaussian noise variables (εgp).
In the XPN procedure, after pre-processing the data and selecting the set of common genes from two stud-
ies, the data are sample standardised and gene median centred (MC) to remove systematic differences (the
result of this simple MC-normalisation is often already directly used in practice as a simple cross-study
normalisation method). Next, the ordered sample vectors from the different studies are combined to a sin-
gle matrix and K-means clustering is applied both to the rows and columns using random initial centroids.
Multiple clusterings are computed to enable a simple form of model averaging. The gene clusters obtained
in both studies can be linked together using the unique gene identifiers and summarised by an assignment
function α : G→ 1, ...,K; where G is the set of genes and K the total number of gene clusters. For the
column clusters two assignment functions are needed: βp : 1, ...,np → 1, ...,L; where p ∈ {1,2} is the index
of the study, np the number of samples in study p and L the number of sample clusters. Based on these
mapping functions α(g) and βp(s) the unknown parameters for the block linear model can be obtained us-
ing maximum likelihood estimation. The required selection of the number of row and column clusters is
made a priori, e.g. by using cluster validity indices. As indicated before, in order to increase robustness, the
clustering procedure is repeated (at least 30 times) with varying random initial centroids and the average
of the estimated expression values is the final result. Importantly, if no clustering solution is found that
combines samples from different studies into a cluster, the procedure will terminate and the datasets cannot
be combined.
The XPN algorithm was tested by the authors on three breast cancer datasets, considering each pair of
datasets, and compared to the following alternative cross-study normalisation techniques: The MC-nor-
malisation (see above), the Empirical Bayes method (EB) [304] and the Distance Weighted Discrimination
(DWD) method [305,306]. The EB method uses a model similar to that of the XPN approach:
xgsp = αg+ γgp+δgpσgεgsp εgsp ∼ N(0,1)
where the platform specific parameters γgp and δgp are approximated by an empirical Bayes estimation
and the remaining parameter values are computed using gene-wise ordinary least squares (OLS). The DWD
method identifies a direction vector in which the projected samples from the two input datasets can be easily
discriminated, and translates the samples along this direction until the corresponding sample groups have a
large overlap.
The authors of the XPN approach propose validation methods for cross-platform data integration, which are
used in their comparative evaluation. These methods aim both at identifying under-correction errors (the
studies still have systematic differences) and over-correction errors (biological information was lost) and
include measures for the centre and spread, the average Euclidean distance to the nearest array in another
platform, the correlation between the data matrices before and after normalisation, the global integrative
correlation [17], the correlation of t-statistics measuring the association between expression values and
the outcome variable for each study, the prediction results for cross-platform sample classification and the
preservation of significant genes in feature selection. On the breast cancer test datasets, the validation
measures suggested that the XPN approach is most successful in avoiding over- and under-correction. Most
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importantly, the cross-platform classification results, where XPN achieved the smallest cross-validated error
using a PAM-classifier, indicate that XPN removes systematic differences between the datasets while at the
same time preserving biological information.
Importantly, the cross-study normalisation methods discussed above can be used to extract new information
from already existing publicly available microarray data-bases and thus provide a significant added scientific
value. Moreover, combining datasets across studies does not only enable a more robust statistical analysis
but also a more reliable cross-validation of the results.
However, cross-platform integration methods are also limited by the fact that the genetic probes and their
identifiers in different microarray datasets often differ significantly, e.g. the set of shared genes might be
small or it might not be possible to map all probes onto unique standardised gene identifiers. If the main goal
of a microarray study is to identify biomarkers, the small sample size problem can alternatively be alleviated
by just comparing the feature selection results on different data sets and searching common genes among
the top-ranked features. Only genes with high ranks on several independent data sets are likely to be good
candidates for prognostic biomarkers.
In summary, although microarray technology is likely to become cheaper in the future and the average
number of samples per study will increase, combining evidence from multiple data sets does not only
alleviate the small sample size problem but is also an effective means to exploit the synergies of already
existing datasets.
3.7 Data Integration 2: Integrating Cellular Pathway Data
Apart from the possibility to integrate data from similar microarray studies, a multitude of opportunities
exist to combine other types of biological information with large-scale gene and protein expression data.
One of the most frequently used external knowledge sources are functional annotations which map genes
and proteins onto cellular pathways and processes, complexes, chromosomal regions, or other biologically
meaningful definitions of sets of functionally related genes/proteins. In particular, the possibility to map the
attributes in a large-scale dataset onto cellular pathway definitions can provide several benefits for biological
data analysis, e.g.:
• The data can be interpreted on the level of pathway deregulations, providing a more general “bird’s
eye view” of the biological activity in the samples and enabling the experimenter to identify systemic
changes across the studied biological conditions.
• The robustness of statistical analyses can be increased significantly, because the information from
multiple noisy measurements on single genes/proteins can be aggregated into more robust pathway
expression fingerprints, analysing global changes in cellular pathways rather than only small changes
in single genes/proteins. Moreover, the dimensionality of the data is reduced, when considering
aggregated feature sets rather than single features individually, alleviating statistical problems asso-
ciated with the “curse of dimensionality” (see section on feature selection).
• The pathway definitions contain biological information on functional associations and similarities be-
tween genes and proteins which are often not extractable from the microarray data alone. Combining
expression data and annotation data can therefore provide new biological insights, revealing dereg-
ulations of gene/protein sets related to specific functional processes (e.g. inflammation processes)
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under certain biological conditions (e.g. a cancer disease).
The first microarray analysis methods using cellular pathway mappings and other definitions of functionally
similar gene/protein sets, analysed the enrichment of these sets in differentially expressed genes/proteins,
and are known as singular enrichment analysis (SEA) methods [307] or over-representation analysis (ORA)
techniques. These approaches first select a set of informative features by applying a feature selection method
on the data and a user-defined significance score threshold (e.g. q-value < 0.05), and then test the enrich-
ment of the corresponding genes or proteins among the selected features using a statistical test, e.g. the
Kolmogorov-Smirnov test (for a ranked list of features) or the one-sided Fisher exact test (for unordered
lists of features). However, the final results depend on the quality of the selection and the choice of the
significance threshold, and several genes with small expression value changes, which only reveal a signif-
icant deregulation pattern when being considered together with other functionally similar genes, might be
neglected.
For this reason, the SEA methodology was followed by a new generic approach known as gene set enrich-
ment analysis (GSEA) [308]. GSEA uses all features in microarray instead of applying a threshold-based
pre-selection, i.e. no information is discarded and no arbitrary parameter selection influences the analy-
sis. The enrichment of pre-defined gene/protein sets, obtained from databases like Gene Ontology (GO),
KEGG, BioCarta, Reactome etc., in the microarray data can be scored using a multitude of parametric and
non-parametric statistical tests, using the raw experimental data directly to compute significance scores.
The methods in this category include non-parametric Kolmogorov-Smirnov-based approaches like GSEA,
CapMap and GeneTrail [309], and parametric methods like PAGE [310], GAGE [311], FatiScan [312],
ErmineJ [313], MEGO [314] and ADGO [315].
Although these GSEA methods tend to outperform classical SEA approaches in terms of sensitivity and
coverage of the biological information in the data, they are still affected by various limitations. Captur-
ing the multitude of functional roles of genes and proteins in gene/protein set definitions (i.e. using a
membership-function with discrete binary values, “member” or “non-member”) is often only possible to a
limited extent, especially when only considering non-overlapping datasets. The similarity between genes
and proteins is often better expressed using continuous similarity scores, and a great variety of similarity
measures have been proposed for this in the past. Therefore, more recently, new types of enrichment ap-
proaches have been developed, termed as modular enrichment analysis (MEA) [307], which try to capture
more complex continuous similarity information and non-linear dependencies between genes and proteins
stored in networks and graphs. These methods take into account the functional interrelations between genes
and proteins [316, 317] or combine the information from multiple types of annotation data (GO terms,
KEGG pathways, protein domains, etc.) [29]. Instead of using pre-defined gene/proteins sets, modules or
clusters are identified in large-scale data sources, and the raw experimental data is used directly on-the-fly
in the computation of significance scores, instead of first extracting subsets of interesting genes/proteins
in a pre-processing step (avoiding performance bottlenecks, similar to the previous improvement of GSEA
over classical SEA).
In summary, these enrichment analysis methods can provide the user with new information on which cellular
pathways, processes and complexes are activated or de-activated under certain biological conditions, and
are therefore of great practical use for the biological interpretation of the data. However, the full potential of
integrating pathway information into the analysis of high-dimensional biological datasets has not been fully
exploited. For example, recent studies have shown that by summarising the expression values in gene sets to
robust meta-gene fingerprints representing entire pathways, powerful predictors for the supervised analysis
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of the data can be obtained [318]. This pathway-based integrative classification of microarray data can help
to improve the robustness of the analysis, but there are still limitations in terms of the interpretability, the
predictive accuracy and the applicability of models across different array platforms. Therefore, as part of
this thesis, a new pathway-based classification algorithm, TSPP, was developed to alleviate some of these
problems [23] (see chapter 7 for a detailed description of this approach), as well as a new approach to extend
cellular pathway definitions based on molecular interaction data (see the description of the PathExpand
approach in chapter 6).
3.8 Data Integration 3: Integrating Molecular Interaction Data
The previous section has discussed methods to exploit functional annotation data for the analysis of large-
scale transcriptomics and proteomics datasets. However, in spite of the fast growth of public functional
annotation databases, the annotations for many genes and proteins are still missing or insufficient. As an
alternative data source, a multitude of large-scale experimental datasets are freely available on the web,
containing implicit functional information which is not covered in the annotation databases. Among these
data sources, one of the most important types is molecular interaction data, including protein-protein and
protein-DNA interactions, gene regulatory interactions and metabolic interactions, which are commonly
represented as networks (with nodes corresponding to molecules and edges corresponding to interactions).
Moreover, in addition to physical molecular interactions, networks of functionally similar genes or proteins
can also be constructed from other data sources for the inference of functional associations, e.g. gene co-
expression data and synthetic lethality experiments, among others (see approaches mentioned in the section
“Protein interaction data pre-processing”).
Both for weighted and unweighted interaction networks, a multitude of analysis methods exist to exploit the
information content for the biological interpretation of other experimental data mapped onto the network.
These include:
1. approaches for the identification of dense network modules, clusters or communities [319–324],
2. methods for the topological analysis of networks [325–327],
3. supervised analysis approaches for using information from the network as predictors [279,328,329].
These methodologies will be discussed in more detail in the following paragraphs.
1) The first type of methods, detecting communities of densely interconnected nodes, exploit the knowl-
edge that in biological networks molecules often tend to work together in modules, e.g. protein com-
plexes represent functional units, in which single proteins perform lower level functions within the same
cellular process. Algorithms for identifying corresponding communities include methods scoring the edge-
connectivity of nodes within a putative community against the connectivity with the rest of the network
[320] (similar to the “within-cluster sum-of-squares” and “between-cluster sum-of-squares” comparison
often used in unsupervised clustering) or using other modularity scores to identify dense subgraphs. Often
advanced search space exploration methods are used to maximise these scores [330], including fast greedy
methods [331], random walk simulations [332], nature-inspired optimisation approaches [333, 334] and
mathematical programming [335]. Other graph-theoretic approaches are the MCODE method [336], us-
ing vertex weighting by computing a measure of the local neighbourhood density, and the Markov Cluster
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(MCL) algorithm [337], simulating random walks by deterministic mathematical operations on stochastic
matrices to identify densely clustered groups of nodes.
Interestingly, the problem of finding dense communities of nodes in a network is closely related to the task
of unsupervised clustering, and recent approaches therefore combine classical clustering techniques with
the identification of network modules [338, 339]. This also means that similar strategies can be used to
overcome common problems, e.g. the problem of overlapping clusters/communities can be addressed with
fuzzy clustering/community detection algorithms [340]. More recently, in this context the clustering of
network edges rather than nodes has been proposed to address the issue of overlapping clusters [341].
A frequently occurring problem in these types of analyses is the size heterogeneity of communities identified
on many real networks [342] (with many very small communities, and few very large communities), and
the difficult interpretation of these modules, if they are not enriched in certain functional annotations. To
circumvent some of these limitations in network community identification, as part of this thesis a new
method to find functional gene set associations using a molecular interaction network was developed, which
exploits network distance information rather than clustering nodes or edges (see the description of the
EnrichNet software [21] in chapter 6).
2) A fundamentally different approach for identifying outstanding and potentially biologically meaning-
ful features in networks is obtained by investigating their topological structures. Both global and local
topological properties of a network can be used for a wide range of analysis purposes. Global analysis tech-
niques often exploit the knowledge that many types of real-world biological networks display a scale-free
topology [122], with a degree distribution following a power-law. This property can be used in the analysis
of high-dimensional experimental data, e.g. for the creation of better gene co-expression networks [343].
Moreover, a global topological analysis can reveal whether a network displays assortative mixing [344],
i.e. whether nodes with the same annotation tend to be closer together in the network than nodes with
different annotations, or whether the network has hierarchical structures like a hub-and-spoke topology, i.e.
few high-degree nodes (regulatory genes or signalling proteins) interlink many small-degree nodes. Lo-
cal topological properties can provide several useful details to characterise single genes/proteins and node
communities, e.g. by computing different centrality measures (degree, eigenvector centrality, betweenness,
closeness), measures of the nodes’ tendency to form clusters (clustering coefficient, transitivity), and the
distances between them (shortest path length, random walk distance and kernel distances). For details on
these descriptors, see [345] and chapter 6 in this thesis.
All these types of topological information are typically not considered in a classical gene set analysis and
in microarray feature selection. However, an informative post-filtering of differentially expressed genes
from a microarray study could be obtained by identifying genes with outstanding topological properties
(see section “Integrating Cellular Pathway Data” above). For this purpose, a new method for the network-
topological analysis and comparison of gene sets was developed during this doctoral project (TopoGSA
[20], see chapter 6).
3) A further alternative approach to integrate network information into microarray analysis is to use net-
work properties for the selection or definition of features in supervised sample classification. For example,
instead of using single genes/proteins or pre-defined gene/protein sets as predictors, differentially expressed
sub-networks can be extracted for sample classification, and have been shown to achieve higher robustness
in cross-study classification than conventional approaches [328,329]. Apart from the use of network-based
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predictors, the edge information in a network also provides a means to account for corresponding depen-
dency structures in the data, e.g. pairs of neighbouring genes can be considered as partly redundant, cor-
related, or functionally related features, and this information can be incorporated into the penalty terms in
regularised classifiers [279]. However, in terms of the overall accuracy, these methods often do not always
provide the high sensitivity and specificity required for clinical diagnosis, and should therefore not be used
as the only source of information but combined with other clinical and experimental data.
Overall, when comparing molecular interaction networks derived from experimental data with cellular path-
way definitions (see previous section) as a potential source of additional information for microarray data
analysis, the interaction networks tend to provide a more holistic view of the complexity and multitude of
interactions in living cells than the pathway definitions, which simplify the representation of processes for
human interpretation by modelling different processes as independent modules. At the same time, this com-
parison also highlights the main drawback of interaction networks, consisting in the limited interpretability
of the often very complex structures found in networks using graph clustering and community detection
algorithms. The resulting gene/protein sets do not always have homogeneous functional annotations, their
size can be too small or large to be used as gene set predictors in sample classification, and the problem of
missing reliable “gold standard” reference partitions for validation purposes (see section on unsupervised
class discovery above) raises questions regarding the reliability and significance of some of these network
clustering results.
Thus, in order to obtain a better trade-off between the high interpretability of cellular pathway based gene set
definitions and the higher precision and information coverage in molecular interaction networks, a method
to redefine pathways using interaction data was developed as part of this doctoral project and tested on
experimental data (see the section on the PathExpand software [22] in chapter 6).
In summary, a wide range of opportunities exist to extend statistical analysis and machine learning based
analysis of functional genomics data by including external biological data within new integrative analysis
techniques. Although several algorithms have already been developed for this purpose in the past, there
is still much room for improvement in terms of robustness, interpretability and accuracy. In the following
chapters, several classical and integrative analysis approaches will be compared using the framework de-
veloped in this doctoral project, and new integrative approaches in the framework will be introduced and
discussed in detail.
Chapter 4
Comparison of Standard Machine
Learning Techniques and Integrative
Extensions
Chapter abstract
To complement the overview of different feature selection, prediction and clustering techniques
for high-dimensional data analysis presented in the literature review in chapter 3 with more
details on the performance of different types of approaches, this chapter provides a comparative
evaluation of machine learning methods on microarray gene expression data.
The first section compares a representative choice of attribute selection methods (including a
univariate filter, a combinatorial filter, an embedded selection method and a filter/wrapper com-
bination) and classification approaches (a kernel-based SVM approach, a tree-based random
forest classifier, the nearest-centroid based PAM classifier and the in-house rule-based classi-
fier BioHEL). The methods are evaluated on real-world microarray cancer datasets, including
two benchmark datasets from the literature (prostate cancer and diffuse large B-cell lymphoma)
and a breast cancer dataset from the co-operating Queen’s Medical Centre in Nottingham using
a two-level external cross-validation procedure [25]. The results show that rule-based methods
with high model interpretability can achieve similar average accuracies as complex kernel-
based classification approaches.
The second part of the chapter will compare and evaluate clustering methods (partition-based
and hierarchical approaches, as well as a consensus clustering method) using multiple internal
and external validity methods. Moreover, as a new integrative approach, a combination of
gene set analysis and clustering methods will be presented, demonstrating that on average
higher adjusted rand indices with known outcome labels are obtained when interlinking gene
set analysis based dimensionality reduction and consensus clustering.
Importantly, this chapter uses material from a recently submitted paper and the compared meth-
ods are all included in the integrative framework for high-dimensional data analysis imple-
mented in this doctoral project. They can be accessed online on the ArrayMining.net web-
application [18].
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4.0.1 Supervised analysis - experimental protocol
The analysis pipeline to compare both feature selection and prediction methods for microarray sample
classification consists of three basic steps: Data pre-processing, supervised analysis and statistical post-
analysis of the results. An illustration of the whole experimental procedure is shown in figure 4.1.
Figure 4.1: Flowchart illustrating the experimental procedure for evaluating feature selection and classification methods,
consisting of three stages: 1) Pre-processing; 2) Supervised analysis; 3) Post-analysis. The wrapper-based SVM-RFE
approach is not included in the flowchart, because feature subset selection and machine learning are linked together in
this method.
In the first stage, the microarray datasets are normalised and an initial dimensionality reduction is performed
(see section “Datasets and pre-processing” below). Next, an external cross-validation scheme is applied, i.e.
in each cycle of the cross-validation, first a feature selection method is applied on the current training data
and then a machine learning method on the resulting subset of features. This procedure is employed using
both 10-fold external cross-validation (CV) and leave-one-out CV (LOOCV) [25] and all possible com-
binations of feature selection algorithms and classification algorithms. Specifically, the feature selection
methods include the univariate filter “Partial-Least-Squares based Feature Selection” (PLSS), the combi-
natorial filter “Correlation-based Feature Selection” (CFS) [160], the embedded feature selection method
“Random Forest based Feature Selection” (RFS), and a filter-wrapper combination using a PLS-based pre-
filter and an SVM-wrapper with recursive-feature elimination (RFE). Similarly, the four chosen machine
learning methods cover a wide range of diverse approaches: An in-house rule-based classifier, BioHEL, a
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support vector machine (SVM) [346], a Random Forest classifier (RF) [191] and the “Prediction Analysis
of Microarrays” method (PAM) [239].
In the last step of the protocol, a post-analysis is applied on the most informative genes to identify putative
oncogenes and tumour suppressors, investigating the frequency of occurrence of gene identifiers in different
types of prediction rules. Finally, an example literature mining is presented, showing that almost all of the
top-ranked genes have known functional associations with the studied cancer diseases.
4.0.2 Datasets
All methods are evaluated on three public microarray cancer datasets representing three different types of
cancer: Diffuse large B-cell lymphoma (DLBCL) [347], prostate cancer [348] and a breast cancer dataset
obtained from the collaborating Queens Medical Centre in Nottingham [19, 349–351]. Below, details are
given for each dataset and pre-processing method used in this comparative evaluation.
Table 4.1: Datasets used for comparative evaluation
Dataset Platform No. of No. of samples references
genes class 1; class 2
DLBCL Affymetrix 7,129 58 (D) ; 19 (F) [347]
Prostate Affymetrix 12,600 52 (T) ; 50 (N) [348]
Breast Illumina 47,293 84 (L) ; 44 (N) [19, 349–351]
Diffuse large B-cell lymphoma (DLBCL)
The DLBCL dataset [347] contains expression values for 7,129 genes and 77 microarray samples, 58 of
which were obtained from patients suffering from diffuse large B-cell lymphoma (D), while the remaining
samples are derived from a related B-cell lymphoma type, termed follicular lymphoma (F). The experiments
were carried out on an Affymetrix HU6800 oligonucleotide platform [352].
To pre-process the raw data, the Variance stabilizing normalisation method [80] was applied to filter out
intensity-dependent variance. This was done using the vsn library and the expresso package in the R sta-
tistical learning environment [353]). Moreover, a thresholding was applied using the suggestions in the
supplementary material of the original publication associated with the dataset [347], and a “fold change”-
filter used to remove features with low variance (all gene vectors with less than a 3-fold change between
the maximum and minimum expression value were discarded), resulting in 2647 remaining genes (see sec-
tion 4.2.3 for comparative classification results from the literature on this dataset). Figure 4.2 shows a 3D
scatter plot of the first 3 principal components in the data.
Prostate cancer
The prostate cancer dataset [348] consists of expression measurements for 12,600 genetic probes across
50 normal tissues and 52 prostate cancer tissues. All experiments have been carried out on Affymetrix
Hum95Av2 arrays [352]. Due to the large number of samples, the fast GeneChip RMA (GCRMA) nor-
malisation algorithm was applied [354], a method that combines stochastic and sequence-based physical
models to estimate the mRNA abundances. Moreover, thresholding was employed using the suggestions of
the original publication associated with the dataset [348] and a fold change filter to remove all probes with
less than a 2-fold change between the maximum and minimum expression value, providing 2135 remaining
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Figure 4.2: 3D visualisation of the first three principal components of the B-cell lymphoma dataset (created using the
VRMLGen software [24], see chapter 8).
genes (see section 4.2.3 for comparative classification results from the literature on this dataset). Figure 4.3
shows a 3D scatter plot of the first 3 principal components in the data.
Figure 4.3: 3D visualisation of the first three principal components of the prostate cancer dataset (created using the
VRMLGen software [24], see chapter 8).
Breast cancer
The breast cancer dataset from the collaborating Queen’s Medical Centre [19, 349–351] provides gene
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expression values for 128 primary breast tumours across 47,293 genetic probes. Two groups of tumour
samples can be distinguished in the data, the luminal group (L, 84 samples), which is characterised by oe-
strogen receptor expression, and the non-luminal group (N, 44 samples, no oestrogen receptor expression).
The expression profiling procedure has previously been described in detail [349–351], and has also been
applied in a recent ensemble gene selection analysis of this dataset [19]. Since the probe level data was not
obtained from a conventional DNA chip, but from a Sentrix Human-6 BeadChip platform (v1.0, Illumina,
San Diego, CA), the data was normalised and summarised using the dedicated Bioconductor “beadarray”
package (see section 4.2.3 for comparative classification results). Figure 4.4 shows a 3D scatter plot of the
first 3 principal components in the data.
Figure 4.4: 3D visualisation of the first three principal components of the breast cancer dataset (created using the
VRMLGen software [24], see chapter 8).
4.1 Comparative Evaluation of Feature Selection Methods
4.1.1 Feature selection methods
As discussed in the literature review (see chapter 3), microarray data typically contain a large number of
uninformative genes with regard to the biological question to be addressed, causing statistical problems sub-
sumed under the term “curse of dimensionality“ (see [355]). Therefore, after normalisation and pre-filtering
of the datasets in the first part of the analysis pipeline, microarray feature selection methods are applied prior
to the classification methods (unless classification and attribute selection are already tied together in one
algorithm), even if the user is only interested in the prediction results and not in the interpretation of the
gene selection outcome.
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To account for the diversity of existing feature selection methods, four different types of approaches are
considered separately in this study. These include a classical univariate filter (PLSS [356]), a combinatorial
filter (CFS [160]), a tree-based feature ranking approach (RFS [190]) and a filter/wrapper combination
(PLS-filter in combination with an SVM-RFE wrapper). For all feature selection methods the maximum
feature subset size was set to 30 to prevent overfitting, reduce the probability of including uninformative
features and facilitate the comparison and interpretation of the results from different algorithms (however,
the methods are allowed to flexibly select less than 30 features). This decision was also motivated by
recent studies estimating the approximate number of features to be selected in different types of microarray
studies to obtain only genes with significant informative value on the outcome attribute (based on different
models to compute p-values for the significance of genes, see [357–359]). The chosen selection methods
are described in detail in the following paragraphs.
Partial-Least-Squares based Feature Selection (PLSS): As a representative of a classical univariate
filter, a method using the Partial Least Squares (PLS) [360] algorithm is employed. Specifically, the features
are ordered by the absolute values of the weight vector defining the first latent component in a PLS model
that was built upon the training data. As previously shown [361], the ordering of features obtained from this
approach is equivalent to the F-statistic used in analysis of variance (ANOVA). Thus, instead of the PLS-
calculation the F-statistic itself could have been used, but PLSS provides a much faster way of performing
the calculation (the fast SIMPLS algorithm [362] is used for this purpose).
Correlation based Feature Selection (CFS): The CFS algorithm [160] searches for subsets of features
that have high correlation to the response variable but low correlation amongst each other (see also the
section on combinatorial filters in chapter 3). This concept is formalized by the following feature subset
score:
CFSS =
k · cr f√
k+ k(k−1)c f f
(4.1)
where S is the selected subset with k features, cr f is the average feature-class correlation and c f f the average
feature-feature correlation. While the denominator reduces the score for correlated features to eliminate
redundant variables, the numerator promotes features with high correlation to the class variable to retain
them as powerful discriminators. As proposed in the original CFS publication, a greedy best-first search
strategy was employed to explore the feature subset space [160].
Random Forest based Feature Selection (RFS): In contrast to the CFS and the PLSS algorithm, the
attribute selection obtained from the Random Forest classifier [190] uses a method directly embedded into
the prediction algorithm. Specifically, a Random Forest model is built by training many binary, unpruned
decision trees on bootstrap sub-samples of the training data. The importance of a feature is evaluated
using the Gini index node impurity measure [192], by calculating the mean decrease in this measure from
parent nodes to their direct descendent nodes over all tree nodes. A feature subset is obtained from the
corresponding attribute ranking by selecting the top n features.
Filter/wrapper combination In order to assess the benefits of the wrapper methodology for feature se-
lection, while retaining relatively short runtimes, a combination of a univariate filter with a wrapper, an
approach that is frequently used in practice, was employed. Specifically, a PLS pre-filtering is used (see
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PLSS method above) to pre-select 300 genes, among which highly predictive subsets are searched using
an SVM-wrapper with a recursive feature elimination (RFE) search procedure [189] (see also the feature
selection section in chapter 3). Employing an SVM-RFE wrapper selection without any pre-filtering would
result in infeasible runtimes for typical microarray data and in an unfair comparison with the other selection
methods, which require at most a few minutes computation time on standard desktop machines, hence, a
“wrapper-only” approach was not considered here.
Feature selection results
When using feature selection to pre-process microarray data prior to supervised classification, the average
accuracy can vary greatly with the choice of the selection method, since the performance does not only
depend on the inclusion of informative features, but can also be affected negatively by the selection of
redundant and irrelevant features. To compare the selection methods considered in this study, the Fried-
man test was applied to the average classification accuracies (once for 10-fold CV and once for LOOCV)
across all datasets and all four prediction methods (BioHEL, SVM, RF and PAM; with the exception of the
filter/wrapper approach, in which the selection is tied to a single algorithm).
In summary, for 10-fold CV, no significant differences in performance were observed between the selec-
tion methods, but for LOOCV the PLSS approach was significantly superior to all other methods at 95%
confidence level according to a subsequent Holm-test (see the ranking in table 4.2). The observation that
a univariate ranking method could not be outperformed by combinatorial, embedded and filter/wrapper
selection methods justifies the still widespread popularity of univariate selection methods. Relatively high
performances of simple selection strategies had already been noted in a similar study byWessels et al. [363]
when comparing other selection methods on microarray data. In particular, the F-statistic has been used fre-
quently in highly successful machine learning systems. For example, in the “NIPS 2003 Feature Selection
Challenge” [364], a method using the F-statistic and an SVM-classifier [365] was ranked among the top 5
entries, performing better than many multivariate selection strategies. Thus, if the independence assumption
represents a good approximation for some of the most informative features, or if multivariate methods fail to
correctly capture the dependence structure between different variables, a classical fast univariate selection
approach may still be the method of choice for complex, high-dimensional microarray data.
The wrapper/filter combination (SVM-RFE) provided the best average accuracy on the DLBCL dataset, but
on both other datasets the average performance was lower than for most other method combinations. How-
ever, in order to obtain a fair comparison between SVM-RFE and filter approaches, the runtimes were kept
approximately similar, hence, the wrapper approach might achieve better results, by running it for a longer
time or using a more stringent pre-filtering (notably, the DLBCL dataset, on which SVM-RFE performed
best, has a smaller dimensionality than the other datasets). These observations match to previous findings
in the literature according to which filter methods tend to provide a better trade-off between predictive ef-
fectiveness and runtime efficiency in comparison to wrappers on most real-world datasets [178] (see also
chapter 3, section 3.3.2).
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Table 4.2: Comparison of feature selection methods
Average ranks
method CFS PLSS RFS
10-fold 2.1 1.9 2.0
LOO 2.4 1.6 2.0
Average rank scores resulting from a Friedman test to compare feature selection methods in terms of classification
accuracy across different datasets and prediction methods. The best average ranks for each row are shown in bold
typeface.
4.2 Comparative Evaluation of Classification Methods
4.2.1 Methods
The main purpose for the comparative evaluation of classification methods conducted in this study was to as-
sess whether classification methods using easily interpretable “if-then-else” decision rules can reach similar
accuracies as other state-of-the-art microarray sample classification methods, e.g. kernel-based approaches
like SVMs. Therefore, the following section will first describe the rule-based in-house classification method
BioHEL [366–369] and then the benchmark approaches (SVM, PAM, RF) employed for comparison, and
the evaluation methods and implementation parameters will be discussed.
Rule-based evolutionary machine learning (BioHEL) BioHEL [366–369] is an evolutionary machine
learning system employing the Iterative Rule Learning (IRL) paradigm [370,371].
The IRL procedure begins with an empty rule set and the complete set of observations as input. Classifi-
cation rules are added iteratively to the set of rules until their combination covers all samples. The final
outputs are structured rule sets, also known as decision lists [372], a knowledge representation inherited
from BioHEL’s predecessor software GAssist [373] (a small example rule set is shown in figure 4.5). Each
time a new decision rule has been learnt and added to a corresponding rule set, the observations it covers
are removed from the examples set.
To explore the search space of possible rules efficiently, BioHEL uses a standard generational Genetic
Algorithm (GA) which is applied in each IRL iteration to find the best rule for samples which have not yet
been covered by rules found in previous iterations. Since GAs are non-deterministic, multiple repetitions
of the rule learning process with identical training sets can be used to increase the probability of finding
the optimal rule. Additionally, repetitions of the complete learning process (i.e. generating a complete rule
set and not just a single rule) can also be applied, in order to combine several rule sets to a majority-vote
consensus prediction and benefit from the variance-reducing effects of ensemble learning [8] (see section
“Ensemble learning methods” in chapter 3).
In order to find the best rule in each IRL iteration, the fitness function used in the GA accounts for both
the accuracy and the generality, i.e. the number of covered observations, of a rule. In BioHEL, this fitness
function accounts for the Minimum Description Length (MDL) principle [374] and has the following basic
structure:
Fitness= TL ·W +EL (4.2)
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Figure 4.5: Example for a BioHEL classification rule set for the prostate cancer dataset (“Att” is short for “Attribute”,
“∧” represents the conjunctive AND-operator, “[x,y]” is an interval of expression values in which the value of the
attribute must lie to fulfil one premise of the rule, and “→” is a class assignment operator, followed by the output class
of the rule).
where TL represents the theory length (reflecting complexity, see precise definition below), EL stands for
exceptions length (reflecting accuracy and coverage, see precise definition below) and Fitness is a score to
be minimised. W is a weighting factor to adjust the relation between TL and EL, which is set automatically
using a previously introduced heuristic [373]. More specifically, TL is given by the following formula:
TL(R) =
NA
∑
i=1
NumZeros(Ri)/Cardi
NA
∈ [0,1] (4.3)
where NA is the number of attributes of the domain, R is a rule, Ri is the predicate of rule R associated to
attribute i, NumZeros measures the rule specificity by counting the number of bits set to zero in the binary
vector representation for the rule predicates (see [375] for details on this representation), and Cardi is the
cardinality of attribute i.
The second scoring term, EL, is designed to maximise both the accuracy (acc) of rules and their sample
coverage (cov). Rules which cover a certain minimum percentage of observations receive a high reward,
but after surpassing this threshold, the additional reward for covering more samples is smaller:
EL(R) = 2−acc(R)− cov(R) (4.4)
acc(R) =
corr(R)
matched(R)
(4.5)
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cov=

 minCovRatio ·
rawCov
covBreak if rawCov< covBreak
minCovRatio+(1−minCovRatio) · rawCov−covBreak1−rawCov if rawCov≥ covBreak
(4.6)
rawCov=
matched(R)
|T | (4.7)
where corr(R) is the number of examples correctly classified by rule R, matched(R) is the number of
examples matched by R, minCovRatio is a weighting factor applied depending on whether the minimum
coverage is achieved, covBreak is the minimum coverage threshold and |T | is the total number of training
examples.
In summary, BioHEL combines the benefits of evolutionary algorithms, IRL and ensemble learning to
obtain rule sets for sample classification that are both informative and accurate.
Benchmark machine learning methods for microarray sample classification In order to compare Bio-
HEL against commonly used methods for microarray sample classification, the cross-validation procedure
was applied to three alternative classifiers in addition to BioHEL: A support vector machine (SVM) [346],
a random forest classifier (RF) [191] and the nearest shrunken centroid classifier (“Prediction Analysis of
Microarrays”, PAM) [239].
The used support vector machine is a linear kernel C-SVM from the e1071-package [376] of the R sta-
tistical learning environment [353], a wrapper for the well-known LibSVM library [377]. Other polyno-
mial kernels and the radial basis function kernel were tested without providing superior results (data not
shown). This observation matches well to earlier findings in the literature according to which linear ker-
nel SVMs often perform similar or better on microarray data than SVMs using higher degree polynomial
kernels [189, 378, 379]. For the RF and PAM methods, the corresponding R packages randomForest and
pamr were used. Moreover, BioHEL was also compared with alternatives from the literature using previ-
ously published results. For this purpose, only average cross-validation accuracies were considered, since
evaluation methods involving only a single random training/test-set partition are now widely regarded as
unreliable [380]. For the same reason, methods from the literature using internal cross-validation instead
of external cross-validation were excluded from the comparison, wherever this was clearly stated by the
authors.
4.2.2 Evaluation methods and implementation parameters
The main evaluation method used in this study is a cross-validation scheme known as two-level external
cross-validation [25]. In an external cross-validation, feature selection is applied independently to each
training set generated within the cross-validation cycles, avoiding the selection bias of classical internal
cross-validation, where feature selection is only applied once to the whole dataset prior to any further
analysis [380]. Two-level external cross-validation uses an additional nested cross-validation procedure to
optimise the parameters for each prediction algorithm. We apply this second level of cross-validation to fit
the parameters for the benchmark predictors SVM, RF, and PAM.
Since BioHEL employs an evolutionary algorithm depending on the initialisation of a stochastic random
number generator, the entire cross-validation process is repeated 10 times for different random number
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seeds. The results are averaged over all repetitions and cross-validation cycles, e.g. for 10-fold cross-vali-
dation the final accuracy is an average over 100 runs of BioHEL. Other algorithm specific parameters used
for the evolutionary learning procedure are shown in table 4.3.
Table 4.3: Parameters used for BioHEL
population size 100
iterations 100
cross-over probability 0.6
mutation probability 0.6
selection type tournament selection
coverage ratio 0.9
coverage break 0.2
(for more details on BioHEL’s workflow and default parameters see [381] and [369])
Moreover, apart from single rule-set classifiers, ensemble models are trained by assigning samples to the
majority-voting class of rule-sets obtained from multiple runs of BioHEL. The number of base models
in ensemble learning can be seen as a trade-off parameter determining the balance between the bias and
variance of the model (see ensemble learning section in chapter 3). Importantly, using a high number of
base models does not necessarily reduce model interpretability, e.g. more robust statistics on the occurrence
of selected genes in different rule sets can be obtained with a larger number of base models (see section
“Identification of potential oncogenes and tumour suppressor genes” below). Since the best results were
obtained with a 100-times ensemble, this was used as the default configuration.
Importantly, the obtained prediction models are only applicable to samples from the same platform, cell
type, environmental conditions and experimental procedure, since this study was designed for the compar-
ative evaluation of different analysis techniques and not for cross-platform data integration. However, as
BioHEL supports both continuous and discretized input data, it is compatible with most of the cross-study
normalization methods that have been proposed in the literature.
4.2.3 Comparison of prediction results
An overview of the comparative prediction results is given in table 4.4 for 10-fold CV and table 4.5 for
LOOCV. Below the results for both datasets are discussed.
Classification results: Diffuse large B-cell lymphoma (DLBCL)
On the DLBCL dataset, the best prediction results with BioHEL were reached in combination with the
PLSS filter, providing average accuracies of 92% (10-fold CV) and 93% (LOOCV). These results are both
comparable to those for parameter-optimised conventional methods considered in this study (SVM, RF and
PAM, see tables 4.4 and 4.5) and results reported in the literature for this dataset (see table 4.6). In the
comparative analysis, only some SVM models outperformed BioHEL by a slight margin (SVM-RFE and
SVM in combination with PLSS-feature selection, reaching an average accuracy of 96%, respectively 94%,
with LOOCV). From the results reported in the literature for the DLBCL dataset (see table 4.6) only the
approach by Liu et al. [382] reached a slightly higher accuracy (94%) than the best BioHEL models.
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Table 4.4: 10-fold CV classification results
Dataset Feature Selection Classification AVG (%) STDDEV
CFS BioHEL 92 8
PLS BioHEL 92 12
RF BioHEL 89 11
CFS SVM 90 10
CFS RF 92 11
CFS PAM 91 10
PROSTATE PLS SVM 90 11
PLS RF 92 9
PLS PAM 94 8
RF SVM 88 8
RF RF 93 9
RF PAM 90 11
SMV-RFE SVM 88 8
CFS BioHEL 83 19
PLSS BioHEL 92 11
RFS BioHEL 87 17
CFS SVM 87 12
CFS RF 87 16
CFS PAM 78 17
DLBCL PLSS SVM 91 13
PLSS RF 87 8
PLSS PAM 86 11
RFS SVM 91 13
RFS RF 89 13
RFS PAM 86 14
SMV-RFE SVM 95 9
CFS BioHEL 86 8
PLSS BioHEL 82 11
RFS BioHEL 83 10
CFS SVM 86 9
CFS RF 86 7
CFS PAM 89 7
BREAST PLSS SVM 84 7
PLSS RF 89 5
PLSS PAM 88 7
RFS SVM 80 17
RFS RF 89 5
RFS PAM 88 7
SMV-RFE SVM 86 9
10-fold cross-validation results obtained with BioHEL, SVM, RF and PAM on the three microarray datasets using four
feature selection methods (CFS, PLSS, RFS, SMV-RFE); AVG = average accuracy, STDDEV = standard deviation.
The highest accuracies achieved with BioHEL and the best alternative method are both shown in bold typeface for each
dataset.
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Table 4.5: LOOCV classification results
Dataset Feature Selection Classification AVG (%) STDDEV
CFS BioHEL 89 31
PLS BioHEL 92 28
RF BioHEL 91 29
CFS SVM 89 31
CFS RF 95 22
CFS PAM 90 30
PROSTATE PLS SVM 93 25
PLS RF 93 25
PLS PAM 93 25
RF SVM 89 31
RF RF 91 29
RF PAM 91 29
SMV-RFE SVM 85.3 36
CFS BioHEL 82 39
PLSS BioHEL 93 26
RFS BioHEL 84 37
CFS SVM 88 32
CFS RF 87 34
CFS PAM 84 37
DLBCL PLSS SVM 94 25
PLSS RF 90 31
PLSS PAM 86 35
RFS SVM 90 31
RFS RF 92 27
RFS PAM 83 38
SMV-RFE SVM 96 19
CFS BioHEL 84 36
PLSS BioHEL 84 36
RFS BioHEL 84 37
CFS SVM 84 37
CFS RF 84 36
CFS PAM 90 30
BREAST PLSS SVM 81 39
PLSS RF 88 33
PLSS PAM 86 35
RFS SVM 86 35
RFS RF 87 34
RFS PAM 88 32
SMV-RFE SVM 78.9 41
Leave-one out cross-validation results obtained with BioHEL, SVM, RF and PAM on the three microarray datasets
using four feature selection methods (CFS, PLSS, RFS, SMV-RFE); AVG = average accuracy, STDDEV = standard
deviation. The highest accuracies achieved with BioHEL and the best alternative are both shown in bold typeface for
each dataset.
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A common problem in the classification of high-dimensional data with small sample sizes is the high vari-
ance in cross-validation error estimates, especially in LOOCV [380,383]. This observation is also made on
the three datasets considered in this study and applies both to BioHEL and the alternative prediction meth-
ods. However, in comparison to random classification assignments, all BioHEL models showed significant
discriminative power on the DLBCL dataset.
Table 4.6: Comparison of prediction results from the literature for the DLBCL dataset
Author (year) Method (Avg.) accuracy (Avg.) number of
genes
Wessels et al. [363] RFLD(10), Monte-Carlo CV 95.7 80
Liu et al. [382] MOEA+WV 93.5 6
Shipp et al. [347] SNR+WV, LOOCV 92.2 30
Goh et al. [384] PCC-SNR + ECF, LOOCV 91 10
Lecocke et al. [385] GA+SVM, LOOCV 90.2 **
GAGA+DLDA, LOOCV 89.8 **
GAGA+3-NN, LOOCV 86.3 **
Hu et al. [386] WWKNN, LOOCV 87.01 12
ECF, LOOCV 85.71 12
our study PLSS+BioHEL, LOOCV 89.68 *30
PLSS+BioHEL, 10-fold CV 92.48 *30
*maximum no. of genes per base classifier in ensemble learning model
**evaluation results averaged over feature subsets using different numbers of genes
Classification results: Prostate cancer
On the prostate cancer data, the highest average accuracies of 92% (10-fold CV) and 92% (LOOCV) with
BioHEL were again obtained using the PLSS feature selection. From the alternative prediction methods
considered in the comparative analysis, only the PLS/PAM combination reached a slightly higher accuracy
(10-fold avg. acc.: 94%. LOOCV avg. acc.: 93%). Similarly, in the results reported in the literature for this
dataset using external cross-validation methods, only Shen et al. (2005) [387] and Paul et al. (2005) [388]
(see table 4.7) obtain a slightly higher average accuracy. However, Shen et al. employ a singular value
decomposition (SVD) instead of feature selection, which includes more genes from the original data than the
maximum of 30 considered here, and which can be more difficult to interpret (unless the derived features can
be linked to biological processes). Paul et al. use original features in their models, but the average number
of included genes also exceeds 30 features (48.5). Thus, considering both accuracy and model complexity,
BioHEL performs well on this dataset in comparison to the benchmark classifiers and alternative approaches
in the literature.
Classification results: Breast cancer
For the breast cancer dataset, obtained from the Nottingham Queen’s Medical Centre, the best average
accuracies obtained with BioHEL were 86% (10-fold CV) and 84% (LOOCV). These results were similar
to those of other benchmark classifiers, with somemethods being slightly superior and some slightly inferior
(the most successful approach was CFS/PAM with 89% acc. for 10-fold CV and 90% acc. for LOOCV).
Importantly, independent of the feature selection and cross-validation method, BioHEL always provided
average accuracies of at least 82% on the breast cancer data.
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Table 4.7: Comparison of prediction results from the literature for the Prostate dataset
Author (year) Method (Avg.) accuracy (Avg.) number of
genes
T.K. Paul et al. [388] RPMBGA, LOOCV 96.6 48.5
Wessels et al. [363] RFLD(0), Monte-Carlo CV 93.4 14
Shen et al. [387] PLR, Monte-Carlo-CV (30 iterations) 94.6 ***
PLR, Monte-Carlo-CV (30 iterations) 94.3 ***
W Chu et al. [389] Gaussian processes, LOOCV 91.2 13
Lecocke et al. [385] SVM, LOOCV 90.1 **
DLDA, LOOCV 89.2 **
GAGA+3NN, LOOCV 88.1 **
our study PLSS+BioHEL, LOOCV 92.8 *30
PLSS+BioHEL, 10-fold CV 93.2 *30
*maximum no. of genes per base classifier in ensemble learning model
**evaluation results averaged over feature subsets using different numbers of genes
***singular value decomposition used instead of classical feature selection
Since this dataset was obtained from a collaborating institute, no external cross-validation results for alter-
native methods are available in the literature, however, the dataset has been published online and can freely
be used for comparative evaluation and analysis purposes [19, 349–351].
On the whole, in all experiments the BioHEL ensemble classification models provided high and robust
classification accuracies, comparable to those for a selection of some of the most popular microarray clas-
sification methods. The good agreement between the performance estimates obtained from 10-fold CV
and LOOCV provides further support for these observations made for individual combinations of datasets
and cross-validation methods. To compare the predictors across all datasets and different feature selection
methods, a Friedman test [390, 391] over the average classification accuracies (once for 10-fold CV and
once for LOOCV) was applied in addition to the direct comparison of accuracies within each dataset (the
wrapper-based approach, which is tied to a single classifier, was disregarded in this analysis). According
to this test, at a 95% confidence level no significant differences between the performances of the differ-
ent classification methods were detected (see the average ranks in table 4.8). These results suggest that
in spite of using simple “if-then-else”-rules, BioHEL’s performance for microarray sample classification is
approximately comparable to that of parameter-optimised SVM-, RF- and PAM-models.
With regard to BioHEL’s runtime, even the most time-consuming experiment (combining LOOCV with the
100-times ensemble and repeating this 10 times for different random seeds) required less than one day on
a 2 GHz dual-core CPU (other experiments lasted between several minutes and a few hours, depending on
the number of CV-cycles and base models in ensemble learning). Across all methods, the overall memory
requirements and the runtimes for applying the trained models were similar and negligibly small.
Table 4.8: Comparison of prediction methods - Friedman test
Average ranks
method SVM RF PAM BioHEL
10-fold 2.9 1.8 2.6 2.7
LOO 2.6 1.9 2.3 3.2
Average rank scores resulting from a Friedman test to compare prediction methods across different datasets and feature
selection methods. The best average ranks are shown in bold typeface.
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Identification of potential oncogenes and tumour suppressor genes
Analysing genes solely based on their differential expression patterns in samples from different disease
conditions can only provide a rough indication of their potential functional roles in the disease. There-
fore, using the rule sets obtained from the BioHEL classification models, occurrence patterns of frequently
selected genes in different rule types were investigated to obtain further insights.
For this purpose, top-ranked genes for each dataset, which had been chosen most frequently across all
selection methods, were studied for their occurrence in the rule predicates of the BioHEL ensemble models.
The example rule set in figure 4.5 contains some of these top-ranked gene attributes (the attribute names
are specified as Affymetrix gene identifiers). This example also shows that each occurrence of a gene in a
rule has an associated value range, in which the expression value of the gene must lie to fulfil one premise
of the rule. Moreover, each rule has an associated class label corresponding to the conclusion of the rule.
Thus, for pairs of selected genes and possible class assignments, sets of upper and lower expression value
bounds can be extracted from the rules and analysed statistically. In some cases, more general rules can
be derived from these extracted value ranges, i.e. “less than”- or “greater than”-rules according to which
the expression value of a gene must always be greater or smaller than a certain threshold-value, when the
sample is assigned to a specific class. In a previous machine learning approach [392], this idea had already
been used to identify potential promoter- and blocker-genes, whose gene products are likely to promote the
disease (potential oncogenes, which are mostly over-expressed in the tumour) or block the disease (potential
tumour suppressor genes, which are mostly under-expressed in the tumour).
Here, an alternative approach is used to extract information from the rule-based models, providing an eas-
ily interpretable bar plot visualisation. For each pair of a selected attribute and a class assignment, the
median of the upper and lower bound of the expression value range is extracted from all occurrences of
this gene/class-pair in conditionals of the rule-sets in the 100-times ensemble model. Thus, for both the
“tumour”- or the “healthy”-class a robust estimate is obtained for the value ranges in which the expression
value of a gene should lie according to the ensemble model. Every gene-class pair is represented by a sin-
gle vertical bar in the bar plot, extending from the median of the lower bounds to the median of the upper
bounds.
In contrast to a binary categorisation of genes into promoters and blockers of a disease [392], this visuali-
sation of median value ranges for the sample classes using coloured bars does not only contain information
on whether a gene tends to be up- or down-regulated in a certain sample class, but the distance between the
median lower and upper bound also provides information on the narrowness of the value range for a certain
gene/class-pair and the size of the overlap for the value ranges of different classes. Thus, this analysis also
provides an intuitive measure of confidence (see example plots in figures 4.6 and 4.7).
More importantly, the plots in figure 4.6 and 4.7 reveal that in the corresponding datasets the differences
between the expression values across the sample classes are not large enough in relation to the within-class
variance for any of the top-ranked individual genes to obtain reliable classification results based on a single
gene as predictor (the expression value ranges for the assignment of a sample to the different classes overlap
for each of these genes). This observation explains why groups of genes are required to build models with
substantial predictive power for these datasets.
In summary, analysing the occurrence of gene attributes in the ensemble rule sets enables the identification
of putative oncogenes and tumour suppressor genes, whose expression values tend to be associated with
a certain disease state. Based on the difference between the upper and lower bounds of the value ranges
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in both classes and the overlap of these value ranges, genes can also be prioritized as potential diagnostic
markers.
Example literature mining for frequently selected genes
To illustrate the usefulness of the analysis pipeline for the biological interpretation of the data, an example
literature mining was performed for the top-ranked genes on the prostate cancer dataset. Table 4.9 shows
the top 20 genes that were chosen by at least two different selection methods among the genes selected most
frequently across the LOOCV cycles (Tables 4.10 and 4.11 show the corresponding results for the DLBCL
and the breast cancer dataset). Since this approach combines results from all cross-validation cycles and
diverse selection methods, the identified consensus gene list is expected to represent a more robust selection
than conventional rankings obtained when applying only a single selection strategy once on the whole data.
Table 4.9: List of high scoring genes for the Prostate cancer dataset
Gene identifier No. of occurrences Annotation
37639 at 3 hepsin (transmembrane protease, serine 1)
32598 at 3 nel-like 2
41706 at 3 alpha-methylacyl-coa racemase (AMACR)
38634 at 3 retinol binding protein 1, cellular (CRBP1)
37366 at 3 pdz and lim domain 5 (PDLIM5)
40282 s at 2 complement factor d (adipsin)
38087 s at 2 s100 calcium binding protein a4 (S100A4)
41468 at 2 T cell receptor gamma (TCR-gamma)
38827 at 2 anterior gradient 2 (AGR2)
38406 f at 2 prostaglandin d2 synthase 21kda (PTGDS)
34840 at 2 we38g03.x1 homo sapiens cdna, 3’ end
List of genes that were chosen by at least two different selection methods among the 20 features with highest Z-scores
on the Prostate dataset (column 1: the Affymetrix gene identifier, column 2: number of feature selection methods for
which the gene appeared among the 20 top-ranked genes, column 3: gene annotation)
Table 4.10: List of high scoring genes for the DLBCL dataset
Gene identifier No. of occurrences Annotation
X02152 at 3 lactate dehydrogenase a (LDHA)
V00594 at 2 metallothionein 2a (MT2A)
HG1980-HT2023 at 2 tubulin, beta 2c (TUBB2C)
U63743 at 2 kinesin family member 2c (KIF2C)
X05360 at 2 cell division cycle 2, g1 to s and g2 to m (CDC2)
M63379 at 2 clusterin
M13792 at 2 adenosine deaminase (ADA)
L19686 rna1 at 2 macrophage migration inhibitory factor (MIF)
D14662 at 2 peroxiredoxin 6 (PRDX6)
S73591 at 2 thioredoxin interacting protein (TXNIP)
List of genes that were chosen by at least two different selection methods among the 30 features with highest Z-scores
on the DLBCL dataset (column 1: the Affymetrix gene identifier, column 2: number of feature selection methods for
which the gene appeared among the 30 top-ranked genes, column 3: gene annotation)
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Figure 4.6: Medians of lower and upper bounds of rule-based assignment intervals in both sample classes for the Prostate cancer dataset (red area = expression values between median lower
and upper bound in tumour class, green = expression values between median lower and upper bound in normal class). Known and putative tumour suppressor genes often have a lower and
narrower value range in the “tumour”-class and a higher and wider value range in the “normal”-class, whereas the opposite pattern is observed for oncogenes.
4
.2
.
C
o
m
p
a
ra
tiv
e
E
v
a
lu
a
tio
n
o
f
C
la
ssifi
ca
tio
n
M
eth
o
d
s
9
6
Figure 4.7: Medians of lower and upper bounds of rule-based assignment intervals in both sample classes for the DLBCL cancer dataset (red area = expression values between median lower
and upper bound in tumour class, green = expression values between median lower and upper bound in normal class).
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Table 4.11: List of high scoring genes for the Breast cancer dataset
Gene identifier No. of occurrences Annotation
GI 4503602-S 3 Homo sapiens estrogen receptor 1 (ESR1)
GI 14249703-S 3 Homo sapiens RAS-like, estrogen-regulated, growth-inhibitor (RERG)
GI 16507967-S 3 Homo sapiens potassium channel, subfamily K, member 15 (KCNK15)
GI 22779933-S 2 Homo sapiens WD repeat membrane protein PWDMP (PWDMP)
GI 42657473-S 2 Uncharacterized protein (C6orf115)
GI 7706686-S 2 Homo sapiens Enah/Vasp-like (EVL)
GI 40788002-S 2 Homo sapiens proteasome (prosome, macropain) activator subunit 4 (PSME4)
GI 33620752-S 2 Homo sapiens hypothetical protein FLJ10876 (FLJ10876)
GI 13236596-S 2 Homo sapiens hypothetical protein MGC10765 (MGC10765)
GI 29029609-A 2 Homo sapiens pyrimidinergic receptor P2Y, G-protein coupled, 6 (P2RY6), variant 1
GI 37551139-S 2 Homo sapiens hypothetical protein PRO2013 (PRO2013)
GI 40255152-S 2 Homo sapiens potassium channel tetramerisation domain containing 6 (KCTD6)
GI 30410031-S 2 Homo sapiens prostate-specific membrane antigen-like protein (PSMAL/GCP III)
GI 4503928-S 2 Homo sapiens GATA binding protein 3 (GATA3), mRNA
GI 42659459-S 2 Homo sapiens hypothetical gene supported by AK128810 (LOC399717)
GI 29738585-S 2 Homo sapiens hypothetical protein LOC143381 (LOC143381)
GI 38455428-S 2 Homo sapiens breast cancer membrane protein 11 (BCMP11), mRNA
GI 22035691-A 2 Homo sapiens GDNF family receptor alpha 1 (GFRA1), transcript variant 2
List of genes that were chosen by at least two different selection methods among the 30 features with highest Z-scores
on the Breast cancer dataset (column 1: the Genbank identifier, column 2: number of feature selection methods for
which the gene appeared among the 30 top-ranked genes, column 3: gene annotation)
In the prostate cancer dataset, five genes were found in the intersection set of the top 20 ranking lists for
all feature selection methods: Hepsin, nel-like 2, alpha-methylacyl-coa racemase, retinol binding protein
1 and pdz and lim domain 5. Annotations for these and all other genes on the list were obtained from the
Gene Cards web-service [26], the DAVID functional annotation database [393] and from the supplemen-
tary material of the microarray dataset. Using this information, the biomedical literature in the PubMed
database was mined to identify articles reporting functional associations of these genes with the disease
under consideration.
The results reveal that almost all of the genes on the list have either known functional associations with can-
cer, have already been used as diagnostic markers or considered as candidates for new markers. Specifically,
genes or associated genetic products on the list which are already used or have been proposed as tumour
markers in the literature include the cell surface serine proteaseHepsin, the Neural epidermal growth factor-
like 2 (nel-like 2) gene, the enzyme Alpha-methylacyl-CoA racemase (AMACR), the T-cell receptor gamma
(TCR-γ), and the secretory protein Anterior gradient homolog 2 (AGR2).
Other genes or corresponding proteins which could be linked to cancer-related processes like apoptosis
(programmed cell-death) or cell cycle progression are the carrier protein Cellular Retinol binding protein 1
(CRBP1), the enzyme Prostaglandin d2 synthase 21kda (PTGDS) and the S100 calcium binding protein A4
(S100A4/Mts1). Similarly, some top-ranked genes are reported to have known or putative functional roles
in cell growth and cell proliferation, e.g. the PDZ and LIM domain 5 (PDLIM5) gene and adipsin.
The genetic probe with identifier 34840 at corresponds to the only nucleotide sequence without additional
annotation information occurring in the list of high-scoring attributes. However, the same genetic probe
also occurred among the top- ranked genes obtained by another research group using other microarray
analysis methods [394], suggesting that the corresponding gene could be a promising candidate for further
investigations.
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In summary, in the experiments conducted here, all except one of the genes appearing in multiple lists of
top-ranked genes from different selection algorithms have either putative or known functional associations
with cancer or related cellular processes. Although this does not imply that all high-scoring genes and their
corresponding products are suitable markers for the diagnosis or monitoring of cancer diseases, it suggests
the selection and ranking methods are useful in identifying and prioritizing putative markers.
While classical gene prioritization methods use a single feature selection method and a single confidence
measure [395], the approach employed here uses information from multiple selection methods, multiple
prediction models given by ensemble rule sets, and multiple sample subsets. Moreover, potential tumour
suppressor genes and oncogenes can be identified by analysing the occurrence of gene attributes in different
conditionals of the prediction rules. The corresponding post-processing procedure exploits the information
content of a multitude of rule sets from an ensemble learning model and provides a bar plot visualisation to
facilitate the interpretation and a confidence measure to prioritize genes.
Finally, since the lists of high-scoring candidate genes which were detected by multiple feature selection
methods are confined to relatively small sets of attributes, it would be feasible to conduct a quantitative
polymerase chain reaction (qPCR) to refine the gene prioritization using more accurate gene expression
measurements than those provided by conventional microarray platforms.
4.2.4 Supervised analysis - summary and conclusion
Overall, the empirical results on three public microarray datasets using three feature selection methods and
two external cross-validation schemes show that a rule-based learning method, BioHEL, can reach clas-
sification accuracies comparable to current state-of-the-art prediction methods for gene array data. These
results are corroborated by comparisons across multiple types of feature selection methods, as well as by
comparisons to other methods in the literature.
As an added value, in contrast to other state-of-the-art benchmark methods, BioHEL’s prediction models
use easily interpretable conjunctive if-then-else-rules. Genes which are frequently selected as informative
features in rule sets across different cross-validation cycles and different ensemble base classifiers provide
robust and informative predictors with regard to the outcome attribute. In this context, using a high number
of base models combined to an ensemble can even be beneficial for data interpretation due to the variance-
reducing effects of ensemble learning [8] which result in more robust statistics on the importance of single
features in the predicates of the decision rules. This matches well with the results of the example literature
analysis for the prostate cancer data, showing that all except one of the top-ranked genes have a known or
putative functional association to the studied cancer disease.
More importantly, biological insights can be gained from ensemble rule sets that are not obtainable by most
other popular machine learning algorithms such as SVM and PAM. Potential oncogenes and tumour sup-
pressor genes can be identified within the set of selected genes by summarizing and visualising information
from the rule sets using easily interpretable bar plots (e.g. the nel-like 2 gene, which is predicted as a
potential tumour suppressor gene by the method proposed here, is already used as a marker in a patented di-
agnostic method for prostate cancer [396]). Thus, simple statistical analyses which can easily be applied to
ensemble rule learning models, can help to accelerate the identification of candidate biomarkers for clinical
diagnosis.
Although the main goal behind the analysis protocol was to show that an evolutionary machine learning
method using simple decision rules can compete against other benchmark microarray classifiers across a
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diverse group of feature selection approaches and multiple datasets, as a by-product of the experiments,
the performance of different types of attribute selection methods were also compared. The PLSS approach
provided significantly better results in LOOCV, while no method significantly outperformed the other ap-
proaches in the 10-fold CV experiments. These results justify the widespread popularity of fast filter-based
feature selection methods in terms of providing a good balance between runtime efficiency and predictive
effectiveness, while wrapper-based selection methods (SVM-RFE) tend to achieve higher accuracies only
with significantly higher runtimes.
Possible future extensions for the machine learning system BioHEL include integrating prior clinical or
biological knowledge into the analysis and directly combining the system with automated literature mining
tools to better exploit the information content of the generated models. On the whole, BioHEL’s perfor-
mance in comparison to other successful predictors and the benefits in terms of interpretability show that
rule-based evolutionary machine learning algorithms can be profitably applied for microarray sample clas-
sification.
4.3 Comparative Evaluation of Clustering Methods
In unsupervised analysis of microarray data, the comparison of diverse clustering approaches and the com-
bination of multiple methods into a consensus can provide similar benefits with regard to algorithmic perfor-
mance and biological data interpretation as corresponding techniques for supervised analysis (see above).
For this purpose, this section will discuss the results of comparing partition-based clustering methods, in-
cluding k-Means, PAM, CLARA and SOM, and hierarchical clustering methods, including Average linkage
agglomerative clustering, DIANA, hybrid hierarchical clustering and SOTA (as a hybrid between SOM and
hierarchical clustering), as well as the combination of these algorithms into a consensus clustering using
a Simulated Annealing based aggregation method. Moreover, different standardisation and dimensionality
reduction methods will be evaluated, including a gene set analysis based data transformation, which im-
proves the robustness of the analysis, while retaining interpretable attributes representing cellular pathways
and processes.
The methods are compared by employing both internal and external validity indices and suitable selections
for the number of clusters are estimated using multiple of these indices and multiple clustering methods.
Additionally, to simplify the interpretation of the data, low-dimensional visualisations using different state-
of-the-art dimensionality reduction methods are presented.
Again, all methods are part of the integrative analysis framework developed during the doctoral project, and
can be accessed online on the ArrayMining.net web-server [18].
4.3.1 Unsupervised analysis - Methods
For the comparative evaluation of clustering methods in this study all possible combinations of 2 stan-
dardisation methods, 2 dimensionality reduction methods, 8 clustering methods and 5 validity indices were
considered. The standardisation methods include the classical standardisation to mean 0 and standard de-
viation 1 (CL), and a robust standardisation method computing the median absolute deviation from the
data’s median (MD) [397]. For computing the dimensionality reduction, a classical variance filter (VF) is
used, selecting the 2000 genes with the highest variance across all samples, and a gene set analysis based
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dimensionality reduction (GSA), mapping the microarray probes onto 37 gene sets representing cancer-
related cellular pathways and processes, obtained from the Van Andel Institute in Michigan, and using the
“Parametric Gene Set Analysis” approach (PAGE) to summarise the gene expression values for each gene
set [310].
The clustering methods include the following partition-based and hierarchical approaches:
Partition-based clustering methods:
• k-Means
• Partitioning around Medoids (PAM)
• Clustering Large Applications (CLARA)
• Self-Organising Maps (SOM)
Hierarchical clustering methods:
• Average linkage agglomerative clustering (AVL)
• Self-Organising Tree Algorithm (SOTA)
• Divisive Analysis clustering (DIANA)
• Hybrid hierarchical clustering (HYBRID)
Additionally, a self-devised consensus clustering approach (CONSENSUS) was implemented , combining
the above methods using a cluster agreement matrix and a Simulated Annealing optimisation method (a
detailed description of this method can be found in chapter 5, section “Ensemble and Consensus Analysis
of Microarray Data”).
Moreover, in order to evaluate the benefit of different clustering methods and find a number of clusters, pro-
viding compact and well-separated clusters, the following internal cluster validity indices were computed
for each clustering result, across cluster numbers varying between 2 and 8:
• Average silhouette width (SILHOUETTE), value range [-1, 1], to maximise
• Calinski-Harabasz index (CH), value range [0, ∞], to maximise
• Dunn index (DUNN), value range [0, ∞], to maximise
• C-index (C-INDEX), value range [0, 1], to minimise
• kNN-Connectivity (CONNECTIVITY), value range [0, ∞], to minimise
The rationale behind this choice of indices was to obtain both a diverse selection of validity measures
and to only use measures which are unbiased and have already been shown to perform well on synthetic
data [230]. A detailed explanation of the above validity indices can be found in the literature survey in
chapter 3 (section “Cluster validity / Selection of the number of clusters”).
In addition to these internal validity indices, the agreement with an external reference partition was mea-
sured using the adjusted rand index (ARI, for details see the section on external validity indices in chapter
3). Importantly, the reference partition corresponds to a partly subjective categorisation of microarray can-
cer samples according to clinical experts and not to a completely reliable “gold-standard”. Moreover, as
outlined in chapter 3, there might be multiple meaningful structures and patterns in a microarray dataset,
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hence, the ARI only provides a further confirmation for a clustering result, if the identified cluster struc-
ture happens to match well to the given reference partition (for a good match the ARI does not necessarily
need to be close to the maximum value 1.0, but should be higher than ARIs computed from random model
clustering solutions).
Finally, for the direct visual inspection of the data, four dimensionality reduction methods for obtaining
low-dimensional visual representations were compared: Principal Component Analysis (PCA), Indepen-
dent Component Analysis (ICA), Locally Linear Embedding (LLE) and Isomap. These approaches were
chosen by taking into account the results of a previous comparative analysis of dimensionality reduction
methods [398] and enable a user to directly identify natural groupings in 2D- and 3D-representations of the
data. Moreover, the visualisations highlight outlier samples and patterns in the data density and variance
across sample groups, which do not always become apparent in algorithmically obtained cluster groupings.
Like all other algorithms above, these unsupervised methods are also part of the clustering module on the
ArrayMining.net web-server for integrative microarray analysis [18].
All methods were applied to the breast cancer dataset obtained from the collaborating Nottingham Queen’s
Medical Centre [19, 349–351] (see the dataset description in the supervised analysis section), in order to
identify informative structures in the data and the number and composition of sample clusters which can
best be separated. Previously, different categorisations have been proposed in the biomedical literature for
breast cancer tumour subtypes, including two-class groupings (e.g. luminal vs. non-luminal samples, see
supervised analysis section) and three-class groupings (e.g. clinical grades 1 to 3, with 1 being the mildest
form of breast cancer and 3 the most severe subtype). Thus, the identification of the number of clusters
which results in the best cluster compactness and cluster separation across multiple clustering methods
and validity indices is of great practical interest for clinical research. For future breast cancer microarray
data analyses, similar comparative evaluations can help to choose subtype definitions that match well to
natural grouping in the data and are useful for clinical prognosis and diagnosis, enabling accurate sample
classifications using computational methods.
4.3.2 Unsupervised analysis - Results and discussion
The estimates for the optimal number of clusters on the QMC breast cancer dataset and the optimal validity
index scores for all combinations of clustering methods and validity measures are shown in tables 4.12 (us-
ing the classical standardisation, CL) and 4.13 (using the robust median absolute deviation standardisation,
MD). These tables include both the results for a simple variance-filter dimensionality reduction (VF) and
a dimensionality reduction involving the extraction of cancer-related gene sets (GSA, see Methods section
above). The optimal scores for a certain validity index are always shown in bold typeface in the tables.
The results reveal that across the great majority of validity indices and clustering methods, the optimal clus-
ter number estimate is 2. This applies both to the CL and the MD standardisation and to both dimensionality
reduction methods. Only the C-index tends to estimate the cluster number for optimal separation to be sig-
nificantly higher (3, 5, 6 or 8), but this method also displays a higher variance in its estimates and has
previously been shown not to perform as well as the other validity measures on simulated datasets [230].
Overall, 7 out of 10 method combinations on both the CL and the MD standardised data agree in their
estimate that the optimal number of clusters is 2.
In general, for the CL and the MD standardisation, the qualitative results (i.e. the optimal cluster number
estimates) were relatively similar, but the CL approach provided slightly better validity scores, hence, only
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the CL standardisation was considered for further analysis.
When comparing the clustering results after variance filtering (VF) and after gene set analysis filtering
(GSA) in detail, although both dimensionality reduction approaches provide the same estimate of the op-
timal number of clusters, the variance in the estimates across the different clustering methods is higher
for VF, whereas the combination of functionally similar genes to a “meta-genes” representing a functional
process in GSA tends to provide more robust estimates. This can also be seen when plotting the estimates
for different validity indices against the number of clusters. Figure 4.8a) shows these estimates for the
Calinski-Harabasz index when using the VF method and figure 4.8b) for the same index when using the
GSA method (the score is scaled to range [0, 1]), and the trend from a maximum score for 2 clusters and
decreasing scores for higher numbers of clusters is much clearer for the GSA approach than for VF, where
the agreement between different methods is smaller. A similar trend can also be observed for validity in-
dices that are to be minimised rather than maximised: In figures 4.9a) and b) the knn-connectivity validity
scores were scaled to range [0, 1] and inverted by subtracting the scaled scores from 1, in order to make the
results comparable to other validity measures like the Calinski-Harabasz (CH) index shown in figure 4.8.
Although the variance in the estimates is generally higher than for the CH index, again the GSA method
tends to provide more robust estimates, with a clear maximum at 2 and decreasing scores for higher cluster
numbers.
Figure 4.8: Visualisation of clustering results - Calinski-Harabasz index (scaled to range [0, 1]) vs. number of clusters:
a) after variance filtering (VF); b) after gene set analysis filtering (GSA); In both cases the optimum number of clusters
for most clustering methods is estimated to be 2.
In addition to the validity scores for complete clustering results, the different methods can also be compared
based on confidence scores for the cluster assignments of single samples. This can be achieved with the
silhouette width validity index, which provides a confidence measure for every single observation (see def-
inition in chapter 3, in the section “Cluster validity / Selection of the number of clusters”). These silhouette
widths have also been used to compute a global validity measure from their average across all samples, as
reported in tables 4.12 and 4.13. However, additionally investigating the silhouette widths for single sam-
ples reveals specific groups of high-confidence sample assignments, which are reliably clustered together,
and low-confidence sample assignments which might results from low-quality experimental measurements
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Table 4.12: Comparison of clustering methods (standardisation: CL, dimensionality reduction: VF or GSA,
QMC breast cancer dataset)
Opt. cluster Opt. cluster
Validity index Method number (VF) Scores (VF) number (GSA) Scores (GSA)
PAM 2 10.19 2 58.05
KMEANS 3 9.48 2 58.94
CLARA 2 10.62 2 58.94
Calinski-Harabasz SOM 2 10 2 50.34
SOTA 2 10 2 50.34
AVL 5 4.65 2 51.48
DIANA 2 9.52 2 52.27
HYBRID 5 4.65 2 51.48
PAM 8 0.47 2 0.29
KMEANS 7 0.48 2 0.28
CLARA 7 0.47 2 0.28
Dunn SOM 6 0.52 4 0.26
SOTA 6 0.52 4 0.26
AVL 2 0.65 2 0.28
DIANA 2 0.47 3 0.34
HYBRID 2 0.65 2 0.28
PAM 2 0.15 2 0.37
KMEANS 3 0.07 2 0.36
CLARA 2 0.13 2 0.36
Silhouette SOM 2 0.13 2 0.31
SOTA 2 0.13 2 0.31
AVL 2 0.23 2 0.38
DIANA 2 0.14 2 0.39
HYBRID 2 0.23 2 0.38
PAM 2 25.67 2 16.93
KMEANS 3 97.93 2 25.77
CLARA 2 40.08 2 25.77
knn-Connectivity SOM 2 35.85 2 39.08
SOTA 2 35.85 2 39.08
AVL 2 2.93 2 18.51
DIANA 2 27.36 2 12.15
HYBRID 2 2.93 2 18.51
PAM 5 0.43 8 0.25
KMEANS 3 0.45 6 0.27
CLARA 6 0.46 8 0.26
C-index SOM 5 0.47 3 0.27
SOTA 5 0.47 3 0.27
AVL 2 0.64 6 0.31
DIANA 3 0.48 5 0.3
HYBRID 2 0.64 6 0.31
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Table 4.13: Comparison of clustering methods (standardisation: MD, dimensionality reduction: VF or GSA,
QMC breast cancer dataset)
Opt. cluster Opt. cluster
Validity index Method number (VF) Scores (VF) number (GSA) Scores (GSA)
PAM 2 8.95 3 31.9
KMEANS 3 8.97 3 33.63
CLARA 2 9.55 3 31.25
Calinski-Harabasz SOM 2 7.35 2 28.43
SOTA 2 7.35 2 28.43
AVL 5 4.46 2 29.99
DIANA 2 7.92 2 30.65
HYBRID 5 4.46 2 29.99
PAM 3 0.48 7 0.25
KMEANS 8 0.45 2 0.28
CLARA 6 0.48 8 0.28
Dunn SOM 3 0.53 6 0.24
SOTA 3 0.53 6 0.24
AVL 2 0.65 2 0.26
DIANA 2 0.46 8 0.28
HYBRID 2 0.65 2 0.26
PAM 2 0.14 2 0.28
KMEANS 3 0.11 2 0.34
CLARA 2 0.14 2 0.2
Silhouette SOM 2 0.13 2 0.25
SOTA 2 0.13 2 0.25
AVL 2 0.23 2 0.33
DIANA 2 0.14 2 0.34
HYBRID 2 0.23 2 0.33
PAM 2 29.17 3 47.19
KMEANS 3 56.07 2 15.48
CLARA 2 32.45 2 35.84
knn-Connectivity SOM 2 34.1 2 35.99
SOTA 2 34.1 2 35.99
AVL 2 2.93 2 24.38
DIANA 2 28.07 2 16.92
HYBRID 2 2.93 2 24.38
PAM 8 0.48 6 0.23
KMEANS 3 0.46 4 0.3
CLARA 3 0.48 7 0.26
C-index SOM 2 0.49 3 0.28
SOTA 2 0.49 3 0.28
AVL 3 0.64 6 0.32
DIANA 3 0.49 7 0.32
HYBRID 3 0.64 6 0.32
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Figure 4.9: Visualisation of clustering results - kNN-Connectivity index (inverted and scaled to range [0, 1]) vs. number
of clusters: a) after variance filtering (VF); b) after gene set analysis filtering (GSA); In both cases the optimum number
of clusters for most clustering methods is estimated to be 2.
and/or membership in a sample group that displays high variance in the gene expression values. Figure 4.10
shows a silhouette plot visualisation of these sample validity scores as horizontal bars with lengths corre-
sponding to the silhouette widths (using the consensus clustering results obtained from the combination of
all 8 clustering methods, once for the VF and once for the GSA dimensionality reduction). The cluster num-
ber for this consensus clustering was set to 2, as suggested by the results from the validity index analysis
of the single clustering methods (see above). Interestingly, the sizes of the two clusters are approximately
similar for VF and GSA, however, the silhouette widths (i.e. confidence scores) for the sample assignment
in the GSA method are much larger than for the VF approach (the average silhouette width 0.37 for GSA, is
more than twice as high as for VF with 0.15). This result again suggests that the robustness can be increased
when using the GSA-based dimensionality reduction.
Apart from the validity measures, another possibility to analyse the quality of tentative clustering solutions
is to plot the data projected onto the first two principal components and compare how well the clusters
are separated in this visualisation. Corresponding PCA plots for the consensus clustering results after VF
and GSA dimensionality reduction are shown in figure 4.11. Clusters are represented by ellipses in these
plots and the overlap between the two ellipses is clearly smaller for the GSA method than for the VF
method, indicating that the GSA method does not only provide more robust clustering results but also a
better separation between the clusters. Moreover, the first two principal components (PCs) for the data
reduced with the GSA method explain 62% of the point variability, whereas for the VF method only 25%
are covered by the first two PCs.
Finally, as mentioned in the Methods section, clustering results can also be compared using external validity
measures like the adjusted rand index (ARI), if a known reference partition (i.e. a biological categorisation
of the samples) is already available. Importantly, a partly subjective categorisation into reference partitions
cannot be considered as a reliable “gold standard”, and multiple biologically meaningful cluster structures
might occur in the data. However, if the agreement of the reference partition to a microarray-data based
sample clustering is significantly higher than the agreement with random cluster assignments, the ARI
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Figure 4.10: Visualisation of clustering results - Silhouette plot (length of horizontal bars represents confidence for each
cluster assignment): a) after variance filtering (VF); b) after gene set analysis filtering (GSA); The average confidence
(silhouette width) is more than twice as high after GSA dimensionality reduction in comparison to a variance filter
reduction
Figure 4.11: Visualisation of clustering results - PCA plot of consensus clustering results (principal component 2 vs.
principal component 1): a) after variance filtering (VF); b) after gene set analysis filtering (GSA).
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can provide greater confidence in sample cluster assignments, if an agreement between the categorisations
derived from different methods and data sources is found.
For the breast cancer data, a reference assignment of the samples into three clinical tumour grade categories
had been provided in combination with the data (33 samples belong to grade 1, 52 samples have grade 2,
and 43 samples grade 3; the higher this clinical grade, the more severe the tumour type). Accordingly, the
clustering results which provided the best validity scores (for a cluster number of 2, see above) could not be
used for a comparison against this 3-class reference partition, but the validity measures also showed that a
clustering into 3 groups corresponds to the second best number of clusters. Thus, the corresponding 3-group
clustering results were combined into a consensus clustering and both this consensus and the single-method
clusterings were compared against the reference. As expected, the obtained ARI scores were generally low
(< 0.25) in relation to the maximum achievable score (1.0), since the reference clustering does not represent
a reliable ground truth and necessarily match to natural groupings in the data. However, the majority
of clustering methods, including the consensus clustering, provided significantly larger ARI scores than
10000 random clusterings (created using a Mersenne-Twister stochastic random number generator [399])
compared against the reference. The results are shown in a graph in figure 4.12 for the VF dimensionality
reduction, and in figure 4.13 for the GSA reduction.
Figure 4.12: Histogram of adjusted rand indices (ARIs) between the tumour grade 3-class reference partition and 10000
random clustering results (VF dimensionality reduction, the ARIs for microarray-based clustering methods are shown
as blue vertical lines (in contrast to the random clusterings, the height does not have a frequency interpretation)
For the VF reduction, all clustering methods except the hierarchical approaches provided significantly
higher ARI scores than the 10000 random clusterings. The consensus clustering belonged to the meth-
ods with the highest scores, and only two single-method clusterings had a slightly higher ARI than the
consensus (K-Means and PAM). Although similar trends were observed for the GSA reduction, with the
partition-based methods again reaching higher ARIs than the hierarchical methods, in comparison to the
VF reduction all clustering methods reached larger ARI scores, and all methods performed significantly
better than the great majority of random clusterings (see figure 4.13, partition-based methods achieved
ARIs exceeding the best scores for the random model by multiple standard deviations). Again, the consen-
sus clustering across all methods provided significantly better results than the random clusterings, but the
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Figure 4.13: Histogram of adjusted rand indices (ARIs) between the tumour grade 3-class reference partition and 10000
random clustering results (GSA dimensionality reduction, the ARIs for microarray-based clustering methods are shown
as blue vertical lines (in contrast to the random clusterings, the height does not have a frequency interpretation)
overall best results were achieved by some of the single-algorithm methods. Since the performance of the
hierarchical clustering methods in terms of the ARI was again low, and the consensus clustering did not
only include hierarchical methods but also methods with a low diversity in their clustering results, a sec-
ond consensus clustering was computed, including only two diverse clustering methods (PAM+SOTA, see
figure 4.13). For this algorithm combination, the consensus clustering provided the best overall clustering
result, outperforming the single-method clusterings. However, since the user does not know a priori which
types of clustering methods will perform well on a new microarray dataset, the consensus clustering involv-
ing all clustering methods provides a more generally applicable, robust solution, providing good clustering
solutions on average, even if not all of the single-method clusterings are outperformed. Moreover, the con-
sensus clustering methodology has room for further improvements, since very recently, new extensions for
consensus clustering have been proposed (e.g. link-based clustering [222], see literature review in chapter
3), that could be combined with the current implementation in the framework for integrative biological data
analysis.
Apart from the clustering results, the dimensionality reduction of the data can also be regarded as an un-
supervised analysis technique for data interpretation, producing low-dimensional representations for visual
inspection, e.g. to identify outlier samples, high-density groupings of samples and other structures in the
data. Thus, four dimensionality reduction methods were used to create 3D data representations, including
Principal Component Analysis (PCA, figure 4.14), Independent Component Analysis (ICA, figure 4.15),
Isomap (figure 4.16) and Locally Linear Embedding (LLE, figure 4.17).
As in the previous evaluations, all results were compared between the variance-filtered data (VF) and the
gene set analysis based pre-processing (GSA). Generally, the data visualisations for a specific dimension-
ality reduction method tend to be similar across the two pre-processing methods, and in none of the 3D
representations a perfect separation between the three sample classes is obtained (the classes are repre-
sented by different colours and shapes in the plots: green box = tumour grade 1, red sphere = tumour grade
2, blue pyramid = tumour grade 3). However, in some plots a certain degree of assortative mixing [344]
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Figure 4.14: Principal Component Analysis (PCA), 3D representation of the breast cancer dataset a) after variance
filtering (VF), b) after gene set analysis (GSA); green = tumour grade 1, red = tumour grade 2, blue = tumour grade 3.
Figure 4.15: Independent Component Analysis (ICA), 3D representation of the breast cancer dataset: a) after variance
filtering (VF), b) after gene set analysis (GSA); green = tumour grade 1, red = tumour grade 2, blue = tumour grade 3
Figure 4.16: Isomap 3D representation of the breast cancer dataset a) after variance filtering (VF), b) after gene set
analysis (GSA); green = tumour grade 1, red = tumour grade 2, blue = tumour grade 3
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Figure 4.17: Locally Linear Embedding (LLE) 3D representation of the breast cancer dataset a) after variance filtering
(VF), b) after gene set analysis (GSA); green = tumour grade 1, red = tumour grade 2, blue = tumour grade 3
can be observed, i.e. samples from the same class tend to be located closer together in space than samples
from different classes. The tumour grade 1 samples tend to be most homogeneous, and are clustered in a
relatively dense region in space, whereas the grade 2 and grade 3 samples display a higher variance in their
positions. As expected, the best separation is obtained between the grade 1 and grade 3 samples, represent-
ing the most diverse tumour sub-types, while the grade 2 samples largely overlap with both of the other
classes.
The ICA visualisations tend provide the best separation, with a very dense grade 1 group having only a
small overlap with the grade 3 group. PCA and Isomap provide relatively similar representations, where
the grade 1 and grade 2 groups have a large overlap, and the grade 3 group displays a larger variance than
the other groups. The LLE visualisations differ markedly from the other representations, displaying a long
vertically stretched sample group consisting mainly of group 1 and group 2 samples, whereas most of the
group 3 samples are separated from this group in horizontal direction. Marked differences between the
VF and the GSA pre-processing in terms of class separation and class homogeneity cannot be observed in
most visualisations, apart from the Isomap representation, where the grade 1 and grade 2 sample groups are
clearly more homogeneous after the GSA pre-processing than after the variance filtering.
Although these visualisations suggest that the breast cancer classes are not easily separable in three di-
mensions, a certain extent of class separation can be observed between grade 1 and grade 3 samples, in
particular in the ICA plots (this can also be seen in figure 8.2 in chapter 7, where only the grade 1 and
grade 3 samples from the same dataset are visualised). The results match to earlier findings by Zervakis et
al., according to which breast cancer tumour classes tend to be difficult to separate in comparison to other
cancer types, like leukaemia and colon cancer data [400] (figure 1 in the corresponding publication contains
a similar plot to the ones shown here). However, as shown in the section on supervised analysis (see above),
by using labelled training data to train a prediction model, samples from different tumour classes can be
more successfully separated than with unsupervised analysis techniques.
4.3.3 Unsupervised analysis - summary and conclusion
In summary, the results of the unsupervised analysis techniques highlight again that ensemble/consensus
techniques provide a significant added value for microarray analysis, leading to higher robustness and often
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to better scores in terms of multiple performance measures. In particular, the observation that the GSA
method tends to provide more robust results than the VF method, and similarly that the consensus clus-
tering tends to provide higher ARI scores than the average of all methods, match well to the intuition that
combining the information from multiple sources (i.e. multiple genes in case of GSA method, and multiple
clustering algorithms in case of the consensus clustering) can help to overcome the shortcomings of the
single input data sources and methods.
Overall, clustering results on microarray data are more difficult to evaluate than supervised analysis, because
multiple biologically meaningful patterns might exist in the data and external reference groupings of the
samples do not provide a reliable ground truth. However, the agreement between algorithmic clustering
results and an expert-based tumour grade categorisation of the samples was significantly better than the
agreement of this categorisation with 10,000 random clusterings, providing an increased confidence in the
biological meaningfulness of the algorithmic clustering solutions. Moreover, an analysis of the data using
low-dimensional visualisations reveals which tumour sub-types can be distinguished best. In combination
with the estimation of the optimal number of classes from the clustering analysis (suggesting that two breast
cancer classes can best be separated according to the given data), this can help the experimenter to re-define
the sample classes in order to obtain more meaningful tumour sub-type definitions, and a better performance
in subsequent supervised analyses.
Chapter 5
An Integrative Framework for
Gene/Protein Expression Data Analysis
(ArrayMining)
Chapter abstract
Given the multitude of publicly available functional genomics datasets and the great variety
of higher-level analysis techniques (see discussion in chapter 3 and comparative evaluation
in chapter 4), an integrative framework to exploit the synergies of different data sources and
algorithms was developed as part of this doctoral project, and its main component, a tool set
for microarray data analysis, was made available in the web-application ArrayMining [18].
Figure 5 highlights ArrayMining’s modules and the links between them and other analysis
tools in the framework.
In this chapter, ArrayMining’s machine learning and network analysis techniques dedicated to
the integrative analysis of high-dimensional gene and protein expression data will be discussed
in detail. The implemented algorithms consist of known state-of-the-art statistical learning
methods, chosen using the information from the literature survey (chapter 3) and the compara-
tive evaluation (chapter 4), as well as new algorithms, ensemble and consensus techniques, and
new pipelines developed during the PhD project.
The first part of the chapter will provide an overview of the analysis modules for different
problem types, discuss the automatic data processing and gene/protein name normalisation
techniques, and the details of the ensemble and consensus methods implemented within these
modules (partly using material from a previous publication [18]). In the second part, the possi-
bilities for creating new cross-domain analysis pipelines using sequential combinations of the
modules will be laid out. Example illustrations for these pipelines can also be found in the
appendix.
Novel data analysis methods in the framework, which extend beyond classical machine learn-
ing methods (i.e. the components which are greyed out in figure 5), will be discussed in the
following chapters. Specifically, chapter 6 will present more general techniques for the analysis
of gene and protein lists, which do not require numerical input data. Chapter 7 will be dedi-
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cated to novel approaches for increasing the interpretability of computational models derived
from the data.
Figure 5.1: The ArrayMining system for microarray data analysis is one of the main components of the integrative data
analysis framework presented in this thesis (highlighted by the colour contrast).
5.0.4 ArrayMining - Overview, motivation and implementation
Overview: ArrayMining is a software tool set and web-application for microarray data analysis, focussing
on ensemble algorithms and cross-domain analysis techniques. It consists of six main analysis modules:
Cross-Study Normalisation, Gene selection, Class Discovery, Class Assignment, Gene Set Analysis and
Network Analysis. Each of these modules contains multiple algorithms for the same problem type acces-
sible through a unified web-interface. The user can upload new data in different raw or pre-processed
formats (tab-delimited flat file format or as zip-compressed Affymetrix CEL-files which will be automati-
cally extracted, normalised and summarised using the Robust Microarray Analysis (RMA) method [401]).
Alternatively, various example datasets have been made available directly on the webpage, and access to
the GEO database [27], the largest public microarray data base, is provided on the class discovery module.
After submitting an analysis task, an output webpage containing the downloadable results as plots, tables,
3D-VRML visualisations etc. is generated. Depending on the chosen module and algorithm, the data can
be forwarded to further analysis modules (see data forwarding pipelines in figure 5, new pipelines are high-
lighted by dotted lines) and is automatically interlinked with annotation data from external web-tools and
data bases, e.g. ENSEMBL [28], DAVID [29], Gene Ontology [30] and KEGG [31].
Motivation: Although statistical programming frameworks like R [353] and Matlab [402] already allow
users to develop and apply complex scripts for expression data analysis, they are difficult to use for non-
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experts and there is a high risk of deviating from standard guidelines. To obviate the need for special-
ized programming skills and manual software installations, several other web-based tools for gene ex-
pression analysis have been presented in recent years. Currently available integrative online analysis ser-
vices includeGEPAS [403], Expression Profiler [404], ASTERIAS [405], EzArray [406], CARMAweb [407],
MAGMA [408], ArrayPipe [409], RACE [410], WebArray [411] and MIDAW [412]. These web-based sys-
tems provide methods for a multitude of data pre-processing and analysis purposes ranging from image
analysis, missing value imputation, single-study normalisation, gene filtering and gene name conversion to
higher-level analysis methods for clustering, gene selection and gene annotation, prediction, data visualisa-
tion and gene set enrichment analysis, among others.
Additionally, numerous web-applications have been developed and optimised for specialized analysis tasks,
e.g. biclustering of genes and samples [413], co-clustering of genes with similar functional annotations
[414], inference of gene regulatory relationships [415] and cross-species clustering [416].
Although various tools provide a choice and comparison between different algorithms for one analysis
task, previous integrative analysis software did not enable the user to easily combine multiple methods
using ensemble learning and consensus clustering techniques, or exploiting multiple validation approaches.
However, studies from the literature have shown that microarray analysis can profit from ensemble feature
selection, ensemble prediction and consensus clustering methods in terms of both robustness and accuracy
[9–12], suggesting that there is significant potential still to be exploited with these approaches.
Similarly, it would be desirable not only to combine different algorithms but also different data sets related
to the same biological problem. Although currently available cross-study normalisation methods use sim-
plified assumptions and are limited in applicability and accuracy, various successful applications [15, 417]
have shown that the benefits of an increased sample size can outweigh the loss of information due to the
normalisation process.
For these reasons, ArrayMining was developed as a new web-application that provides access to multiple
algorithms for each of the most common tasks in statistical microarray analysis, namely gene selection,
sample clustering, sample classification, network and gene set analysis, available from a single, easy-to-use
interface. In contrast to other web-tools, providing the results of individual methods as outputs, here, alter-
native techniques can be compared and their different strengths combined using ensemble and consensus
approaches. Likewise, instead of using only data from a single study, different cross-study normalisation
methods are made available to integrate similar data from different experimental platforms and compare the
results using density and quantile-quantile plots.
Apart from these combinations of data sets and methods within an analysis module, different modules have
been interlinked in new ways, enabling for example the integration of gene set analysis with clustering or
network analysis, or cross-study analysis with gene selection or prediction. These new analysis pipelines
have a similar practical value as new algorithms and method combinations, because they provide different
insights than standard analysis approaches and can lead the experimenter to a new interpretation the data
(e.g. by inferring cellular pathway associations from the similarity of deregulation patterns in corresponding
gene sets).
Other new features include access to an in-house developed rule-based evolutionary classification algorithm,
automatic parameter selection mechanisms in all modules, the availability of specific cancer-related gene
sets for enrichment analysis in addition to gene sets from KEGG and GO, and a 3D VRML visualisation of
clustering results using a self-devised software package for creating interactive 3D data representations [24]
(see the discussion of the VRMLGen tool in chapter 7).
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Since the above methods and features are not available in other web-tools or software packages, and simi-
larly, other tool sets include methods distinct from the system discussed here, ArrayMining is designed as
a complement rather than an alternative to existing services, and has been interlinked with other external
web-applications.
Implementation: ArrayMining uses software written in the programming languages R [353] and C++
and a PHP-interface combining all implementations together. All analysis modules run on an Apache web
server. The system uses in-house algorithms and implementations as well as standard packages from the
Bioconductor project [418] (see the discussion of the single modules below for more details).
5.1 Automatic Data Processing and Gene/Protein Name Normalisa-
tion
One of the main goals behind the development of ArrayMining.net was to facilitate the analysis of com-
plex, high-dimensional biological data for users with no prior background knowledge in computer science
and statistics. Currently, many wet-lab experimenters, including academic and clinical researchers, cannot
always benefit from the capabilities of recent analysis approaches, because setting up a corresponding data
processing pipeline (with suitable parameter selections and analysis and validation procedures following ac-
cepted guidelines) would be a time-consuming and difficult task, often requiring knowledge about the inner
workings of several algorithms. Instead, experimenters often apply standard microarray software, which is
directly supplied with the array scanning machine and typically only contains a single dedicated algorithm
for some of the most common analysis tasks. This prevents the user from comparing different methods,
achieving performance gains from ensemble and consensus techniques and gaining new biological insights
from integrative cross-domain analysis methods.
For this reason, the ArrayMining framework was designed to facilitate complex analyses by automating
analysis tasks wherever possible, and providing an easy-to-use interface to control and run a wide choice
of feature selection, clustering, prediction, gene set analysis and cross-study normalisation methods. Set-
ting up an individual analysis pipeline only requires a few mouse-clicks, and the results can be explored
interactively in low-dimensional data visualisations and sortable tables, in some cases with dynamic and
expandable content.
In this section, the automatic data processing and gene/protein name normalisation features of the frame-
work will be discussed. They allow experienced users to save time in common data analysis tasks, and
prevent researchers without prior experience in the field of microarray analysis from deviating from estab-
lished guidelines and practices.
5.1.1 Automatic data processing
Automatic normalisation and pre-filtering of high-dimensional data, and automated parameter selection
within the generation of clustering, prediction and co-expression network models requiring fast processing
using heuristics that can adapt to different types of input data.
Particularly, when users upload gene or protein expression data on a public web application, a great variety
of file formats and experimental platforms have to be supported, and format errors and missing data entries
have to be recognised. In the ArrayMining framework, both pre-normalised microarray data in tab- or
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space-delimited flat file format, and raw data in the standard CEL-format (compressed in a zip-archive) is
accepted and recognised as input. More importantly, the framework identifies common errors and provides
the user with easily understandable warning messages, if an uploaded input file does not match with the
format specifications (e.g. “Your input file contains missing entries or non-numeric characters in line 5” or
“Your input file does not contain any class labels” for a supervised analysis).
Dedicated algorithms are required to find optimal parameter settings for various algorithms. To relieve the
user from having to manually adjust internal settings, heuristics for automatic parameter selection where
used wherever possible. Specifically, the following techniques were used on the different analysis modules:
• Feature Selection and Pathway analysis module: Most feature selection methods do not require
many parameter settings, apart from the possibility to limit the number of selected attributes. The
ArrayMining feature selection module contains fully automated selection approaches, like the CFS
method [160, 161], which can also determine an optimal number of selected features for a predictive
analysis by scoring the relevance and redundancy of feature subsets (see feature selection section
in chapter 3). However, in order to let the user control the behaviour of the selection methods, a
maximum number of features can always be specified additionally, e.g. to reduce the runtime, or
to only identify the most significant genes/proteins. In the feature ranking list obtained as the main
output of an analysis, the user can sort the identified features using different scores (e.g. significance
scores adjusted for multiple testing and relative expression fold changes) and identify attributes whose
values exceed an arbitrary threshold for one of these scores. The same techniques are used on the
pathway analysis module (see detailed description below), which also solves an attribute selection
problem, but on a set of extracted pathway expression fingerprints.
• Class Assignment module: In order to choose model parameters for maximum predictive perfor-
mance automatically, e.g. the number of nearest neighbours in the k-NN algorithm or the capacity
constant C in the C-SVM algorithm, a nested (in most cases leave-one-out) cross-validation using
grid search is applied. Importantly, not the parameter values with smallest cross-validation error are
chosen, but those parameters for the least complex model within one standard deviation of the opti-
mal settings (e.g. for k-NN this would be the model with largest k within one standard deviation of
the parameter k with smallest cross-validated error). This common regularisation technique reduces
the model complexity helps to avoid overfitting to noisy and spurious structures in the data.
• Class Discovery module: Selecting optimal parameters for clustering algorithms on the class dis-
covery module is more difficult than the parameter selection for supervised modules, because there is
no “gold standard” for an optimal clustering solution. To solve the problem of finding a suitable se-
lection for the number of clusters, the module computes a combination of five diverse cluster validity
indices (Calinski-Harabasz, Silhouette width, Dunn index, C-index and knn-Connectivity; see also
chapters 3 and 4), and three consensus rankings of clustering solutions from 2 to 8 clusters using these
validity indices (majority vote, median and sum of ranks; see detailed discussion in section 5.2). The
user can also inspect the rankings using the individual validity indices (as plots and in tabular form)
and enter class labels as input to obtain an estimate of the association between the best clustering
result and the given outcome labels using the adjusted rand index.
Moreover, the class discovery module also provides the option to apply an automatic feature-preserv-
ing dimensionality reduction on the data using different techniques. To remove uninformative low-
variance genes, while at the same time retaining low-variance regulator genes, the automatic filter
size detection method SUMCOV [145] can be employed. Alternatively, a sparse PCA filtering [146]
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can be computed automatically. If the user wishes to use a classic variance filter with a self-defined
threshold value, this is also supported as a further option (although not recommended, due to the risk
of removing low-variance regulators).
• Network Analysis module: The task of identifying co-regulated or co-expressed genes and visualis-
ing these relations in a network representation also involves the selection of different parameters. On
the ArrayMining Network Analysis module this task is facilitated by only requiring the user to spec-
ify an edge adjacency threshold, corresponding to a trade-off between the significance of the included
edges and the coverage of feature relations. Other internal parameters are chosen automatically by
the algorithm (see section 5.2 for details on the network analysis).
5.1.2 Gene/Protein name normalisation:
As discussed in the literature survey (see section 3.1.4 in chapter 3), the mapping of gene and protein iden-
tifiers in different formats onto a single standardized format is a common task in cross-domain integrative
analyses. Due to the multitude of naming conventions, and deviations from these conventions in human-
annotated datasets, often only a subset of the input identifiers can be converted into a standard format.
Importantly, since gene and protein annotation databases are continuously updated, fast automatic access
to public databases is required to obtain the best conversion results. For this purpose, the ArrayMining
framework is connected to different mirror web-servers of the ENSEMBL database [28], and always at-
tempts to retrieve the most current annotation data for an analysis. Moreover, the framework is interlinked
with the DAVID functional annotation web-service and database [29] and enables the user to forward a list
of genes/proteins, obtained from an analysis, to DAVID for further functional annotation analysis or gene
name conversions. If these external data repositories are temporarily inaccessible, the software will attempt
to convert the identifiers using a locally stored mapping database. These mappings are less comprehensive
and not up-to-date, but provide reasonable results for the interpretation of common queries (e.g. for most
Affymetrix gene expression platforms, a majority of the genetic probes can be converted to a standard iden-
tifiers). Importantly, genes which could not be annotated will still be taken into account in a standard feature
selection analysis, but if they are selected, they appear with the annotation “unknown” in the ranking list.
To prevent false positive annotations, literature mining based synonym identification has not been employed
here, because even for the most common model organisms, the accuracy of corresponding methods does
normally not exceed 80% (see section 3.1.4 in chapter 3).
5.2 Ensemble and Consensus Analysis of Microarray Data
Both the results from microarray analysis studies in the literature (see chapter 3) and the comparative
analyses conducted for this doctoral project (see chapter 4) have shown that new insights and improvements
in terms of robustness and accuracy can be obtained by comparing different methods and combining them
into ensemble techniques.
This section will present the methodology behind the new ensemble and consensus techniques for feature
selection, clustering and classification, that have been integrated into ArrayMining and made accessible via
a unified web-interface.
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The main new biological findings obtained with this tool set (see chapter 8), and other novelties of the
framework, including the new analysis pipelines connecting different analysis modules (see section 5.4),
and novel cross-domain analysis methods (see chapter 6) will be described in other dedicated sections.
Figure 5.2 shows ArrayMining’s main interface and the six analysis types it covers, including three general
machine learning modules (feature selection, clustering, prediction) and three modules for analysis tasks
specific to microarray data (cross-study integration, gene set analysis and network analysis). In the follow-
ing, first the generic machine learning modules will be discussed, focussing on the ensemble and consensus
techniques, and then the modules tailored to more specific biology-oriented analysis types.
Figure 5.2: The main web-interface of the ArrayMining system for microarray data analysis, covering six different
analysis types.
Feature selection module
The gene/feature selection module enables the comparison and combination of a diverse choice of methods
for identifying differentially expressed genes, proteins or metabolites from a high-throughput dataset with
sample labels and replicates. These methods include the empirical Bayes t-statistic (eBayes) [150,151], the
Significance Analysis in Microarrays method (SAM) [419], correlation-based feature selection (CFS) [160],
Random Forest embedded feature selection (RF-MDA) [191] and a Partial-Least-Squares based filter (PLS-
CV) [356] using the weight vectors defining the first latent components in cross-validated PLS models
(see also the literature survey in chapter 3 for details on most of these methods). Moreover, to exploit the
synergies of different algorithms, a method to compute aggregated gene ranks from the sum of ranks of the
individual methods was implemented (ENSEMBLE [18]).
The main result generated by the web-application is a ranked list of genes, in which known gene identifiers
become clickable navigation items, referring the user to related entries in functional annotation databases
and literature search engines. Additionally, box plots and heat maps (see examples in figure 5.3 and 5.4)
visualise the expression values of top-ranked genes across different sample groups. If the supplied data
uses common gene identifiers (Entrez Gene ID, NCBI GI accession, RefSeq Genomic ID, etc.), the list of
selected genes can be forwarded to external analysis tools, e.g. the DAVID functional annotation clustering
service [29].
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Figure 5.3: Box plots: Example of a box plot illustrating the spread of a gene’s expression values across three classes
of leukaemia samples: Acute Lymphoblastic leukaemia (ALL), Acute Myeloid leukaemia (AML) and Mixed Lineage
leukaemia (MLL); data set by Armstrong et al. [420]
Figure 5.4: Heat map: Example of a heat map visualising the expression values of selected genes (rows) across samples
(columns); data set by Armstrong et al. [420]
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Class discovery module
The class discovery module is designed to account for the great variety of existing scoring and search
space exploration methods for microarray sample clustering, by including both partition-based and hi-
erarchical clustering algorithms, an evaluation using multiple validity indices and a consensus cluster-
ing method. Currently, the partition-based clustering methods available are k-Means, Partitioning around
medoids (PAM) [239] and Self-organising maps (SOM) [209]; and the hierarchical clustering methods
include Average Linkage Agglomerative Clustering, Divisive Analysis Clustering and a combination be-
tween the agglomerative and divisive approach, Hybrid Hierarchical Clustering [421] (the Self-organising
tree algorithm (SOTA) [422] is additionally included as a hybrid between SOM and hierarchical cluster-
ing). To combine the information content from multiple clusterings into a single representative solution, a
self-devised consensus clustering approach was implemented, which maximises a score for the agreement
between sample-pair assignments of the tentative solution and all input clusterings using a simulated anneal-
ing (SA) approach. This SA approach is a variant of the classical SA algorithm by Kirkpatrick [423] and
uses an exponential cooling scheme and a stochastic random number generator creating Cauchy-distributed
numbers [424]. The score for each cluster of size s j is computed according to Swift et al. [12] using the
so-called agreement matrix A, which counts the number of times the cluster assignments for two samples i
and j agree across all input clusterings (see also section 3.4 in chapter 3). Specifically, the fitness score is
obtained as a sum over entries of the upper triangle of A that correspond to sample-pairs occurring in the
tentative cluster Gi:
f (Gi) =

∑
s j−1
j=1 ∑
s j
k= j+1(AGi jGik −β),s j > 1
0,otherwise
(5.1)
where Gi j is the j-th element of cluster i and β is a user-defined trade-off parameter with a value between
min(A) (i.e. the score promotes the assignment of samples to a single, large cluster) and max(A) (i.e. the
score promotes the assignment of samples into different, small clusters). The total score for a clustering
is the sum of scores for each single cluster, and has to be maximised. Simulated Annealing algorithms
have been shown to work well for optimising this scoring function, hence, by testing different variants
of Kirkpatrick’s Simulated Annealing (SA) algorithm as part of this doctoral project (comparing linear,
exponential and geometric cooling schedules, and thermodynamic SA [425] and adaptive SA [426]), the
Fast Simulated Annealing approach by Szu et al. [424] was found to provide the best scores for a given
runtime across multiple datasets.
Apart from providing access to single-algorithm and consensus clustering methods, the clustering module
also estimates the number of clusters automatically by means of multiple validity indices. In particular,
robust estimates of this number can be obtained by combining all pairs of algorithms and validity indices
(method “ALL” on the web-interface). In the results page for a submitted clustering task, the user is provided
with the output of three different methods to aggregate the validity scores for different numbers of clusters
using all input algorithms and all validity indices: A majority vote ranking (i.e. the number of clusters is the
one that most frequently obtained the best ranking score across all combinations of clustering algorithms
and validity methods), a median score ranking (i.e. the estimated number of clusters is the median of the
vector of best solutions across all method combinations) and a sum of ranks aggregation (i.e. the chosen
number of clusters is obtained by summing up all ranks the different numbers of clusters received across all
method combinations). Since there might be multiple meaningful clustering results, the user will also be
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informed about the next best solutions according to these rankings.
Prior to an analysis, the user can optionally apply different types of data standardisation and dimensionality
reduction. Apart from the classical standardisation to mean zero and standard deviation one, a more robust
method using the median absolute deviation [397] can alternatively be applied to pre-process the data. The
dimensionality reduction methods include the automatic, parameter-free COVSUM approach [145], which
can distinguish between uncorrelated, uninformative genes and regulators with high correlation to other
genes, a sparse PCA based filtering approach [146], and a classical variance-based filter, removing genes
with low variance across all samples (see also section 3.4 in chapter 3). Moreover, as an alternative filtering
approach, the user can first upload the input data on the gene set analysis module (see description of this
module below) to extract “meta-genes” representing cellular processes, complexes and pathways, and then
forward this data to the class discovery module.
As a result for each analysis, the user will obtain a tabular summary of the calculated validity indices and
clustering results and various graphical outputs including a silhouette-plot [227], a 2D principal components
plot and 3D VRML visualisations (see example in figure 5.2) generated with the self-devised visualisation
software package VRMLgen [24] for different dimensionality reduction methods including Principal Com-
ponent Analysis (PCA), Independent Component Analysis (ICA), Locally Linear Embedding (LLE) and
Isomap (see comparative evaluation in chapter 4).
Figure 5.5: Independent Component Analysis: Example of a VRML-visualisation for an Independent Component
Analysis; data set by Armstrong et al. [420]. The three sample types correspond to the leukaemia subtypes Acute Lym-
phoblastic Leukaemia (ALL), Acute Myeloid leukaemia (AML) and ALL with mixed-lineage leukaemia gene translo-
cation (MLL).
Class Assignment module
One of the main driving forces behind supervised microarray analysis is the goal to improve the diagnosis
of diseases with genetic components by classifying the disease type for new samples using labelled training
data. The third module on the ArrayMining web server is therefore dedicated to microarray sample classi-
fication, providing access to popular machine learning methods like SVM [377], RF [191], PAM [239] and
kNN. Additionally, an in-house developed rule-based machine learning approach, BioHEL [366–369], is
made available to the user (see the detailed description of BioHEL in section 4.2 in chapter 4). BioHEL had
previously been shown to achieve high prediction accuracies on other complex biological data sets [427],
5.3. Specialised Analysis Methods for Microarray Data 122
providing additional benefits in terms of the high interpretability of the decision rules in its prediction
models.
All classification methods can be combined with any of the attribute selection methods from the feature
selection module. The user has the choice of evaluating a chosen algorithm combination on a dataset
either using the widely accepted external two-level cross-validation methodology [25], an automatic pa-
rameter optimisation within a nested cross-validation (see the “automatic data processing” section above)
or a user-defined training/test set partition of the data. Moreover, since prediction models derived from
training data of a single study can typically not be applied to samples from other platforms and laboratories,
the combination of the cross-study normalisation module (see corresponding description below) with the
class assignment module provides a means to obtain more general models derived from a larger number of
samples.
The results for an analysis contain several performance measures for the evaluation and comparison of
prediction methods, including the mean accuracy and standard deviation, Cohen’s Kappa score [428], the
sensitivity and specificity, as well as a classification p-value according to Huberty et al. [429]. Moreover,
Z-scores are computed for the genes that were most frequently selected across different cross-validation
cycles [430]. To obtain more insights on these genes, similar analysis plots and links to external database
entries are available as on the feature selection module.
5.3 Specialised Analysis Methods for Microarray Data
Gene Set Analysis module
Two common problems in microarray analysis are high noise levels for single genes and a high number
of redundant and uninformative genes. Using gene set analysis (GSA) to aggregate functionally related
genes into gene sets and summarising their expression values to a robust “meta”-gene expression vector is
a promising approach to overcome some of these limitations [318] (see chapter 3, section 3.7). Moreover,
differentially expressed gene sets can provide insights on the differences between the biological conditions
of the samples on the level of cellular processes, pathways and protein complexes represented by these gene
sets.
On the ArrayMining server, the GSA module provides access to three annotation databases to extract sets of
functionally related genes from a dataset (Gene Ontology [30], KEGG [31], and a collection of 37 cancer-
related gene sets from the van Andel Institute in Michigan [310]). Alternatively, users can specify their own
gene sets by entering the corresponding gene identifiers into a text box on the web-interface. Since common
non-parametric GSA methods are often computationally expensive or provide only rough estimates of a
gene’s significance score, the p-values are computed using the parametric PAGE approach [310], requiring
a minimum gene set size of approx. 10 genes. To adjust these scores for multiple testing, the Benjamini-
Hochberg method [3] is used. Finally, to summarise the information for a gene set into a single meta-gene
expression vector, a dimensionality reduction method is applied to the original matrix of expression levels
(using either the first component from a principal components analysis (PC-GSA) or the first dimension
from a multidimensional scaling (MDS-GSA)).
The final results obtained on this module are presented as a list of gene sets, ranked according to their
enrichment p-value score, with additional box plot and heat map visualisations, similar to those on the
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gene selection module. Moreover, meta-gene expression values obtained from the GSA module can be
downloaded or forwarded to other analysis modules, e.g. to use them as predictors for sample classification.
Network Analysis module
As discussed in chapter 2, many diseases with genetic components are believed to be driven or influenced by
a complex network of interacting biological molecules. Thus, the identification of modules of co-expressed
genes or proteins can help to identify the cellular processes and their associated molecules, which are
modulated in response to changes in the biological conditions of interest.
For this purpose, the ArrayMining framework contains a module for gene co-expression network analysis,
which uses a single-parameter method to build a graph representing the co-expression relations between
the genes in a dataset. Specifically, the graph nodes (representing genes) are connected by edges, if the
corresponding genes are estimated to be significantly co-expressed, given the Pearson correlation of their
gene expression vectors. As mentioned in the “Automatic data processing” section above, the user only
needs to specify the edge adjacency threshold parameter, representing the trade-off between the reliability
of identified co-expression relations and the coverage of all potential co-expression relations, and all other
internal parameters are chosen automatically. For this purpose, the one-step automatic network construction
approach for weighted gene co-expression networks by Zhang and Horvath [343] is employed.
The user can display a co-expression network in six different automatic graph layouts, using the Fruchter-
man-Rheingold method [431], Graphopt [432], DrL [433], the Kamada-Kawai layout [434], singular value
decomposition (SVD) of the graph’s adjacency matrix, or a simple circular layout. In order to facilitate the
interpretation of labelled data, the user can provide binary sample labels in combination with the microarray
input data, which will be used to generate a coloured graph as output, where nodes representing genes which
have a higher median expression level in the reference condition (class 1) in relation to the target condition
(class 2) are coloured in blue, and genes with the opposite relation are coloured in red. Figure 5.3 shows
an example graph visualisation created with the network module for the breast cancer dataset used in the
comparative analysis in chapter 4 (employing the force-directed layout generation by Fruchterman and
Reingold [431]).
Additionally, the network analysis module computes several topological statistics for the generated network,
enabling the user to identify the gene with the maximum number of co-expressed neighbours (maximum
degree node), the mean number of neighbours per node, and the global clustering coefficient, among others
(see section 6.1.2 in chapter 6 for details on these and other topological descriptors).
To use the results for further analysis, a generated network can be downloaded in a variety of common
graph/network file formats to export the data for visualisation in other software tools (e.g. Cytoscape [435]).
Moreover, gene identifiers belonging to the same connected components are provided as a downloadable
text file, enabling the user to analyse these gene sets with other external tools (e.g. functional annotation
clustering using the DAVID web-service [29]).
Cross-study normalisation module
Integrating data from multiple microarray studies can be an effective means to alleviate the common prob-
lem of small sample sizes in microarray data analysis (see also section 3.6 in chapter 3). To enable experi-
menters to benefit from the possibilities of cross-platform integration methods, five of these methods have
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Figure 5.6: Example graph visualisation of gene co-expression network modules identified with the ArrayMining net-
work analysis module on a breast cancer dataset with 128 samples [19] from two tumour subtype classes (luminal and
non-luminal) using the force-directed layout generation by Fruchterman and Reingold [431]. Green nodes correspond
to genes which are down-regulated in the luminal samples in relation to the non-luminal samples, whereas the opposite
relation holds for the genes represented by red nodes. Accordingly, various modules of co-expressed genes exist as
potential markers for both classes.
been made available in a dedicated module of the framework. These algorithms combine sample expression
values from two different studies into a unified dataset using different strategies to adjust the distributions in
the original input data. These include several of the approaches discussed in the literature survey in chapter
3, specifically, a linked gene- and sample-clustering approach (XPN [417]), an empirical Bayes method
(EB [16]), a median rank score based method (MRANK [15]), an outlier-removing discretization technique
(NorDi [436]) and a quantile discretization procedure (QDISC [15]). While the first three methods provide
continuous-valued outputs, the last two use discretization to filter out noise, exploiting the fact that for many
higher-level analysis tasks only a general categorisation of gene expression levels in different conditions is
required (e.g. “unaltered”, “up”- or “down”-regulated). However, since the discretization of the data might
not only remove noise but also biological information from the data, the user should choose the cross-study
integration method depending on the analysis techniques to be applied subsequently, and ideally compare
the results for both continuous and discretization-based approaches.
Importantly, although the input data sets can originate from different microarray platforms, the genes rep-
resented on these platforms need to have a significantly large overlap and the samples should be derived
from the same tissue type under the same biological conditions. If these requirements are fulfilled, the
module will generate density and quantile-quantile plots to assist the user in evaluating and comparing dif-
ferent algorithms (figure 5.3 shows example density plots before and after an XPN normalisation). If the
user is satisfied with the outcome of the normalisation procedure, the combined data can be downloaded or
forwarded to other modules for further analysis.
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Figure 5.7: Example of kernel density estimation curves for microarray data before (left) and after (right) cross-study
normalisation with the XPN method [417]. The normalisation procedure clearly leads to a better match between the
two distribution curves.
5.4 Modular Combination of Analysis Techniques / Novel Analysis
Pipelines
Single analysis types (clustering, gene set analysis, etc.) can only help to extract parts of the biological
information within the measurements of a microarray experiment. However, by exploiting interconnections
between different analysis domains and devising new analysis pipelines, novel insights and improvements
in terms of robustness and accuracy can be gained using already existing algorithms. Moreover, if a wide
selection of possible modular combinations of analysis techniques is made available via a simple inter-
face, an experimenter can also set up a self-devised data analysis pipeline, tailored to a specific biological
question, by freely choosing a sequential combination of methods.
ArrayMining enables such combinations of multiple analysis types (highlighted by arrows between the
modules in figure 5) by a few mouse clicks, while ensuring that the user cannot use the methods in a
manner that violates widely accepted validation guidelines.
For example, if the user wishes to combine a supervised feature selection with a classification algorithm
within a cross-validation scheme, the ArrayMining interface will only allow the user to apply the feature
selection within the cross-validation procedure (also known as external cross-validation, as opposed to a
global feature selection using the whole data applied prior to the cross-validation). Thus, information leaks
are prevented and more reliable estimates of the attainable classification accuracies on external test data can
be obtained.
More novel and interesting combinations of analysis types result from interlinking the gene set analysis
module with the classification, the clustering or the network analysis module. For example, the user can
extract cancer-related gene sets or gene sets representing cellular pathways of interest from a dataset, sum-
marise their expression values into meta-genes using a dimensionality reduction method (see the section on
the Gene Set Analysis module), and then use these gene set fingerprints as predictors to train a machine
learning algorithm for sample classification (see figure 11.2 in the appendix for another example pipeline).
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This will not only provide more robust classification models, but also enable an interpretation of the data
from a different perspective, e.g. revealing associations between pathway deregulations and different dis-
ease states in a dataset.
Another example application could be the alleviation of problems with small sample sizes and high levels of
noise in input datasets from different studies. An effective means to increase the robustness of the analysis
in this case would be to both increase the number of samples and reduce the number of features, by using
the cross-study normalisation module to integrate two datasets from different platforms, in combination
with the gene set analysis module to aggregate information from multiple functionally related genes into
pathway fingerprints.
Interestingly, the combination of modules can also be helpful for a qualitative validation of the results from
a single module. An example would be the independent application of the network analysis module on two
separate datasets analysing the same cell type and biological conditions, compared to a network analysis of
the combined data using the cross-study normalisation module. This comparison will enable the user to see
whether similar modules of co-expressed genes in the individual datasets are also maintained in the unified
dataset.
More importantly, ArrayMining is interlinked with other software tools and web-applications in the frame-
work. Differentially expressed genes obtained from a feature selection analysis can be forwarded to the
TopoGSA web-server for network topological analysis of gene sets [20], or the EnrichNet web-application
for network-based gene set enrichment analysis (see chapter 6 for both of these algorithms). Moreover, a
pre-filtered dataset can also be used as input for the Top-Scoring Pathway Pairs algorithm (see chapter 7).
Finally, ArrayMining also exploits synergies with external tools, allowing users to forward selected genes to
the DAVID web-service [29] for a functional annotation clustering analysis, to load datasets from the GEO
database [27] into ArrayMining’s clustering module, or to inspect gene functional annotations in more detail
using a variety of other web-based annotation services [28, 30].
Chapter 6
Integrative Analysis of Gene/Protein
Sets
Chapter abstract
Apart from gene and protein expression microarray analysis, discussed in the previous chap-
ters, a multitude of other experimental methods exist to analyse the involvement of genes and
proteins in a biological process of interest. However, many of these techniques do not produce
data in a suitable format for machine learning purposes. For example, instead of containing
numerical measurements, the data might just provide information on whether a gene is fre-
quently mutated in a certain cancer type, silenced by a hypermethylated promotor, or inhibited
by a repressor. Accordingly, the experimenter often just obtains lists with genes or proteins
of interest as input for further analysis, instead of a dataset with numerical measurements for
different genes/proteins across multiple samples.
Although various computational analysis techniques have been made available to investigate
these gene/protein sets using additional annotation data, e.g. functional enrichment analysis
methods, the possibilities to use existing interaction network, cellular pathway and literature
data to investigate the experimentally derived gene/protein lists in more detail have not been
exploited to their full potential.
This chapter therefore presents new analysis techniques dedicated to the general analysis of
gene and protein lists from an arbitrary experiment. Although these methods are not designed
to profit from additionally available numerical measurements, they are applicable to both data
from high-throughput, noisy experiments and small-scale experiments like qPCR, with high
sensitivity but low coverage. Moreover, these general analysis approaches can easily be inter-
linked in an analysis pipeline with more specific analysis methods dedicated to specific experi-
mental platform, e.g. selected genes/proteins on the ArrayMining.net feature selection module
(or from other external tools) can be forwarded to any of the analysis modules described below.
In the first part of this chapter, the software TopoGSA [20] for the analysis of network topolog-
ical properties of gene/protein sets will be presented. Next, EnrichNet [21] is discussed, a web-
application extending functional enrichment analysis by including information from interac-
tion networks. Finally, for gene/protein sets representing cellular pathways or processes, a new
127
6.1. Network Topological Analysis of Gene/Protein Sets (TopoGSA) 128
method to expand these pathway definitions using protein interaction data, PathExpand [22],
will be explained in detail. The chapter uses material from the publications dedicated to each
of these software tools.
Figure 6.1: The new integrative analysis tools TopoGSA, EnrichNet and PathExpand as components of the integrative
data analysis framework (highlighted by the colour contrast).
6.1 Network Topological Analysis of Gene/Protein Sets (TopoGSA)
6.1.1 Introduction and motivation
Functional genomic experiments provide researchers with a wealth of information delineating gene and
protein sets of biological interest. To exploit these data sources, common steps in a functional gene/protein
set analysis include the search for enrichment patterns [437], e.g. to identify significant signalling pathways
or protein domains, as well as text-mining of the literature [438]. A further alternative approach for the
functional interpretation of gene/protein sets is the analysis of molecular interactions in which the genes or
their corresponding proteins are involved, in particular protein-protein interactions. In this context, various
existing bioinformatics tools already allow users to map genes onto networks of interacting or functionally
associated molecules to identify related genes and proteins [439, 440]. However, for the analysis and com-
parison of gene sets these tools have not taken into account topological properties in interaction networks
so far.
This was the motivation for introducing TopoGSA (Topology-based Gene Set Analysis), a web-application
to compute, visualise and compare network topological properties of gene or protein sets mapped onto in-
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teraction networks. TopoGSA was developed as part of a collaboration with the Spanish National Cancer
Centre (CNIO, Madrid), focussing on the analysis of cancer-related gene sets, in particular, gene sets known
to be mutated in specific tumour types. TopoGSA maps these gene or protein sets onto a protein-protein
interaction (PPI) network and computes different topological characteristics, such as the centrality of nodes
in the network or their tendency to form clusters, and compares them to those of known cellular path-
ways and processes. This enables both the identification of genes with outstanding topological properties
(e.g. as a post-processing procedure after a microarray feature selection analysis) and a ranking of known
gene/protein sets with regard to their topological similarity to a target gene/protein set, which might point
to previously undiscovered functional similarities.
6.1.2 Workflow and methods
Analysis of network topological properties: A network topological analysis on TopoGSA begins with
the upload of a list of gene or protein identifiers (e.g. Ensembl IDs, HGNC symbols, among others).
Alternatively, a microarray dataset can be used as input and differentially expressed genes will be extracted
automatically using the feature selection module from ArrayMining [18] (see chapter 5 and the pipeline
illustration in figure 11.2 in the appendix). Moreover, the user can add labels to the uploaded identifiers to
compare different sub-sets of genes (e.g. “up-regulated” vs. “down-regulated” genes).
After submitting the list of identifiers, the application maps them onto an interaction network (see descrip-
tion in the Implementation section below), and computes topological properties for the entire network,
the uploaded gene/protein set and matched-size random protein sets. Specifically, the considered network
topological properties are:
• The degree of a node (gene or protein) is the average number of edges (interactions) incident to this
node. Genes involved in many interactions are likely to have a vital functional role in the network,
thus, a high average degree of a gene set can indicate that it contains such genes as members.
• The local clustering coefficient provides a measure of the tendency of nodes in a network to cluster
together [441]. More formally, the measure quantifies the probability that the neighbours of each
vertex are connected, by defining the local clustering coefficient Ci for a vertex vi in an undirected
graph G = (V,E) as:
Ci =
2|e jk|
ki(ki−1) : v j,vk ∈ v j : e ji ∈ E ∧ ei j ∈ E,e jk ∈ E (6.1)
where ki is the degree of vertex vi and e jk is the edge between vertices v j and vk. Gene sets with a
high average local clustering coefficient contain many genes in dense groups of nodes which could
represent functional modules in the interaction network.
• The shortest path length (SPL) for two nodes vi and v j in an undirected, unweighted network is
defined as the minimum number of edges which have to be traversed to reach v j from vi. Here, the
SPL is used as a centrality measure, computing the average SPL from each node of interest to all
other nodes in the network.
• The node betweenness B(v) of a node v is a centrality measure that can be calculated from the number
of shortest paths σst from nodes s to t going through v:
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B(v) = ∑
s 6=v,s 6=t,v6=t∈V
σst(v)
σst
(6.2)
Thus, the average node betweenness of a gene sets provides a measure of the network centrality of
its corresponding genes with regard to their importance for the information flow across the network.
• The eigenvector centrality measures the importance of network nodes by applying a centrality defi-
nition, in which the score of each node reciprocally depends on the scores of its neighbours. More
precisely, the centrality scores are given by the entries of the dominant eigenvector of the network
adjacency matrix (see [442] for a detailed discussion of this property).
More details on network topological descriptors can be found in the book by Junker and Schreiber [345].
In order to visualise these topological properties for each individual gene/protein in an uploaded dataset,
TopoGSA displays user-defined 2D and 3D representations in which the plotted data points are interlinked
with corresponding entries in an online annotation database.
Interaction network construction: To generate a genome-scale interaction network, human protein-
protein interactions were retrieved from five public databases. These include MIPS [93], DIP [94], MINT
[95], HPRD [96] and IntAct [97]. Following the guidelines in the “Protein interaction data pre-processing”
section in the literature review in chapter 3, only experimental methods dedicated to the identification of di-
rect binary protein interactions were considered (see webpage www.infobiotics.org/topogsa, Datasets
section). The final protein interaction network contained 9392 proteins (nodes) and 38857 interactions
(edges).
Comparison with known gene sets: The analysis of network topological properties of only a single
gene/protein set (“Individual Gene Set Analysis” module) does not lend itself to direct functional inter-
pretation, although it facilitates the identification of genes with outstanding topological characteristics.
However, a second analysis module on TopoGSA (“Comparative Gene Set Analysis”) additionally enables
the user to compare the properties of a dataset of interest to a multitude of pre-defined gene/protein sets
corresponding to known functional processes from public databases. For the human species, these include
signalling pathways (KEGG [36], BioCarta [32]), Gene Ontology functional terms (i.e. Biological Process,
Molecular Function and Cellular Component terms [30]) and InterPro protein domains [443]. Correspond-
ing collections of datasets for other model organisms, including plants (A. thaliana), worms (C. elegans),
fly (D. melanogaster) and yeast (S. cerevisiae), have also been made available.
When applying a comparative analysis using these data sources, summaries of network topological proper-
ties are provided for all gene/protein sets, and in the 2D and 3D plots different colours distinguish different
datasets. Users can identify pathways and processes similar to the uploaded dataset visually, using these
plots, or by inspecting a tabular ranking using a numerical score to quantify the similarity across all topo-
logical properties. This similarity score is obtained by computing five ranks for each pathway/process
set according to the absolute differences between each of its five median topological properties and the
corresponding value for the uploaded dataset. The sum of ranks across all topological properties is then
computed and normalised to a range between 0 and 1. Accordingly, the smaller this value, the more similar
the corresponding gene/protein set is to the uploaded dataset in terms of its topological properties.
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6.1.3 TopoGSA - Example analysis
Since TopoGSA was built in co-operation with the Spanish National Cancer Institute (CNIO), an important
motivation behind the tool was to use it for the analysis of cancer genes. Both the individual and comparative
topological analysis was therefore applied to the complete set of genes currently known to be mutated in
cancer [34].
Overall, the results confirmed previous observations according to which proteins encoded by genes which
are known to be mutated in cancer have a higher average node degree in interaction networks than other
proteins [444]. Moreover, the cancer genes were involved in more than twice as many interactions, on
average, than matched-size random subsets of network nodes (with a difference of more than 15 standard
deviations for 10 random simulations). Furthermore, the analysis with TopoGSA reveals that the cancer
genes occur in closer proximity to each other (in terms of their average pairwise shortest path distances)
than random gene sets of matched sizes and occupy more central positions in the interaction network (see
Figure 6.2a) for details). In particular, the 3D plot displaying node betweenness, degree and shortest path
length highlights the tumour suppressor p53’s (TP53) outstanding network topological properties.
Figure 6.2: Example results generated with TopoGSA using the cancer gene set by Futreal et al. [34].
a) Topological properties can be computed and examined as visual (1) and tabular (2) outputs; b) The gene set can be
compared with a chosen reference database (here the KEGG database).
When comparing the network topological properties of the cancer proteins with pathways from the KEGG
database, representing each pathway by its corresponding set of genes (Figure 6.2b), the cancer proteins
have similar network properties as several KEGG cellular processes and environmental information pro-
cessing pathways (according to the KEGG-BRITE pathway hierarchy, [36], Figure 6.2b, purple and brown),
whereas they clearly differ from metabolism related pathways (figure 6.2b, yellow). Interestingly, although
the network topological properties of cancer genes are in agreement with their role in promoting cell division
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and inhibiting cell death [445], they differ from those of most disease related KEGG pathways (Figure 6.2b,
green), which tend to have higher degrees and network centralities.
6.1.4 TopoGSA - Implementation
The network analysis and gene mapping was implemented in the programming language R [353] and the
web-interface in PHP. To build a human protein interaction network, experimental data from five public
databases (MIPS [93], DIP [446], BIND [447], HPRD [448] and IntAct [97]) were combined and filtered for
binary interactions by removing entries with PSI-MI codes for detection methods that cannot verify direct
binary interactions (these are evidence codes for co-immunoprecipitation or co-localization, for example;
the complete list of used method definitions and PSI-MI codes can be found in the “Datasets” section on
the TopoGSA webpage, www.infobiotics.net/topogsa). Additionally, protein interaction networks for
the model organisms yeast (S. cerevisiae), fly (D. melanogaster), worm (C. elegans) and plant (A. thaliana)
have been built using the same methodology as for the human network and using the BioGRID database [92]
as an additional data source (see the help sections on the webpage for additional details on these networks).
Importantly, users also have the option to upload their own interaction networks for a topological analysis,
and instructions can be obtained from a demonstration video and manual available in the “Tutorial”-section
on the webpage.
In summary, TopoGSA is a new web-application mapping gene and protein sets obtained from an exper-
iment onto a pre-specified or user-defined molecular interaction network and providing insights on their
topological properties and similarities to datasets representing known pathways, processes and complexes.
All properties can be inspected and compared visually using 2D and 3D representations or ranked lists of
the most similar pre-defined gene sets from cellular process databases.
6.2 Integrative Functional Enrichment Analysis of Gene and Protein
Sets (EnrichNet)
6.2.1 EnrichNet - Introduction and motivation
Using molecular interaction networks in integrative data analysis approaches, gene and protein sets can-
not only be analysed in terms of their topological properties (see previous section), but also by using the
network distance information to assess their functional associations. In fact, the general task of assessing
functional associations between an experimentally derived gene/protein set of interest and a database of
known gene/protein sets is a common problem in the analysis of functional genomics data. A classical ap-
proach to address this problem is to apply an overlap-based enrichment analysis using the one-sided Fisher’s
exact test. However, this method has various limitations:
• it can only score functional associations of overlapping gene sets
• some of the genes are not annotated for any pathways or processes and therefore disregarded
• the network structure of physical interactions between the gene/protein sets is not taken into account
Since publicly available large-scale molecular interaction data provides a source of information both for
analysing the network structure between the molecules of interest and for inferring protein function at the
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cellular scale, a network-based integrative analysis approach can help to address these problems. This was
the motivation to develop EnrichNet, a web-application complementing overlap-based enrichment analysis
by an association measure using the network structure of interactions between proteins.
6.2.2 EnrichNet - Workflow
Similar to TopoGSA, on the EnrichNet web-interface the user only needs to copy and paste a set of gene
or protein identifiers into a text box, select a reference database (KEGG, BioCarta, Reactome, or Gene
Ontology), and submit the analysis task. The EnrichNet approach will then compute network-based enrich-
ment scores to estimate the functional association between the uploaded gene/protein set and the reference
datasets, and if desired, visualise sub-graphs corresponding to the gene/protein sets of interest. This is
achieved by the following four steps procedure:
1. The uploaded gene or protein set is mapped onto a molecular interaction network (a protein-protein,
protein-DNA or genetic interaction network).
2. The distribution of distances between all protein/gene pairs from the dataset of interest and every
reference dataset from the chosen database is computed (possible distance measures: shortest path
length, random walk or kernel distance).
3. This distribution is compared against the distribution across all pathway/process protein sets from the
chosen database using the Xd-distance [449] (see detailed explanation in the Methods section below).
4. For the chosen pair of gene/protein sets the corresponding network nodes and connecting edges are
visualised and can be explored interactively.
In summary, the user obtains two types of outputs: A ranking of the reference datasets in terms of the
network-based association with the uploaded gene set (measured by the Xd-distance), and additionally, an
interactive visualisation for each entry in this ranking list, displaying the sub-networks of the interaction
network corresponding to the uploaded and the reference gene set and highlighting their overlapping genes
(nodes) and the interactions (edges) between the non-overlapping nodes. Thus, the user does not only obtain
an estimate for the strength of the functional association between two gene sets, but can also investigate the
interactions in detail which contribute to this association.
6.2.3 EnrichNet - Methods
To obtain a large-scale molecular interaction network as input data, experimentally verified, direct binary
protein-protein interactions were assembled from the databases MIPS, DIP, MINT, HPRD and IntAct, and
combined into a graph of 9392 nodes (proteins) and 38857 edges (interactions), which has also been used as
part of the TopoGSA approach (see previous section). Distances between pairs of gene/protein sets mapped
to this network were scored by comparing the distribution of pairwise distances between single nodes using
shortest path distances (alternatively, randomwalk distances or different distance measure induced by kernel
matrices could be applied) against a background distribution. This background distribution is obtained
from the distances between the gene/protein set of interest and all pathway/process protein sets in a chosen
database. In order to compare the distributions, a distance measure that has previously been used in the
evaluation of protein contact map predictions, the Xd-distance [449], is employed. This measure is defined
as follows:
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Figure 6.3: Left: Lymphoma mutated genes (blue) and genes/proteins from the BioCarta RElA pathway (red) mapped
onto a human protein-protein interaction network. Right: distribution of shortest path distances for two related gene
sets (blue) and the background distribution across all gene set pairs (red).
Xd =
n
∑
i=1
Pic−Pia
din
∈ [−1,1] (6.3)
where Pic is the percentage of node pairs with a distance di in the current gene set pair, Pia is the correspond-
ing percentage across all gene set pairs in the reference database, di is the shortest path distance between
a pair of genes/nodes in the network, and n is the number of distance bins (equivalent to the network di-
ameter + 1). Accordingly, this measure assigns higher weights to small distances and lower weights to
large distances, ensuring that large distance outliers do not distort the results. Figure 6.3, right, shows an
example distribution of shortest path distances for two closely related gene sets (blue) and the background
distribution (red). The Xd-score, which is also defined in the same figure, rewards gene set pairs with a
distance distribution that is shifted towards the left in relation to the background distribution, i.e. short dis-
tances (indicating strong functional associations) occur more often than expected, whereas long distances
appear less often than expected. Thus, high Xd-scores point to strong functional associations between the
corresponding gene sets and low scores to weak or non-existing functional associations.
Importantly, this definition of the Xd-score leads to a different interpretation of the ranking scores in com-
parison to classical p-value significance scores. While p-values lie in a range between 0 and 1, and findings
with low p-values have a higher statistical significance than observations with high p-values, the Xd-score
ranges from -1 to 1 and findings with higher scores are more significant than low-scoring results (more
specifically, for Xd-scores larger than 0, the frequency of short network distances between the gene sets is
shorter than expected based on the background model). In order to find an approximate cut-off Xd-score
corresponding to a desired p-value significance threshold, the user can compute classical overlap-based sig-
nificance scores using the Fisher exact test for the overlapping gene sets and fit a linear regression model to
relate the overlap-based scores to the corresponding Xd-scores.
To test this approach on real-world data, Xd-distances were computed for sets of genes known to be mu-
tated in different tumour types (bladder cancer, breast cancer and lymphoma) compared against pre-defined
protein sets from KEGG, BioCarta and Gene Ontology corresponding to cellular pathways and processes.
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As an example, figure 6.3 (left) shows the network structure for two non-overlapping gene sets (lymphoma
mutated genes (blue), BioCarta RelA pathway (red); Xd-score: 0.2). A large number of edge connections
between the genes from the two gene sets suggests a strong functional association between them, which
would not have been discovered using an overlap-based enrichment analysis, since the overlap is zero.
6.2.4 EnrichNet - Results
Similar to TopoGSA, the EnrichNet methodology and web-application was developed in co-operation with
the Spanish National Cancer Institute, and the main biological goal was again to analyse cancer-associated
gene sets. Specifically, cancer mutated gene sets were mapped to a large-scale human protein interaction
network and their shortest path distances to mapped gene/protein sets from KEGG, BioCarta and Gene
Ontology were scored with the Xd-distance measure. These scores were then compared against classical
overlap-based enrichment scores using the Fisher exact test, for all cases in which the gene/protein sets had
non-zero overlaps.
In agreement with prior expectations, high Pearson correlations between the network-based and the overlap-
based significance scores were observed (absolute correlations above 0.75, considering only datasets with
non-zero overlap). More importantly, new functional associations were identified for gene/protein sets with
small or no overlap. For example, figure 6.4a) displays the network structure obtained when comparing
the sarcoma mutated gene set (40 mapped genes) against the BioCarta cell cycle pathway “RacCycD” (26
mapped genes), related to a cell’s transition from the so-called G1 phase (growth phase) to the S phase
(DNA synthesis phase).
Figure 6.4: Protein-protein interaction sub-network for: a) Sarcoma mutated genes (blue) and genes/proteins from the
BioCarta RacCycD pathway (red); b) Bladder cancer mutated genes (blue) and genes/proteins from Gene Ontology
term “Insulin receptor signaling pathway” (red, GO:0008286).
These datasets have an overlap of only three genes (HRAS, NRAS and RB1) and would therefore not have
been considered as significantly associated by an overlap-based enrichment analysis using the Fisher exact
test (q-value of 0.17), whereas the obtained Xd-score is comparatively high (0.18, please note the different
interpretation of the Xd-score in comparison to classical p-values described in the Methods section) and
suggests a strong association (which is supported by the multitude of interactions between the corresponding
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proteins for these gene sets, see figure 6.4a)).
A further example for an identified functional association is shown in figure 6.4b), which reveals strong in-
terconnections between the non-overlapping set of bladder mutated genes (blue) and the dataset representing
the Gene Ontology “Insulin receptor signalling pathway” (red, GO:0008286, Xd-score: 0.27). While this
association between cancer and insulin receptor signalling is well described in the literature [450,451], there
are only few studies reporting an association between lymphoma tumours and the RelA pathway [452] (see
figure 6.3, Xd-score: 0.2), whose network mappings are also strongly interconnected.
On the whole, EnrichNet successfully identifies all the functionally associated gene sets detected by an
overlap-based enrichment analysis, but additionally finds new associations for non-overlapping gene sets,
some of which have not yet been reported in the literature. The associations detected for the sarcoma,
lymphoma and bladder cancer gene sets discussed above and similar results for other cancer mutated gene
sets suggest that the EnrichNet approach provides an effective means to identify and prioritize previously
unknown functional associations between gene and protein sets.
Furthermore, in addition to the ranking of gene set associations using the Xd-score, the user can visualise all
network-based associations online and inspect them in further detail using an interactive interface. Specifi-
cally, this interface enables the user to zoom into the sub-networks of interest, search for specific genes and
highlight them in the network, and view their topological properties and functional annotations by clicking
on the corresponding nodes. In contrast to a simple ranking table provided by standard overlap-based en-
richment analysis methods, this exploratory data analysis allows the user to investigate the biology behind
the ranking scores in more detail and obtain specific insights on the functional and topological properties
for the molecules of interest and the network of interactions between them.
6.2.5 EnrichNet - Summary and conclusions
EnrichNet is an integrative analysis method for gene and protein sets, addressing limitations of classical
overlap-based enrichment analysis by introducing the following new features:
1. Putative gene/protein set associations can be identified and prioritised even if the input data sets have
only small or no overlaps.
2. A visual analysis of corresponding sub-networks reveals the structure of molecular interactions and
potential linker proteins (i.e. proteins involved in the communication between different cellular path-
ways). Moreover, interactive features like mouse wheel zoom-in and node context menus with net-
work topological information and annotation data for genes/proteins enable an in-depth exploration
of the regions of interest in the interaction network.
3. The approach enables the combination of experimental evidence from multiple data sources, differ-
ent interaction networks (protein-protein, genetic interactions, etc.) and functional genomics experi-
ments.
EnrichNet represents a natural extension of classical overlap-based enrichment analysis, since the classical
distinction between overlapping and non-overlapping genes can be understood as a special case of the
EnrichNet approach (using a binary distance measure that considers only shortest path distances of zero
(overlapping) or greater than zero (non-overlapping)).
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Due to the availability of large-scale molecular interaction data for a wide range of species and even specific
tissue types, EnrichNet is applicable to a great variety of data analysis tasks in the biosciences, including
problems in basic biological research, biotechnology and biomedicine.
6.3 Integrative Methods to Extend Gene/Protein Set Based Cellular
Pathway Definitions (PathExpand)
6.3.1 PathExpand - Introduction, background and motivation
Both in the TopoGSA and the EnrichNet analysis approach, gene/protein sets obtained from an experiment
are compared against known gene/protein sets representing cellular pathways, processes and complexes. So
far, these “known datasets” have been considered as fixed and correct representations of the corresponding
biological processes. However, although these expert-based cellular pathway representations provide a rich
source of information, the pathway definitions are partly subjective and inconsistent across the different
databases. For example, when comparing the pathway diagrams of the cancer-related p53 signalling path-
way in the databases KEGG [36], BioCarta [32], Wikipathways [453] and Invitrogen iPath [454], they do
not only differ in form and layout but in the molecules involved and the connections between them. In fact,
the assignment of a protein to a pathway often relies on the experimental procedure and on a subjective
assessment of the protein’s importance for the process. Many associated regulators, effectors or targets of
core cellular pathways may therefore have been overlooked or mistakenly not been considered as relevant
enough by classical approaches to define pathways.
In addition to the mentioned inconsistencies, classical representations are limited to portraying pathways
as independent cascades of proteins transmitting a signal from the cell surface to the nucleus. However,
recent functional genomics high-throughput initiatives have identified a large number of interaction partners
for signalling proteins, suggesting more complex relationships between cellular pathways than in their
traditional representations [455], and challenging the classical view of pathways as independent functional
entities. Therefore, an integrative approach to extend cellular pathway definitions, combining information
from the original pathway databases and molecular interaction networks and using objective criteria to score
pathway definitions, could be an opportunity to create more consistent and informative pathway and process
definitions.
For this reason, a new methodology for extending pre-defined protein sets representing cellular pathways
and processes, PathExpand, was developed as part of this doctoral project. PathExpand amalgamates the
information from process and pathway databases with large-scale protein-protein interaction data. Previous
approaches for in silico generation of cellular processes using molecular interaction data have constructed
pathways from scratch [456–459], and related approaches for disease candidate gene prioritisation also rely
on interaction network data [460–462]. However, an extension approach which preserves the information
content in existing process definitions, but expands these definitions by identifying new strongly associated
biomolecules, has previously not been investigated.
This was the motivation behind PathExpand, which maps original pathway definitions from public databases
onto a protein-protein interaction network, and extends them to include their most densely interconnected
interaction partners (using various graph-theoretic criteria). Both the added proteins and the extended path-
way definitions can be used for a wide range of practical analysis tasks, to gain new biological insights
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related to the cellular processes represented by these pathways.
In the following sections, the methodology behind PathExpand and statistical and biological results ob-
tained on real-world data will be presented and discussed in detail. Specifically, the analysis of proteins
added to pathway definitions by the method reveals that these proteins display distinctive network topolog-
ical features and molecular function annotations and can be proposed as putative new components of the
corresponding cellular processes, and/or as regulators of the communication between different processes.
This is illustrated by the prediction of novel Alzheimer’s disease candidate genes and the identification of
proteins with potential involvement in the crosstalk between several interleukin signalling pathways.
As with the TopoGSA and EnrichNet tool, PathExpand resulted from a collaboration with the Spanish Na-
tional Cancer Institute (CNIO), and the prime target was therefore to investigate pathways whose deregula-
tion may contribute to the development of cancers [445]. Thus, extended cellular pathways and processes
were also used to analyse their enrichment in pancreatic mutated genes from a large-scale resequencing
study.
6.3.2 PathExpand - Methods
Implementation: All data processing and analysis steps in PathExpand were implemented in the program-
ming language R, and the web-interface on www.infobiotics.net/pathexpand was developed in PHP.
The human protein-protein interaction network used for all network-based computations is the same as the
one used for TopoGSA and EnrichNet (see above).
Gene/protein sets corresponding to cellular pathways/processes were extracted from the public databases
KEGG [31], BioCarta [32] and Reactome [37] and then mapped onto the protein interaction network. Since
the interaction data does not represent the entire proteome, on average about 60% of the pathway proteins
could be mapped onto the network.
Process extension procedure: Original cellular pathways/processes containing a minimum size of 10 pro-
tein members were used as seeds and mapped onto the interaction network. The direct neighbours of these
seed nodes were then considered as candidates for the extension procedure and filtered according to multiple
graph-theoretic criteria to assess the strength of their association with the pathway nodes. More specifically,
in the first filtering step, a candidate node v has to fulfil condition (6.4) below and at least one of the follow-
ing conditions (6.7-6.7) to be added to a pathway p (an illustration of these conditions is shown in figure
6.5).
node degree:
degree(v)> 1 (6.4)
direct pathway/process association:
process links(v, p)
outside links(v, p)
> T1 (6.5)
indirect pathway/process association:
triangle links(v, p)
possible triangles(v, p)
> T2 (6.6)
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pathway/process node coverage:
process links(v, p)
process nodes(p)
> T3 (6.7)
where degree(v) is the number of neighbours of node v, process links(v, p) is the number of direct links
from v to a node in process p and outside links(v, p) is the number of direct links from v to a node outside
of process p. In equation 6.6, triangle links(v, p) is the number of triangles in which v occurs together with
a node in p and another candidate node, and possible triangles(v, p) is the number of these triangles which
could potentially be formed, if all other candidate nodes would be part of a triangle connecting v and p.
The thresholds T1, T2 and T3 are defined here as T1 = 1.0, T2 = 0.1 and T3 = 0.3 (this selection provided
a reasonable trade-off between the number of extended pathways and the average size of the extension).
For T1 = 1.0, equation 6.5 corresponds to a well-known condition in graph theory introduced to define
strong communities in networks (stating that the number of connections to the pathway/community must
exceed the number of connections to the rest of the graph, see [320]). Given that a candidate node can have
connections with all the original pathway nodes, the threshold T3 always has to be smaller than 1 (i.e. the
maximum pathway node coverage is 1).
Since the extension procedure should ideally also provide more compact pathway representations in the
network, this first candidate protein filter is complemented by applying a second filter to the candidate
nodes passing the first. Specifically, a candidate node is only accepted, if the following compactness score
for a pathway protein set P, given by the mean of the shortest path lengths between all pairs of proteins
belonging to P, is reduced after adding the candidate:
compact score(P) =
∑
i, j∈P;i< j
dist(Pi,Pj)
|P| ∗ (|P|−1)/2 (6.8)
Thus, the filtering criteria ensure that proteins added to a pathway are both strongly associated with the orig-
inal pathway members and provide an extended pathway with a compact network representation. Moreover,
in particular the added proteins which increase the compactness by connecting disconnected proteins in the
original pathway can be expected to have a very strong association with the original pathway. Finally, to
ensure that the extension procedure is deterministic, the order in which proteins are added to a pathway is
given by a greedy strategy, i.e. the protein that increases the compactness the most is always added first.
Topological network analysis: To quantify local and global topological properties of proteins in the net-
work, the web-application TopoGSA [20] (see above) was used to compute five topological descriptors: the
number of connections to other nodes (degree), the tendency of nodes to form clusters (clustering coeffi-
cient), their centrality in the network (betweenness and eigenvector centrality) and the distances between
them (shortest path length). See the section on TopoGSA above for a detailed explanation of these topolog-
ical characteristics.
Cross-validation: In order to validate the expansion procedure, the extent to which randomly deleted
proteins in the original pathways/processes can be recovered by the proposed method is analysed using the
following cross-validation strategy:
1. 10% of the proteins from each pathway were removed randomly among those proteins that are con-
nected to at least one other protein in the pathway. If the set of proteins that are connected to other
pathway members covers less than 10% of the total number of proteins, we iteratively remove random
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Figure 6.5: Filtering criteria: Visualisation of graph-based filtering criteria used to extend the cellular processes (the
process nodes are shown in black, coloured and circled nodes represent cases in which different filtering criteria are
fulfilled by a candidate node).
proteins from this set and recompute the set until it is empty.
2. To each reduced pathway the proposed extension procedure was applied as well as 100 alternative
random extensions, computed by sampling randomly the same number of proteins from the candidate
proteins of the reduced pathway (see definition of candidates in the previous section).
3. P-value significance scores are estimated as the relative frequency of cases where more proteins
were correctly recovered by a random extension than by the proposed extension procedure across all
pathways in a database.
Semantic similarity analysis of Gene Ontology terms: For further validation, the functional similarity
between the added proteins and the original pathway members was assessed against the same background
model used in the previous cross-validation analysis. For this purpose, pairwise similarities between pro-
tein annotations were quantified with Jiang and Conrath’s semantic similarity measure for GO terms [103].
Using this similarity score, the average GO-term similarities between all pairwise combinations of GO bi-
ological process (BP) terms from the original proteins in the cellular pathway and the added proteins was
computed. The random extension model was again created by randomly sampling the same number of pro-
teins from the candidates for the pathway (see definition of candidates in the pathway extension section) as
in the real extension, excluding the proteins from the extended cellular pathway under consideration. Im-
portantly, it is not possible to compare the extensions of real pathways to extensions of random gene/protein
sets with similar connectivity in the network, because in most cases these sets would largely overlap with
other pathways.
Enrichment Analyses:
6.3. Integrative Extension of Cellular Pathway Definitions (PathExpand) 141
• The enrichment of molecular functions among the proteins added to the cellular pathways/processes
by the extension procedure was tested for all databases independently using the DAVID functional
annotation clustering tool [393] (Gene Ontology Molecular Functions and InterPro protein domains),
with the proteins from the interaction network. Functional annotation clusters with a more than 2-fold
enrichment were selected and manually labelled.
• To estimate the probability of observing certain overlaps between extended or original protein sets
representing pathways and other protein sets of interest, e.g. cancer-related proteins, we employed
a classical over-representation analysis (ORA) using the one-tailed Fisher exact test. To adjust for
multiple testing, we employ the approach by Benjamini and Hochberg [3].
6.3.3 PathExpand - Results and Discussion
In the following section, the results obtained by applying the pathway extension approach to cellular path-
way and process datasets from the databases KEGG [31], BioCarta [32] and Reactome [37] will be dis-
cussed. Across all databases, 1859 different processes were considered (with a minimum size of 10 pro-
teins) and mapped onto a network containing 38857 interactions (see Methods).
General extension statistics: The proposed procedure could extend 159 pathways from BioCarta, 90 from
KEGG and 52 from Reactome (see table 6.1 and www.infobiotics.net/pathexpand). The pathway sizes
increased on average from 113% to 126% of the original size.
Table 6.1: Statistics on added proteins across different databases
Property BioCarta KEGG Reactome
no. of examined pathways 322 199 79
no. of extended pathways 195 140 62
avg. pathway size 19 49 75
avg. size after extension 24 61 85
total no. of added proteins 935 1745 622
no. of unique added proteins 280 623 409
Molecular function Phosphatase activity, Phosphatase activity, Regulator activity
categories of proteins Regulator activity, Regulator activity,
added by the Binding, Kinase Cytokine binding
extension method inhibitor/regulator, /TNF receptor
(2-fold enrichment, Cytokine binding
see methods) /TNF receptor
Statistics on the number of pathways that could be extended, the average extension size, the number of added (unique) proteins and
their molecular function categories.
Network properties of added proteins: The added proteins in the interaction network had a more than
one standard deviation higher node degree, betweenness and average local clustering coefficient (Methods)
than 10 matched size random protein sets [20] (see table 6.2). Moreover, the shortest path lengths between
the added proteins were smaller by several standard deviations (table 6.2). This tendency of the proteins
added by the extension method to occur in more central and dense regions of the network is consistent with
similar trends observed for the topological properties of proteins from the original cellular pathways and
processes (see table 6.2).
Functional annotations of the proteins added to the cellular pathways/processes: A semantic similarity
6.3. Integrative Extension of Cellular Pathway Definitions (PathExpand) 142
Table 6.2: Topological properties of BioCarta pathway/process extensions [32]
Property Proposed extension: Random model: Added Original cellular All network
Added proteins proteins only processes proteins
only (mean) (mean / stddev.) (mean / stddev.) (mean/stddev.)
Shortest path length 3.68 4.11(0.03) 3.77 (0.51) 4.12(0.94)
Node betweenness 21998 14545(4751) 49888 (153173) 14669(68893)
Degree 10.3 8.11(0.94) 21.53 (32.64) 8.27(16.2)
Clustering coefficient 0.34 0.11(0.01) 0.12 (0.17) 0.11(0.21)
Eigenvector centrality 0.04 0.01(0.04) 0.05 (0.09) 0(0.57)
Comparison of different numerical topological properties for the proteins added by the proposed extension method
(column 1) or the random model (column 2), as well as a comparison of these properties for the nodes corresponding
to the original cellular processes (column 3) and the entire protein-protein interaction network (column 4).
analysis of the GO terms was used to compare the functional annotations of the original cellular process
proteins with the annotations of the proteins added during the extension procedure (see Methods). For
almost all cellular pathways, the GO terms of the added proteins are more similar to the GO terms of the
original cellular pathway proteins than those of matched-size random protein sets (see figure 6.6). These re-
sults confirm that the added proteins belong to similar functional categories as the proteins from the cellular
processes they were assigned to. Furthermore, a functional enrichment analysis of the combined set of pro-
teins added to all cellular processes (applied to each database separately) reveals an enrichment in proteins
annotated for regulatory activity (see table 6.1). More interestingly, for the databases KEGG and BioCarta,
the added proteins are enriched in phosphatases. This result could indicate that phosphatases, which might
correspond to negative regulators, have previously been overlooked in the definition of canonical pathways.
Figure 6.6: Semantic similarity analysis: Similarities in Gene Ontology Biological Process terms between original
BioCarta pathway proteins and added proteins (red) and between original pathway proteins and matched-size random
protein sets (blue)
The extension procedure can recover known pathway proteins after deletion
A cross-validation procedure (Methods) showed that the cellular pathway extension recovers a significantly
larger number of randomly deleted pathway-nodes in the network than a simplistic extension using a random
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selection among the candidate nodes (p-values< 0.01 for all databases). Specifically, the distribution of the
number of recoveries across the 100 randommodel extensions never provided a higher number of recoveries
than the proposed extension method.
Prediction of new pathway/process components
From the following observations we conclude that the proteins added to pathways by the extension pro-
cedure can be proposed as new candidate components with a functional role in the corresponding cellular
processes:
1. The proteins added by the proposed method are well connected with the original pathway nodes and
central in the protein interaction network.
2. The added proteins display gene ontology annotations matching better to the original cellular path-
way/process annotations than random proteins, and are enriched in processes known to be related to
cellular signalling.
3. The method is able to recover known cellular pathway/process proteins in a cross-validation experi-
ment.
To illustrate the utility of the extension procedure for the prediction of new components, an expert-based
pathway diagram modelling the process likely to be deregulated by the most penetrant Alzheimer’s suscep-
tibility genes (created using information from the literature [463] and available in the KEGG database [31])
was analysed as example case. The proposed extension method added five different proteins to this cellular
map (see figure 6.7, the interactive visualisation of the extension is available online: www.infobiotics.
net/pathexpand).
Figure 6.7: Extended KEGG Alzheimer’s pathway: Nodes with surrounding circles represent added proteins
Interestingly, three of them have previously been implied in Alzheimer’s disease (the proteins TMED10,
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APH1B and PITX3). Two other proteins, METTL2B and MMP17, which are also added to the Alzheimer’s
cellular map by the proposed method, have not been linked to the disease so far. MMP17 is a member
of the metallopeptidase protein family involved in the breakdown of the extracellular matrix. Accord-
ing to the Huge navigator [464], six other members of this protein family have been associated with the
Alzheimer’s disease. The other candidate is a methyltransferase-like, METTL2B. Another member of this
family, MMETL10 has been associated with Alzheimer’s disease in a case-control study [464]. Thus, us-
ing the Alzheimer’s disease pathway as a first test case of the extension method, MMP17 and METTL2B
can be proposed as new candidate disease genes. Recent successes in bioinformatics-based identification
of combined biomarkers [465–467] and screening for new drugs against Alzheimer’s [468] have already
shown, that clinically relevant insights on the disease can be gained by applying new computational biology
approaches to existing datasets.
The extension of cellular processes points to extensive inter-pathway communication
The involvement of some proteins in multiple processes suggests that extensive communication occurs
between different cellular processes. Indeed, before applying the extension procedure, about 50% of the
cellular process proteins are annotated for more than one cellular process. Interestingly, after the extension
procedure, the percentage of unique proteins among all proteins added to the cellular processes ranged
from 30% (BioCarta) to 66% (Reactome), revealing that many proteins are added to more than one cellular
process. In agreement with the observations for the original process proteins, again about 50% of the added
proteins belong to more than one cellular process. Accordingly, many proteins in the protein interaction
network are well connected with different cellular processes, and might therefore be expected to have a
functional role in the communication between them.
As an example for these types of connections, the class of interleukins (ILs) was considered. ILs are
secreted proteins mainly involved in the immune system to regulate the communication between immune
cells. They activate different signalling pathways, which can share intracellular signalling cascades (e.g.
MAPK, RAS or STAT), but which also display distinct properties (e.g. by binding to different receptors). In
this context, some IL-pathway proteins are annotated only for one IL pathway (see figure 6.8, each colour
corresponds to an IL pathway), while other proteins occur in multiple pathways (figure 6.8, multiple colour
node proteins). Furthermore, all the IL pathways share protein interactions (figure 6.8, blue links). Thus,
the analysis of protein interactions between the members of different IL pathways highlights the complexity
of this signalling system.
The pathway extension method was applied to the seven interleukin signalling pathways depicted in figure
6.8, and added between 1 to 10 proteins to each pathway. As the figure reveals, some proteins were added
to only a single IL pathway. For instance, the CTAG1B (cancer/testis antigen 1B) protein was only added
to the IL5-signalling pathway (figure 6.8, green proteins). Interestingly, the added protein is an antigen
expressed only in cancer cells and in normal testis cells, and could represent a regulatory member of this
pathway in these two particular conditions. Moreover, four other proteins were jointly added to more than
one IL pathway. Three of them extend the IL2, IL3 and IL6 pathways, which are all activating the STAT
and Ras/MAPK signalling cascades. These proteins are known regulators of these cascades and can also
participate in the regulation of the communication between the different interleukin signalling pathways.
Functional enrichment of tumour mutated genes in extended pathways
Large-scale tumour resequencing projects have revealed a large number of genes mutated in different cancer
types [469–471]. To understand the biological significance of these mutated genes, those cellular processes
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Figure 6.8: Crosstalk between interleukin signalling pathways: Protein interaction sub-network containing the proteins
annotated for 7 different Interleukin (IL)-related pathways from the BioCarta database (each colour represents a path-
way, nodes for proteins annotated for multiple pathways have more than one colour). Proteins added by the extension
method are highlighted by surrounding circles and coloured according to the pathway(s) they were added to (they ap-
pear mostly within peripheral clusters or as links between process members). They were not annotated for any of the
IL-related pathways before applying the extension procedure, and the original pathway members did not become mem-
bers in further IL-related pathways. Therefore, to simplify interpretation and provide a compact data representation, the
node colours are only used to visualise the pathway memberships after the application of the extension procedure.
containing more mutated genes than expected by chance have been identified previously (see for example
[470]).
Here, an enrichment analysis was applied on cancer mutated genes extracted from a pancreatic large-scale
resequencing study [470], using extended cellular processes from BioCarta, KEGG and Reactome. This
enabled the identification of significant associations between different cancer types and the extended path-
ways (see also Methods section for details on the methodology). Interestingly, 8 out of 12 core signalling
pathways whose association with pancreatic cancer had previously been identified, were retrieved as signif-
icantly associated with this disease [470]. An over-representation analysis (ORA) shows that some cellular
pathways and processes are more significantly enriched in mutated genes in the extended versions than in
the original versions (see table 6.3). These include signalling pathways, like MAPK, p38 MAPK, p53, Wnt,
PDGF, FC epsilon receptor I, ErbB or functions like apoptosis and cell cycle G1/S check point (table 6.3).
Interestingly, some of the proteins added to these processes by the extension procedure are also pancreatic
mutated genes (see last column in table 6.3). These proteins include, for instance, the BCL2-related protein
A1, which is added to the Apoptosis Reactome pathway and indeed known to be involved in apoptosis. A
less obvious example is the dual specificity phosphatase 19 (DUSP19), a phosphatase added by the exten-
sion procedure to different MAPK pathways, the Fc epsilon receptor I signalling pathway and to a pathway
known to be activated in response to HIV Nef protein (negative effector of Fas and TNF). This protein is
highly expressed in the pancreas [472] and displays a frameshift mutation in pancreatic tumours [470].
Finally, new insights can be gained when analysing the BioCarta cell cycle G1/S check point process (see
figure 6.9). This process contains several proteins that were found mutated in large-scale pancreatic rese-
quencing studies (figure 6.9, red nodes), as well as many other proteins known to be involved in canceroge-
nesis.
The proposed extension procedure adds seven proteins to this process (figure 6.9, circled nodes). All of these
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Figure 6.9: Cell cycle G1/S check point sub-network: Protein-protein interaction sub-network corresponding to the
proteins annotated for the BioCarta pathway “Cell cycle G1/S check point” and proteins added by the proposed exten-
sion procedure (circled). Proteins whose corresponding genes have been found mutated in pancreatic whole-genome
resequencing studies [470] are highlighted in red.
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proteins are either transcription factors, kinases or other signal transduction regulators, and six of them are
known to be involved in cell cycle regulation (all except TGIF2). Interestingly, the cancer resequencing
study showed that the TGIF2 gene is mutated in a pancreatic tumour (figure 6.9, circled red node). This
transcriptional repressor gene has also been reported to be amplified in some ovarian cancers, and can be
recruited by TGF-β-activated SMADs [473] (SMADs are intracellular proteins that forward extracellular
growth factor signals to the cell nucleus). Accordingly, both the involvement of the corresponding TGIF2
protein in the cell cycle G1/S check point process, and its involvement in cancer through the deregulation
of this process can be predicted from these observations.
In conclusion, the network-based extensions of the cell cycle G1/S and other processes provide useful
explanatory information for the cancer association of these pathways/processes by adding new regulators
that increase the connectivity between cancer mutated genes and other process members in the interaction
network. For instance, in the G1/S process, SMAD3 is connected to other process members by adding the
proteins TGIF2, GRB2 and PLAGL1; and SMAD4 is connected to the process member CDK2 by adding
UHRF2. Thus, the overall coherence of the processes is increased and an expanded view of the influence
of different cancer genes in these processes is obtained.
6.3.4 PathExpand - Conclusions
The extension of known cellular pathways and processes with densely interconnected interaction partners in
a protein-protein interaction network can provide bioscientific and biomedical researchers with several new
insights. Specifically, the example analyses conducted in this study have shown that the extensions lead
to the proposal of new putative components and to the identification of mediators of the communication
between the processes. These results do not only help to better understand the cellular processes and their
interrelations, but the novel extended pathways can also be used as input for bioinformatics tools dedicated
to the pathway-based analysis of new experimental functional genomics data (including other tools from
the framework, see also the example analysis pipeline in figure 11.2 in the appendix). Thus, by taking into
account canonical knowledge as well as large-scale interaction data, the extended pathways can be of direct
practical use in a wide range of biological applications, illustrated by their utility in helping to explain the
functions of cancer mutated genes.
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Table 6.3: Cellular processes enriched in pancreatic mutated genes
Cellular Cellular ORA Q-value Pathway Number of Number of Mutated genes
Process process before/ size before/ mutated mutated genes among added
database after extension after genes in new among added genes
extension pathway genes
Reactome Hemostasis 0.475 / 5.18e-06 221 / 278 19 4 LRP1B, TFPI2
PON1, SIGLEC11
KEGG Tight junction 1.48E-4 / 4.5e-05 106 / 126 14 3 RASIP1, RASGRP3, PLEKHG2
KEGG MAPK signaling 3.35E-4 / 4.87e-05 225 / 279 21 6 DOCK2, MAPKBP1, SLC9A5
pathway RASIP1, DUSP19, PLEKHG2
KEGG Cell adhesion 2.87E-4 / 1.03E-4 109 / 116 12 2 TNR,
molecules (CAMs) SEC14L3
KEGG Wnt signaling 3.35E-4 / 1.39E-4 123 / 147 14 3 MAPKBP1,
pathway PLEKHG2, ANKRD6
KEGG Neuroactive ligand- 3.35E-4 / 1.72E-4 198 / 217 17 3 EML1, ACE
receptor interaction
BioCarta MAPKinase 1.33E-3 / 2.89E-4 81 / 111 8 2 MAPKBP1,
Signaling Pathway DUSP19
Reactome Apoptosis 3.7E-2 / 4.42E-4 124 / 146 11 2 BCL2A1, RASGRP3
Reactome Signaling 5.72E-3 / 4.43E-4 61 / 121 10 3 VPS13A, LIG3
by PDGF FMR2
BioCarta Cell Cycle 1.7E-3 / 5.06E-4 27 / 34 5 1 TGIF2
G1/S Check Point
BioCarta Agrin Postsynaptic 1.27E-2 / 8.21E-4 27 / 38 5 2 PGM5,
Differentiation PLEKHG2
BioCarta p38 MAPK 3.25E-3 / 1.13E-3 34 / 42 5 1 PLEKHG2
Signaling Pathway
BioCarta ALK in 2.89E-3 / 1.25E-3 32 / 44 5 1 TBX5
cardiac myocytes
KEGG Fc epsilon RI 2.69E-2 / 2.71E-3 67 / 114 10 5 DOCK2,MAPKBP1,
signaling pathway DUSP19,ATF2,RASGRP3
KEGG ErbB signaling 2.32E-2 / 3.52E-3 86 / 196 13 7 VPS13A,MAPKBP1,NEK8,
pathway LIG3,DUSP19,AFF2,GLTSCR1
KEGG Regulation of 4.94E-3 / 2.72E-3 184 / 236 15 4 RASIP1, CDC42BPA,
actin cytoskeleton PLEKHG2, CYFIP1
BioCarta HIV-I Nef 7.88E-3 / 4.78E-3 50 / 66 5 1 DUSP19
negative effector
of Fas and TNF
KEGG p53 signaling 5.62E-3 / 5.44E-3 59 / 64 7 1 PPP2R4
pathway
Reactome Signaling in 0.459 / 7.02E-3 228 / 266 12 1 SEC14L3
Immune system
The complete list of cellular processes that display a statistically significant enrichment in pancreatic cancer mutated genes after applying the proposed
extension method (Q-value < 0.01) and improved significance scores in relation to the original pathways (i.e. Q-values decreasing after the extension).
The significance scores for the overrepresentation analysis (ORA) and the pathway sizes are shown before and after the extension, and the total number
of mutated genes in the extended pathways is provided, as well as the size and the annotations for the set of mutated genes among those that were added
to these pathways.
Chapter 7
Simplifying Classification Rules to
Enhance Model Interpretability
Chapter abstract
One of the major limitations of many analysis methods for high-dimensional, noisy data is the
complexity of the resulting models, which impedes a clear interpretation and the direct ex-
traction of new biological insights. In most biological applications however, the interpretation
of computational models has a higher practical value than the exclusive use of a model for
predictive tasks.
In particular, since most microarray sample classification models do not reach 100% accuracy
on large external test sets, and statistical confidence score estimates are often subject to high
variance, confidence in the biological meaningfulness of a model is often an essential require-
ment for the acceptance of the model by the scientific community. For example, to justify
the selection of a specific treatment approach, clinical researchers need to understand from a
biological point of view why a model assigns a certain patient sample to a specific diagnostic
group. Moreover, the knowledge obtained from interpretable models can improve the under-
standing of the molecular basis behind a disease and help to design novel therapies and assays
for disease monitoring and diagnosis using small sets of biomarkers.
This chapter will therefore present an integrative method to increase the interpretability of ma-
chine learning models for high-dimensional biological data analysis. This novel rule-based
learning technique, the Top-scoring pathway pair (TSPP) algorithm [23], combines informa-
tion from gene or protein expression data with cellular pathway definitions to learn simple
“if-then-else” decision rules for sample classification. The first part of the chapter will intro-
duce the TSPP method and examine the results of its application to microarray cancer datasets
using material from the original TSPP publication. The final part will discuss how TSPP relates
to other rule learning methods and provide an overall summary. Figure 7 shows how TSPP is
integrated into the complete integrative data analysis framework for this doctoral project.
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Figure 7.1: The Top-scoring pathway pairs (TSPP) method as a component of the integrative data analysis framework
(highlighted by the colour contrast).
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7.1 Integrative Rule Learning for High-Dimensional Biological Data
(TSPP)
7.1.1 TSPP - Background and motivation
As outlined in the literature survey in chapter 3, the supervised classification of microarray gene expression
samples into different biological categories is often hampered by several limitations resulting from a high
dimensionality of the data in relation to a small number of available samples and high noise levels.
In recent years, several novel machine learning methods have extended or replaced classical generic ap-
proaches, by providing more compact, robust and/or easily interpretable classification models. These ap-
proaches reduce the prediction model complexity and increase its robustness by using regularization and
shrinkage techniques [238, 474], by generating more human-interpretable machine learning models, which
consist of simple decision rules [367, 475], or by using more robust data representations and model for-
mulations, e.g. computing rank score expression values [15] or only considering relative expression values
by comparing pairs of genes [284, 285]. One of these methods, the ensemble rule learning method Bio-
HEL [366–369], has already been discussed in detail in chapter 4, which focussed on the comparison of
standard machine learning methods with ensemble and consensus approaches. The results obtained with
BioHEL showed that high classification accuracies obtained with ensemble models do not necessarily come
at the expense of model comprehensibility, since a post-analysis of BioHEL’s ensemble models does not
only provide robust rankings of informative attributes in the data, but also information to prioritize putative
oncogenes and tumour suppressors.
However, the techniques mentioned above and the algorithms presented in chapter 4 are not designed to
exploit the information content from diverse biological data sources, including cellular pathway definitions
and protein interaction data in addition to microarray expression level measurements. Moroever, these
methods analyse microarray data on the level of single genes as attributes, and since the expression mea-
surements for single genes are often very noisy, there is still ample room for improvement in terms of the
cross-platform robustness of the corresponding machine learning models.
This motivated the development of the Top-scoring pathway pairs (TSPP) classification method, which ad-
dresses the problem of low model robustness due to noise and uncertainty in the data by combining ideas
from the techniques mentioned above with an approach to analyse the data at the level of pairwise compar-
isons of cellular pathways, rather than at the single-gene or pairwise-gene level. Briefly, the genes (or pro-
teins) in a microarray study are mapped onto cellular pathways and processes from public databases (e.g.
KEGG, Gene Ontology, BioCarta and Reactome) and simple decision rules for sample classification are
learned by comparing the expression levels in pairs of pathways against each other. Rules describing single
pathway-pairs are then weighted and combined into a unified classification model by applying a boosting
algorithm (see literature survey, chapter 3). For an additional post-analysis, the top-ranked pathway-pairs
can be mapped onto a protein-protein interaction network for visual inspection or to analyse their functional
association with the EnrichNet method (see chapter 6).
The proposed approach can be understood as a pathway-based extension of the “top-scoring pairs” (TSP)
algorithm [284, 285] (see also the rule-based learning section in the literature review in chapter 3), which
identifies discriminative pairs of genes in microarray data, and has therefore been named Top-scoring path-
way pairs (TSPP). Moreover, the method draws inspiration from functional enrichment analysis approaches,
summarising expression values for genes in cellular pathways and processes to “meta-gene” expression val-
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ues (e.g. the methods GSEA [476], MaxMean [477] and the global test [478]), and pathway-based sample
classification methods [318].
The TSPP procedure generates compact and comprehensible sets of rules, describing changes in the relative
ranks of gene expression levels in pairs of cellular pathways across different biological conditions. The rules
are robust against monotonic transformations of the data and can be computed efficiently using a simple
algorithm.
In the following sections, the TSPP methodology will be explained in detail and example results for two
real-world large-scale microarray studies (prostate cancer and B-cell lymphoma sample classification) will
be shown. The example results show that the method provides robust rule sets with significant predictive
information in relation to random model classification, as well as new insights on differentially regulated
pathway pairs. However, the benefit of these predictive models in comparison to other classification meth-
ods like support vector machines lies not in the attained accuracy levels but in the ease of interpretation and
the insights they provide on the relative regulation of cellular pathways in the biological conditions under
consideration.
In summary, the TSPP approach is not designed to compete with existing microarray sample classification
and data mining methods in terms of maximising accuracy, but to complement them with the following
added benefits:
• New biological insights on the relative up- and down-regulation of cellular pathways in biological
conditions of interest can be gained from easily interpretable decision rules.
• The prediction models are applicable to data from other microarray platforms without requiring that
all platforms contain the same genetic probes and that cross-study normalisation is applied (the in-
tegration takes place at the level of pathways, and the gene expression values are replaced by rank
scores).
• By summarising the expression values of multiple genes belonging to the same pathway, the di-
mensionality of the data is reduced (from about 50.000 genes to a few hundred pathways) and the
summarised pathway expression fingerprints have a higher robustness than single gene expression
vectors (however, at the expense of losing detail; therefore single-gene based methods should be
applied additionally).
7.1.2 TSPP - Methods
In contrast to previous microarray machine learning methods comparing single gene expression values or
summarised expression values for single pathways against fitted threshold values, TSPP provides increased
robustness by both combining expression levels of multiple genes into pathway expression fingerprints and
making pairwise, relative comparisons between pathways instead of using fitted thresholds. Specifically,
the TSPP algorithm identifies, scores and combines decision rules using pathway pairs according to the
following five-step procedure (an illustration of the workflow is also shown in figure 7.2):
1. Rank score transformation:
A gene expression matrix X with dimension n× p (n: number of samples, p: number of genes) and
class labels y for the samples is read as input and transformed into a rank matrix R by sorting the
expression values for each gene across the n samples and replacing them with their position index
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Figure 7.2: An overview of the workflow in the TSPP algorithm (example data is derived from a human prostate cancer
microarray dataset [348])
in the sorted vector (ties are handled by replacing equal values by the mean of the corresponding
position indices).
2. Pathway mapping:
Gene/protein sets representing cellular pathways and processes are extracted from a public database
(e.g. KEGG [36], BioCarta [32], Reactome [37] or Gene Ontology [30]). Pathway assignments are
obtained for the p genes or corresponding proteins in the microarray input data by testing whether
they occur in any of these known gene/protein sets (for simplicity, in the following the term genes
will be used instead of genes/proteins, but the method is also applicable to protein data). For genes
which cannot be assigned to any pathway, the corresponding rows are removed from matrix R.
3. Scoring of pathway pairs:
To score a pair of pathways as being useful for discriminating between two sample class labels 1
and 2, e.g. “tumour (1) vs. normal (2)” or “drug treatment (1) vs. no treatment (2)”, the pathway
submatrices R1 and R2, corresponding to these two samples classes, are extracted from matrix R
using the mapping data from step 2. The matrices R1 and R2 are then reduced to robust pathway
expression vectors r1 and r2 by replacing each column of expression level ranks by its median value.
This median value computation is just one example for a great variety of dimensionality reducing
data transformation that can be used at this stage (a principal component or multidimensional scal-
ing reduction could likewise be applied, or the variance across genes could be computed to analyse
pathway-variance patterns).
For a two-class prediction problem, the score for a pathway-pair is then obtained by comparing
the median ranks in pathway 1 to those in pathway 2 and computing the maximum of two relative
frequencies: The percentage of samples which are up-regulated for class 1 and down-regulated for
class 2, and vice versa, the percentage of cases which are down-regulated for class 1 and up-regulated
for class 2 (i.e. there are two possibilities for the relation of sample ranks in two pathways to differ
across the sample classes). Given the sets of column indices for two sample classes S1 and S2, the
final score can thus be computed as follows:
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partial score1 = ∑
i∈S1
I(r1i >= r2i)+ ∑
i∈S2
I(r1i < r2i) (7.1)
partial score2 = ∑
i∈S1
I(r1i < r2i)+ ∑
i∈S2
I(r1i >= r2i) (7.2)
score=
max(partial score1, partial score2)
|S1|+ |S2| (7.3)
where I is the indicator function. For a multi-class problem, a similar score can be obtained by
computing the mean of the scores obtained for all pairs of sample classes. To obtain significance
scores in addition to a relative ranking of pathway-pairs, the user can also apply a non-parametric
statistical test, like the Wilcoxon rank sum test (at the expense of higher run-times).
4. Searching for top-scoring pairs:
By default, top-scoring pathway pairs (TSPPs) are identified by performing an exhaustive search
across all pairs of cellular pathways. This strategy will be feasible in most practical applications,
because the number of pathways is typically much smaller than the number of genes, and the scoring
method is kept simple and efficient (see above). Importantly, in spite of the simplicity of the scoring
function, the method does not assume that all genes in a pathway are either up- or down-regulated
in a sample class in relation to genes in another pathway, but searches for trends across most genes
(i.e. identifying pairs of pathways for which many genes occurring in the first pathway change their
relation of expression level ranks across the sample classes to genes in the second pathway).
A further variant of the search methodology was considered to investigate whether alterations in the
pathway definitions can provide improved results. For this purpose, the user can allow the algorithm
to introduce mutations into the pathway gene sets, by randomly adding or deleting genes up to a
small user-defined maximum number, and replacing the exhaustive search by a previously published
evolutionary search algorithm [479]. Only one modification is applied to the evolutionary search
method: A genome contains two bit-vectors representing two pathways and mutations are only ap-
plied to one of these bit-vectors, selected randomly. Apart from these changes, the scoring function
in the evolutionary algorithm is the same as for the exhaustive search variant (see above).
5. Classification model generation:
Each TSPP provides a simple decision rule for classifying microarray samples depending on the
relative median expression value ranks of their genes in a pair of pathways. To combine multiple
TSPPs into a unified ensemble classification model, the TSPP decision rules are used as “base clas-
sifiers” within the Adaboost.M1 algorithm [297], adding one decision rule at a time to the boosting
model according to the order of the TSPP-scores computed in the previous step. The main purpose
of the boosting scheme is to assigns weights to each decision rule in the combined ensemble model,
accounting for a rule’s prediction accuracy and capacity to correctly classify samples that were mis-
classified by decision rules added in previous iterations of the algorithm. Previous experiments with
boosting and ensemble techniques applied to microarray data (see section “Ensemble learning meth-
ods” in chapter 3) have shown that improvements can be obtained both in terms of robustness and
accuracy. Thus, TSPP exploits cross-domain integrative analysis (using pathway and microarray
data), ensemble analysis (using the AdaBoost algorithm) and a robust pairwise analysis of features.
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7.2 Evaluation of Integrative Rule Learning on Microarray Data
In order to evaluate the predictive performance and investigate the insights that can be obtained from an
integrative rule learning analysis of microarray data, the TSPP algorithm was applied to two public cancer
gene expression datasets. Specifically, the data was retrieved from studies on B-cell lymphoma [347] (7129
genes and 77 samples) and prostate cancer [348] (12600 genes and 102 samples). Both datasets contain
samples from two biological classes: In the B-cell lymphoma dataset, 58 samples were obtained from pa-
tients suffering from diffuse large B-cell lymphoma (class 1), while the remaining 19 samples are derived
from a related follicular B-cell lymphoma (class 2; importantly, this class imbalance complicates the pre-
diction problem). For the prostate cancer dataset, expression measurements were obtained from 50 healthy
control tissues (class 1) and 52 tumour tissues (class 2) (for details on the normalisation and pre-processing
of the datasets, see section 4.0.2).
To evaluate the predictive accuracy for TSPP models generated for these datasets, an external leave-one-
out cross-validation procedure (ELOOCV, i.e. including all modelling steps in the cross-validation) was
applied, and repeated using different numbers of top-scoring pairs k (for k = 1, 3, 5, 10 and 15). The
parameter k can be regarded as a bias/variance trade-off, enabling the user to control the complexity of
the generated classifiers. The cross-validation results, computed both for mappings of genes to KEGG
pathways and to Gene Ontology (GO) terms, include the average accuracy, sensitivity and specificity for
each LOOCV run and are shown in Tables 7.1 and 7.2.
Table 7.1: Leave-one-out cross-validation results (TSPP on KEGG database)
Dataset No. of top- Sensitivity Specificity Avg.
scoring pairs (%) (%) Accuracy (%)
1 83.7 71.7 77.5
3 87.8 73.6 80.4
Prostate cancer 5 85.7 77.4 81.4
10 77.6 73.6 75.5
15 79.6 64.2 71.6
1 64.9 85.0 70.1
3 68.4 90.0 74.0
Lymphoma 5 78.9 90.0 81.8
10 77.2 90.0 80.5
15 75.4 90.0 79.2
Leave-one-out cross-validation results obtained with the TSPP classifier using different numbers of top-scoring pathway pairs on the
KEGG database.
In summary, average classification accuracies above 70% were obtained in all cases, and for both datasets
the best accuracies (prostate cancer: 81.4%, DLBCL: 81.8%) were achieved when using 5 top-scoring pairs,
suggesting that k = 5 represents a reasonable bias/variance trade-off, providing models which are still easily
interpretable.
Apart from using the decision rules for class prediction, their simplicity also makes them suitable for direct
human interpretation. These rules, i.e. the ten top-scoring pathway pairs for each dataset, are shown in
tables 7.4 and 7.5. Interestingly, the top-ranked rule for the prostate cancer dataset contains the KEGG-
pathways Prostate cancer and Insulin signaling, which both are known to be de-regulated in the disease
[480, 481]. However, the results also point to relative de-regulations in other pathways with less obvious
associations to the cancer disease, e.g. Pyrimidine metabolism and Glycerolipid metabolism, with a ranking
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Table 7.2: Leave-one-out cross-validation results (TSPP on GO database)
Dataset No. of top- Sensitivity Specificity Avg.
scoring pairs (%) (%) Accuracy (%)
1 83.7 67.9 75.5
3 89.8 67.9 78.4
Prostate cancer 5 89.8 69.8 79.4
10 91.8 66.0 78.4
15 85.7 67.9 76.5
1 68.4 80.0 71.4
3 57.9 90.0 66.2
Lymphoma 5 71.9 90.0 76.6
10 52.6 90.0 62.3
15 71.9 85.0 75.3
Leave-one-out cross-validation results obtained with the TSPP classifier using different numbers of top-scoring pathway pairs on the
GO database.
Table 7.3: Leave-one-out cross-validation results (eBayes & SVM)
Dataset No. of features (genes) Sensitivity Specificity Avg. Accuracy (%)
2 88.0 84.6 86.3
6 96.0 88.5 92.2
Prostate cancer 10 96.0 86.5 91.2
20 90.0 88.5 89.2
30 90.0 90.4 90.2
2 91.4 68.4 85.7
6 93.1 78.9 89.6
Lymphoma 10 94.8 94.7 94.8
20 96.6 84.2 93.5
30 98.3 100.0 98.7
Leave-one-out cross-validation results obtained using eBayes feature selection on single genes and an SVM classifier.
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score close to the best-ranked pair.
Similarly, for the B-cell dataset the top-ranked pathway pairs contain processes known to be associated
with B-cell neoplasia, e.g. the Wnt signaling pathway [482, 483], whereas for other pathways no direct
and specific associations with the disease are known. In spite of the class-imbalance in this dataset, the
prediction models did not display a preference to assign samples to the majority class; however, similar to
other statistical methods for microarray data analysis, problems with robustness can occur when the sample
size per condition is very small. Thus, when planning a microarray study, the experimenter might first
want to consider techniques for sample size estimation [484], microarray study design [485] and sampling
techniques [486] to alleviate these problems.
Importantly, in a top-scoring pathway pair (TSPP), not necessarily both pathways are differentially regu-
lated across the sample classes, but one pathway might have an almost constant expression, while the other
pathway is highly de-regulated in one of the sample classes. The motivation for comparing pairs of path-
ways lies in the possibility to avoid comparing single pathways against fitted thresholds, which would more
likely be affected by experimental bias and thus provide prediction models with higher generalisation error.
However, if a user’s main goal is to identify pathway associations rather than obtaining a prediction model,
then TSPPs in which one of the pathways is not differentially regulated across the sample classes can easily
be identified and filtered out by computing the variance for the corresponding gene expression vectors and
removing TSPPs containing a low-variance pathway expression fingerprint.
When using the evolutionary search methodology and allowing the algorithm to introduce small numbers of
random gene deletions and insertions into the pathways (up to five genes), in spite of the higher flexibility
of this method, in all experiments the prediction accuracies are either similar or lower than those obtained
for the original pathways using an exhaustive search (data not shown). The weaker performance might
result from an entrapment in local minima due to the expansion of the search space, but could also suggest
that the original pathways and processes are already well defined and therefore hard to optimise using an
evolutionary search procedure.
Overall, the results from the cross-validation analysis and the lists of top-scoring pathways show that the
method can generate compact predictive models with both high interpretability and high accuracy in com-
parison with a random model predictor (when applying the proportional chance criterion by Huberty [429],
p-values < 0.01 are obtained in all cases). To show how these results relate to existing machine learning
methods with single genes as predictors, a C-SVM [376] was applied using different kernel functions, in-
cluding the radial basis function and polynomial kernels with a degree up to 3 (the results for the best
kernel, a linear SVM, are reported in Table 7.3). The gene-based SVM-models achieve higher average
accuracies than pathway-based models, with the best models reaching more than 90% accuracy on both
datasets, which matches with the fact that the model operates at the finer level of detail of single genes
instead of pathways. However, these models do not enable an interpretation of the data on the level of
cellular pathways and processes, and are not designed to be applied on other array platforms with different
genetic probes representing the same pathways. Although the simple decision rules generated by the TSPP
algorithm do not reach the highest accuracies obtained by the support vector machine on single genes, their
high interpretability and significant predictive information content allow the user to quickly identify cases,
in which the relative gene expression in pathway pairs is differentially regulated across different biological
conditions.
In order to investigate the biological utility of the top-scoring pathway pairs (TSPPs) in more detail, the
genes in these pathways were mapped onto their corresponding proteins in a large-scale protein-protein
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Table 7.4: Top-ranked pathway pairs (Prostate cancer data)
RankPathway 1 Pathway 2 DirectionScore
1 hsa05215 Prostate hsa04910 Insulin down 0.81
cancer signaling pathway
2 hsa00240 Pyrimidine metabolism hsa00561 Glycerolipid metabolism up 0.80
3 hsa04540 Gap junction hsa05210 colorectal cancer up 0.78
4 hsa04115 p53 signaling pathway hsa00230 Purine metabolism down 0.75
5 hsa04510 Focal adhesion hsa00071 Fatty acid metabolism down 0.75
6 hsa04514 Cell adhesion hsa04610 Complement and up 0.72
molecules (CAMs) coagulation cascades
7 hsa03050 Proteasome hsa01430 Cell Communication up 0.69
8 hsa04920 Adipocytokine hsa04730 Long-term up 0.69
signaling pathway depression
9 hsa04810 Regulation of hsa04530 Tight down 0.65
actin cytoskeleton junction
10 hsa04512 ECM-receptor interaction hsa04110 Cell cycle down 0.63
The 10 top-ranked pathways for the prostate cancer dataset according to the TSPP-score (direction “down” means that in the healthy
control samples, pathway 1 is down-regulated in relation to pathway 2, whereas in the prostate cancer samples, pathway 1 is up-
regulated in relation to pathway 2, and respectively, “up” means the pathways have opposite relations in the two sample classes).
Table 7.5: Top-ranked pathway pairs (B-cell lymphoma data)
RankPathway 1 Pathway 2 DirectionScore
1 hsa00020 Citrate hsa04310 Wnt signaling down 0.88
cycle (TCA cycle) pathway
2 hsa00052 Galactose hsa04664 Fc epsilon RI down 0.87
metabolism signaling pathway
3 hsa04670 Leukocyte hsa03050 Proteasome up 0.87
transendothelial migration
4 hsa04514 Cell adhesion hsa00030 Pentose up 0.86
molecules (CAMs) phosphate pathway
5 hsa04730 Long-term depression hsa00240 Pyrimidine metabolism up 0.85
6 hsa00562 Inositol hsa00051 Fructose an up 0.84
phosphate metabolism mannose metabolism
7 hsa00220 Urea cycle and hsa00980 Metabolism of xenobiotics down 0.84
metabolism of amino groups by cytochrome P450
8 hsa04540 Gap junction hsa00330 Arginine and up 0.84
proline metabolism
9 hsa00252 Alanine and hsa04630 Jak-STAT down 0.84
aspartate metabolism signaling pathway
10 hsa00970 Aminoacyl-tRNA hsa04912 GnRH down 0.81
biosynthesis signaling pathway
The 10 top-ranked pathways for the B-Cell lymphoma dataset according to the TSPP-score (direction “down” means that in the
DLBCL samples, pathway 1 is down-regulated in relation to pathway 2, whereas in the follicular B-cell lymphoma samples, pathway
1 is up-regulated in relation to pathway 2, and respectively, “up” means the pathways have opposite relations in the two sample
classes).
7.2. Evaluation of Integrative Rule Learning on Microarray Data 159
interaction network, consisting of 38857 interactions between 9392 proteins assembled from direct binary
interactions in a previous study [20] (see also the network construction methodology for TopoGSA, de-
scribed in chapter 6). Figure 7.3a) shows the largest connected component of an example mapping for the
TSPP with the highest score on the Prostate cancer dataset, hsa05215 Prostate cancer vs. hsa04910 Insulin
signaling pathway (see also Figure 7.2), revealing a strong network connectivity between these pathways,
which also share a significantly large set of overlapping genes/proteins (the q-value significance score is
5.1E-17, when testing the Insulin pathway for overlaps with all other KEGG pathways using the one-sided
Fisher exact test and adjusting for multiple testing with the Benjamini-Hochberg method [3]).
Figure 7.3: Analysing TSPPs in a protein-protein interaction network: a) Largest connected component for the KEGG
pathways Prostate cancer and Insulin signaling (blue: Prostate cancer, red: Insulin signaling, green: members in both
pathways); b) Largest connected component for KEGG pathways P53 signaling and Purine metabolism (blue: P53
signaling, red: Purine metabolism, green: members in both pathways)
However, the TSPP method also points the user to differentially regulated pathway pairs which would not
be detected as significantly associated using an overlap-based significance test, e.g. figure 7.3b) shows
the largest connected component for the TSPP hsa04115 p53 signaling pathway vs. hsa00230 Purine
metabolism, with only two overlapping proteins, but a multitude of direct protein-protein interactions be-
tween the two pathways. Further experimental evidence for an association between these pathways is
provided by a study showing that the inhibition of de novo purine synthesis by the drug AG2034, which
also inhibits prostate cancer cell growth, increases the expression levels of p53 [487].
Accordingly, although the patterns identified by the top-scoring pathway pairs method do not necessarily
result from regulatory relationships between the pathways, the analysis of the TSPPs can help to identify
pathway pair relations associated with changes in biological conditions, which would remain unnoticed by
other computational/statistical methods.
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7.2.1 Conclusion
In summary, TSPP is a new method for extracting pathway-based decision rules from combined microar-
ray expression data and gene/protein sets representing cellular pathways and processes. When applying
prediction models derived from these decision rules for sample classification on two public microarray can-
cer datasets, compact and easily interpretable models are obtained with significant predictive information
content. The generated decision rules are robust against monotonic transformations of the data, and the
algorithm is easy to implement and has a comparatively short run-time due to the reduction of the data
dimensionality when summarising gene sets to pathway expression fingerprints. Moreover, the resulting
rule-based prediction models enable the interpretation of microarray data from a different perspective, at
the level of pairwise relations between pathways. More specifically, the top-scoring pathway pairs can point
the user to regulatory relationships or other functional associations between the corresponding pathways,
which are associated with changes in the biological conditions, and would not be detected by other func-
tional genomics analysis methods. Thus, in a nutshell, the TSPP algorithm provides both a novel method to
generate compact and accurate classification models and a new exploratory tool to analyse microarray data
at the level of pairwise pathway relations.
Chapter 8
Visualisation and Interactive
Exploration of High-Dimensional
Biological Data (VRMLGen)
Chapter abstract
The analysis methods discussed in the previous chapters mostly rely on machine learning, net-
work analysis and optimisation techniques, and provide results in the form of ranking tables or
simple 2D graphical representations. However, as illustrated in the section “Comparative Eval-
uation of Clustering Methods” in chapter 4, creating low-dimensional representations directly
from the original data is a further unsupervised analysis approach, enabling the experimenter
to visually identify informative structures in the data.
Both for dimensionality reduction and 2D and 3D data visualisation, a multitude of software
tools are already available, however, in particular for high-dimensional, noisy biological data
with a wealth of additionally available annotation data, standard visualisation software often
does not fully exploit the potential of flexibly combining different pre-processing and data
transformation methods and providing interactive means to explore a data representation and
interlink it with external data repositories.
Since web-based low-dimensional data visualisation is required in different analysis modules
of the integrative framework presented here, this chapter will discuss a dedicated software
package for 3D interactive data visualisation, VRMLGen (using material from the original pub-
lication [24]), which has been developed as a general purpose software package and is used in
several components of the framework. VRMLGen creates 3D visualisations in common web-
formats like the Virtual Reality Markup Language (VRML) and LiveGraphics3D, including
3D charts and bar plots, scatter plots with density estimation contour surfaces, visualisations of
height maps, 3D object models and parametric functions. To maximise flexibility, the user can
also access low- level plotting methods through a unified interface and freely group different
function calls together to create new higher-level plotting methods.
Since VRMLGen’s functionality is not limited and specifically targeted towards integrative
biological data analysis, but represents an important component of the integrative analysis
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framework, this chapter will focus on providing a brief overview of VRMLGen’s functions
and features, and how they are used in the framework to facilitate the analysis of functional
genomics data (for a more detailed discussion of VRMLGen, see [24]).
8.0.2 VRMLGen - Background and motivation
Low-dimensional data visualisations using dimensionality reduction techniques like Principal Component
Analysis (PCA, figure 4.14), Independent Component Analysis (ICA, figure 4.15), Isomap (figure 4.16) and
Locally Linear Embedding (LLE, figure 4.17) provide an intuitive means to identify underlying structures
and patterns in a data set which would otherwise often remain undetected. For this reason, a wide variety
of software tools exist to generate 3D visual data representations with interactive means to explore different
2D perspectives, analyse class membership and data density using colour schemes and contour surfaces,
or compare different data sources using overlay-plots. The widely used statistical programming language
R [353], for example, contains several software packages for 3D data analysis including a package to
interconnect R with OpenGL [488] and various packages for the visualisation of multivariate data [489–
494].
However, these tools are not tailored towards the analysis of biological data, in which the molecular en-
tities (genes, proteins, and metabolites) are associated with numerous functional annotations, chromoso-
mal/subcellular localisation information and further meta-data stored in different databases, which can typ-
ically not be interlinked with the graphic representation of the data. Moreover, although users can choose
between many freely available offline tools to inspect 3D data on their own computer, currently available
programming libraries for 3D statistical data plotting do not provide features to make interactive 3D visu-
alisations directly viewable on the web.
For this purpose, the VRMLGen software package was developed for the R statistical data analysis envi-
ronment to enable users to generate interactive web-based visualisations for 3D input data, enabling the
user to annotate the data points with biological information and interlink them with public web-databases.
VRMLGen visualises charts, graphs, bar plots and scatter plots, 3D meshes and parametric functions in two
common web-formats, VRML (Virtual Reality Markup Language) and LiveGraphics3D. The software is
used within the web-application ArrayMining.net (see chapter 5) to create such visualisations automatically
when a new analysis task is submitted on the web-interface.
Although comparative analyses of unsupervised dimensionality reduction methods suggest that some tech-
niques tend to provide superior results in relation to other methods [398], ArrayMining prevents the user
from relying on a single reduction algorithm and instead enables a comparison between multiple methods.
Specifically, on the ArrayMining clustering module, the user will obtain multiple low-dimensional VRML
visualisations for each analysis task, including Principal Component Analysis (PCA), Independent Com-
ponent Analysis (ICA), Isomap and Locally Linear Embedding (LLE). These visualisations can be viewed
directly in the browser or downloaded on the bottom of the clustering results web page.
8.0.3 VRMLGen - Methods
The VRMLGen software package contains both higher-level plotting functions for creating common data
visualisations like scatter plots, bar charts and mesh visualisations, and lower-level methods, enabling users
to draw shapes and objects through a unified, format-independent interface.
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Many higher level plotting tasks can be realized directly with a single function call of one of VRMLGen’s
three main plotting functions:
• the cloud3d() function for creating 3D scatter plots and contour surfaces,
• the bar3d() function for generating bar plots and height map visualisations, and
• the mesh3d() function for displaying parametric functions and 3D meshes.
Figure 8.1 provides an overview of the main plot types and functions available in the VRMLGen package.
Figure 8.1: Overview of VRMLGen’s main functions and features.
Alternatively, for users with more advanced computational skills, VRMLGen provides direct access to
several lower level plotting functions (for drawing points (points3d()), lines (lines3d()), text (text3d() and
coordinate axes (axis3d()) through a format-independent interface, enabling users to switch between the
VRML- and the Livegraphics3D-output format by changing a single parameter.
In addition to the functionality provided by these plotting methods, both low- and high-level function calls
can be combined together by placing them between open() and close() statements (using vrml.open() or
lg3d.open(), depending on the plot type). This modular design enables the user to build complex 3D scenes
by sequentially adding new primitive objects, or instances of newly defined object groups.
In contrast to other plotting functions in the R statistical programming environment and other statistical
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software tools, VRMLGen provides features related to the interactive exploration and HTML-embedding
of the 3D data. For example, the cloud3d function allows users to specify biological “meta-labels” for data
points in a 3d scene, i.e., gene or protein labels, or functional annotations are displayed when the user hovers
the mouse over a data point in the 3D plot (available in all Javascript-enabled VRML-plugins). Moreover,
hyperlinks can be added to each object in a 3D scene, interlinking data points corresponding to biological
entities (genes, proteins and metabolites) with their corresponding database entries in online annotation
databases (e.g. the ENSEMBL database for genes or SwissProt for proteins).
8.0.4 VRMLGen - Example application for bioinformatics data visualisation
In the following paragraphs, some of VRMLGen’s basic and extended functionalities, including meta-
labels and density estimation contour surfaces, are illustrated using an example dataset from a breast cancer
microarray study in collaboration with the Queen’s Medical Centre (QMC) in Nottingham [19, 349–351]
(see chapter 4 for a detailed description of the data).
VRMLGen’s cloud3d function to create 3D scatter plots allows the user to provide any type of numerical
data as input that can be coerced to a numerical matrix with 3 columns (e.g. 3 vectors, a matrix, or a
formula with 3 variables). Using microarray data after dimensionality reduction (with PCA, ICA, Isomap
or LLE; see chapter 4) as input, the information from class labels and sample annotations can automatically
be integrated into the generated visualisations. For example, class labels are automatically highlighted in
the plots by different colours and point styles, and a class legend is generated above the Z-axis.
To illustrate the functionality using the QMC breast cancer dataset (and complement the VRMLGen visu-
alisations shown in chapter 4), two diverse classes of samples were extracted from the data, corresponding
to samples with two different tumour grades (tumour grade 1, the least aggressive form of the tumour, and
tumour grade 3, the most severe stage of the tumour). The dimensionality reduction method Independent
Component Analysis (ICA), whose visualisations tended to provide the best class separation in the compar-
ison of reduction techniques in chapter 4, was then applied using the fastICA R software package [495] in
combination with VRMLGen. Figure 8.2, left, shows the resulting VRMLGen visualisation, revealing that
the samples from the two classes can be successfully separated in 3D space by means of the ICA data trans-
formation. Similar visualisations of microarray data can be generated either directly with the VRMLGen
software package or using only a few mouse-clicks on the ArrayMining.net clustering module to inspect
the data as an interactive plot on the web.
Apart from the colour highlighted sample classes, generated automatically by VRMLGen when providing
class labels, density estimation contour surfaces can optionally be added to the plot (Figure 8.2, right), by
changing a single parameter setting. These contour surfaces represent regions of high data density in the
plot (visualised by green and yellow surfaces, with green representing the highest data density). In the breast
cancer example dataset, interestingly, most of the low-grade tumour samples appear to be clustered together
in a high-density region of the plot, whereas the high-grade tumour samples are scattered more widely across
the plot. This observation agrees well with earlier findings according to which gene expression levels in
samples with strong tumour activity tend to display a higher variance than for example in cell samples after
tumour resection (i.e. the surgical removal of the tumour) [496].
If the user wishes to include additional meta-information for the data (e.g. function annotation data) in a
plot, or interlink each data point with an entry in a public web database, then the necessary information only
needs to be specified in a vector of “meta-labels” or hyperlinks. After creating the visualisation, the user
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Figure 8.2: Left: Scatter plot visualisation of breast cancer microarray samples [19, 349–351] after dimensionality
reduction with an Independent Component Analysis. Right: The same scatter plot with density estimation contour
surfaces (yellow = high data density regions, green = region of highest density), see source code in Figure 8.3).
R> # VRMLGen - Example source code (R statistical programming language)
R> data("bc_dat")
R> data("bc_classes")
R> cloud3d(bc_dat, labels = paste("tumor grade",
+ as.numeric(bc_classes)), vrml_showdensity = TRUE,
+ metalabels = paste("sample", 1:nrow(bc_dat)),
+ lab.axis = paste("ICA dimension", 1:3),
+ filename = "example2.wrl", htmlout = "example2.html")
Figure 8.3: VRMLGen Example source code: Generating a 3D VRML scatter plot for a breast cancer gene expression
dataset obtained after dimensionality reduction with Independent Component Analysis (see Figure 8.2). First, the
data, bc dat, and the class labels, bc classes, are loaded. Next, a plot with density estimation contour surfaces
(vrml showdensity), meta-labels for the samples (metalabels) and user-defined axis labels (lab.axis) is generated,
and the output is embedded in an HTML-file (htmlout). If the last parameter is not provided, only the VRML output
will be generated.
can access the database entry for a data point by clicking on it, or view the meta-information as a tool-tip
message above the Z-axis, when hovering the mouse over a data point.
To illustrate how complex plots with density estimation contour surfaces can be generated with a single
function call, the R source code in figure 8.3 reveals how the visualisation for the breast dataset (see fig-
ure 8.2) can be generated (for other examples and more detailed explanations of VRMLGen’s features and
functions to generate other plot types like 3D meshes and parametric function visualisations, see [24]).
8.0.5 VRMLGen - Summary and conclusions
VRMLGen is a software package to generate 3D visualisations for interactive data exploration on the web,
providing particular benefits for the analysis of high-dimensional biological data with additionally available
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functional annotations, class labels and associations with external database entries. It contains functions for
the creation of 3D scatter and bar plots, visualisations of meshes, parametric functions and height maps, as
well as access to low-level plotting functions. Calls of different plotting functions can be grouped together
to generate complex 3D scenes, and the user can program new higher-level plotting methods using the
already existing functionality. Additional features, targeted specifically towards the analysis of biological
data, include the possibility to assign hyperlinks and meta-labels to the data points, e.g. to interlink genes
and proteins with corresponding online database entries. Moreover, regions of high data density can be
highlighted by contour surfaces to assist the user in visually identifying cluster structures in a dataset. All
outputs can be generated in two common web-formats, the VRML- and LiveGraphics3D-format. Apart
from using the obtained 3D plots for direct visual inspection and to present the data on the web, the visu-
alisation files can also serve as input for freeware rendering software to generate high-quality perspective
plots for scientific publications.
The VRMLGen package is available as a standalone software package from the Comprehensive R Archive
Network (CRAN, http://cran.R-Project.org) and from the Nottingham University Infobiotics project
repository (http://www.infobiotics.net). Finally, the software package is employed within the Ar-
rayMining web-server for microarray data analysis [18] to generate low-dimensional visualisations of un-
labelled microarray data (see also the discussion of the ArrayMining clustering module in chapter 5).
In summary, the low-dimensional VRMLGen visualisations can often facilitate the interpretation of mi-
croarray data, allowing a user to visually and interactively explore the data and identify sample outliers and
cluster groupings in the data, which are sometimes not detected by automatic bioinformatics methods.
Chapter 9
Main Biological Contributions
Chapter abstract
Although algorithms, software tools and data analysis pipelines are the main deliverables of this
doctoral project, the implemented analysis techniques have also been used to address current
research questions in the biosciences with a focus on cancer biology.
This chapter will provide an overview of the main biological findings that were obtained by
applying tools from the framework, including ArrayMining, TopoGSA, PathExpand and TSPP,
to real-world problems based on recent data from collaborating institutions.
Following the structure of the previous chapters, the first section will present results derived
from the integrative machine learning analysis of high-dimensional biological data, whereas
the second part discusses results obtained from the analysis of general gene and protein lists,
representing cellular pathways and processes.
Breast cancer tumour sub-classification and marker gene identification
The study of heterogeneous diseases with complex genetic components and in particular cancer diseases,
which are known to result from a variety of possible causes (e.g. hereditary risk factors, environmental
influences, virus infections and spontaneous mutations [65, 66]) is a prime target for new high-throughput
data analysis techniques, like gene and protein expression microarrays. Since deregulations of whole cellu-
lar signalling pathways and networks of interactions between multiple genes and proteins have been found
to influence these diseases, systems biology approaches investigating entire genomes, transcriptomes, pro-
teomes and metabolomes are suitable means to analyse these networks of associated biomolecules.
In collaboration with the department of Histopathology at the Queens Medical Centre in Nottingham, the
integrative analysis modules from ArrayMining were used to analyse data from a large-scale microarray
cohort study with samples from 128 breast cancer patients and 47,293 gene transcripts [19, 349–351] (see
data description in chapter 4). The biological goal was to identify and experimentally validate tumour
marker genes, which discriminate between two major breast cancer tumour subtypes, the luminal and the
non-luminal subtype. These subtypes reflect whether certain protein receptors (in particular the oestrogen
receptor, ER, and the human epidermal growth factor receptor 2, ErbB2) are expressed on the tumour
cell surface, and influence the choice of the treatment for a patient and the clinical prognosis (e.g. the
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risk for tumour relapse, preoperative chemotherapy response [497]). Importantly, an early and accurate
diagnosis of the tumour type tends to improve the outcome of the therapy. More specifically, in recent
years a sub-classification of the two major breast cancer categories into five molecular subtypes has become
widely accepted: Luminal samples are divided into luminal A and B, and non-luminal samples into basal-
like, ErbB2 overexpressing and normal-like samples [498–501]. Luminal A tumours have a relatively
good prognosis in relation to luminal B tumours, since they express the hormone receptor ER at a higher
level and can therefore be targeted by a therapy with the drug substance tamoxifen [502]. For ErbB2+
(overexpressing) breast cancers, the prognosis is poor, but a targeted treatment using the drug substances
trastuzumab or lapatinib exists [503]. Similarly, for basal-like tumours, which lack the ER and ErbB2
receptors, the prognosis is poor, but poly(ADP-ribose) polymerase (PARP) inhibitors targeted against basal-
like tumour cells with defects in DNA repair pathways are currently being developed [502]. Finally, for
normal breast-like tumours, the biology is not yet well understood and the prognosis is similar to the basal-
like tumours. Overall, as a first diagnostic step, the general categorisation of a sample into the luminal and
non-luminal group is an important pre-requisite for the choice of an appropriate treatment (e.g. hormone,
radiation, chemotherapy or surgical treatment).
To maximise the robustness of biomarker screening approaches for the identification of genes discriminat-
ing between the two breast cancer subtypes, a combination of an ensemble feature selection and ensemble
learning approach with cross-validation based sub-sampling using the ArrayMining framework was applied.
Specifically, three diverse feature selection methods, a combinatorial method (CFS [160]), a tree-based fea-
ture ranking approach (RFS [190]) and a classical univariate filter (PLSS [356]), were employed within an
external leave-one-out cross-validation (LOOCV) procedure, in combination with four classification meth-
ods, the in-house developed evolutionary computation based machine learning system BioHEL, a linear
C-SVM [346], Breiman’s random forest classifier (RF) [191] and the nearest shrunken centroid classifier
(PAM) [239] (see chapter 4 for details). The genes were ranked according to how often they were chosen
among the top 30 features in the LOOCV across each of the three selection methods. The final list of top-
ranked genes consisted of those features that were selected by at least two feature selection methods across
all cross-validation cycles - three of these genes were in fact selected across all three selection approaches:
The gene RAS-like, estrogen-regulated, growth-inhibitor (RERG, identifier: GI 14249703-S), estrogen re-
ceptor 1 (ESR1, identifier: GI 4503602-S) and potassium channel, subfamily K, member 15 (KCNK15,
identifier: GI 16507967-S). The complete ranking list can be found in table 4.11.
The ESR1 gene, which encodes the oestrogen receptor (ER) α, is already a well-known breast cancer marker
gene. In luminal samples, the ER-α is known to be expressed in tumour cells (ER+, see above), whereas
it is not expressed in basal-like samples (ER-, see the approach by Nielsen et al. for breast cancer subtype
categorisation [504]). The oestrogen hormone is well-known to cause the growth of ER+ breast cancer cells,
and some hormone therapies use anti-oestrogens as drugs against corresponding forms of breast cancer.
The second top-ranked gene, RERG (see gene expression box plot in figure 9.1), is again known to be asso-
ciated with breast cancer, but had not been used before to separate the luminal and the non-luminal class as
distinct prognostic subgroups. RERG is a GTP-binding protein and its expression has been reported to be
decreased in aggressive ER negative subtypes [505]. Moreover, in vitro studies in which RERG expression
was found to be induced in ER-responsive MCF-7 cells stimulated by estradiol and repressed by tamoxifen
treatment confirm a potential tumour suppressive role of the gene. Therefore, this gene was investigated
in detail as a potential tumour marker in a recently published pre-clinical study in collaboration with the
Queen’s Medical Centre in Nottingham [19]. The study validated the microarray results using immunohis-
tochemistry on tissue microarrays (TMAs) containing 1,140 invasive breast cancers (see figure 9.1).
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Figure 9.1: Left: Box plot revealing the gene RERG’s potential as a new candidate marker of the ER-positive luminal-
like breast cancer subtype. Right: Tissue microarrays of invasive breast cancer show strong RERG expression. The
image displays infiltrating and malignant tumour cells in breast tissue (invasive ductal carcinoma cells, IDC) after im-
munohistochemical staining of the RERG protein using monoclonal antibodies (blue colour, see [506, 507] for details
on the immunohistochemistry procedure). These regions stained in blue corrrespond to the cytoplasm of the tumour
cells (which have a light orange/pink colour and include the blue cytoplasmic regions), revealing that the RERG expres-
sion is localised to the cytoplasm. Moreover, by assessing the intensity of staining and the percentage of stained cells
following immunohistochemistry using the histochemical score (H-score) [508], RERG was found to be more strongly
expressed in the cytoplasm of luminal cells than in non-luminal cells [19].
Specifically, the protein expression study revealed that RERG expression was positively associated with
several markers of luminal differentiation including ER, luminal cytokeratins (CK19, CK18, and CK7/8)
and FOXA1 (p=0.013), as well as with other clinical markers for good prognosis in breast cancer including
small tumour size, low histological grade and positive expression of androgen receptor, nuclear BRCA1,
FHIT and cell cycle inhibitors p27 and p21. An inverse association with RERG expression was detected
for the proliferation markers MIB1, P53 and EGFR. Moreover, strong RERG expression was associated
with longer breast cancer specific survival (BCSS) and distant metastasis free interval (DMFI) in the whole
series as well as in the ER+ luminal group (independent of other prognostic variables) [19].
A role for the third top-ranked gene, KCNK15 (also known as TASK-5), in oncogenesis is currently un-
known, but the gene has been found to be silenced by hypermethylation of the promotor region in many
tumours [509]. KCNK15 encodes a two-pore potassium channel protein, which matches to findings for other
ion channels, like the Ca2+ channel CACNA1G and the Na+ channel SLC5A8 with putative tumour sup-
pressive function, which have already been reported to be hypermethylated in different cancers [510, 511].
Future investigations are planned to analyse this gene/protein in more detail.
Identifying associations between cancer mutated genes, cellular pathways and different disease pro-
cesses
As noted in chapter 2, multifactorial genetic diseases can often be interpreted as modulations of normal
cellular pathway and process activities, where defects in different genes can have the same final effect. For
example, the normal activity of theWnt/β-catenin signalling pathway, a pathway associated with embryoge-
nesis, can be disrupted by a deactivation of a protein known as Adenomatous-polyposis-coli (APC) protein,
or by a mutation of the β-catenin protein that prevents its degradation, which can lead to the development
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of the same form of colorectal cancer in both cases [512].
For this reason, the pathway-based analysis of high-throughput biomedical datasets and in particular re-
search aimed at discovering disease-associated cellular processes is an effective means to improve the un-
derstanding of the molecular basis behind these diseases. In cooperation with the Spanish National Cancer
Institute (CNIO), the software tool PathExpand from the framework (see chapter 6) was used to extend
the definitions of various disease pathways by extracting information from molecular interaction data, and
to analyse their associations with gene sets known to be mutated in different cancers. By extending the
network representations of the original pathway and process definitions, novel putative candidate disease
genes could be identified among the new genes/proteins added to the pathway definitions. For example,
among five genes added to the Alzheimer’s pathway from the KEGG database, three had already previ-
ously been implied in the disease (TMED10, APH1B and PITX3), and the remaining two, METTL2B and
MMP17, were studied in more detail. Although forMMP17, a metallopeptidase protein, there was no other
public experimental evidence implicating a role of the gene in Alzheimer’s, six other members of the same
protein family have been associated with the Alzheimer’s disease (see Huge navigator [464]). Similarly,
the second gene, METTL2B, a methyltransferase-like protein, did not occur in any public disease associ-
ated datasets, but a member from the same protein family,MMETL10, had previously been associated with
Alzheimer’s disease in a case-control study [464]. For this reason, MMP17 and METTL2B were proposed
as new candidate disease genes in the PathExpand paper [22].
In the same study, extended cellular pathways were also used to study their enrichment in cancer mutated
genes. Specifically, a large set of pancreas mutated genes had been obtained from pancreatic resequencing
studies, and this set was tested both against the original cellular pathway definitions as well as against the
extended pathways using a one-sided Fisher exact test. Several pathways, whose original definitions had
already been enriched in cancer mutated genes received higher enrichment scores after the extension, due
to an over-representation of these cancer mutated genes among the added genes. A particularly interesting
case was the cancer-related cell cycle G1/S check point process from the BioCarta database, which already
contained mutated genes in the original pathway/process definition. Seven proteins were added to this
process, all of which were either transcription factors, kinases or other signal transduction regulators, and
six of them are known to be involved in cell cycle regulation - all except the gene TGIF2. However, TGIF2
is mutated in a pancreatic tumour and known to be amplified in some ovarian cancers. Thus, the evidence
for the involvement of the seven predicted pathway members in the corresponding process and pancreatic
cancer provides a starting point for further research to improve the understanding of the disease.
Pairwise cellular pathway associations deregulated in genetic diseases
After having analysed diseases with genetic components on the level of cellular pathways, processes and
complexes rather than at the single-gene or -protein level, a next logical step leads to the analysis of pair-
wise relations between pathways and processes, and how these relations change across different disease
phenotypes.
Although the main motivation behind the development of the Top-scoring pathways pairs (TSPP) method
[23] (see chapter 7) was to increase the robustness of microarray sample classification by replacing single
gene predictors with pathway expression fingerprints and comparing relative expression values against each
other rather than fitting continuous-valued threshold values, this method also enabled the identification of
pairwise associations between pathways, whose genes change their relation of expression values across
different disease conditions.
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For example, the KEGG pathways p53 signalling and purine metabolism share only two genes/proteins,
however, the TSPP method shows that the relation between the pathway expression fingerprints for these
two processes changes across the sample classes in the prostate cancer microarray dataset by Singh et al.
[348]. Indeed, when mapping the two pathways on a large human protein-protein interaction network [20],
a multitude of direct protein interactions connect the two pathways tightly in the network (see chapter 7).
Moreover, recent findings from the literature corroborate the association of the pathways with the disease:
The inhibition of de novo purine synthesis by a drug was shown to also inhibit prostate cancer cell growth
and increase the expression levels of p53 [487]. This is consistent with the inverse relation between gene
expression levels in p53 signalling and purine metabolism pathways in prostate cancer detected by the TSPP
method.
Genome-wide transcription network analysis in seeds
The study of networks using bioinformatics approaches does not only involve the analysis of molecular
interaction networks representing direct, physical interactions between functional molecules in a cell, but
also networks of indirect functional relations inferred from high-dimensional biological data, e.g. gene
co-expression data from microarray experiments.
In co-operation with the Division of Plant and Crop Sciences at Nottingham University, condition-depen-
dent gene co-expression in seeds was analysed using 138 microarray samples from the plant model organism
Arabidopsis thaliana, representing the two temporal conditions of dormancy (73 samples) and germination
(65 samples). These conditions are associated with important agronomic and ecological traits, and im-
proving the understanding of the gene regulatory network influencing these conditions can therefore also
facilitate research aimed at enhancing seed performance in agriculture. Since classical gene co-expression
data analysis is unsupervised, the condition-dependent analysis of this data represents a new type of analy-
sis, which can identify gene associations specific to a certain developmental state.
In order to create a condition-specific gene co-expression network, the microarray data obtained from
the 138 Nottingham Arabidopsis Stock Centre (NASC) arrays was first normalised using the Affymetrix
GCOS/MAS5 method [352] with a trimmed mean target intensity value (TGT) of 100. Genes that were
not expressed at least once above the background level in any of the samples were removed from the anal-
ysis, resulting in a pre-processed dataset with 14,092 genes. On this data, a weighted gene co-expression
network analysis (WGCNA) was applied using the ArrayMining network analysis module [18] (see chap-
ter 5). Moreover, a further unweighted network was computed by creating an edge between two genes if
the absolute value of the Pearson correlation coefficient between their expression values exceeds a cut-off
ρ > τ where τ was chosen as 0.75, a parameter choice providing a network closest to having a scale-free
topology [122]. To enable researchers to inspect this data online using a queryable interface, the interactive
network visualisation SeedNet was built (available online [35], see also figure 9.2). SeedNet enables users
to zoom into the co-expression network, search and highlight genes of interest, forward chosen gene sets to
other analysis services (e.g. to find overrepresented cis-regulatory elements, i.e. regions of DNA or RNA
regulating the expression of genes on the same chromosome) and download images of the network represen-
tation. Moreover, the condition-specific up- and down-regulation of genes is highlighted by a colour coding
in the network (blue background = up-regulated in germinating samples, red background = up-regulated in
non-germinating samples; computed using the Significance Analysis of Microarrays (SAM) method [419],
see figure 9.2).
The network analysis verified the existence of two distinct modules of state-dependent genetic interactions,
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Figure 9.2: The SeedNet network visualisation interface, enabling a user to find modules of co-expressed genes in
dormant and germinating Arabidopsis thaliana seeds to better understand the transition between these phases. The
interface consists of four windows: 1) the Detailed View window to visualise and explore co-expressed genes, 2) the
Overview window to zoom into different regions of the network, 3) the Menu window to search and highlight genes
in the network, and 4) the Neighbourhood search window to find the co-expression partners of a specified gene (see
http://vseed.nottingham.ac.uk for details).
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identified using the MCODE graph clustering software [336] and automatic graph layout generation, cor-
responding to the germination and dormancy phases. Specifically, genes associated with seed dormancy
are up-regulated by the hormone abscisic acid (ABA) and down-regulated by the hormone gibberellic acid
(GA), and located in a distinct region the network, whereas genes related to germination have the opposite
regulation pattern and are clustered in a separate network region.
One of the main benefits of the new network model is that the accuracy by which regulators of germination
can be predicted was improved from 22% by using genes within the SAM top-ranked non-germination
(NG) list to 50% when considering high-degree “hub” genes within the dormancy region of the network.
This suggests that the consideration of the network topology has an added predictive value for the inference
of gene functions, complementing the results from a differential gene expression analysis.
In summary, information from the SeedNet co-expression network enables the prediction of novel regulator
genes for seed germination and the identification of state-dependent sets of genetic interactions associated
with germination and dormancy. The co-expression data and the network visualisation is publicly available
at: http://vseed.nottingham.ac.uk/.
Chapter 10
Conclusions
Chapter abstract
As part of this dissertation three types of new scientific results in the field of functional ge-
nomics data analysis have been presented:
• Novel methodological results: New ensemble/consensus algorithms and cross-domain
analysis techniques, and new analysis pipelines were developed and implemented as pub-
licly available software tools.
• Comparative evaluation results: A systematic comparative evaluation of supervised and
unsupervised techniques for high-dimensional microarray data analysis, including ensem-
ble and consensus methods, was conducted.
• New biological results: A new breast cancer biomarker was proposed as part of a pre-
clinical study, and new candidate disease genes and extended pathway/process definitions
were identified for different cancers and genetic diseases.
Below, the findings for each of these deliverables are summarised and remaining limitations
and challenges are discussed. The final section will conclude the thesis with an outlook on
future perspectives in the field of integrative bioinformatics and potential extensions of the
work presented here.
10.1 General Summary and Discussion
New methodological results: The main deliverable of the dissertation was an integrative platform for
the analysis of experimental gene and protein data, consisting both of new combinations between already
known machine learning, cross-study normalisation, gene set and network analysis methods, i.e. new data
analysis pipelines, as well as new algorithms, integrating multiple data types and analysis techniques.
The largest software project within this framework is ArrayMining [18], a web-server for microarray data
analysis, extending classical machine learning methods and specialised gene expression data analysis meth-
ods by two types of integrative analysis: Ensemble and consensus techniques for single algorithmic problem
types (within analysis modules), and cross-domain analysis approaches combining different problem types
(interlinking different analysis modules). In addition to providing new data mining methods, the system
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enables a user to set up new integrative analysis pipelines for microarray data, e.g. analysing combined
data from two different studies obtained using cross-platform integration methods (Cross-study normalisa-
tion module), by extracting gene sets expression fingerprints representing cellular pathways and processes
(Gene set analysis module), and using this data for a consensus clustering or an ensemble sample clas-
sification, comparing and combining multiple feature selection and prediction methods. In spite of the
complexity of such analysis pipelines, they can be configured and run using only a few mouse clicks on a
unified web-interface.
The results obtained with ArrayMining can also be interlinked with other novel integrative algorithms in
the framework, including the methods TopoGSA, EnrichNet, PathExpand and TSPP.
TopoGSA [20] complements classical data mining techniques for investigating single genes and gene sets
in experimental data by a topological analysis in molecular interaction networks. On the corresponding
web-application, arbitrary gene sets for different model organisms (human, yeast, plant, worm and fly), e.g.
sets of differentially expressed genes obtained from ArrayMining, can be mapped onto a large-scale protein
interaction network (or other user-defined networks) and characterised with regard to several topological
properties. This analysis enables the identification of genes with outstanding topological characteristics or
the discovery of new discriminative patterns between genes which are up- or down-regulated in different
sample classes. Moreover, uploaded gene sets can be compared to entire databases of pre-defined gene sets
(KEGG, BioCarta, GO, InterPro and MetaCyc) representing cellular pathways and processes, e.g. to find
similarities between experimentally derived and known disease-related gene sets.
The rich information content in molecular interaction networks is also exploited by the novel analysis
methods EnrichNet, PathExpand and TSPP, included as modular components in the framework. While
the web-application EnrichNet [21] uses network distance information and sub-network visualisations to
improve the sensitivity and interpretability of gene set enrichment analysis results, PathExpand [22] goes
one step further and extends the definitions of pathway-representing gene sets using a graph-theoretic anal-
ysis of sub-networks. By adding new genes/proteins that are tightly interconnected with a pathway to the
corresponding pathway gene set, improved representations of cellular processes in terms of network com-
pactness and connectivity are obtained, which can be used as input for pathway-based bioinformatics data
analysis methods.
The TSPP algorithm [23] builds on both gene set definitions and molecular interactions as data sources in
order to improve the supervised analysis of microarray data. More specifically, it complements classical
single-gene based machine learning methods by a robust method to learn easily interpretable decision rules
on the differential relation of pairs of cellular pathways (represented by gene set expression fingerprints). In
addition to the sample classification results and ranking of differentially regulated pathway pairs provided
by this algorithm, the top-ranked pathway pairs can be mapped onto molecular interaction data to identify
subsets of significantly associated pathway-pairs, which are deregulated in certain biological conditions of
interest.
Although most analysis modules in the framework are very generic and can be applied to biological data
from different experimental data sources, the full benefit of emerging experimental approaches like RNA
sequencing based gene expression profiling can only be exploited with dedicated analysis methods. For this
purpose, the framework has been extended by the web-application RNAnalyze [33]. RNAnalyze performs
a gene set analysis tailored to RNA sequencing data, exploiting the potential of multiple gene selection
methods by combining their outputs into a majority vote selection, in a similar fashion as other ensemble
learning methods within the framework. RNAnalyze, which is currently still an isolated analysis module
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in the framework, will be interlinked with the other modules and external web-services in a similar man-
ner as the related Gene Set Analysis module for microarray gene expression data in ArrayMining. More
specifically, the user will have the possibility to forward the data to the ArrayMining Clustering and Class
Assignment Analysis modules to identify sample clusters with differentially regulated gene sets and to use
supervised feature selection and classification to learn predictive models from the data. Moreover, net-
works of gene sets with correlated expression values will be visualised on the Network Analysis module,
and the identifiers for pathway-representing gene sets and single genes will be interlinked with external
web-applications including GeneCards [26], DAVID [393] and the web-services for KEGG [31], Gene
Ontology [30] and possibly other pathway and gene set data repositories.
Finally, in order to provide low-dimensional, visual representations of the results in all these analysis tools,
the framework also contains a software package for interactive, web-based 3D visualisations of biological
data, VRMLGen [24]. Different methods for creating 3D scatter plots, bar charts and mesh visualisations,
in combination with the possibility to add biological annotations to the plots and density estimation contour
surfaces, facilitate the exploration of complex data. Moreover, a more effective knowledge management
can be achieved, by integrating these visual data representations into standard web-pages and directly inter-
linking them with external data repositories.
Each of the above tools can be used both as a stand-alone software and in combination with other methods
from the framework or several external web-portals and databases. Importantly, the methods in the frame-
work have been interlinked in a manner that enables new types of analyses, e.g. combining an ensemble
gene selection to identify differentially expressed genes (DEGs) on ArrayMining with a network topologi-
cal analysis using TopoGSA to detect DEGs with outstanding topological properties in a protein interaction
network. Since the module interfaces are standardised and accept gene/protein expression matrices, class
labels and annotation data in a common format, the user is not confined to using the algorithms and appli-
cations in a pre-arranged manner, but can define new analysis pipelines consisting of modular combinations
of framework tools and other external software.
Comparative evaluation results: To evaluate the benefit of ensemble, consensus and classical machine
learning techniques for microarray analysis, several supervised and unsupervised methods, including novel
approaches, were evaluated on real-world cancer datasets.
In summary, when comparing sample classification results for the in-house rule-based ensemble classifier
BioHEL with the benchmark methods SVM, RF and PAM using external leave-one-out cross-validation,
similar average accuracies were obtained on three datasets, in spite of the simplicity of BioHEL’s if-then-
else decision rules. The ensemble rule sets cannot only be used to obtain robust feature rankings but also
to extract information on the expression value ranges of features associated with different outcome classes,
which enable the user to identify putative tumour suppressor genes and oncogenes.
Moreover, the comparative evaluation showed that the application of a univariate method for feature selec-
tion equivalent to the F-score, can have advantages in comparison to combinatorial, embedded and wrap-
per selection approaches, when considering predictive performance and runtime efficiency in conjunction,
rather than allowing significantly longer runtimes for the wrapper-based methods.
A comparative analysis of clustering methods highlighted not only the benefit of combining multiple meth-
ods into a consensus, but also showed that a higher robustness, and in terms of some validity indices also
a better cluster separation, can be obtained by integrating additional annotation data into a gene-set based
dimensionality reduction of the data. Although multiple biologically meaningful patterns can occur in the
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data, the obtained clustering results, and in particular those obtained from consensus clustering and gene-set
based dimensionality reduction, displayed a significantly higher agreement with an external, expert-based
tumour grade categorisation than 10,000 random clusterings. Finally, when comparing different dimen-
sionality reduction methods for creating 3D representations of the data (Principal Component Analysis,
Independent Component Analysis, Locally Linear Embedding and Isomap), major differences were ob-
served between the results of the different reduction methods, and overall, the Independent Component
Analysis (ICA) provided the best separation of the different tumour grades.
In summary, although in accordance with the No-free-lunch theorem [513] no single algorithm in machine
learning is superior to every other algorithm across all possible datasets, the comparative analysis shows
that some methods tend to perform better across multiple diverse microarray datasets, and that ensemble
and consensus techniques and the integration of additional biological information provide benefits both for
supervised and unsupervised analysis of the data. Importantly, the idea of generating a consensus of multiple
methods can also be applied to the validation of machine learning methods, and is particularly useful in
clustering, where different cluster validity indices often provide different estimates of the optimal number of
clusters. The comparative evaluation results indeed confirm that when combining multiple validity measures
to a summary statistic, the obtained estimates are more robust across different clustering, standardisation
and dimensionality reduction methods.
Importantly, the framework developed as part of this doctoral project allows external users to perform simi-
lar comparative analyses on their own data online, and to profit from the possibilities of combining multiple
datasets and statistical techniques into an ensemble/consensus approach, an integrative cross-domain algo-
rithm, or a new analysis pipeline.
New biological results: The biological results of the thesis have been discussed in detail in chapter 8, and
will therefore only be summarised briefly here:
• Discovery and validation of a novel breast cancer marker gene: In collaboration with the Not-
tingham Queens Medical Centre, a gene expression analysis of 128 breast cancer samples using the
ArrayMining software identified the gene RERG as a putative marker for the discrimination between
the clinically relevant categories of luminal and non-luminal samples. The utility of this marker was
confirmed by a large-scale experimental validation using immunohistochemistry on tissue microar-
rays containing 1,140 invasive breast cancers [19].
• Identification of candidate disease genes and improvement of disease pathway definitions: With
the PathExpand tool from the framework (see chapter 6), various disease pathways were analysed
and extended by adding densely interconnected interaction partners in a large-scale protein interaction
network. For an Alzheimer’s pathway, this led to the discovery of two associated proteins, METTL2B
and MMP17, which had previously not been linked to the neurodegenerative disease. Since several
members of the corresponding protein families (metallopeptidases, methyltransferase-like proteins)
are known to be associated with Alzheimer’s, the two predicted pathway members were proposed as
new candidate disease genes [22].
Moreover, by studying the enrichment of extended cellular pathways in genes mutated in pancreatic
cancer, biologically insightful extensions of cancer-related pathways were obtained. The extended
pathways were both enriched in pancreatic cancer mutated genes and had functional annotations
similar to those of the original pathway members.
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• Identification of associations between pairs of cellular pathways and diseases:
The Top-scoring pathway pairs (TSPP) method [23] identified pathway pairs that are differentially
regulated across different disease conditions in microarray data. Apart from already known pathway-
pair/disease associations, new functional relations were discovered and investigated in detail by map-
ping corresponding pathway pairs onto molecular interaction networks. For example, complementary
information from the literature confirmed a proposed association between the KEGG pathways p53
signaling pathway and Purine metabolism in prostate cancer. Specifically, the inhibition of de novo
purine synthesis was observed to inhibit prostate cancer cell growth and increase p53 expression
levels [487]. Thus, in contrast to classical enrichment analysis methods for identifying functional
associations between gene sets, the TSPP methods can also prioritize putative pathway-pair/disease
associations and help to uncover de-regulated pathway-relations using microarray data.
• Genome-wide transcription network analysis in seeds:
Although bioinformatics methods for large-scale biological data analysis have many of their most
important practical applications in biomedicine, a multitude of other applications exist in biotech-
nology and agriculture. To analyse the gene regulation in Arabidopsis thaliana, a model organism
for crop plants, microarray samples representing the temporal conditions of dormancy and germi-
nation were studied in co-operation with the Division of Plant and Crop Sciences at Nottingham
University. Using the ArrayMining network analysis module, a condition-specific, weighted gene
co-expression network was constructed from the data, and an interactive network visualisation, Seed-
Net, was created and published online [35]. The network analysis identified two distinct modules
of state-dependent genetic interactions reflecting the two different biological states and enabling the
topology-based prediction of germination regulators with higher accuracy than previous methods. As
an online gene regulation data repository and network visualisation tool, SeedNet will help to further
improve the understanding of the gene regulatory network influencing the conditions of dormancy
and germination, facilitating research aimed at improving seed performance in agriculture.
10.2 Outlook on Future Work
The framework for integrative biological data analysis presented in this dissertation was designed to cover
some of the most wide-spread experimental techniques in functional genomics, and to be directly applica-
ble to real-world bioscientific and biomedical problems, as illustrated by the wide range of collaborative
projects employing the framework tools.
Prior to this doctoral project and during its implementation, other public software frameworks for analysing
gene and protein microarray data and general gene and protein lists already provided access to a multitude of
different analysis methods, but these tools were not interlinked to exploit the synergies of different analysis
types like machine learning, network analysis and gene set based dimensionality reduction, or only en-
abled a fixed sequential combination of known analysis techniques. These existing analysis frameworks
include GEPAS [403], Expression Profiler [404], ASTERIAS [405], EzArray [406], CARMAweb [407],
MAGMA [408], ArrayPipe [409], RACE [410], WebArray [411] and MIDAW [412], as well as more gen-
erally applicable statistical programming languages like R [353] and Matlab [402]. While the dedicated
analysis frameworks are easier to use in comparison to the statistical programming languages and con-
tain both pre-implemented methods for data pre-processing (e.g. single-study normalisation, missing value
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imputation and gene filtering) and higher level analysis (e.g. clustering, gene selection and annotation,
classification, data visualisation and gene set enrichment analysis), they are less flexible and do not enable
the user to set up complex analysis pipelines and exploit recent algorithmic advances provided by ensem-
ble and consensus analysis techniques. The software framework presented here addresses these limitations
by allowing users to benefit from the possibility to freely combine algorithms in parallel (using ensem-
ble/conensus techniques) and sequentially (using modular combinations) to build new analysis pipelines,
while keeping the interface simple and easy to use by applying automatic parameter selection mechanisms.
Additionally, in contrast to existing integrative analysis frameworks, different analysis types are not just
combined using already existing, domain-specific algorithms, but new cross-domain data analysis methods,
operating on multiple, diverse data sources at the same time, have been developed and interlinked with other
modules in the framework. Apart from their statistical advantages in terms of robustness and accuracy, the
main benefit of these new integrative analysis techniques is that they provide new biological insights by
enabling an interpretation of the data from a different perspective, e.g. by identifying associations between
pathway deregulations and different disease states in microarray-based machine learning models (TSSP
method) instead of only scoring the importance of single genes, by measuring the similarity of gene/protein
sets in terms of topological properties (TopoGSA) and network distances (EnrichNet) rather than computing
overlap-based enrichment scores (like the existing tools DAVID [393] and FatiGO [514], among others),
and by re-defining cellular pathways to provide dense and compact network representations in molecu-
lar interaction networks (PathExpand). Importantly, both highly specialised algorithms and more general
integrative analysis methods are required to fully exploit the information content in functional genomics
datasets and ideally, these different types of approaches should also be interlinked. Thus, future versions
of the integrative framework might also profit from the data exchange with recently developed specialized
analysis tools, e.g. for biclustering of genes and samples [413], co-clustering of genes with similar func-
tional annotations [414], inference of gene regulatory relationships [415] and cross-species clustering [416].
Although the framework already covers a wide range of data types, including gene/protein expression data,
cellular pathway definitions, and many of the machine learning techniques in the framework are applicable
to even further biological data sources (e.g. mass spectrometry data, nucleotide and amino acid sequence
data, protein structural data, array comparative genomic hybridisation data (aCGH), clinical measurements,
etc.), the full information content in other data sources can only be exploited by additionally considering
dedicated analysis methods, adjusted to the specific properties of these data types (e.g. the types of noise
sources, data distributions, and the feature and sample sizes).
Therefore, the framework presented here is designed to be modular and easily extensible by new analysis
techniques for other types of input data. Specifically, a common, generic template is used for the web-
interface, the storage and forwarding of the data, and the representation of the results in sortable tables and
2D and 3D visualisations.
However, before adding new analysis modules to the framework, future extensions could, in a first step,
include mappings of other data types to the currently used gene and protein data, e.g. mapping the genes
from a differential expression analysis onto gene mutation, alternative splicing, epigenetics and RNA/DNA
and microRNA-mRNA interaction databases, or mapping proteins onto protein structural, protein-domain
and functional annotation databases. These mappings would enable the user to investigate the results from
the existing analysis modules in more detail using other interlinked web-services, e.g. to identify whether a
differentially expressed gene in a cancer dataset is also known to have a hypermethylated promotor region
in certain cancers or to contain mutations driving the tumour growth.
In a second extension step, new data types and analysis techniques could directly be integrated into the
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framework. However, these extensions should not exceed the scope of the framework, and focus on wide-
spread experimental methodologies in functional genomics, benefiting from synergies with already included
data sources and methods. An important biological data type, which could be targeted by more dedicated
analysis techniques to increase the utility of the framework, is mass spectrometry data, which can partly al-
ready be analysed using the current machine learning modules in ArrayMining, if the data has already been
processed. Accordingly, by including mass spectrometry specific pre-processing steps into ArrayMining
(i.e. raw data filtering, peak detection, peak grouping/alignment and retention time normalisation meth-
ods), the existing machine learning analysis modules could be used for a greater variety of purposes.
Alternative data sources, which are particularly useful for integrative analysis purposes, also include dif-
ferent types of systems biology network data, e.g. gene regulatory networks, protein-DNA interaction
networks, protein domain networks, gene/protein functional association networks [439] and disease net-
works [515]. Moreover, in particular for microarray cancer data, the consideration of classical clinical
measurements (e.g. tumour size, histological grade, status of angioinvasion, and status of lymphocytic infil-
tration, oestrogen receptor and progesterone receptor parameters) would provide a valuable extension of the
framework. While additional annotation data for the features of a dataset can be integrated into an analysis
using an approach that is also employed for gene set analysis, i.e. defining “meta-features” corresponding
to summarised fingerprints of features with similar annotation data (see chapter 3 and 4), additional labels
or numerical data for the samples can be used as additional outcome variables in a supervised analysis or as
weight vectors within ensemble learning techniques, e.g. Feature Weighted Linear Stacking (FWLS) [516].
The focus on transcriptomics, proteomics and metabolomics data analysis could also be broadened by
directly integrating analysis methods for further “omics” data types into the framework, e.g. to find homol-
ogous genes with known functions for differentially expressed genes with missing annotations (genomics),
or to detect genes that are alternatively spliced under different conditions (spliceosomics), as well as mu-
tated and epigenetically silenced genes (mutagenomics and epigenomics). Importantly, the goal would not
be to add already existing tools and web-services to the framework, but to develop new integrative data min-
ing approaches that exploit the information sources and analysis types from different biological domains,
e.g. by combining machine learning models trained on independent data sources to a meta-model, or using
features from diverse datasets within a single model.
While this task of better exploiting the synergies of diverse “omics” data types is rather a long-term goal,
improvements of the currently used ensemble learning techniques and metaheuristics for search space ex-
ploration specific to single data types can be achieved more quickly. For example, alternative evolutionary
learning operators and niching techniques could be integrated into the existing optimisation methods (e.g.
within the TSPP algorithm or the consensus clustering method), as well as alternative boosting and ensem-
ble learning methods like variants of the stacked generalisationmethod [516] to combine different machine
learning models. Moreover, some of the current implementations could be parallelised to increase the run-
time (however, most algorithms in the framework already terminate in few minutes rather than hours or
days).
In conclusion, the current integrative analysis framework already covers a wide range of data analysis
problems in transcriptomics and proteomics, but also provides many opportunities for further extensions,
both by interlinking the framework with external tools and web-services and by integrating analysis methods
for other functional genomics data types to exploit synergies between different “-omics” disciplines.
As new generations of high-throughput experimental methodologies are becoming more sensitive, cheaper
and more widespread in the academic community, integrative analysis methods will be more frequently
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required to combine the incomplete information from different sources to obtain a more coherent picture
of the biological systems of interest. Thus, many new opportunities are likely to emerge for bioinformatics
data and algorithm integration approaches to support systems biology studies unravelling the processes
taking place in different diseases, biotechnologically relevant microorganisms and agriculturally important
plants.
The integrative framework presented here illustrates how ensemble, consensus and cross-domain integrative
methods can provide novel biological insights, which are often not obtained when using domain-specific
approaches and considering single algorithms and datasets independently. The promising results achieved
so far and the almost infinite reservoir of unsolved problems in biology highlight the opportunities for
integrative bioinformatics data analyses. The framework built in this doctoral project can therefore be
useful both to tackle further specific biological problems and as a template for the development of new
integrative analysis methods in the future.
Bibliography
[1] Bellman R. Adaptive Control Processes. Princeton University Press, NJ, USA, 1961.
[2] Miller Jr R. Simultaneous Statistical Inference. McGraw-Hill Book Co., New York, NY, USA, 1966.
[3] Benjamini Y and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J
Roy Statist Soc Ser B Methodological, 57(1):289, 1995.
[4] Ding C and Peng H. Minimum redundancy feature selection from microarray gene expression data. J Bioinform Comput Biol,
3(2):185, 2005.
[5] Yu L and Liu H. Redundancy based feature selection for microarray data. In Proceedings of the 10th ACM SIGKDD Interna-
tional Conference on Knowledge Discovery and Data Mining, pages 737–742. ACM New York, NY, USA, 2004.
[6] Hastie T, Tibshirani R, and Friedman J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction. Springer,
New York, NY, USA, 2001.
[7] Braga-Neto U and Dougherty E. Bolstered error estimation. Pattern Recognition, 37(6):1267, 2004.
[8] Dietterich TG. Ensemble methods in machine learning. In International Workshop on Multiple Classifier Systems, pages 1–15.
Springer-Verlag Berlin, Heidelberg, 2000.
[9] Saeys Y, Abeel T, and Peer Y. Robust Feature Selection Using Ensemble Feature Selection Techniques. In Proceedings of the
European Conference on Machine Learning and Knowledge Discovery in Databases-Part II, pages 313–325. Springer-Verlag
Berlin, Heidelberg, 2008.
[10] Tan A and Gilbert D. Ensemble machine learning on gene expression data for cancer classification. Appl Bioinformatics, 2(3
Suppl):S75, 2003.
[11] Monti S, Tamayo P, Mesirov J, and Golub T. Consensus clustering: a resampling-based method for class discovery and
visualization of gene expression microarray data. Machine Learning, 52(1):91, 2003.
[12] Swift S, Tucker A, Vinciotti V, Martin N, et al. Consensus clustering and functional interpretation of gene-expression data.
Genome Biol, 5(11):R94, 2004.
[13] Bacardit J and Krasnogor N. Empirical evaluation of ensemble techniques for a Pittsburgh Learning Classifier System. In
Revised Selected Papers of the 10th International Workshop on Learning Classifier Systems 2006, pages 255–268. Springer-
Verlag Berlin, Heidelberg, 2008.
[14] Shabalin AA, Tjelmeland H, Fan C, Perou CM, et al. Merging two gene-expression studies via cross-platform normalization.
Bioinformatics, 24(9):1154, 2008.
[15] Warnat P, Eils R, and Brors B. Cross-platform analysis of cancer microarray data improves gene expression based classification
of phenotypes. BMC Bioinformatics, 6(1):265, 2005.
[16] Walker W, Liao I, Gilbert D, Wong B, et al. Empirical Bayes accomodation of batch-effects in microarray data using identical
replicate reference samples: application to RNA expression profiling of blood from Duchenne muscular dystrophy patients.
BMC Genomics, 9(1):494, 2008.
[17] Cope L, Garrett-Mayer E, Gabrielson E, and Parmigiani G. The integrative correlation coefficient: a measure of cross-study
reproducibility for gene expression array data. Johns Hopkins University Dept of Biostatistics Working Papers, page 152, 2007.
[18] Glaab E, Garibaldi J, and Krasnogor N. ArrayMining: a modular web-application for microarray analysis combining ensemble
and consensus methods with cross-study normalization. BMC Bioinformatics, 10(1):358, 2009.
[19] Habashy HO, Powe DG, Glaab E, Krasnogor N, et al. RERG (Ras-related and oestrogen-regulated growth-inhibitor) expression
in breast cancer: A marker of ER-positive luminal-like subtype. Breast Cancer Res Treat, 128(2):315, 2011.
[20] Glaab E, Baudot A, Krasnogor N, and Valencia A. TopoGSA: network topological gene set analysis. Bioinformatics,
26(9):1271, 2010.
[21] EnrichNet: Network-based gene set enrichment analysis, 2010. http://www.infobiotics.net/enrichnet.
[22] Glaab E, Baudot A, Krasnogor N, and Valencia A. Extending pathways and processes using molecular interaction networks to
analyse cancer genome data. BMC Bioinformatics RECOMB Computational Cancer Biology 2010, 11(1):597, 2010.
[23] Glaab E, Garibaldi J, and Krasnogor N. Learning pathway-based decision rules to classify microarray cancer samples. In
D Schomburg and A Grote, editors, German Conference on Bioinformatics 2010, volume 173 of Lecture Notes in Informatics,
pages 123–134. Gesellschaft fuer Informatik, 2010.
[24] Glaab E, Garibaldi J, and Krasnogor N. vrmlgen: An R Package for 3D Data Visualization on the Web. J Stat Software, 36(8):1,
2010.
182
Bibliography 183
[25] Wood I, Visscher P, and Mengersen K. Classification based upon gene expression data: bias and precision of error rates.
Bioinformatics, 23(11):1363, 2007.
[26] Rebhan M, Chalifa-Caspi V, Prilusky J, and Lancet D. GeneCards: a novel functional genomics compendium with automated
data mining and query reformulation support. Bioinformatics, 14(8):656, 1998.
[27] Edgar R, Domrachev M, and Lash A. Gene Expression Omnibus: NCBI gene expression and hybridization array data reposi-
tory. Nucleic Acids Res, 30(1):207, 2002.
[28] Hubbard TJ, Aken BL, Ayling S, Ballester B, et al. Ensembl 2009. Nucleic Acids Res, 37(Database issue):D690, 2009.
[29] Dennis Jr G, Sherman B, Hosack D, Yang J, et al. DAVID: database for annotation, visualization, and integrated discovery.
Genome Biol, 4(5):P3, 2003.
[30] Ashburner M, Ball C, Blake J, Botstein D, et al. Gene Ontology: tool for the unification of biology. Nat Genet, 25(1):25, 2000.
[31] Kanehisa M and Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res, 28(1):27, 2000.
[32] Nishimura D. BioCarta. Biotech Software Internet Report, 2(3):117, 2001.
[33] RNAnalyze: RNA sequencing data enrichment analysis, 2010. http://bree.cs.nott.ac.uk/R-php-1/RNAseq.
[34] Futreal P, Coin L, Marshall M, Down T, et al. A census of human cancer genes. Nat Rev Cancer, 4(3):177, 2004.
[35] Bassel GW, Lan H, Glaab E, Gibbs DJ, et al. A genome-wide network model capturing seed germination reveals co-ordinated
regulation of plant cellular phase transitions. Proc Natl Acad Sci USA, 108(23):9709, 2011. http://vseed.nottingham.ac.
uk.
[36] Kanehisa M et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res, 34(Database
Issue):D354, 2006.
[37] Joshi-Tope G, Gillespie M, Vastrik I, D’Eustachio P, et al. Reactome: a knowledgebase of biological pathways. Nucleic Acids
Res, 33(Database Issue):D428, 2005.
[38] U.S. National Institute of Cancer. A to Z List of Cancers, 2011. http://www.cancer.gov/cancertopics/types/
alphalist.
[39] World Health Organization. Cancer, 2007. http://www.who.int/mediacentre/factsheets/fs297/en.
[40] Cancer Research UK. Cancer incidence by age - UK statistics, 2011. http://info.cancerresearchuk.org/cancerstats/
incidence/age.
[41] Reik W and Walter J. Genomic imprinting: parental influence on the genome. Nat Rev Genet, 2(1):21, 2001.
[42] Tayles N. Anemia, genetic diseases, and malaria in prehistoric mainland Southeast Asia. Am J Phys Anthropol, 101(1):11,
1996.
[43] Allison A. Protection afforded by sickle-cell trait against subtertian malarial infection. Br Med J, 1(4857):290, 1954.
[44] Hesdorffer C, Markowitz D, Ward M, and Bank A. Somatic gene therapy. Hematol Oncol Clin North Am, 5(3):423, 1991.
[45] Vela´zquez F, Matson D, Guerrero M, Shults J, et al. Serum antibody as a marker of protection against natural rotavirus infection
and disease. J Infect Dis, 182(6):1602, 2000.
[46] Fahey J, Taylor J, Detels R, Hofmann B, et al. The prognostic value of cellular and serologic markers in infection with human
immunodeficiency virus type 1. N Engl J Med, 322(3):166, 1990.
[47] Chen P, Ratcliff G, Belle S, Cauley J, et al. Cognitive tests that best discriminate between presymptomatic AD and those who
remain nondemented. Neurology, 55(12):1847, 2000.
[48] Edstro¨m G. Rheumatoid arthritis and Still’s disease in children a survey of 161 cases. Arthritis Rheumatism, 1(6):497, 1958.
[49] Pyorala K, Backer G, Graham I, Goole-Wilson P, et al. Prevention of coronary heart disease in clinical practice. In Annales de
Cardiologie et d’Angeiologie, volume 44, pages 379–388. Paris, L’Expansion scientifique francaise, 1995.
[50] Aronson J. Biomarkers and surrogate endpoints. Br J Clin Pharmacol, 59(5):491, 2005.
[51] Colburn W and Lee J. Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling. Clin Pharmacokinet,
42(12):997, 2003.
[52] Rarey M, Kramer B, Lengauer T, and Klebe G. A fast flexible docking method using an incremental construction algorithm. J
Mol Biol, 261(3):470, 1996.
[53] Rarey M and Dixon J. Feature trees: a new molecular similarity measure based on tree matching. J Comput Aided Mol Des,
12(5):471, 1998.
[54] Lemmen C, Lengauer T, and Klebe G. FLEXS: a method for fast flexible ligand superposition. J Med Chem, 41(23):4502,
1998.
[55] Kubinyi H. QSAR: Hansch analysis and related approaches. Wiley-VCH, Weinheim, 1993.
[56] Kim K, Greco G, and Novellino E. A critical review of recent CoMFA applications. Perspect Drug Discov Des, 12:257, 1998.
[57] Shaw K, Woods C, and Mulholland A. QM and QM/MM Approaches to Evaluating Binding Affinities. Wiley-VCH, Weinheim,
2008.
[58] Pusztai L and Leyland-Jones B. Promises and caveats of in silico biomarker discovery. Br J Cancer, 99(3):385, 2008.
[59] Dearden J. In silico prediction of ADMET properties: how far have we come? Expert Opin Drug Metab Toxicol, 3(5):635,
2007.
[60] Beard D and Kushmerick M. Strong inference for systems biology. PLoS Comput Biol, 5(8):347, 2009.
Bibliography 184
[61] van’t Veer L, Dai H, van de Vijver M, and He Y. Gene expression profiling predicts clinical outcome of breast cancer. Nature,
415(6871):530, 2002.
[62] Heid C, Stevens J, Livak K, and Williams P. Real time quantitative PCR. Genome Res, 6(10):986, 1996.
[63] Prader A, Labhart A, and Willi H. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach mya-
tonieartigem Zustand im Neugeborenenalter. Schweiz Med Wochenschr, 86:1260, 1956.
[64] Angelman H. Puppet Children A Report on Three Cases. Dev Med Child Neurol, 7(6):681, 1965.
[65] Lichtenstein P, Holm N, Verkasalo P, Iliadou A, et al. Environmental and heritable factors in the causation of cancer–analyses
of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med, 343(2):78, 2000.
[66] Crow J. The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet, 1(1):40, 2000.
[67] Bozinov D and Rahnenfu¨hrer J. Unsupervised technique for robust target separation and analysis of DNA microarray spots
through adaptive pixel clustering, 2002.
[68] Ahmed A, Vias M, Iyer N, Caldas C, et al. Microarray segmentation methods significantly influence data precision. Nucleic
Acids Res, 32(5):e50, 2004.
[69] Bolstad B, Irizarry R, Astrand M, and Speed T. A comparison of normalization methods for high density oligonucleotide array
data based on variance and bias. Bioinformatics, 19(2):185, 2003.
[70] Smyth G. Limma: linear models for microarray data. Springer-Verlag Berlin, Heidelberg, 2005.
[71] McClure J and Wit E. Post-normalization quality assessment visualization of microarray data. Comp Funct Genomics, 4:460,
2003.
[72] Piper M, Daran-Lapujade P, Bro C, Regenberg B, et al. Reproducibility of oligonucleotide microarray transcriptome analyses.
J Biol Chem, 277(40):37001, 2002.
[73] Szabo A, Perou C, Karaca M, Perreard L, et al. Statistical modeling for selecting housekeeper genes. Genome Biol, 5(8):R59,
2004.
[74] Fan J and Niu Y. Selection and validation of normalization methods for c-DNA microarrays using within-array replications.
Bioinformatics, 23(18):2391, 2007.
[75] Cleveland W. LOWESS: A program for smoothing scatterplots by robust locally weighted regression. Am Stat, 35, 1981.
[76] Yang Y, Dudoit S, Luu P, Lin D, et al. Normalization for cDNA microarray data: a robust composite method addressing single
and multiple slide systematic variation. Nucleic Acids Res, 30(4):e15, 2002.
[77] Buness A, Huber W, Steiner K, Su¨ltmann H, et al. arrayMagic: two-colour cDNAmicroarray quality control and preprocessing.
Bioinformatics, 21(4):554, 2005.
[78] Workman C, Jensen L, Jarmer H, Berka R, et al. A new non-linear normalization method for reducing variability in DNA
microarray experiments. Genome Biol, 3:1, 2002.
[79] Davis P. B-splines and geometric design. SIAM News, 29(5), 1996.
[80] Huber W, von Heydebreck A, Su¨ltmann H, Poustka A, et al. Variance stabilization applied to microarray data calibration and
to the quantification of differential expression. Bioinformatics, 18(1):96, 2002.
[81] Durbin B, Hardin J, Hawkins D, and Rocke D. A variance-stabilizing transformation for gene-expression microarray data.
Bioinformatics, 18:105, 2002.
[82] Wu Z and Irizarry R. Pre-processing of oligonucleotide array data. Nat Biotechnol, 22(6):656, 2004.
[83] Turro E, Bochkina N, Hein A, and Richardson S. BGX: a Bioconductor package for the Bayesian integrated analysis of
Affymetrix GeneChips. BMC Bioinformatics, 8(1):439, 2007.
[84] Pearson R, Liu X, Sanguinetti G, Milo M, et al. puma: a Bioconductor package for propagating uncertainty in microarray
analysis. BMC Bioinformatics, 10(1):211, 2009.
[85] Ono N, Suzuki S, Furusawa C, Agata T, et al. An improved physico-chemical model of hybridization on high-density oligonu-
cleotide microarrays. Bioinformatics, 24(10):1278, May 2008.
[86] Quackenbush J. Microarray data normalization and transformation. Nat Genet, 32:496, 2002.
[87] Hoaglin D, Mosteller F, and Tukey J. Understanding robust and exploratory data analysis. Wiley, New York, NJ, USA, 1983.
[88] Li C and Wong W. Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc
Natl Acad Sci USA, 98(1):31, 2001.
[89] Lazaridis E, Sinibaldi D, Bloom G, Mane S, et al. A simple method to improve probe set estimates from oligonucleotide arrays.
Math Biosci, 176(1):53, 2002.
[90] Bolstad B. Low-level Analysis of High-density Oligonucleotide Array Data: Background, Normalization and Summarization.
Ph.D. thesis, University of California, 2004.
[91] Tukey J and Mosteller F. Data Analysis and Regression. Addison Wesley Reading MA USA, 1977.
[92] Stark C, Breitkreutz B, Reguly T, Boucher L, et al. BioGRID: a general repository for interaction datasets. Nucleic acids
research, 34(Database Issue):D535, 2006.
[93] Mewes H, Heumann K, Kaps A, Mayer K, et al. MIPS: a database for genomes and protein sequences. Nucleic Acids Res,
27(1):44, 1999.
[94] Xenarios I, Salwinski L, Duan X, Higney P, et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular
networks of protein interactions. Nucleic Acids Res, 30(1):303, 2002.
Bibliography 185
[95] Chatr-Aryamontri A, Ceol A, Palazzi L, Nardelli G, et al. MINT: a Molecular INTeraction database. Nucleic Acids Res,
35(Database Issue):D572, 2007.
[96] Peri S, Navarro J, Amanchy R, Kristiansen T, et al. Development of human protein reference database as an initial platform for
approaching systems biology in humans. Genome Res, 13(10):2363, 2003.
[97] Hermjakob H, Montecchi-Palazzi L, Lewington C, Mudali S, et al. IntAct: an open source molecular interaction database.
Nucleic Acids Res, 32(Database Issue):D452, 2004.
[98] von Mering C, Krause R, Snel B, Cornell M, et al. Comparative assessment of large-scale data sets of protein–protein interac-
tions. Nature, 417(6887):399, 2002.
[99] Hermjakob H, Montecchi-Palazzi L, Bader G, Wojcik J, et al. The HUPO PSI’s molecular interaction formata community
standard for the representation of protein interaction data. Nat Biotechnol, 22(2):177, 2004.
[100] Harris M, Clark J, Ireland A, Lomax J, et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res,
32(Database issue):D258, 2004.
[101] Jain S and Bader G. An improved method for scoring protein-protein interactions using semantic similarity within the Gene
Ontology. BMC Bioinformatics, 11(1):562, 2010.
[102] Resnik P. Semantic similarity in a taxonomy: An information-based measure and its application to problems of ambiguity in
natural language. J Artif Intell Res, 11(95):130, 1999.
[103] Jiang JJ and Conrath DW. Semantic Similarity Based on Corpus Statistics and Lexical Taxonomy. In International Conference
Research on Computational Linguistics, pages 19–33. September 1997.
[104] Dandekar T, Snel B, Huynen M, and Bork P. Conservation of gene order: a fingerprint of proteins that physically interact.
Trends Biochem Sci, 23(9):324, 1998.
[105] Overbeek R, Fonstein M, D’Souza M, Pusch G, et al. The use of gene clusters to infer functional coupling. Proc Natl Acad Sci
USA, 96(6):2896, 1999.
[106] Enright A, Iliopoulos I, Kyrpides N, and Ouzounis C. Protein interaction maps for complete genomes based on gene fusion
events. Nature, 402(6757):86, 1999.
[107] Marcotte E, Pellegrini M, Ng H, Rice D, et al. Detecting protein function and protein-protein interactions from genome
sequences. Science, 285(5428):751, 1999.
[108] Suhre K. Inference of Gene Function Based on Gene Fusion Events: The Rosetta-Stone Method. Methods Mol Biol, 396:31,
2007.
[109] Matthews LR, Vaglio P, Reboul J, Ge H, et al. Identification of Potential Interaction Networks Using Sequence-Based Searches
for Conserved Protein-Protein Interactions or ”Interologs”. Genome Res, 11(12):2120, December 2001.
[110] Pellegrini M, Marcotte E, Thompson M, Eisenberg D, et al. Assigning protein functions by comparative genome analysis:
protein phylogenetic profiles. Proc Natl Acad Sci USA, 96(8):4285, 1999.
[111] Marcotte E, Xenarios I, Van Der Bliek A, and Eisenberg D. Localizing proteins in the cell from their phylogenetic profiles.
Proc Natl Acad Sci USA, 97(22):12115, 2000.
[112] Bhardwaj N and Lu H. Correlation between gene expression profiles and protein–protein interactions within and across
genomes. Bioinformatics, 21(11):2730, 2005.
[113] Huh W, Falvo J, Gerke L, Carroll A, et al. Global analysis of protein localization in budding yeast. Nature, 425(6959):686,
2003.
[114] Pazos F and Valencia A. In silico two-hybrid system for the selection of physically interacting protein pairs. Proteins Struct
Funct Bioinf , 47(2):219, 2002.
[115] de Lichtenberg U, Jensen L, Brunak S, and Bork P. Dynamic complex formation during the yeast cell cycle. Science,
307(5710):724, 2005.
[116] Chagoyen M, Carmona-Saez P, Gil C, Carazo J, et al. A literature-based similarity metric for biological processes. BMC
Bioinformatics, 7(1):363, 2006.
[117] Liu G, Li J, and Wong L. Assessing and predicting protein interactions using both local and global network topological metrics.
Genome Inform, 21:253, 2008.
[118] Topinka C and Shyu C. Predicting cancer interaction networks using text-mining and structure understanding. In AMIA Annual
Symposium Proceedings, volume 2006, page 1123. American Medical Informatics Association, 2006.
[119] Lage K, Karlberg E, Størling Z, O´lason P, et al. A human phenome-interactome network of protein complexes implicated in
genetic disorders. Nat Biotechnol, 25(3):309, 2007.
[120] Singh R, Park D, Xu J, Hosur R, et al. Struct2Net: a web service to predict protein–protein interactions using a structure-based
approach. Nucleic Acids Res, 38(Web Server issue):W508, 2010.
[121] Skrabanek L, Saini H, Bader G, and Enright A. Computational prediction of protein–protein interactions. Mol Biotechnol,
38(1):1, 2008.
[122] Baraba´si A and Albert R. Emergence of scaling in random networks. Science, 286(5439):509, 1999.
[123] Chen L, Liu H, and Friedman C. Gene name ambiguity of eukaryotic nomenclatures. Bioinformatics, 21(2):248, 2005.
[124] Maglott D, Ostell J, Pruitt KD, and Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res,
35(Database issue), 2007.
Bibliography 186
[125] Alibe´s A, Yankilevich P, et al. IDconverter and IDClight: Conversion and annotation of gene and protein IDs. BMC Bioinfor-
matics, 8(1):9, 2007.
[126] Bussey K, Kane D, Sunshine M, Narasimhan S, et al. MatchMiner: a tool for batch navigation among gene and gene product
identifiers. Genome Biol, 4(4):R27, 2003.
[127] Durinck S, Spellman P, Birney E, and Huber W. Mapping identifiers for the integration of genomic datasets with the
R/Bioconductor package biomaRt. Nat Protoc, 4(8):1184, 2009.
[128] Durinck S, Moreau Y, Kasprzyk A, Davis S, et al. BioMart and Bioconductor: a powerful link between biological databases
and microarray data analysis. Bioinformatics, 21(16):3439, 2005.
[129] Fang H, Murphy K, Jin Y, Kim J, et al. Human gene name normalization using text matching with automatically extracted
synonym dictionaries. In Proceedings of the Workshop on Linking Natural Language Processing and Biology: Towards Deeper
Biological Literature Analysis, pages 41–48. Association for Computational Linguistics, 2006.
[130] Schuemie M, Jelier R, and Kors J. Peregrine: Lightweight gene name normalization by dictionary lookup. In Proceedings of
the Second BioCreative Challenge Evaluation Workshop, pages 131–133. 2007.
[131] Wermter J, Tomanek K, and Hahn U. High-performance gene name normalization with GeNo. Bioinformatics, 25(6):815,
2009.
[132] Morgan A, Lu Z, Wang X, Cohen A, et al. Overview of BioCreative II gene normalization. Genome Biol, 9(Suppl 2):S3, 2008.
[133] Hakenberg J, Plake C, Royer L, Strobelt H, et al. Gene mention normalization and interaction extraction with context models
and sentence motifs. Genome Biol, 9(Suppl 2):S14, 2008.
[134] Hirschman L, Yeh A, Blaschke C, and Valencia A. Overview of BioCreative: critical assessment of information extraction for
biology. BMC Bioinformatics, 6(Suppl 1):S1, 2005.
[135] Neves M, Carazo J, and Pascual-Montano A. Moara: a Java library for extracting and normalizing gene and protein mentions.
BMC Bioinformatics, 11(1):157, 2010.
[136] Crim J, McDonald R, and Pereira F. Automatically annotating documents with normalized gene lists. BMC Bioinformatics,
6(Suppl 1):S13, 2005.
[137] McDonald R and Pereira F. Identifying gene and protein mentions in text using conditional random fields. BMC Bioinformatics,
6(Suppl 1):S6, 2005.
[138] Cohen A. Unsupervised gene/protein named entity normalization using automatically extracted dictionaries. In Proceedings of
the ACL-ISMB workshop on linking biological literature, ontologies and databases: Mining biological semantics, pages 17–24.
Association for Computational Linguistics, 2005.
[139] Hanisch D, Fundel K, Mevissen H, Zimmer R, et al. ProMiner: rule-based protein and gene entity recognition. BMC Bioinfor-
matics, 6(Suppl 1):S14, 2005.
[140] Torii M, Hu Z, Wu C, and Liu H. BioTagger-GM: a gene/protein name recognition system. J Am Med Inform Assoc, 16(2):247,
2009.
[141] Lowe H and Barnett G. Understanding and using the medical subject headings (MeSH) vocabulary to perform literature
searches. JAMA, 271(14):1103, 1994.
[142] Hastie T, Tibshirani R, and Walther G. Estimating the number of data clusters via the Gap statistic. J Roy Stat Soc B, 63:411,
2001.
[143] van’t Veer et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415:530, 2002.
[144] Ma S, Song X, and Huang J. Supervised group Lasso with applications to microarray data analysis. BMC Bioinformatics,
8(1):60, 2007.
[145] Tritchler D, Parkhomenko E, and Beyene J. Filtering genes for cluster and network analysis. BMC Bioinformatics, 10(1):193,
2009.
[146] Zou H, Hastie T, and Tibshirani R. Sparse principal component analysis. J Comp Graph Stat, 15(2):265, 2006.
[147] Blumer A, Ehrenfeucht A, Haussler D, and Warmuth M. Occam’s razor. Inf Process Lett, 24(6):377, 1987.
[148] Peterson D and Thaut M. Model and feature selection in microarray classification. 2004 CIBCB04 Proceedings of the 2004
IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology, pages 56–60, 2004.
[149] Cilibrasi R and Vitanyi P. Clustering by compression. IEEE T Inform Theory, 51(4):1523, 2005.
[150] Lo¨nnstedt I and Speed T. Replicated microarray data. Stat Sin, 12(1):31, 2002.
[151] Smyth G. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat
Appl Genet Mol Biol, 3(1):3, 2004.
[152] Bonferroni C. Teoria statistica delle classi e calcolo delle probabilita. Pubblicazioni del R Istituto Superiore di Scienze
Economiche e Commerciali di Firenze, 8, 1936.
[153] Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6:65, 1979.
[154] Benjamini Y and Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat, pages
1165–1188, 2001.
[155] Cortes C and Vapnik V. Support-vector networks. Machine learning, 20(3):273, 1995.
[156] Kononenko I. Estimating attributes: Analysis and extensions of RELIEF. In Machine Learning, pages 171–182. Springer-
Verlag Berlin, Heidelberg, 1994.
Bibliography 187
[157] Kira K and Rendell L. The Feature Selection Problem: Traditional Methods and a New Algorithm. Proceedings of the Tenth
National Conference on Artificial Intelligence, 1992.
[158] Robnik-Sˇikonja M and Kononenko I. Theoretical and empirical analysis of ReliefF and RReliefF. Machine learning, 53(1):23,
2003.
[159] Sun Y, Goodison S, Li J, Liu L, et al. Improved breast cancer prognosis through the combination of clinical and genetic markers.
Bioinformatics, 23(1):30, 2007.
[160] Hall M. Correlation-based Feature Selection for Discrete and Numeric Class Machine Learning. In Proc. Int. Conf. Mach.
Learn., pages 359–366. Morgan Kaufmann, San Francisco, CA, 2000.
[161] Hall M. Correlation-based feature selection for discrete and numeric class machine learning. Proceedings of the Seventeenth
International Conference on Machine Learning, pages 359–366, 2000.
[162] Wu Y and Zhang A. Feature selection for classifying high-dimensional numerical data. In Proceedings of the 2004 IEEE
Computer Society Conference on Computer Vision and Pattern Recognition, pages 251–258. 2004.
[163] Zhang J and Deng H. Gene selection for classification of microarray data based on the Bayes error. BMC Bioinformatics,
8(1):370, 2007.
[164] Fukunaga K and Kessell D. Nonparametric Bayes error estimation using unclassified samples. IEEE T Inform Theory,
19(4):434, 2002.
[165] Hellman M and Raviv J. Probability of error, equivocation, and the Chernoff bound. IEEE T Inform Theory, 16(4):368, 1970.
[166] Fano R. Transmission of information. M.I.T. Press New York, 1961.
[167] Guo S, Lyu M, Lok T, and Kong H. Gene Selection Based on Mutual Information for the Classification of Multi-class Cancer.
Lect Notes Comput Sci, 4115:454, 2006.
[168] Witten I and Frank E. Data Mining: Practical Machine Learning Tools and Techniques. 2005.
[169] Li M and Vitanyi P. An introduction to Kolmogorov complexity and its applications. Springer-Verlag, New York, NY, USA,
2008.
[170] Vitanyi P, Balbach F, Cilibrasi R, and Li M. Normalized information distance. Inform Theory Stat Learn, pages 45–82, 2009.
[171] Koller D and Sahami M. Toward optimal feature selection. In Proc. Int. Conf. Mach. Learn., pages 284–292. 1996.
[172] Subramani P, Sahu R, and Verma S. Feature selection using Haar wavelet power spectrum. BMC Bioinformatics, 7(1):432,
2006.
[173] Liu Y. Wavelet feature selection for microarray data. In Proceedings of the IEEE/NIH on Life Science Systems and Applications
Workshop, pages 205–208. Bethesda, MD, USA, 2007.
[174] Nanni L and Lumini A. Wavelet selection for disease classification by dna microarray data. Expert Syst Appl, 38:990, January
2011.
[175] Pudil P, Novovicova´ J, and Kittler J. Floating search methods in feature selection. Pattern Recogn Lett, 15(11):1119, 1994.
[176] Skurichina M and Duin R. Combining Feature Subsets in Feature Selection. Proceedings of the 6th International Workshop on
Multiple Classifier Systems, pages 165–175, 2005.
[177] Deutsch JM. Evolutionary algorithms for finding optimal gene sets in microarray prediction. Bioinformatics, 19(1):45, 2003.
[178] Freitas A. The principle of transformation between efficiency and effectiveness: towards a fair evaluation of the cost-
effectiveness of KDD techniques. In Proceedings of the First European Symposium on Principles of Data Mining and Knowl-
edge Discovery, pages 299–306. Springer-Verlag Berlin, Heidelberg, 1997.
[179] Inza I. Gene selection by sequential search wrapper approaches in microarray cancer class prediction. J Intelligent and Fuzzy
Systems, 12:25, 2002.
[180] Li L, Pedersen L, Darden T, and Weinberg C. Computational Analysis of Leukemia Microarray Expression Data Using the
GA/KNN Method. In Methods of Microarray Data Analysis, pages 81–95. Kluwer Academic Publishers, 2002.
[181] Golub T, Slonim D, Tamayo P, Huard C, et al. Molecular Classification of Cancer: Class Discovery and Class Prediction by
Gene Expression Monitoring. Science, 286:531, 1999.
[182] Blanco R, Larranaga P, Inza I, and Sierra B. Selection of highly accurate genes for cancer classification by estimation of
distribution algorithms. Workshop of Bayesian Models in Medicine, pages 29–34, 2001.
[183] Bishop C and Nasrabadi N. Pattern Recognition and Machine Learning. Journal of Electronic Imaging, 16(4):9901, 2007.
[184] Tibshirani R. Regression shrinkage and selection via the lasso. J Roy Statist Soc Ser B, 58:267, 1996.
[185] Osborne M, Presnell B, and Turlach B. On the lasso and its dual. J Comp Graph Stat, 9:319, 2000.
[186] Roth V. The generalized LASSO: a wrapper approach to gene selection foe microarray data. Technical report, Dept. of
Computer Science, University of Bonn, 2002.
[187] Liu J, Iba H, and Ishizuka M. Selecting informative genes with parallel genetic algorithms in tissue classification. Genome
Inform, 12:14, 2001.
[188] Ooi C and Tan P. Genetic algorithms applied to multi-class prediction for the analysis of gene expression data. Bioinformatics,
19(1):37, 2003.
[189] Guyon I, Weston J, Barnhill S, and Vapnik V. Gene Selection for Cancer Classification using Support Vector Machines.Machine
Learning, 46(1):389, 2002.
Bibliography 188
[190] Breiman L. Manual – Setting Up, Using, and Understanding Random Forests V4.0, 2003. ftp://ftp.stat.berkeley.edu/
pub/users/breiman.
[191] Breiman L. Random forests. Machine Learning, 45(1):5, 2001.
[192] Gini C. Measurement of Inequality of Incomes. The Economic Journal, 31(121):124, 1921.
[193] Diaz-Uriarte R and Alvarez de Andres S. Gene selection and classification of microarray data using random forest. BMC
Bioinformatics, 7(1):1471, 2006.
[194] Jiang H, Deng Y, Chen H, Tao L, et al. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma
marker genes. BMC Bioinformatics, 5(1):81, 2004.
[195] Nicodemus K, Malley J, Strobl C, and Ziegler A. The behaviour of random forest permutation-based variable importance
measures under predictor correlation. BMC Bioinformatics, 11(1):110, 2010.
[196] Hoerl A and Kennard R. Ridge regression: Biased estimation for nonorthogonal problems. Technometrics, 42(1):80, 2000.
[197] Bielza C, Robles V, and Larran¸aga P. Regularized logistic regression without a penalty term: An application to cancer classifi-
cation with microarray data. Expert Syst Appl, 38(5):5110, 2011.
[198] Xing EP, Jordan MI, and Karp RM. Feature selection for high-dimensional genomic microarray data. In Proc. Int. Conf. Mach.
Learn., pages 601–608. Morgan Kaufmann, San Francisco, CA, 2001.
[199] El Akadi A, Amine A, El Ouardighi A, and Aboutajdine D. A two-stage gene selection scheme utilizing MRMR filter and GA
wrapper. Knowl Inform Syst, pages 1–14, 2010.
[200] Leung Y and Hung Y. A multiple-filter-multiple-wrapper approach to gene selection and microarray data classification. IEEE
ACM Trans Comput Biol Bioinform, 7(1):108, 2010.
[201] Raczynski L, Wozniak K, Rubel T, and Zaremba K. Application of Density Based Clustering to Microarray Data Analysis. Int
J Electron Telecommun, 56(3):281, 2010.
[202] Karypis G, Han E, and Kumar V. Chameleon: Hierarchical clustering using dynamic modeling. IEEE Computer, 32(8):68,
2002.
[203] Hartigan J and Wong M. A K-means clustering algorithm. JR Stat Soc Ser C, 28:100, 1979.
[204] MacQueen J. Some methods for classification and analysis of multivariate observations. Proceedings of the Fifth Berkeley
Symposium on Mathematical Statistics and Probability, 1:281, 1967.
[205] Forgy E. Cluster analysis of multivariate data: Efficiency vs. interpretability of classifications. Biometrics, 21:768, 1965.
[206] Lloyd S. Least squares quantization in PCM. Special issue on quantization. IEEE Trans Inform Theory, 28:129, 1982.
[207] Kaufman L and Rousseeuw P. Finding groups in data: an introduction to cluster analysis. Wiley-Interscience, New York, NY,
USA, 1990.
[208] Ng R and Han J. CLARANS: A Method for Clustering Objects for Spatial Data Mining. IEEE T Knowl Data En, 14:1003,
2002.
[209] Kohonen T. Self-Organizing Maps. Springer-Verlag Berlin, Heidelberg, Berlin, 2001.
[210] Bezdek J. Pattern recognition with fuzzy objective function algorithms. Kluwer Academic Publishers Norwell, MA, USA,
1981.
[211] Stutz C. Anwendungsspezifische Fuzzy-Clustermethoden. Ph.D. thesis, Dissertation Fakultat fur Informatik, Technische Uni-
versitat Munchen, Germany, 1999.
[212] Ward J. Hierarchical grouping to optimize an objective function. J Am Stat Assoc, 58:236, 1963.
[213] McQuitty L. Similarity Analysis by Reciprocal Pairs for Discrete and Continuous Data. Educ Psychol Meas, 26:825, 1966.
[214] Macnaughton-Smith P. Some Statistical and Other Numerical Techniques for Classifying Individuals. Her Majesty’s Stationery
Office: London, 1965.
[215] Ben-Dor A and Yakhini Z. Clustering gene expression patterns. In Proceedings of the Third Annual International Conference
on Computational molecular biology, RECOMB’99, pages 33–42. ACM, New York, NY, USA, 1999.
[216] Heller K and Ghahramani Z. Bayesian hierarchical clustering. In Proc. Int. Conf. Mach. Learn., pages 297–304. ACM, 2005.
[217] Savage R, Heller K, Xu Y, Ghahramani Z, et al. R/BHC: fast Bayesian hierarchical clustering for microarray data. BMC
Bioinformatics, 10(1):242, 2009.
[218] Kim E, Kim S, Ashlock D, and Nam D. MULTI-K: accurate classification of microarray subtypes using ensemble k-means
clustering. BMC Bioinformatics, 10(1):260, 2009.
[219] Fred A and Jain A. Combining multiple clusterings using evidence accumulation. IEEE Trans Pattern Anal Mach Intell, pages
835–850, 2005.
[220] Fern X and Brodley C. Solving cluster ensemble problems by bipartite graph partitioning. In Proceedings of the Twenty-First
International Conference on Machine learning, page 36. ACM, 2004.
[221] Ghosh J, Strehl A, and Merugu S. A consensus framework for integrating distributed clusterings under limited knowledge
sharing. In Proceedings of the NSF Workshop on Next Generation Data Mining, pages 99–108. 2002.
[222] Iam-On N, Boongoen T, and Garrett S. LCE: a link-based cluster ensemble method for improved gene expression data analysis.
Bioinformatics, 26(12):1513, 2010.
[223] Iam-On N and Garrett S. Linkclue: A matlab package for link-based cluster ensembles. J Stat Software, 36(9):1, 2010.
Bibliography 189
[224] Reuther P, Walter B, Ley M, Weber A, et al. Managing the quality of person names in DBLP. Res Adv Tech Digit Libr, pages
508–511, 2006.
[225] Marinakis Y, Marinaki M, and Matsatsinis N. A hybrid clustering algorithm based on honey bees mating optimization and
greedy randomized adaptive search procedure. Learning and Intelligent Optimization, pages 138–152, 2008.
[226] Zhang A. Advanced Analysis of Gene Expression Microarray Data. World Scientific Publishing Co. Pte. Ltd., Singapore, 2006.
[227] Rousseeuw P. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math, 20:53,
1987.
[228] Dunn J. Well-separated clusters and optimal fuzzy partitions. Cybernetics and Systems, 4(1):95, 1974.
[229] Hubert L and Schultz J. Quadratic assignment as a general data analysis strategy. Br J Math Stat Psychol, 29:190, 1976.
[230] Milligan G and Cooper M. An examination of procedures for determining the number of clusters in a data set. Psychometrika,
50(2):159, 1985.
[231] Brock G, Pihur V, Datta S, and Datta S. clValid, an R package for cluster validation. J Stat Software, 25(4):1, 2008.
[232] Handl J, Knowles J, and Kell D. Computational cluster validation in post-genomic data analysis. Bioinformatics, 21(15):3201,
2005.
[233] Hubert L and Arabie P. Comparing partitions. Journal of Classification, 2:193, 1985.
[234] Tavazoie S, Hughes J, Campbell M, Cho R, et al. Systematic determination of genetic network architecture. Nat Genet, 22:281,
1999.
[235] Boutin F and Hascoet M. Cluster validity indices for graph partitioning. Proceedings of the Eighth International Conference
on Information Visualisation, pages 376–381, 2004.
[236] Alon U, Barkai N, Notterman D, Gish K, et al. Broad patterns of gene expression revealed by clustering analysis of tumour and
normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA, 96(12):6745, 1999.
[237] Fisher R. The use of multiple measurements in taxonomic problems. Ann Eugen, 7:179, 1936.
[238] Ancona N, Maglietta R, D’Addabbo A, Liuni S, et al. Regularized least squares cancer classifiers from DNA microarray data.
BMC Bioinformatics, 6(Suppl 4):S2, 2005.
[239] Tibshirani R, Hastie T, Narasimhan B, and Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression.
Proc Natl Acad Sci USA, 99(10):6567, 2002.
[240] Guo Y, Hastie T, and Tibshirani R. Regularized linear discriminant analysis and its application in microarrays. Biostatistics,
8:86, 2007.
[241] Tai F and Pan W. Incorporating prior knowledge of gene functional groups into regularized discriminant analysis of microarray
data. Bioinformatics, 2007.
[242] Theilhaber J, Connolly T, Roman-Roman S, Bushnell S, et al. Finding genes in the C2C12 osteogenic pathway by k-nearest-
neighbor classification of expression data. Genome Res, 12(1):165, 2002.
[243] Day W and Edelsbrunner H. Efficient algorithms for agglomerative hierarchical clustering methods. Journal of Classification,
1(1):7, 1984.
[244] Cleary J and Trigg L. K*: An Instance-based Learner Using an Entropic Distance Measure. In Proceedings of the Twelfth
International Conference on Machine Learning, Tahoe City, California, pages 108–114. Morgan Kaufmann, 1995.
[245] Hastie T and Tibshirani R. Discriminant adaptive nearest neighbor classification. IEEE Trans Pattern Anal Mach Intell,
18(6):607, 2002.
[246] Domeniconi C, Peng J, and Gunopulos D. Locally adaptive metric nearest-neighbor classification. IEEE Trans Pattern Anal
Mach Intell, 24(9):1281, 2002.
[247] Cohen I, Cozman F, Sebe N, Cirelo M, et al. Semisupervised learning of classifiers: Theory, algorithms, and their application
to human-computer interaction. IEEE Trans Pattern Anal Mach Intell, 26(12):1553, 2004.
[248] Driessens K, Reutemann P, Pfahringer B, and Leschi C. Using weighted nearest neighbor to benefit from unlabelled data.
Advances in Knowledge Discovery and Data Mining, pages 60–69, 2006.
[249] Hassan M, Hossain M, Bailey J, and Ramamohanarao K. Improving k-nearest neighbour classification with distance functions
based on receiver operating characteristics. Machine Learning and Knowledge Discovery in Databases, pages 489–504, 2008.
[250] Fujibuchi W and Kato T. Classification of heterogeneous microarray data by maximum entropy kernel. BMC Bioinformatics,
8(1):267, 2007.
[251] Zou H and Hastie T. Regularization and variable selection via the elastic net. J Roy Statist Soc Ser B Methodological, 67(2):301,
2005.
[252] Rosset S and Zhu J. Piecewise linear regularized solution paths. Ann Stat, 35(3):1012, 2007.
[253] Liu Y. Active learning with support vector machine applied to gene expression data for cancer classification. J Chem Inf
Comput Sci, 44(6):1936, 2004.
[254] Sassano M. An empirical study of active learning with support vector machines for Japanese word segmentation. Proceedings
of the 40th Annual Meeting of the Association for Computational Linguistics, pages 505–512, 2001.
[255] Tong S, Koller D, and Kaelbling L. Support Vector Machine Active Learning with Applications to Text Classification. J Mach
Learn Res, 2:45, 2001.
[256] Chu W, Ghahramani Z, Falciani F, and Wild D. Biomarker discovery in microarray gene expression data with Gaussian
processes. Bioinformatics, 21(16):3385, 2005.
Bibliography 190
[257] Cho J, Lee D, Park J, and Lee I. Gene selection and classification from microarray data using kernel machine. FEBS Lett,
571(1-3):93, 2004.
[258] Rosenblatt F. Principles of neurodynamics: Perceptrons and the theory of brain mechanisms. Spartan Books, Washington,
D.C., USA, 1962.
[259] Schwarzer G, Vach W, and Schumacher M. On the misuses of artificial neural networks for prognostic and diagnostic classifi-
cation in oncology. Stat Med, 19(4):541, 2000.
[260] Fariselli P, Olmea O, Valencia A, and Casadio R. Progress in predicting inter-residue contacts of proteins with neural networks
and correlated mutations. Proteins, 45(S5):157, 2001.
[261] Fariselli P and Casadio R. Prediction of disulfide connectivity in proteins. Bioinformatics, 17(10):957, 2001.
[262] Fariselli P and Casadio R. HTP: a neural network-based method for predicting the topology of helical transmembrane domains
in proteins. Computer applications in the biosciences CABIOS, 12(1):41, 1996.
[263] Khan J, Wei J, Ringne´r M, Saal L, et al. Classification and diagnostic prediction of cancers using gene expression profiling and
artificial neural networks. Nat Med, 7(6):673, 2001.
[264] Lancashire L, Rees R, and Ball G. Identification of gene transcript signatures predictive for estrogen receptor and lymph node
status using a stepwise forward selection artificial neural network modelling approach. Artif Intell Med, 43(2):99, 2008.
[265] Lancashire L, Powe D, Reis-Filho J, Rakha E, et al. A validated gene expression profile for detecting clinical outcome in breast
cancer using artificial neural networks. Breast Cancer Res Treat, 120(1):83, 2010.
[266] Ritchie M, White B, Parker J, Hahn L, et al. Optimization of neural network architecture using genetic programming improves
detection and modeling of gene-gene interactions in studies of human diseases. BMC Bioinformatics, 4(1):28, 2003.
[267] Ritchie M, Motsinger A, Bush W, Coffey C, et al. Genetic programming neural networks: a powerful bioinformatics tool for
human genetics. Applied Soft Computing, 7(1):471, 2007.
[268] Towell G, Shavlik J, and Noordewier M. Refinement of approximate domain theories by knowledge-based neural networks. In
Proceedings of the Eighth National Conference on Artificial Intelligence, pages 861–866. 1990.
[269] Yang R, Wang Z, Heng P, and Leung K. Classification of heterogeneous fuzzy data by Choquet integral with fuzzy-valued
integrand. IEEE T Fuzzy Syst, 15(5):931, 2007.
[270] Duch W, Setiono R, and Zurada JM. Computational intelligence methods for rule-based data understanding. In Proceedings of
the IEEE, pages 771–805. 2004.
[271] Duch W, Adamczak R, and Grabczewski K. A new methodology of extraction, optimization and application of crisp and fuzzy
logical rules. IEEE Transactions on Neural Networks, 12(2):277, 2001.
[272] Ve´lez M, Sa´nchez O, Romero S, and Andu´jar J. A new methodology to improve interpretability in neuro-fuzzy TSK models.
Applied Soft Computing, 10(2):578, 2010.
[273] Eiamkanitchat N, Theera-Umpon N, and Auephanwiriyakul S. A novel neuro-fuzzy method for linguistic feature selection and
rule-based classification. In The 2nd International Conference on Computer and Automation Engineering, volume 2, pages
247–252. 2010.
[274] Webb G, Boughton J, and Wang Z. Not so naive bayes: Aggregating one-dependence estimators. Machine Learning, 58(1):5,
2005.
[275] Bressan M and Vitria J. On the selection and classification of independent features. IEEE Trans Pattern Anal Mach Intell,
25(10):1312 , 2003.
[276] Fan L, Poh K, and Zhou P. Partition-conditional ICA for Bayesian classification of microarray data. Expert Syst Appl, 37:8188,
2010.
[277] Miguel H et al. Network-based sparse Bayesian classification. Pattern Recognit, 44(4):886, 2011.
[278] Minka T. A family of algorithms for approximate Bayesian inference. Ph.D. thesis, Massachusetts Institute of Technology, MA,
USA, 2001.
[279] Zhu Y, Shen X, and Pan W. Network-based support vector machine for classification of microarray samples. BMC Bioinfor-
matics, 10(Suppl 1):S21, 2009.
[280] Jacob L, Obozinski G, and Vert J. Group Lasso with overlap and graph Lasso. In Proc. Int. Conf. Mach. Learn., pages 433–440.
ACM, 2009.
[281] Quinlan J. C4.5: Programs for Machine Learning. Morgan Kaufmann, San Francisco, CA, USA, 1993.
[282] Breiman L. Classification and Regression Trees. Chapman & Hall/CRC, Monterey, CA, USA, 1998.
[283] Goodarzi M and Kangavari M. Using Fuzzy Decision Trees for Authentication via Keystroke Timings. In Proceedings of the
4th International Conference on Intelligent Systems Design and Application, pages 1–5. Budapest, Hungary, 2004.
[284] Geman D et al. Classifying gene expression profiles from pairwise mRNA comparisons. Stat Appl Genet Mol Biol, 3:19, 2004.
[285] Tan A, Naiman D, Xu L, Winslow R, et al. Simple decision rules for classifying human cancers from gene expression profiles.
Bioinformatics, 21(20):3896, 2005.
[286] Czajkowski M and Kretowski M. Novel Extension of k-TSP Algorithm for Microarray Classification. New Frontiers in Applied
Artificial Intelligence, pages 456–465, 2008.
[287] Yoon S and Kim S. k-Top Scoring Pair Algorithm for feature selection in SVM with applications to microarray data classifica-
tion. Soft Computing A Fusion of Foundations Methodologies and Applications, 14(2):151, 2010.
Bibliography 191
[288] Li J and Tang X. A new classification model with simple decision rule for discovering optimal feature gene pairs. Comput Biol
Med, 37(11):1637, 2007.
[289] Tsymbal A, Pechenizkiy M, and Cunningham P. Diversity in search strategies for ensemble feature selection. Inform Fusion,
6(1):83, 2005.
[290] Breiman L. Bagging predictors. Machine learning, 24(2):123, 1996.
[291] Efron B and Tibshirani RJ. An Introduction to the Bootstrap. Chapman and Hall/CRC, Monterey, CA, USA, 1 edition, 1994.
[292] Valentini G, Muselli M, and Ruffino F. Cancer recognition with bagged ensembles of support vector machines. Neurocomput-
ing, 56:461, 2004.
[293] Amaratunga D, Cabrera J, and Lee Y. Enriched random forests. Bioinformatics, 24(18):2010, 2008.
[294] Zhang H, Yu C, and Singer B. Cell and tumor classification using gene expression data: construction of forests. Proc Natl Acad
Sci USA, 100(7):4168, 2003.
[295] Chen X, Wang M, and Zhang H. The use of classification trees for bioinformatics. Wiley Interdisciplinary Reviews Data Mining
and Knowledge Discovery, 1(1):55, 2011.
[296] Zhang H and Wang M. Search for the smallest random forest. Stat Interface, 2(3):381, 2009.
[297] Freund Y and Schapire R. Experiments with a new boosting algorithm. In Proc. Int. Conf. Mach. Learn., pages 148–156.
ACM, 1996.
[298] Friedman J, Hastie T, and Tibshirani R. Additive logistic regression: a statistical view of boosting. Ann Stat, 28(2):337, 2000.
[299] Demiriz A, Bennett K, and Shawe-Taylor J. Linear programming boosting via column generation. Machine Learning,
46(1):225, 2002.
[300] Dettling M and Buhlmann P. Boosting for tumour classification with gene expression data. Bioinformatics, 19(9):1061, 2003.
[301] Wolpert D. Stacked generalization. Neural networks, 5(2):241, 1992.
[302] Bell R and Koren Y. Lessons from the Netflix prize challenge. ACM SIGKDD Explorations Newsletter, 9(2):75, 2007.
[303] Warnat P et al. Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes.
BMC Bioinformatics, 6(1):265, 2005.
[304] Johnson W, Li C, and Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods.
Biostatistics, 8:118, 2007.
[305] Benito M, Parker J, Du Q, Wu J, et al. Adjustment of systematic microarray data biases. Bioinformatics, 20(1):105, 2004.
[306] Marron J, Todd M, and Ahn J. Distance-weighted discrimination. J Am Stat Assoc, 102(480):1267, 2007.
[307] Huang D, Sherman B, and Lempicki R. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis
of large gene lists. Nucl Acids Res, 37(1):1, 2009.
[308] Subramanian A, Tamayo P, Mootha V, Mukherjee S, et al. Gene set enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc Natl Acad Sci USA, 102(43):15545, 2005.
[309] Backes C, Keller A, Kuentzer J, Kneissl B, et al. GeneTrail–advanced gene set enrichment analysis. Nucleic Acids Res, 35(suppl
2):W186, 2007.
[310] Kim S and Volsky D. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics, 6(1):144, 2005.
[311] Luo W, Friedman M, Shedden K, Hankenson K, et al. GAGE: generally applicable gene set enrichment for pathway analysis.
BMC Bioinformatics, 10(1):161, 2009.
[312] Al-Shahrour F, Arbiza L, Dopazo H, Huerta-Cepas J, et al. From genes to functional classes in the study of biological systems.
BMC Bioinformatics, 8(1):114, 2007.
[313] Lee H, Braynen W, Keshav K, and Pavlidis P. ErmineJ: tool for functional analysis of gene expression data sets. BMC
Bioinformatics, 6(1):269, 2005.
[314] Tu K, Yu H, and Zhu M. MEGO: gene functional module expression based on gene ontology. Biotechniques, 38:277, 2005.
[315] Nam D, Kim S, Kim S, Yang S, et al. ADGO: analysis of differentially expressed gene sets using composite GO annotation.
Bioinformatics, 22(18):2249, 2006.
[316] Bauer S, Grossmann S, Vingron M, and Robinson P. Ontologizer 2.0–a multifunctional tool for GO term enrichment analysis
and data exploration. Bioinformatics, 24(14):1650, 2008.
[317] Carmona-Saez P, Chagoyen M, Tirado F, Carazo J, et al. GENECODIS: a web-based tool for finding significant concurrent
annotations in gene lists. Genome Biol, 8(1):R3, 2007.
[318] Guo Z et al. Towards precise classification of cancers based on robust gene functional expression profiles. BMC Bioinformatics,
6(1):58, 2005.
[319] Gagneur J, Krause R, Bouwmeester T, and Casari G. Modular decomposition of protein-protein interaction networks. Genome
Biol, 5(8):R57, 2004.
[320] Radicchi F, Castellano C, Cecconi F, Loreto V, et al. Defining and identifying communities in networks. Proc Natl Acad Sci
USA, 101(9):2658, 2004.
[321] Theocharidis A, Van Dongen S, Enright A, and Freeman T. Network visualization and analysis of gene expression data using
BioLayout Express3D. Nat Protoc, 4(10):1535, 2009.
[322] Cerami E, Demir E, Schultz N, Taylor B, et al. Automated network analysis identifies core pathways in glioblastoma. PLoS
ONE, 5(2):e8918, 2010.
Bibliography 192
[323] Ulitsky I, Maron-Katz A, Shavit S, Sagir D, et al. Expander: from expression microarrays to networks and functions. Nat
Protoc, 5(2):303, 2010.
[324] Jiang P and Singh M. SPICi: a fast clustering algorithm for large biological networks. Bioinformatics, 26(8):1105, 2010.
[325] Va´zquez C, Freyre-Gonza´lez J, Gosset G, Loza J, et al. Identification of network topological units coordinating the global
expression response to glucose in Bacillus subtilis and its comparison to Escherichia coli. BMC Microbiol, 9(1):176, 2009.
[326] Vellaichamy A, Dezso˝ Z, JeBailey L, Chinnaiyan A, et al. ”Topological Significance” Analysis of Gene Expression and
Proteomic Profiles from Prostate Cancer Cells Reveals Key Mechanisms of Androgen Response. PLoS ONE, 5(6):e5364,
2010.
[327] Ray M and Zhang W. Analysis of Alzheimer’s disease severity across brain regions by topological analysis of gene co-
expression networks. BMC Syst Biol, 4(1):136, 2010.
[328] Chuang H, Lee E, Liu Y, Lee D, et al. Network-based classification of breast cancer metastasis. Mol Syst Biol, 3(1), 2007.
[329] Rogers G, Moscato P, and Langston M. Graph algorithms for machine learning: a case-control study based on prostate cancer
populations and high throughput transcriptomic data. BMC Bioinformatics, 11(Suppl 4):P21, 2010.
[330] Newman M. Modularity and community structure in networks. Proc Natl Acad Sci USA, 103(23):8577, 2006.
[331] Clauset A, Newman M, and Moore C. Finding community structure in very large networks. Physical Review E, 70(6):66111,
2004.
[332] Pons P and Latapy M. Computing communities in large networks using random walks. J Graph Algorithms Appl, 10(2):191,
2006.
[333] Reichardt J and Bornholdt S. Statistical mechanics of community detection. Physical Review E, 74(1):16110, 2006.
[334] Pizzuti C. Community detection in social networks with genetic algorithms. In Proceedings of the 10th Annual Conference on
Genetic and Evolutionary Computation, pages 1137–1138. ACM, 2008.
[335] Li Z, Zhang S, Wang R, Zhang X, et al. Quantitative function for community detection. Physical Review E, 77(3):36109, 2008.
[336] Bader G and Hogue C. An automated method for finding molecular complexes in large protein interaction networks. BMC
Bioinformatics, 4(1):2, 2003.
[337] Van Dongen S. Graph clustering by flow simulation. Ph.D. thesis, University of Utrecht, Netherlands, 2000.
[338] Moschopoulos C, Pavlopoulos G, Schneider R, Likothanassis S, et al. GIBA: a clustering tool for detecting protein complexes.
BMC Bioinformatics, 10(Suppl 6):S11, 2009.
[339] Rivera C, Vakil R, and Bader J. NeMo: Network Module identification in Cytoscape. BMC Bioinformatics, 11(Suppl 1):S61,
2010.
[340] Sun PG, Gao L, and Han SS. Identification of overlapping and non-overlapping community structure by fuzzy clustering in
complex networks. Inf Sci, 18(6):1060, 2010.
[341] Ahn Y, Bagrow J, and Lehmann S. Link communities reveal multiscale complexity in networks. Nature, 466(7307):761, 2010.
[342] Zarei M and Samani K. Eigenvectors of network complement reveal community structure more accurately. Phys Stat Mech
Appl, 388(8):1721, 2009.
[343] Zhang B and Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol,
4(1):1128, 2005.
[344] Newman M. Assortative mixing in networks. Phys Rev Lett, 89(20):208701, 2002.
[345] Junker B and Schreiber F. Analysis of biological networks. John Wiley & Sons, Hoboken, New Jersey, USA, 2008.
[346] Vapnik V and Chervonenkis A. Theory of Pattern Recognition. Nauka, Moscow, 1974.
[347] Shipp M, Ross K, Tamayo P, Weng A, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling
and supervised machine learning. Nat Med, 8(1):68, 2002.
[348] Singh D, Febbo P, Ross K, Jackson D, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell,
1(2):203, 2002.
[349] Chin S, Teschendorff A, Marioni J, Wang Y, et al. High-resolution aCGH and expression profiling identifies a novel genomic
subtype of ER negative breast cancer. Genome Biol, 8(10):R215, 2007.
[350] Naderi A, Teschendorff A, Barbosa-Morais N, Pinder S, et al. A gene-expression signature to predict survival in breast cancer
across independent data sets. Oncogene, 26(10):1507, 2006.
[351] Zhang H, Rakha E, Ball G, Spiteri I, et al. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient
outcome in human breast cancer. Breast Cancer Res Treat, 121(1):41, 2010.
[352] Affymetrix. Affymetrix Microarray Suite User Guide, Version 5, 2001.
[353] Ihaka R and Gentleman R. R: A language for data analysis and graphics. J Comput Graph Stat, 5(3):299, 1996.
[354] Wu Z and Irizarry R. Stochastic Models Inspired by Hybridization Theory for Short Oligonucleotide Arrays. J Comput Biol,
12(6):882, 2005.
[355] Hastie T and Tibshirani R. Generalized Additive Models. Chapman & Hall/CRC, Monterey, CA, USA, 1990.
[356] Boulesteix A and Strimmer K. Partial least squares: a versatile tool for the analysis of high-dimensional genomic data. Brief
Bioinform, 8(1):32, 2007.
[357] Zhang C, Lu X, and Zhang X. Significance of gene ranking for classification of microarray samples. IEEE ACM Trans Comput
Biol Bioinform, 3(3):312, July 2006.
Bibliography 193
[358] Li W and Yang Y. How many genes are needed for a discriminant microarray data analysis? In Methods of Microarray Data
Analysis, pages 137–150. Kluwer Academic, Boston, USA, 2001.
[359] Wolfinger R, Gibson G, Wolfinger E, Bennett L, et al. Assessing Gene Significance from cDNA Microarray Expression Data
via Mixed Models. J Comput Biol, 8(6):625, 2001.
[360] Wold H. Soft modeling by latent variables: the nonlinear iterative partial least squares approach. In Perspectives in Probability
and Statistics, pages 117–142. 1975.
[361] Boulesteix A. PLS Dimension Reduction for Classification with Microarray Data. Stat Appl Genet Mol Biol, 3(1):33, 2004.
[362] de Jong S. SIMPLS: An alternative approach to partial least squares regression. Chemom Intell Lab Syst, 18:251, 1993.
[363] Wessels L, Reinders M, Hart A, Veenman C, et al. A protocol for building and evaluating predictors of disease state based on
microarray data. Bioinformatics, 21(19):3755, 2005.
[364] Guyon I, Gunn S, Ben-Hur A, and Dror G. Result analysis of the NIPS 2003 feature selection challenge. Adv Neural Inf
Process Syst, 17:545, 2005.
[365] Chen Y and Lin C. Combining SVMs with Various Feature Selection Strategies. Studies in fuzziness and soft computing,
207:315, 2006.
[366] Stout M, Bacardit J, Hirst J, and Krasnogor N. Prediction of Recursive Convex Hull Class Assignments for Protein Residues.
Bioinformatics, 24(7):916, 2008.
[367] Bacardit J and Krasnogor N. Fast Rule Representation for Continuous Attributes in Genetics-Based Machine Learning. In
Proceedings of the 10th Annual Conference on Genetic and Evolutionary Computation, pages 2039–2046. ACM Press, New
York, NY, USA, 2008.
[368] Bacardit J, Stout M, Hirst JD, Valencia A, et al. Automated alphabet reduction for protein datasets. BMC Bioinformatics,
10(1):6, 2009.
[369] Bacardit J, Burke E, and Krasnogor N. Improving the scalability of rule-based evolutionary learning. Memetic Computing,
1(1):55, 2009.
[370] Giraldez R, Aguilar-Ruiz J, and Riquelme J. Natural Coding: A more efficient representation for evolutionary learning. Lect
Notes Comput Sci GECCO, 2723:979, 2003.
[371] Venturini G. Sia: A supervised inductive algorithm with genetic search for learning attributes based concepts. In Proceedings
of the European Conference on Machine Learning, pages 280–296. Springer-Verlag, London, UK, 1993.
[372] Rivest R. Learning decision lists. Machine Learning, 2(3):229, 1987.
[373] Bacardit J. Pittsburgh Genetics-Based Machine Learning in the Data Mining era: Representations, generalization, and run-time.
Doctoral dissertation Ramon Llull University Barcelona Catalonia Spain, 2004.
[374] Rissanen J. A Universal Prior for Integers and Estimation by Minimum Description Length. Ann Stat, 11(2):416, 1983.
[375] De Jong KA and Spears WM. Learning concept classification rules using genetic algorithms. In In Proceedings of the Interna-
tional Joint Conference on Artificial Intelligence, pages 651–656. Morgan Kaufmann, 1991.
[376] Dimitriadou E, Hornik K, Leisch F, Meyer D, et al. Misc functions of the department of statistics (e1071), TU Wien, 2005.
R-Package e1071 version 1.5-19.
[377] Chang CC and Lin CJ. LIBSVM: a library for support vector machines, 2001. Software available at http://www.csie.ntu.
edu.tw/˜cjlin/libsvm.
[378] Furey T, Cristianini N, Duffy N, Bednarski D, et al. Support vector machine classification and validation of cancer tissue
samples using microarray expression data. Bioinformatics, 16(10):906, 2000.
[379] Hsu C, Chang C, and Lin C. A practical guide to support vector classification, 2008. http://www.csie.ntu.edu.tw/
˜cjlin/papers/guide/guide.pdf.
[380] Ambroise C and McLachlan G. Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl
Acad Sci USA, 99(10):6562, 2002.
[381] Bacardit J and Krasnogor N. BioHEL: Bioinformatics-oriented Hierarchical Evolutionary Learning, 2006. Nottingham eprints,
University of Nottingham.
[382] Liu J and Zhou H. Tumor classification based on gene microarray data and hybrid learning method. In Proc. Int. Conf. on
Machine Learning and Cybernetics, pages 2275–2280. 2003.
[383] Braga-Neto U and Dougherty E. Is cross-validation valid for small-sample microarray classification? Bioinformatics,
20(3):374, 2004.
[384] Goh L, Kasabov N, and Song Q. A novel feature selection method to improve classification of gene expression data. In Second
Asia-Pacific Bioinformatics Conference, pages 161–166. ACS, 2004.
[385] Lecocke M and Hess K. An empirical study of univariate and genetic algorithm-based feature selection in binary classification
with microarray data. Cancer Inform, 2:313, 2007.
[386] Hu Y and Kasabov N. Ontology-based framework for personalized diagnosis and prognosis of cancer based on gene expression
data. In M Ishikawa, K Doya, H Miyamoto, and T Yamakawa, editors, Neural Information Processing, pages 846–855.
Springer-Verlag Berlin, Heidelberg, 2008.
[387] Shen L and Tan E. Dimension Reduction-Based Penalized Logistic Regression for Cancer Classification Using Microarray
Data. IEEE ACM Trans Comput Biol Bioinformatics, 2(2):166, 2005.
Bibliography 194
[388] Paul T and Iba H. Extraction of informative genes from microarray data. In Proceedings of the 7th Annual Conference on
Genetic and Evolutionary Computation, pages 453–460. ACM Press, 2005.
[389] Chu W, Ghahramani Z, Falciani F, and Wild D. Biomarker discovery in microarray gene expression data with Gaussian
processes. Bioinformatics, 21(16):3385, 2005.
[390] Conover WJ. Practical Nonparametric Statistics. John Wiley, New York, NY, USA, 1971.
[391] Demsˇar J. Statistical Comparisons of Classifiers over Multiple Data Sets. J Mach Learn Res, 7:1, 2006.
[392] Alexe G et al. Breast cancer prognosis by combinatorial analysis of gene expression data. Breast Cancer Res, 8(4):R41, 2006.
[393] Dennis Jr G, Sherman B, Hosack D, Yang J, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery.
Genome Biol, 4(9):R60, 2003.
[394] Hu P, Greenwood C, and Beyene J. Integrating Affymetrix microarray data sets using probe-level test statistic for predicting
prostate cancer. In IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology, pages
63–70. 2006.
[395] Gerhold D, Jensen R, and Gullans S. Better therapeutics through microarrays. Nat Genet, 32(Suppl.):547, 2002.
[396] Belacel N, Cuperlovic-Culf M, and Ouellette R. Molecular method for diagnosis of prostate cancer, September 13 2006. US
Patent App. 11/519,892.
[397] Bolstad B, Irizarry R, Gautier L, and Wu Z. Pre-processing high-density oligonucleotide arrays. In R Gentleman, V Carey,
W Huber, R Irizarry, and S Dudoit, editors, Bioinformatics and Computational Biology Solutions Using R and Bioconductor,
pages 15–16. Springer-Verlag Berlin, Heidelberg, 2005.
[398] Bartenhagen C, Klein H, Ruckert C, Jiang X, et al. Comparative study of unsupervised dimension reduction techniques for the
visualization of microarray gene expression data. BMC Bioinformatics, 11(1):567, 2010.
[399] Matsumoto M and Nishimura T. Mersenne twister: a 623-dimensionally equidistributed uniform pseudo-random number
generator. ACM Transactions on Modeling and Computer Simulation, 8(1):3, 1998.
[400] Zervakis M, Blazadonakis M, Tsiliki G, Danilatou V, et al. Outcome prediction based on microarray analysis: a critical
perspective on methods. BMC Bioinformatics, 10(1):53, 2009.
[401] Irizarry R, Bolstad B, Collin F, Cope L, et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res,
31(4):e15, 2003.
[402] The MathWorks Inc., Natick, MA, USA. Matlab, 1998.
[403] Tarraga J, Medina I, Carbonell J, Huerta-Cepas J, et al. GEPAS, a web-based tool for microarray data analysis and interpretation.
Nucleic Acids Res, 31(13):3461, 2008.
[404] Kapushesky M, Kemmeren P, Culhane A, Durinck S, et al. Expression Profiler: next generation–an online platform for analysis
of microarray data. Nucleic Acids Res, 32(Web Server Issue):W465, 2004.
[405] Dı´az-Uriarte R, Alibe´s A, Morrissey E, Can˜ada A, et al. Asterias: integrated analysis of expression and aCGH data using an
open-source, web-based, parallelized software suite. Nucleic Acids Res, 35(Web Server issue):W75, 2007.
[406] Zhu Y, Zhu Y, and Xu W. EzArray: A web-based highly automated Affymetrix expression array data management and analysis
system. BMC Bioinformatics, 9(1):46, 2008.
[407] Rainer J, Sanchez-Cabo F, Stocker G, Sturn A, et al. CARMAweb: comprehensive R-and bioconductor-based web service for
microarray data analysis. Nucleic Acids Res, 34(Web Server issue):W498, 2006.
[408] Rehrauer H, Zoller S, and Schlapbach R. MAGMA: analysis of two-channel microarrays made easy. Nucleic Acids Res,
35(Web Server issue):W86, 2007.
[409] Hokamp K, Roche F, Acab M, Rousseau M, et al. ArrayPipe: a flexible processing pipeline for microarray data. Nucleic Acids
Res, 32(Web Server Issue):W457, 2004.
[410] Psarros M, Heber S, Sick M, Thoppae G, et al. RACE: remote analysis computation for gene expression data. Nucleic Acids
Res, 33(Web Server Issue):W638, 2005.
[411] Xia X, McClelland M, andWang Y. WebArray: an online platform for microarray data analysis. BMC Bioinformatics, 6(1):306,
2005.
[412] Romualdi C, Vitulo N, Favero M, and Lanfranchi G. MIDAW: a web tool for statistical analysis of microarray data. Nucleic
Acids Res, 33(Web Server Issue):W644, 2005.
[413] Wu C, Fu Y, Murali T, and Kasif S. Gene expression module discovery using Gibbs sampling. Genome Inform, 15(1):239,
2004.
[414] Lee J, Sinkovits R, Mock D, Rab E, et al. Components of the antigen processing and presentation pathway revealed by gene
expression microarray analysis following B cell antigen receptor (BCR) stimulation. BMC Bioinformatics, 7(1):237, 2006.
[415] Aburatani S, Goto K, Saito S, Toh H, et al. ASIAN: a web server for inferring a regulatory network framework from gene
expression profiles. Nucleic Acids Res, 33(Web Server Issue):W659, 2005.
[416] Lu Y, He X, and Zhong S. Cross-species microarray analysis with the OSCAR system suggests an INSR -> Pax6 -> NQO1
neuro-protective pathway in aging and Alzheimer’s disease. Nucleic Acids Res, 35(Web Server issue):W105, 2007.
[417] Shabalin A, Tjelmeland H, Fan C, Perou C, et al. Merging two gene-expression studies via cross-platform normalization.
Bioinformatics, 24(9):1154, 2008.
[418] Gentleman R, Carey V, Bates D, Bolstad B, et al. Bioconductor: open software development for computational biology and
bioinformatics. Genome Biol, 5(10):R80, 2004.
Bibliography 195
[419] Tusher V, Tibshirani R, and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl
Acad Sci USA, 98(9):5116, 2001.
[420] Armstrong S, Staunton J, Silverman L, Pieters R, et al. MLL translocations specify a distinct gene expression profile that
distinguishes a unique leukemia. Nat Genet, 30(1):41, 2001.
[421] Chipman H and Tibshirani R. Hybrid hierarchical clustering with applications to microarray data. Biostatistics, 7(2):286, 2006.
[422] Herrero J, Valencia A, and Dopazo J. A hierarchical unsupervised growing neural network for clustering gene expression
patterns. Bioinformatics, 17(2):126, 2001.
[423] Kirkpatrick S, Jr CG, and Vecchi M. Optimization by Simulated Annealing. Science, 220:671 , 1983.
[424] Szu H. Fast simulated annealing. In AIP Conference Proceedings, volume 151, page 420. 1986.
[425] de Vicente J, Lanchares J, and Hermida R. Placement by thermodynamic simulated annealing. Phys Lett A, 317(5-6):415,
2003.
[426] Ingber L. Simulated annealing: Practice versus theory. Math Comput Model, 18(11):29, 1993.
[427] Bacardit J, Stout M, Hirst J, and Krasnogor N. Data mining in proteomics with learning classifier systems. In L Bull,
E Bernado Mansilla, and J Holmes, editors, Learning Classifier Systems in Data Mining, pages 17–46. Springer-Verlag Berlin,
Heidelberg, 2008.
[428] Cohen J et al. A coefficient of agreement for nominal scales. Educ Psychol Meas, 20(1):37, 1960.
[429] Huberty CJ. Applied Discriminant Analysis. John Wiley, New York, NY, USA, 1994.
[430] Zhu Z, Ong Y, and Dash M. Markov blanket-embedded genetic algorithm for gene selection. Pattern Recognit, 40(11):3236,
2007.
[431] Fruchterman T and Reingold E. Graph drawing by force-directed placement. Software Practice and Experience, 21(11):1129,
1991.
[432] Schmuhl M. Graphopt, 2010. http://www.schmuhl.org/graphopt.
[433] Martin S. Drl, 2010. http://www.cs.sandia.gov/˜smartin/software.htm.
[434] Kamada T and Kawai S. An algorithm for drawing general undirected graphs. Information processing letters, 31(12):7, 1989.
[435] Shannon P, Markiel A, Ozier O, Baliga N, et al. Cytoscape: a software environment for integrated models of biomolecular
interaction networks. Genome Res, 13(11):2498, 2003.
[436] Martinez R, Pasquier C, and Pasquier N. GenMiner: Mining Informative Association Rules fromGenomic Data. In Proceedings
of the 2007 IEEE International Conference on Bioinformatics and Biomedicine, pages 15–22. 2007.
[437] Abatangelo L et al. Comparative study of gene set enrichment methods. BMC Bioinformatics, 10(1):275, 2009.
[438] Krallinger M et al. Linking genes to literature: text mining, information extraction, and retrieval applications for biology.
Genome Biol, 9(Suppl 2):S8, 2008.
[439] Snel B et al. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids
Res, 28(18):3442, 2000.
[440] Jenssen T et al. A literature network of human genes for high-throughput analysis of gene expression. Nat Genet, 28(1):21,
2001.
[441] Watts D and Strogatz S. Collective dynamics of ’small-world’ networks. Nature, 393(6684):440, 1998.
[442] Bonacich P and Lloyd P. Eigenvector-like measures of centrality for asymmetric relations. Social Networks, 23(3):191, 2001.
[443] Apweiler R, Attwood T, Bairoch A, Bateman A, et al. The InterPro database, an integrated documentation resource for protein
families, domains and functional sites. Nucleic Acids Res, 29(1):37, 2001.
[444] Jonsson P and Bates P. Global topological features of cancer proteins in the human interactome. Bioinformatics, 22(18):2291,
2006.
[445] Vogelstein B and Kinzler K. Cancer genes and the pathways they control. Nat Med, 10(8):789, 2004.
[446] Xenarios I et al. DIP: the database of interacting proteins. Nucleic Acids Res, 28(1):289, 2000.
[447] Bader G, Donaldson I, Wolting C, Ouellette B, et al. BIND–the biomolecular interaction network database. Nucleic Acids Res,
29(1):242, 2001.
[448] Peri S et al. Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res, 32(Database
Issue):D497, 2004.
[449] Olmea O, Rost B, and Valencia A. Effective use of sequence correlation and conservation in fold recognition. J Mol Biol,
293(5):1221, 1999.
[450] Baserga R, Peruzzi F, and Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer, 107(6):873, 2003.
[451] Haluska P, Carboni J, Loegering D, Lee F, et al. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-
I/insulin receptor inhibitor, BMS-554417. Cancer Res, 66(1):362, 2006.
[452] Houldsworth J, Mathew S, Rao P, Dyomina K, et al. REL proto-oncogene is frequently amplified in extranodal diffuse large
cell lymphoma. Blood, 87(1):25, 1996.
[453] Pico A, Kelder T, Van Iersel M, Hanspers K, et al. WikiPathways: pathway editing for the people. PLoS Biol, 6(7), 2008.
[454] Life Technologies. Invitrogen iPath, 2011. http://escience.invitrogen.com/ipath.
Bibliography 196
[455] Natarajan M, Lin K, Hsueh R, Sternweis P, et al. A global analysis of cross-talk in a mammalian cellular signalling network.
Nat Cell Biol, 8(6):571, 2006.
[456] Kelley R and Ideker T. Systematic interpretation of genetic interactions using protein networks. Nat Biotechnol, 23(5):561,
2005.
[457] Ulitsky I and Shamir R. Pathway redundancy and protein essentiality revealed in the Saccharomyces cerevisiae interaction
networks. Mol Syst Biol, 3(1), 2007.
[458] Ma X, Tarone A, and Li W. Mapping genetically compensatory pathways from synthetic lethal interactions in yeast. PLoS
ONE, 3(4):e1922, 2008.
[459] Brady A, Maxwell K, Daniels N, and Cowen L. Fault tolerance in protein interaction networks: Stable bipartite subgraphs and
redundant pathways. PLoS ONE, 4(4):e5364, 2009.
[460] Cerami E, Demir E, Schultz N, Taylor BS, et al. Automated network analysis identifies core pathways in glioblastoma. PLoS
ONE, 5(2):e8918, 2010.
[461] Nitsch D, Tranchevent L, Thienpont B, Thorrez L, et al. Network analysis of differential expression for the identification of
disease-causing genes. PLoS ONE, 4(5):e5526, 2009.
[462] Aerts S, Lambrechts D, Maity S, Van Loo P, et al. Gene prioritization through genomic data fusion. Nat Biotechnol, 24(5):537,
2006.
[463] Limviphuvadh V, Tanaka S, Goto S, Ueda K, et al. The commonality of protein interaction networks determined in neurode-
generative disorders (NDDs). Bioinformatics, 23(16):2129, 2007.
[464] Yu W, Clyne M, Khoury M, and Gwinn M. Phenopedia and Genopedia: disease-centered and gene-centered views of the
evolving knowledge of human genetic associations. Bioinformatics, 26(1):145, 2010.
[465] Ravetti M and Moscato P. Identification of a 5-protein biomarker molecular signature for predicting Alzheimer’s disease. PLoS
ONE, 3(9):e3111, 2008.
[466] Moscato P, Berretta R, Hourani M, Mendes A, et al. Genes related with alzheimers disease: A comparison of evolutionary
search, statistical and integer programming approaches. In F Rothlauf, J Branke, S Cagnoni, DW Corne, R Drechsler, Y Jin,
P Machado, E Marchiori, J Romero, GD Smith, and G Squillero, editors, Applications on Evolutionary Computing, volume
3449 of Lect. Notes Comput. Sci., pages 84–94. Springer-Verlag Berlin, Heidelberg, 2005.
[467] Moscato P, Gomez-Ravetti M, Rosso O, and Berretta R. Towards a multimarker molecular signature that identifies biomarkers
that correlated with cognitive decline in Alzheimer’s disease: The entropic perspective. Alzheimers and Dementia, 6(4):S530,
2010.
[468] Zheng H, Wei D, Zhang R, Wang C, et al. Screening for New Agonists Against Alzheimers Disease. Med Chem, 3(5):488,
2007.
[469] Wood L, Parsons D, Jones S, Lin J, et al. The Genomic Landscapes of Human Breast and colorectal Cancers. Science,
318(5853):1108, 2007.
[470] Jones S, Zhang X, Parsons D, Lin J, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic
analyses. Science, 321(5897):1801, 2008.
[471] Parsons D, Jones S, Zhang X, Lin J, et al. An integrated genomic analysis of human glioblastoma multiforme. Science,
321(5897):1807, 2008.
[472] Cheng H, Gao Q, Jiang M, Ma Y, et al. Molecular cloning and characterization of a novel human protein phosphatase, LMW-
DSP3. Int J Biochem Cell Biol, 35(2):226, 2003.
[473] Melhuish T, Gallo C, and Wotton D. TGIF2 interacts with histone deacetylase 1 and represses transcription. J Biol Chem,
276(34):32109, 2001.
[474] Guo Y, Hastie T, and Tibshirani R. Regularized linear discriminant analysis and its application in microarrays. Biostatistics,
8(1):86, 2007.
[475] Alexe G et al. Breast cancer prognosis by combinatorial analysis of gene expression data. Breast Cancer Res, 8(4):R41, 2006.
[476] Subramanian A et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA, 102(43):15545, 2005.
[477] Efron B and Tibshirani R. On testing the significance of sets of genes. Ann Appl Stat, 1(1):107, 2007.
[478] Goeman J et al. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics, 20(1):93, 2004.
[479] Jirapech-Umpai T and Aitken S. Feature selection and classification for microarray data analysis: Evolutionary methods for
identifying predictive genes. BMC Bioinformatics, 6(1):148, 2005.
[480] Stattin P and Kaaks R. Prostate cancer, insulin, and androgen deprivation therapy. Br J Cancer, 89(9):1814, 2003.
[481] Hsing A et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst,
93(10):783, 2001.
[482] Qiang Y, Endo Y, Rubin J, and Rudikoff S. Wnt signaling in B-cell neoplasia. Oncogene, 22(10):1536, 2003.
[483] Lustig B and Behrens J. The Wnt signaling pathway and its role in tumour development. J Cancer Res Clin Oncol, 129(4):199,
2003.
[484] Lin W, Hsueh H, and Chen J. Power and sample size estimation in microarray studies. BMC Bioinformatics, 11(1):48, 2010.
[485] Churchill G. Fundamentals of experimental design for cDNA microarrays. Nat Genet, 32:490, 2002.
Bibliography 197
[486] Van Hulse J, Khoshgoftaar T, Napolitano A, and Wald R. Feature Selection with High-Dimensional Imbalanced Data. In IEEE
International Conference on Data Mining Workshops, pages 507–514. 2009.
[487] Obajimi O, Keen J, and Melera P. Inhibition of de novo purine synthesis in human prostate cells results in ATP depletion,
AMPK activation and induces senescence. Prostate, 69(11):1206, 2009.
[488] Adler D and Murdoch D. rgl: 3D Visualization Device System (OpenGL), 2010. R package version 0.91.
[489] Feng D and Tierney L. misc3d: Miscellaneous 3D Plots, 2010. R package version 0.7-0.
[490] Feng D and Tierney L. Computing and Displaying Isosurfaces in R. J Stat Software, 28(1):1, 2008.
[491] Sarkar D. lattice: Multivariate Data Visualization with R. Springer Verlag, New York, NY, USA, 2008.
[492] Sarkar D. lattice: Lattice Graphics, 2010. R package version 0.18-8.
[493] Ligges U and Maechler M. scatterplot3d: 3D Scatter Plot, 2010. R package version 0.3-30.
[494] Ligges U and Maechler M. scatterplot3d – an r package for visualizing multivariate data. J Stat Soft, 8(11):1, 2003.
[495] Marchini JL, Heaton C, and Ripley BD. fastICA: FastICA Algorithms to Perform ICA and Projection Pursuit, 2010. R package
version 1.1-11.
[496] Blackhall F, Pintilie M, Wigle D, Jurisica I, et al. Stability and heterogeneity of expression profiles in lung cancer specimens
harvested following surgical resection. Neoplasia, 6(6):761, 2004.
[497] Rouzier R, Perou C, Symmans W, Ibrahim N, et al. Breast cancer molecular subtypes respond differently to preoperative
chemotherapy. Clin Cancer Res, 11(16):5678, 2005.
[498] Perou C, Sørlie T, Eisen M, van de Rijn M, et al. Molecular portraits of human breast tumours. Nature, 406(6797):747, 2000.
[499] Sørlie T, Perou C, Tibshirani R, Aas T, et al. Gene expression patterns of breast carcinomas distinguish tumour subclasses with
clinical implications. Proc Natl Acad Sci USA, 98(19):10869, 2001.
[500] Sørlie T, Tibshirani R, Parker J, Hastie T, et al. Repeated observation of breast tumour subtypes in independent gene expression
data sets. Proc Natl Acad Sci USA, 100(14):8418, 2003.
[501] Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, et al. Gene expression profiling identifies molecular subtypes of inflam-
matory breast cancer. Cancer Res, 65(6):2170, 2005.
[502] Lønning P. Tailored targeted therapy for all: a realistic and worthwhile objective? Breast Cancer Res, 11(Suppl 3):S7, 2009.
[503] Longo R, Torino F, and Gasparini G. Targeted therapy of breast cancer. Curr Pharm Des, 13(5):497, 2007.
[504] Nielsen T, Hsu F, Jensen K, Cheang M, et al. Immunohistochemical and clinical characterization of the basal-like subtype of
invasive breast carcinoma. Clin Cancer Res, 10(16):5367, 2004.
[505] Finlin B, Gau C, Murphy G, Shao H, et al. RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in
breast cancer. J Biol Chem, 276(45):42259, 2001.
[506] Habashy H, Powe D, Rakha E, Ball G, et al. Forkhead-box a1 (foxa1) expression in breast cancer and its prognostic significance.
European Journal of Cancer, 44(11):1541, 2008.
[507] Abd El-Rehim D, Ball G, Pinder S, Rakha E, et al. High-throughput protein expression analysis using tissue microarray
technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cdna
expression analyses. International journal of cancer, 116(3):340, 2005.
[508] McCarty Jr K, Miller L, Cox E, Konrath J, et al. Estrogen receptor analyses: correction of biochemical and immunohistochem-
ical methods using monoclonal antireceptor antibodies. Archives of pathology laboratory medicine, 109(8):716, 1985.
[509] Shu J, Jelinek J, Chang H, Shen L, et al. Silencing of bidirectional promoters by DNA methylation in tumourigenesis. Cancer
Res, 66(10):5077, 2006.
[510] Li H, Myeroff L, Smiraglia D, Romero M, et al. SLC5A8, a sodium transporter, is a tumour suppressor gene silenced by
methylation in human colon aberrant crypt foci and cancers. Proc Natl Acad Sci USA, 100(14):8412, 2003.
[511] Toyota M, Ho C, Ohe-Toyota M, Baylin S, et al. Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant
methylation of its 5’ CpG island in human tumours. Cancer Res, 59(18):4535, 1999.
[512] Markowitz S and Bertagnolli M. Molecular basis of colorectal cancer. N Engl J Med, 361(25):2449, 2009.
[513] Wolpert D. The lack of a priori distinctions between learning algorithms. Neural Comput, 8(7):1341, 1996.
[514] Al-Shahrour F, Diaz-Uriarte R, and Dopazo J. Fatigo: a web tool for finding significant associations of gene ontology terms
with groups of genes. Bioinformatics, 20(4):578, 2004.
[515] Goh K, Cusick M, Valle D, Childs B, et al. The human disease network. Proc Natl Acad Sci USA, 104(21):8685, 2007.
[516] Sill J, Takacs G, Mackey L, and Lin D. Feature-Weighted Linear Stacking. Arxiv preprint arXiv09110460, 2009.
[517] Bachmann K. Genotyping and phenotyping the cytochrome p-450 enzymes. Am J Ther, 9(4):309, 2002.
[518] Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. In International Joint
Conference on Artificial Intelligence, volume 14, pages 1137–1145. Citeseer, 1995.
[519] Shaffer J. Multiple hypothesis testing. Annu Rev Psychol, 46(1):561, 1995.
[520] Cardoso J. Infomax and maximum likelihood for blind source separation. IEEE Signal Process Lett, 4(4):112, 2002.
Appendix
11.1 Glossary
All terms in the glossary appear underlined when they first occur in the thesis.
11.1.1 Biological terminology
• Gene: A gene is a stretch of DNA encoding functional biomolecules and corresponding to a unit of
heredity in living organisms.
• Allele: An allele is an alternative form of a gene occupying a given position on a specific chromosome.
Individuals inherit two alleles for each gene, one from each parent.
• Genotype/phenotype: The genotype is an organism’s full gene-based hereditary information (exclud-
ing only epigenetic information, see below). The phenotype corresponds to the observable properties
of an organism, i.e. the expressed hereditary information resulting in a specific morphology, devel-
opment or behaviour.
• Autosomes/gonosomes: Sex-linked chromosomes are called gonosomes, whereas all other chromo-
somes are called autosomes. In the human species the gonosomes are the chromosomes X and Y.
• Genome: The genome is the entirety of an organism’s hereditary information that is encoded in DNA
or in RNA for some viruses. It includes both genetic and non-coding nucleotide sequences, but does
not include epigenetic information (see Epigenome below).
• Epigenome: The epigenome is the entirety of an organism’s hereditary information encoded by other
structures than genomic DNA and RNA sequences. Epigenetic inheritance mechanisms include DNA
methylation and chromatin remodelling (e.g. histone acetylation/de-acetylation), RNA signalling and
certain transcription factor activity.
• Transcriptome: The transcriptome is the entirety of all RNA molecules (transcribed from the genes
in a genome) in a certain cell type under well-defined conditions. In contrast to the genome, which is
mostly static for a given cell line, the transcriptome can change in response to alterations in environ-
mental conditions.
• Proteome/Metabolome: The proteome/metabolome is the entirety of proteins/metabolites in a given
cell type under well-defined conditions. Similar to the transcriptome, the proteome/metabolome can
vary in response to changes in environmental conditions.
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• Functional Genomics: Functional genomics is a discipline studying the large-scale, genome-wide ex-
perimental data obtained from genomics and proteomics projects to investigate gene/protein functions
and interactions. In contrast to genomics and proteomics, functional genomics focuses on dynamic
functions and processes like transcription, translation, protein-protein interactions, rather than the
mostly static genome or a static fingerprint of a proteome under well-defined environmental condi-
tions.
• Biomarker: A biomarker (or biological marker) is a biological substance or process used as an indi-
cator of a biological state. The most common examples are disease- and drug-related biomarkers, for
the monitoring, diagnosis and prognosis of disease conditions and drug effects.
• Polymerase-chain reaction (PCR): The PCR is an experimental technique in molecular biology to
amplify DNA fragments by several order magnitudes, generating exact copies of the original tem-
plate DNA. The procedure consists of the repeated application of three different temperature changes
(cycles), including a denaturation step (separating the double-stranded template DNA into single
strands), an annealing step (attaching small primer fragments to the single strands) and an exten-
sion/elongation step (synthesising a new DNA strand using the primer, the single-stranded template
and heat-resistant DNA polymerase enzymes).
• qPCR: The quantitative real-time PCR (also Q-PCR, qrt-PCR) is an extension of the PCR method,
which does not only amplify the target DNA, but also quantifies its original abundance. The quan-
tification is achieved by measuring the amount of fluorescence emitted when scanning fluorescent
dyes which intercalate with the double-stranded template DNA and become detectable after a cer-
tain replication cycle. The quantification is typically more precise in comparison to high-throughput
quantification methods (seeMicroarray below), and enables both relative and absolute quantification
of the original nucleic acid abundances for different samples.
• Microarray: A microarray is a miniaturized chip which allows experimenters to make thousands of
biomolecular measurements in parallel using only a small amount of probe material. Depending on
the type of the probe material, microarrays can be employed for different purposes, e.g. transcrip-
tomics (DNA microarray) or proteomics (Protein microarray) data analysis. In this thesis, the term
“microarray” will mostly be used to refer to DNA gene expression microarrays, rather than SNP
arrays (see below) and protein arrays (the latter will always by referred to by the full name).
• SNP, “snips”: Single-nucleotide polymorphisms (SNPs) are DNA sequence variations affecting a
single nucleotide in a genome, but occurring more frequently in a population than mutations (as a
rule of thumb, if the frequency of occurrence of the variant is greater than 1%, and there are at least
two variants, the variant is considered as a polymorphism and not as a mutation [517]).
• Target DNA/probe DNA: On a DNA microarray, the probe DNA corresponds to fragments of DNA
which are immobilised on the chip surface and typically represent genes from single species’ genome.
The target DNA corresponds to the nucleic acid sequences in the biological samples to be analysed,
which are labelled with a fluorescent dye, and hybridised with the probe DNA on the chip to measure
the relative abundance of corresponding fragments within the target DNA using a laser scanner and a
CCD chip detector.
• Probe replicates: On a DNA microarray, the probe DNA representing a specific gene does typically
not only occur once on the chip, but multiple times, to obtain a more accurate quantification of
transcript abundance in a biological sample by summarising the measurements for all replicates.
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• Homology: Homologous traits are inherited characteristics of organisms derived from a common
ancestor, i.e. resulting from a divergent evolutionary process as opposed to analogous traits corre-
sponding to similarities between organisms resulting from convergent evolution. Homology can be
analysed using bioinformatics methods to detect significant similarities in DNA or protein sequences
(typically employing sequence alignment and hierarchical clustering techniques).
• Orthology/paralogy: Homologous sequences are orthologous if they were separated by a speciation
into two separate species (sequences with similar function, but occurring in different organisms).
Vice-versa, sequences are paralogous if they were separated by a gene duplication event (homologous
sequences with different functions, but occurring in the same organism).
• Yeast-2-Hybrid (Y2H): Y2H is a molecular biology screening methodology to discover protein-pro-
tein and protein-DNA interactions by testing for direct physical interactions between the correspond-
ing molecules. The idea behind the method is to fuse one of the proteins to be tested with the
activating domain (AD) of a transcription factor (TF) and the other with the corresponding binding
domain (BD), and since these domains work in a modular fashion, an interaction of the target proteins
is likely to activate the transcription of a reporter gene by bringing these TF domains close together.
In the case of a protein-DNA interaction (also called One-Hybrid), a single fusion protein is used,
in which the AD is directly linked to the BD. Importantly, the Y2H method is error-prone, and can
provide both false positive and false negative results.
• Tandem affinity purification (TAP): TAP is an alternative technique for identifying protein-protein
interactions (PPIs) and protein complexes. A fusion protein with a designed end tag, the TAP tag,
is created, so that it binds to beads coated with Immunoglobin G (IgG) antibody molecules. This
enables the extraction of this protein in combination with its binding partners using a washing proce-
dure with two affinity columns. The binding partners can then be identified using other experimental
techniques, e.g. mass spectrometry or SDS-PAGE. Importantly, since proteins might also bind indi-
rectly to the target protein, e.g. by only binding to one of its binding partners, TAP can only identify
indirect PPIs and protein complexes, but not direct binary interactions like Y2H. Moreover, adding a
tag to a protein might also negatively affect the binding of some potential interaction partners, hence,
this method is also error-prone.
11.1.2 Statistical terminology
• Classification and regression: Classification techniques in statistics are methods that predict categor-
ical, nominal outputs (class labels) for an observation, and regression techniques are methods that
predict numerical, continuous-valued outputs. Depending on whether the predictions are made using
training data with known or unknown outputs, these approaches are also called supervised (data with
known outputs), semi-supervised (both data with known and unknown outputs) or unsupervised (data
with unknown outputs) classification and regression methods.
• sensitivity/specificity: In the result of a binary classification, the sensitivity is the proportion of pos-
itively labelled samples which are correctly identified (sensitivity = true positives / (true positives +
false negatives)), and the specificity is the proportion of correctly identified negative samples (speci-
ficity = true negatives / (true negatives + false positives)).
• Receiver Operating Characteristic (ROC): The ROC curve is a plot of the true positive rate (= sensi-
tivity) against the false positive rate (= 1 - specificity) of a binary classification model with varying
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discrimination threshold applied to a test dataset with known class labels. This plot assists the exper-
imenter in comparing the performance of different classification methods and in choosing a suitable
discrimination threshold to obtain a good balance between sensitivity and specificity. Moreover, the
area under the ROC curve (AUROC) is a frequently used performance measure for machine learn-
ing methods, and in contrast to the average classification accuracy, it accounts for biased predictions
resulting from class imbalances in the training data.
• “Type 1” and “type 2” errors: In statistical hypothesis testing and binary classification models two
types of errors can be made. Type 1 errors are false positives or incorrect rejections of a null hy-
pothesis, whereas type 2 errors are false negatives or failed rejections of a null hypothesis that is
false.
• P-value: The p-value in statistical significance testing is the probability of obtaining a value for a test
statistic which is at least as extreme as the actually observed value, assuming that the null hypothesis
is true (i.e. the probability for observing the value or a more extreme value by chance and not because
the null hypothesis is false). The lower the p-value, the less likely is the observed value if the null
hypothesis is true, and therefore the more significant the observation is.
• Cross-validation (CV): Cross-validation is a statistical method to evaluate the performance of a pre-
dictive model on training data, by partitioning the samples in the data into n approx. equal-sized
subsets and using each combination of n− 1 subsets to train a predictive model, which is then eval-
uated on the left-out subset. The average accuracy or average area under the ROC curve across
all cross-validation cycles provides nearly unbiased performance estimates [518], which tends to be
closer to the performances obtained on large external test sets than the often overly optimistic perfor-
mance estimates obtained when applying the model on the training data (training accuracy or training
AUROC). If n is equal to the total number of samples, the method is also called leave-one-out CV, or
LOOCV.
• Data fusion: Data fusion techniques are approaches which combine data from different sources,
while at the same time reducing the total amount of data, e.g. by removing redundant information,
exploiting synergies and replacing low-confidence data with high-confidence data (in contrast to the
more general term data integration, which also refers to integrative methods without a reduction
step). The assumption behind data fusion is that the individual input data sources contain incomplete
but complementary information, so that some of the information gaps in the single data sources can
be filled by aggregating the information from all inputs.
• False-discovery rate (FDR), q-value: The FDR is the expected proportion of false discoveries (type 1
errors) among all statistically significant hypotheses identified by a hypothesis test. It is used to adjust
a hypothesis test in a multiple testing scenario. Given a number of false positives # f p and a number
of all positives #ap, the FDR can be written as: FDR = E[# f p/#ap]. The q-value for a specific
hypothesis test is the minimum FDR threshold at which the test would be regarded as significant.
• Familywise error rate (FWER): The FWER is the probability of making one or more false discoveries
(type 1 errors) among all hypotheses in a multiple testing scenario. Given a number of false positives
# f p, the FWER can be written as: FWER = Pr(# f p > 0) = 1−Pr(# f p = 0). Like the FDR, the
FWER is used to adjust hypothesis tests for multiple comparisons, and has a stronger control of type
1 errors, but less statistical power than the FDR method [519]. FWER methods tend to be more
conservative than FDR approaches, because the FDR can be rewritten as: FDR= E[# f p/#ap|# f p>
0]Pr(# f p > 0) = E[# f p/#ap|# f p > 0] ·FWER, and given that # f p/#ap <= 1 it follows that FDR
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• Bagging: Bagging or “bootstrap aggregating” is a special model averaging and ensemble technique in
machine learning to improve classification and regression models in terms of accuracy and robustness.
Given a training dataset with n samples, bagging generatesm new training datasets of size n′<= n, by
sampling uniformly from the original data with replacement (generating so-called bootstrap samples).
Finally, m machine learning models are fitted using the bootstrap samples and their prediction results
are combined using averaging (for regression) or majority voting (for classification).
• Boosting: Boosting is a further model averaging and ensemble technique in machine learning to im-
prove classification and regression models by combining weak learning algorithms (classifying sam-
ples only slightly better than a random classifier) into a more robust and accurate ensemble model.
There are many specific boosting algorithms, but most of them iteratively add weighted weak learn-
ers to an additive ensemble model, where the weight depends on the weak learners accuracy in the
classification of weighted samples (the sample weights typically increase for samples that were mis-
classified in previous iterations of the algorithm, to force future learners to improve the classification
for these samples). Examples for boosting algorithms are AdaBoost [297], LogitBoost [298] and
Linear Programming Boosting (LPBoost) [299], among others.
• Principal Component Analysis (PCA): PCA is a dimensionality reduction and orthogonal data trans-
formation method used to convert a set of potentially correlated variables into a (smaller or equal-
sized) set of uncorrelated, derived variables termed “principal components” (PCs). The PCs corre-
spond to the eigenvectors of the data covariance matrix and can therefore be computed by the eigen-
value decomposition of the covariance matrix, or alternatively, using singular value decomposition
(SVD) of the original data matrix. The PCA decomposition has the special property, that the first PC
and every succeeding PC covers as much of the data variance as possible, so that low-dimensional
representations can cover a large degree of the variance (and thus a large degree of the information
content) in the data, in spite of a potentially very high original dimensionality of the data.
• Independent Component Analysis (ICA): ICA is a dimensionality reduction and data transformation
method used to convert a multivariate signal into additive components, assuming that the original
signal consists of a mixture of mutually independent non-Gaussian source signals (the independent
components). To identify the independent components, the statistical independence of the estimated
components is maximised, and ICA algorithms for this purpose differ mainly in the definition of inde-
pendence, e.g. minimising the mutual information between the components, or maximising the non-
Gaussianity of the components (whose mixture is assumed to have become more Gaussian according
to the central limit theorem). Popular algorithms for ICA include fastICA [495] and infomax [520]
among others.
• Expectation maximisation (EM) algorithm: The EM algorithm is an iterative approach for finding
maximum likelihood estimates for parameters in statistical models which depend on unobserved la-
tent variables. The generic algorithm iteratively repeats two steps: An expectation step (E-step),
which computes the expectation of the log-likelihood given current estimates for the latent vari-
ables, and a maximisation step (M-step), which computes parameters maximising the expected log-
likelihood found on the E-step (initially, the parameters are often set to random values). Next, these
parameter estimates are used to determine the distribution of the latent variables in the following
E-step, and the procedure continues until the parameter estimates converge.
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Figure 11.1: Example flowchart illustrating combinations of analysis modules within the web-application ArrayMin-
ing. Data from two microarray studies is combined using cross-study normalisation (output: density plot), gene sets
representing cellular pathways are extracted (output: box plots for differentially regulated gene sets), the pathway ex-
pression matrix is clustered (output: low-dimensional cluster representations) and a network of co-expressed pathway
expression fingerprints is computed (output: network visualisation).
Figure 11.2: Example flowchart illustrating a cross-domain combination between modules from ArrayMining and
TopoGSA. Differentially expressed genes from a microarray study are identified using the ArrayMining Gene Selection
Analysis module (output: heat map of differentially expressed genes) and mapped to a protein-protein interaction (PPI)
network for a network topological analysis with TopoGSA, revealing outstanding topological properties of single genes
(output: Individual Gene Set Analysis plot) and similarities between the selected genes and known gene sets from
functional annotation databases (output: Comparative Gene Set Analysis plot).
Figure 11.3: Example flowchart illustrating a cross-domain modular combination between PathExpand, EnrichNet and
the Top-scoring pathway pairs method (TSPP). Protein interaction data and cellular pathway data is used by PathExpand
to create extended pathways with compact network representations (output: new pathways), which are investigated for
functional associations with known and experimentally derived gene sets using EnrichNet (output: similarity ranking
and network visualisations) and used for sample classification within TSPP (output: classification model and network
representations).
